











This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
• This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
• A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
• This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
• The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
• When referring to this work, full bibliographic details including the author, title, 














Lauren Michelle Webb 
 
 
A thesis submitted for the degree of Doctor of Philosophy 












I, the undersigned, hereby declare that the contents of this thesis have been 






































Andrew, thank you for your endless optimism and excitement about science, it has been 
invaluable to me throughout my PhD. Thank you for your unerring support (& recipes!). I 
am looking forward to lots more scientific adventures in the MacDonald lab in the future.     
 
Thank you to all the lovely members of the MacDonald lab: Rach, Alex, Pete, Lucy, Angela 
and Gareth, for all your help throughout. You have always been a great source of advice 
and ideas… And hilarity! I couldn’t have done it without you. 
 
Thank you to all the amazing people of IIIR, who make the department such an awesome 
place to do science. Thanks Martin for all your sorting & FACS-wizardry. Thanks to the 
guys in Glasgow – Simon, Steph & Vuk - for patiently attempting to turn me into a surgeon.  
 
To all the lovely friends I have made on the PhD adventure. The L’s – Lucy & Lisa – I miss 
you guys! Luce, I will miss having you in the corner of the office, dispensing wisdom & 
cake. Come visit soon! Reynolds, I look forward to many more adventures (and probably 
mishaps!) in the future. And crisp & coke breaks, lots of those please! Kara, I can’t believe 
you’ll soon be flying off to the other side of the world! Please can we pack in as much 
dancing, cocktails and cultural activities as possible before you go! Not forgetting J-dog, 
Stevo, Henners, Dom, Jess & Helen, excellent drinking companions these past few years! 
 
James, I have to say a massive thank you to you for your awesome editing skills, you have 
certainly made this tome more readable! I count myself lucky to have a friend who is 
almost as grumpy and neurotic as I am (!), but also an amazing scientist, with great ideas 
and insights, which makes you the perfect dining and drinking companion. Riggers, you 
have been an endless source of entertainment and positivity, thank you for all the baked 
goods, the G&Ts, the motivational speeches and the A-mazing roast dinners!  And now, at 
last, we are “immortalised forever together in PubMed”!  
 
Thanks to all my friends & family outside the science bubble, for supplying some light 
relief. Finally, thank you so much to my parents for all your love and support. I promise I’ll 
leave you in peace soon!  
 3!
EXPERIMENTAL CONTRIBUTIONS 
The FLDC project was developed in collaboration with Dr Rachel Lundie. Rachel 
performed the FLDC sorting and CD205-deficient FLDC experiments in chapter 3, as well 
as the gene expression analysis of S. mansoni infected livers in chapter 5.  
 
The TLR3 reporter experiments were performed by members of Dr Hermelijn Smits 
laboratory in LUMC, Leiden, the Netherlands.  
 
Dr Jess Borger undertook the confocal microscopy involved in the dsRed experiments 
detailed in chapter 4.  
 
Dr Rachel Lundie, Dr Lucy Jones, Dr Alex Phythian-Adams, Dr Peter Cook, Angela Marley 
and Professor Andrew MacDonald provided technical assistance in FLDC adoptive 
transfer experiments detailed in chapter 4, and in S. mansoni infection experiments in 
chapters 5 and 6.  
 
The H. polygyrus experiments in chapter 5 were performed in collaboration with Dr James 
Hewitson. James also provided invaluable technical assistance during the intravenous Ag 
challenge experiments detailed in chapter 5.  
 
Dr Bart Everts (University of Washington, St. Louis, USA) prepared the human DC 
samples for analysis in chapter 5. 
 
Professor David Dunne at the University of Cambridge kindly provided human serum 
samples from a study cohort in Kenya. 
 
Dr Lucy Jones, Dr James Hewitson and Gareth-Rhys Jones provided technical assistance 
for LP tissue preparations in chapter 6.  
 
The subserosal egg injection model was developed in collaboration with Dr Simon Milling 
and members of his lab at the University of Glasgow. Stephanie Houston provided 
invaluable training and technical support in the surgical experiments.    
LAY SUMMARY 
 
Dendritic cells (DCs) play a critical role in the immune system, recognising invading 
pathogens and activating other cells that can fight off the attack. One such invader 
is the parasitic worm Schistosoma mansoni, which afflicts millions of people in the 
tropics. Adult worms, once inside the host, reside within the blood system, where 
female worms lay hundreds of eggs a day. Surprisingly, the adult worms remain 
largely invisible to the immune system – it is the eggs that activate a strong 
response. Parasite eggs must pass through the wall of the intestine to escape the 
host, but very few make it that far, with the majority being swept by blood flow into 
the liver or getting stuck in intestinal tissue. This causes lots of damage to the 
intestine and the liver. In an attempt to control this damage, immune cells form a 
wall around the eggs, protecting other cells from the secretions they release. DCs 
are crucial to stimulating the response against S. mansoni eggs. In order to 
understand how DCs can do this, we have studied how they respond to molecules 
that make up the parasite eggs, and have identified signals that are essential for 
optimal DC function. We have also investigated whether these signals are required 
when DCs interact with and activate other immune cells. However, there is not just 
one type of DC, but many different subsets within the different tissues in the body. 
As well as using cells grown in culture, we have studied the responses of DC 
subsets in the spleen, lymph nodes and the intestine following injection of parasite 
eggs, but also the characteristics of different DCs during active infection. A greater 
understanding of these cells and the different roles they play in immune activation 
against S. mansoni is essential for the development of therapies that could help to 
augment or alter the immune response during worm infection. Not only that, this 
knowledge also helps us to understand what is happening when the immune 




Dendritic cells (DCs) play an essential role in bridging the innate and adaptive immune 
system, activating T cell responses against invading pathogens. It has been shown 
definitively that DCs fulfil the vital role of activating Th2 responses in the liver and spleen 
during infection with the parasitic helminth Schistosoma mansoni. However, DCs are an 
incredibly heterogeneous cell type, with diverse subsets displaying different phenotypes 
and functions in specific tissues in the body. Moreover, relatively little is known about how 
DCs become activated and stimulate T cells in response to Th2-associated parasitic 
helminths. This thesis addresses how distinct DC subsets function in response to 
schistosomes, both in vitro and in vivo.  
 
The primary DC differentiation factor, Flt3-L, generates DC subsets in vitro that are 
analogous to the subsets resident in the lymphoid organs in the steady-state: CD24+ 
conventional DCs (cDCs, CD8α+ equivalents), CD11b+ cDCs and plasmacytoid DCs 
(pDCs). These different DC subsets displayed distinct responses to the strongly Th2-
polarising soluble egg antigens (SEA) from S. mansoni. pDCs are unlikely to play a role in 
priming the Th2 response against SEA, although pDCs upregulated surface expression of 
MHC II and co-stimulatory molecules, these markers were expressed only at very low-
levels, and pDCs failed to migrate to the draining lymph node (dLN) following adoptive 
transfer. In contrast, cDCs migrated efficiently to the T cell zone of the dLN. CD11b+ and 
CD24+ cDCs also significantly upregulated expression of the surface markers associated 
with T cell priming in response to SEA, however, this was a muted surface phenotype 
when compared to the classical activation elicited by a bacterial stimulus.  
 
The DC subsets produced very little cytokine in response to SEA stimulation, with the 
exception of Type I Interferons (IFN-I), which were uniquely secreted by CD24+ cDCs. The 
Toll-like receptor (TLR) adaptor proteins, TRIF and MyD88, were revealed to have 
contrasting roles in the control of SEA-specific IFN-I production. TRIF was essential for 
this response, whilst MyD88 acted as a negative regulator. TLRs are not the only 
receptors involved in this response however, as the C-type lectin CD205 was also required 
for optimal IFN-I production by SEA-stimulated cells.  
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IFN-I proved critical to the ability of Flt3L-generated cDCs (FL-cDCs) to polarise responses 
following adoptive transfer, as IFN-I receptor-deficient (Ifnar1-/-) cells failed to prime an 
SEA-specific Th2 response in the dLN. Ifnar1-/- cells were almost completely unresponsive 
to SEA stimulation, failing to upregulate co-stimulatory molecules on their surface or to 
produce IFN-I. However Ifnar1-/- FL-cDCs displayed no deficiency in their ability to initiate 
T cell proliferation or IL-4-dependent Th2 polarisation in vitro. As T cell priming was 
abrogated in vivo only, this suggests that optimal cDC migration may be abrogated in the 
absence of the IFN-I receptor, although this is yet to be demonstrated definitively. 
 
The importance of IFN-I responsiveness for optimal Th2 induction during helminth infection 
was also assessed. Th2 responses were normal in the liver of S. mansoni Ifnar1-/- mice; 
however, IL-4 and IL-13 levels in the mesenteric LN (MLN) were drastically reduced. It was 
found that Th2 induction in the MLN was also ablated in mice infected with the 
gastrointestinal helminth Heligomosoides polygyrus. This suggests that there is a selective 
dependency on IFN-I for the activation of Th2 responses in lymphoid organs. 
 
The small intestine and the MLN provided an ideal site for further investigation of the 
development of the schistosome-specific immune response in peipheral tissues versus the 
draining lymph nodes, as this site is directly affected by parasite egg traffic during S. 
mansoni infection. The intestine is a unique immune environment – with a propensity 
towards regulation and tolerance, and a large population of innate effectors. Intestinal DCs 
depend on Flt3-L for their generation; however, the importance of DCs resident in the 
intestinal lamina propria (LP) for the initiation of Th2 inflammation in response to helminths 
is not yet known. Characterisation of LP DCs indicated that the activation of these cells is 
modulated during acute S. mansoni infection, whilst a novel model of schistosome egg 
deposition in the intestinal tissue illustrated that CD11c+ cells are essential for induction of 
the egg-specific Th2 response in both the LP and MLN following egg challenge.   
 
These data demonstrate the importance of IFN-I signalling for the development of 
helminth-specific immune responses, highlighting for the first time a role for this pluripotent 
innate effector in Th2 induction. Development of an egg challenge model in the intestine 
also provides an ideal setting with which to further explore the importance of IFN-I for Th2 
polarisation in peripheral tissues and lymphoid organs.   
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ABBREVIATIONS 
AAMΦ: Alternatively-activated macrophage 
Ag: Antigen 
APC: Antigen presenting cell 
ATP: Adenosine triphosphate 
BDCA: Blood dendritic cell antigen 
Batf3: Basic Leucine Zipper transcription factor, ATF-like 3 
BM: Bone marrow 
BMDC: Bone marrow derived dendritic cell 
BMM: Bone marrow derived macrophage 
CARD: Caspase recruitment domain 
CCL: CC Chemokine Ligand 
CCR: CC Chemokine receptor 
CD: Complementarity Determining 
cDC: Conventional DC 
CDP: Common DC precursor 
CLR: C-type lectin receptor 
CpG: CpG oligodeoxynucleotide  
CTLA-4: Cytotoxic T-lymphocyte antigen 4 
CXCR: CXC chemokine receptor 
DAMP: Danger associated molecular pattern 
DC: Dendritic cell 
Dectin1: Dendritic cell C-type lectin 1 
dLN: draining lymph node 
DNA: Deoxyribonucleic acid 
DNase: Deoxyribonuclease 
dsRNA: double-stranded ribonucleic acid 
DSS: Dextran sulphate sodium 
DTR: Diptheria toxin receptor 
DTx: Diptheria toxin 
ELISA: Enzyme linked immunosorbent assay 
EOS: Eosinophil 
ERK: Extracellular signal related kinase 
FACS: Fluorescence activated cell sorting 
FCS: Foetal-calf serum 
FLDC: Flt3-L differentiated BMDC 
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Flt3: Fms like tyrosine kinase 3  
Flt3-L: Fms like tyrosine kinase 3 ligand 
Foxp3: Forkhead box protein 3 
g: gram 
GAS: Interferon-γ activated site 
GBS: Group B streptococci 
GFP: Green-fluorescent protein 
GM-CSF: Granulocyte macrophage-colony stimulating factor 
GMDC: GMCSF differentiated BMDC 
GMFI: Geometric mean fluorescence intensity 
GMP: Granulocyte macrophage progenitor 
HBV: Hepatitis B virus 
HCV: Hepatitis C virus 
HEV: High endothelial venule 
HLA: Human leukocyte antigen 
HPC: haematopoietic progenitor cell 
HSC: haematopoietic stem cell 
ICOS: Inducible costimulator 
Id2: Inhibitor of DNA binding 2 
IEC: Intestinal epithelial cell 
IFN: Interferon 
IFNAR: Interferon-alpha/beta receptor 
IFN-I: Type I interferon 
IFIT: IFN-induced protein with tetratricopeptide repeats 
IGSF: Immunoglobulin super family 
IKK: IκB kinase 
IL: Interleukin 
ILC: Innate lymphoid cell 
ILF: Isolated lymphoid follicle 
iNOS: Inducible nitric oxide synthase 
i.p.: Intraperitoneal 
IPSEα-1: IL-4-inducing principle of S. mansoni eggs alpha-1 
IPS-1: Interferon-β promoter stimulator 1 
IRAK: IL-1 receptor associated kinase 
IRF: Interferon regulatory factor 
ISG: Interferon-stimulated gene 
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ISGF3: Interferon-stimulated gene factor 3 
ISRE: Interferon-stimulated response element 
ITAM: Immunoreceptor tyrosine based activation motif 
iTreg: peripherally induced FoxP3 expressing Treg 
i.v.: Intravenous 
JAK: Janus associated kinase 
JNK: c-Jun N-terminal kinase 
LGP2: Laboratory of genetics and physiology 2 
LN: Lymph Node 
LO: Lymphoid organ 
LP: Lamina propria 
LPS: Lipopolysaccharide 
LCMV: Lymphocytic choriomeningitis virus  
LNFPIII: Lacto-N-fucopentaose III  
M-CSF: Macrophage- colony stimulating factor 
MAL: MyD88-adaptor like 
MAPK: Mitogen activated protein kinase 
MDA5: Melanoma differentiation-associated gene 5 
MDP: macrophage-DC precursor 
MHC: Major Histocompatibility Complex 
MKK: MAPK kinase 
MKKK: MAPK kinase kinase 
MKPs: MAPK phosphatases 
MLN: Mesenteric lymph node 
MLNX: Mesenteric lymphadenectomy  
Mo-DC: monocyte-derived dendritic cell 
MR: Mannose Receptor 
mRNA: Messenger ribonucleic acid 
miRNA: Micro-ribonucleic acid 
Mx: Myxoma resistance protein 
MyD88: Myeloid differentiation factor 88 
MΦ: Macrophage 
NFκB: Nuclear factor κ B 
NK: Natural killer 
NOD: Nucleotide oligomerisation domain 
nTreg: natural Treg 
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°C: Degrees centigrade 
Pa: Heat-killed Propionibacterium acnes 
PAMP: Pathogen associated molecular pattern 
PBMC: Peripheral blood mononuclear cell 
PBS: Phosphate buffered saline 
PD-L: Programmed death Ligand 
pDC: Plasmacytoid dendritic cell 
PDCA-1: Plasmacytoid denritic cell antigen-1 
PD: Programmed death 
pDC: Plasmacytoid DC 
PGE2: Prostaglandin E2 
PI3K: phosphoinositide 3 kinase 
pLN: Popliteal LN 
PMA: Phorbol 12-myristate 13-acetate 
PP: Peyers patch 
PRR: pattern recognition receptor 
R848: Resiquimod 
RA: Retinoic acid 
RAG: Recombination activating gene 
RALDH: Retinal dehydrogenase 
RANK: Receptor activator of NFκB 
RIG: Retinoic acid inducible gene 
RNase: Ribonuclease 
RLR: RIG-like receptor 
RNA: ribonucleic acid 
RORγt: RAR-related orphan receptor gamma-t 
RT-PCR: Real-time polymerase chain reaction 
S1P: Sphingosine-1 phosphate 
s.c.: Subcutaneous 
SCF: Stem cell factor 
SEA: Soluble egg antigen of Schistosoma mansoni 
SI: Small intestine 
SLO: Secondary lymphoid organ 
St: Salmonella typhimurium 
STAT: Signal transducer and activator of transcription 
STING: Stimulator of interferon genes 
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Syk: Spleen tyrosine kinase 
TAK: TGFβ activated kinase 
TAP: Transporter associated with antigen processing  
TBK-1: TANK binding kinase-1 
TCR: T-cell receptor 
TF: Transcription factor 
Tfh: T follicular helper cell 
Tg: Transgenic 
TGFβ: Transforming growth factor beta 
Th: T helper cell 
Tip: TNFα and iNOS producing  
TIR: Toll IL-1R homology domain 
TIRAP: Toll-IL-1receptor domain containing adaptor 
TLR: Toll like receptor 
TNFα: Tumour necrosis factor alpha 
TNFRSF: TNF receptor super family 
Tr1: Foxp3 independent IL-10 dependent Treg 
TRAF: TNFR associated factor 6 
TRAM: TRIF related adaptor molecule 
Treg: T regulatory cell 
TRIF: Toll-IL-1receptor domain containing adaptor IFNβ 
TSLP: Thymic stromal lymphopoietin 
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Chapter 7 




The mammalian immune system is extraordinarily complex, involving numerous different 
types of cells capable of 1) recognising pathogen attack and mobilising a response, and 2) 
bringing the pathogen under control and ultimately guarding against future invasions. The 
cells responsible for orchestrating the first phase of this response comprise the innate 
immune system; cells of the adaptive immune system fulfil the second. The coordination 
required for such a system to work is gargantuan in scope and attests to a high degree of 
evolutionary sophistication.!
 
1.1 Dendritic cells 
Dendritic cells (DCs) are the sentinels of the immune system, providing an essential bridge 
between innate and adaptive immunity due to their ability to orchestrate T cell responses 
(Kapsenberg, 2003; Merad et al., 2013). DCs reside in lymphoid tissues, but also in 
peripheral tissues at sites of potential pathogen entry, such as the skin and mucosal 
tissues (airways, lung, gastrointestinal and urogenital tracts) (Banchereau and Steinman, 
1998). They are highly specialised antigen-presenting cells (APCs), capable of sensing, 
taking up and processing antigen (Ag), and presenting it to naïve T cells. Unlike other APC 
populations, such as macrophages (MΦs), DCs residing in peripheral tissues display 
enhanced migratory capacity following encounter with Ag and will migrate to the draining 
lymph node (dLN), where they can interact with naïve T cells (Banchereau and Steinman, 
1998; Geissmann et al., 2010a). The signals provided by DCs dictate the nature of the 
adaptive response by polarising T cells to a particular fate. Immunologists have known for 
some time the essential contribution of DCs to the immune system, and human health and 
disease (Collin et al., 2012; Steinman, 2012). The importance of this cell type was 
highlighted to the world at large in 2012 with the posthumous award of the Nobel Prize for 
medicine or physiology to Prof. Ralph Steinman, who discovered DCs in 1973.  
 
DCs were initially identified in mouse spleen as a cell type distinct from MΦs due to their 
dendritic morphology (Steinman, 2012; Steinman and Cohn, 1973). In time, it was shown 
that DCs express high levels of major histocompatibility complex (MHC) molecules on their 
surface (Steinman et al., 1979). Some years later, the integrin CD11c was identified as a 
marker expressed at high levels on DCs that could be used to enrich for this cell 
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population (Metlay et al., 1990). However, neither of these molecules provides a 
discriminating surface marker with which to identify DCs, as they are expressed on other 
cell types, such as B cells (MHC II), monocytes and MΦs (CD11c and MHC II). In 
particular, the overlapping expression profile of surface markers on DCs with MΦs and 
monocytes has been a complicating factor in the study of myeloid populations. The recent 
discovery of transcription factors (TFs) that are required during the differentiation of the DC 
lineage, and for development of specific subtypes, has begun to provide some clarity to 
those that study DC biology (Satpathy et al., 2012b).  
 
Broadly, DCs belong to two major subsets, conventional (or classical) DCs (cDCs) and 
plasmacytoid DCs (pDCs) (Merad and Manz, 2009). cDCs have two main functions: the 
maintenance of tolerance in peripheral tissues in the steady state, and the induction of 
specific immune responses against invading pathogens. The primary role of pDCs is the 
production of substantial amounts of type I interferon (IFN-I) in response to viral challenge 
or tissue damage (Colonna et al., 2004; McKenna et al., 2005).  
 
1.1.1 Conventional DCs 
For some years, researchers studying the role of DCs have made use of a depletable 
mouse model that depletes CD11c+ cells; in this model all CD11c-expressing cells also 
express the transgene for the diptheria toxin receptor (CD11c-DTR) (Hochweller et al., 
2008; Jung et al., 2002). There are two slightly different models: the original CD11c-DTR 
mice use a simian DTR transgene (Jung et al., 2002), whilst CD11c-DOG mice use a 
human DTR inserted into a BAC construct (Hochweller et al., 2008). Administration of 
diptheria toxin (DTx) leads to the selective loss of all CD11c+ cells. The drawback of this 
model is that it is not selective for DCs; other CD11c-expressing cell populations are also 
ablated such as some MΦs, including marginal zone MΦs in the spleen, and monocytes 
(Hochweller et al., 2008; Jung et al., 2002; Probst et al., 2005b; van Blijswijk et al., 2013). 
There is variability in the depletion of DC subsets in the two models; in CD11c-DOG 
animals cDCs and pDCs are depleted, however, in CD11c-DTR mice pDCs are not 
affected, at least not in all tissues (Sapoznikov et al., 2007). DTx treatment of CD11c-DTR 
mice also causes neutrophilia and monocytosis (Tittel et al., 2012; van Blijswijk et al., 
2013). The recent discovery of the cDC-specific TF, Zbtb46, has provided a very useful 
tool to differentiate cells belonging to the cDC lineage from other myeloid cell populations 
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(Meredith et al., 2012; Satpathy et al., 2012a). Zbtb46 is also expressed by endothelial and 
erythroid cells, but in the immune system its expression is restricted to cDCs (Satpathy et 
al., 2012a). Zbtb46 is expressed by committed cDC progenitors, all lymphoid tissue 
resident cDC subsets and cDCs in peripheral tissues (Meredith et al., 2012; Satpathy et 
al., 2012a). The TF is not expressed by pDCs, MΦs or monocyte-derived cells. By 
inserting the DTR transgene into the Zbtb46 promoter and creating bone marrow 
chimeras, a cDC-specific depletable mouse model has been developed (Meredith et al., 
2012; Satpathy et al., 2012a), providing a more selective tool with which to study the role 
of cDCs.  
 
Lymphoid tissue resident cDCs differentiate in situ from blood-borne precursors (Liu et al., 
2009; Liu et al., 2007; Naik et al., 2006) (Fig. 1.1), and remain in the lymphoid tissue for 
their entire lifespan (Merad et al., 2013). Lymph node cDC populations also include 
nonlymphoid tissue migratory cDCs that enter via the lymphatics (Jakubzick et al., 2008), 
whilst the spleen cDC population is comprised entirely of lymphoid resident cells 
(Randolph et al., 2008). Lymphoid tissue cDCs primarily consist of two subsets: CD8α+ 
and CD11b+ cDCs (Satpathy et al., 2012a; Shortman and Heath, 2010)(Fig. 1.2). Other 
markers associated with the CD8α+ lineage include: CD24, and the C-type lectins Clec9a 
(DNGR1) and CD205 (Askew and Harding, 2008; Caminschi et al., 2008; Jiang et al., 
1995; Sancho et al., 2008). The TFs involved in the differentiation and maturation of 
CD8α+ cDCs are IFN Regulatory Factor (IRF)8, Id2 and Batf3 (Aliberti et al., 2003; Hacker 
et al., 2003; Hildner et al., 2008; Tailor et al., 2008). CD8α+ cDCs are specialised in their 
ability to cross-present Ag to CD8+ T cells (den Haan et al., 2000; Dudziak et al., 2007; 
Hildner et al., 2008; Schulz and Reis e Sousa, 2002).  
 
CD11b+ cDCs in lymphoid tissues can also be identified by high-level expression of Sirpα 
(Lahoud et al., 2006). The development of CD11b+ cDCs requires the TFs IRF2 and IRF4 
(Ichikawa et al., 2004; Suzuki et al., 2004). CD11b+ splenic cDCs also depend on Notch 
signalling for their development (Caton et al., 2007; Lewis et al., 2011). CD8α+ cDCs 
express the cellular machinery to facilitate Ag processing for cross-presentation to CD8+ T 
cells (Dudziak et al., 2007), including enriched levels of transporter associated with antigen 
processing (TAP) proteins, which are required for the loading of peptides onto MHC I 
(Joffre et al., 2012). Studies in Batf3-deficient mice have demonstrated that CD8α+ cDCs 
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are uniquely required for cross presentation and activation of CD8+ T cells during viral 
infection (Hildner et al., 2008; Pinto et al., 2011). In contrast, CD11b+ cDCs are enriched in 
their expression of the components required for Ag processing and presentation to CD4+ T 
cells, including cathepsins – proteases that breakdown Ag into peptide ligands for loading 
on MHC II (Dudziak et al., 2007). CD11b+ cDCs display an enhanced capacity to prime Ag-
specific CD4+ T cells when compared with CD8α+ cDCs (Dudziak et al., 2007). In 
agreement with this, CD11b+ cDCs preferentially present Ag to CD4+ T cells (del Rio et al., 
2007), even during viral infection (Kim and Braciale, 2009). However, CD8α+ cDCs are 
also very good at activating CD4+ T cells, by virtue of the fact that they express high levels 
of MHC II and produce large quantities of IL-12 (Shortman and Heath, 2010).  
 
Tissue-resident cDCs account for around 1-5% of all cells in peripheral tissues, where the 
primary subsets are CD103+ CD11b- and CD103- CD11b+ populations (Merad et al., 2013). 
There are also other tissue-specific, subsets that are present in the skin (Henri et al., 
2010) and the gastrointestinal tract (see Section 1.7). Tissue-resident CD11b+ cDCs 
closely resemble their counterparts resident in lymphoid tissues, whilst CD103+ cDCs are 
developmentally and functionally equivalent to CD8α+ cDCs (Bedoui et al., 2009; Edelson 
et al., 2010; Ginhoux et al., 2009). CD103+ cDCs, except in the intestine and pancreas, 
express the integrin langerin (Ginhoux et al., 2009; Merad et al., 2008). A subset of 
CD103+ cDCs is also resident in the mesenteric lymph nodes (MLNs) (Johansson-Lindbom 
et al., 2005; Satpathy et al., 2013), and should not be confused with the migrating DC 
populations from the intestinal tissue.  
 
Perhaps one criticism of the work concerning the identification of the different DC subsets 
and their ontogeny is that there is too much focus on characterisation and profiling with 
little functional readout. However, It could be argued that a clear understanding of the 
different subsets is required before their function can be assessed under different 
conditions. A comprehensive knowledge of DC ontogeny may also inform understanding of 
their function. For example, it has been shown that CD103+ cDCs in peripheral tissues are 
developmentally related to splenic CD8α+ cDCs, suggesting that they may also be 
specialised in the cross-presentation of Ag, as had previously been reported (Bedoui et al., 
2009; Edelson et al., 2010). Identification of the markers and TFs that are associated with 
the different DC subsets also enables the development of mouse models with targeted 
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deletion or depletion of specific subsets, tools that can be very useful for investigating 
function. This work also ensures that researchers are able to differentiate DCs from MΦs, 
and can make appropriate conclusions about the functions of these distinct cell 
populations.     
 
1.1.2 Plasmacytoid DCs 
pDCs are a small subset of DCs that share a similar origin to cDCs but have distinct 
lifecycle and functions. Unlike cDCs, which do not fully differentiate until they reach the 
tissues, pDCs develop in the bone marrow (BM) (Reizis, 2010). Both cDCs and pDCs 
develop from a common DC progenitor (CDP) (Naik et al., 2007; Onai et al., 2007), but 
cDC development requires a further intermediate: the pre-cDC (Diao et al., 2006; Naik et 
al., 2006). pDCs depend on expression of the TF E2-2, both for their differentiation in the 
BM, and for maintenance in the periphery (Cisse et al., 2008; Ghosh et al., 2010). Other 
TFs involved in pDC development include IRF8 and SpiB (Reizis et al., 2011). In the 
steady state, pDCs are found primarily in lymphoid organs, entering from the blood (Cella 
et al., 1999; Diacovo et al., 2005). However, they are also found in surprisingly high 
numbers in the liver (Merad and Manz, 2009) and are rapidly recruited to sites of infection 
(Baldwin et al., 2004; GeurtsvanKessel et al., 2008; Smit et al., 2006). Murine pDCs 
express only low-level MHC II and CD11c in the steady state, while other markers 
associated with this subset include CD45R (B220), PDCA-1, Ly6C, and the C-type lectins 
Siglec-H and Ly49Q (Reizis et al., 2011).  
 
The primary role of pDCs is thought to be as a source of IFN-I, particularly following viral 
infection, when they are involved in the early control of viral load and contribute to natural 
killer (NK) cell and CD8+ T cell recruitment and activation (Pinto et al., 2011; Swiecki et al., 
2010). However, despite their reputation for being key mediators of anti-viral immunity, in 
many viral infections including lymphocytic choriomeningitis virus (LCMV), murine 
cytomegalovirus, respiratory syncytial virus and herpes simplex virus, pDCs are not 
essential for the development of the immune response or for host survival (Reizis et al., 
2011). Mouse hepatitis is the only documented viral infection where the development of 
the immune response is pDC-dependent, as pDC IFN-I production is essential for control 
of viral expansion and host survival (Cervantes-Barragan et al., 2007).  
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The ability of pDCs to act as APCs and prime naïve T cells is a contentious issue. A 
number of studies have suggested that pDCs can prime naïve T cells under certain 
circumstances, particularly when peptide Ag, which does not require further processing for 
presentation to T cells, is used (Irla et al., 2010; Sapoznikov et al., 2007). However, pDCs 
lack the cellular adaptations required to take up, process and present exogenous Ag 
effectively (Villadangos and Young, 2008). cDCs can regulate the cellular machinery 
involved in exogenous Ag presentation following activation: these modifications allow 
prolonged expression of MHC II on their surface, which is essential for optimal priming of 
CD4+ T cells (Section 1.3)(LeibundGut-Landmann et al., 2004; Young et al., 2008). In 
contrast, pDCs do not have these adaptations and so are poor activators of naïve CD4+ T 
cells (LeibundGut-Landmann et al., 2004; Young et al., 2008). However, unlike cDCs, 
pDCs retain the ability to present endogenous Ag following activation (Young et al., 2008). 
Although pDCs accumulate in infected tissues, few migrate to the dLNs, and even then 
only relatively late after the onset of infection (GeurtsvanKessel et al., 2008). Furthermore, 
since pDCs migrate to the dLNs via the blood rather than the afferent lymph (Cella et al., 
1999; Cerovic et al., 2012; Diacovo et al., 2005), it is unlikely that pDCs are directly 
involved in Ag transport to the dLNs. Instead, it is more likely that pDCs present Ag in the 
tissues to effector or memory T cells to enhance the efficacy of the immune response 
(GeurtsvanKessel et al., 2008).  
 
1.1.3 Monocyte-derived DCs 
Monocytes derive from BM precursors, via a distinct pathway to DCs, and circulate in the 
blood in the steady state (Dominguez and Ardavin, 2010) (Fig. 1.1). They belong to two 
distinct subsets: patrolling monocytes (Ly6Clo CX3CR1hi CCR2lo) and inflammatory 
monocytes (Ly6Chi CX3CR1lo CCR2hi) (Geissmann et al., 2008; Satpathy et al., 2012b). 
Patrolling monocytes have a close association with the blood endothelium and so are 
rapidly recruited to sites of inflammation, where they provide a source of inflammatory 
mediators or aid in tissue repair (Auffray et al., 2007; Geissmann et al., 2008). 
Inflammatory monocytes are recruited to sites of inflammation with delayed kinetics 
compared to patrolling cells and are capable of differentiating into tumour necrosis factor- 
and inducible nitric oxide synthase- producing DCs (Tip-DCs), during Listeria 
monocytogenes infection and in response to some viral infections (Aldridge et al., 2009; 
Geissmann et al., 2008; Serbina et al., 2003). These cells express low levels of CD11c 
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and have a DC-like morphology (Geissmann et al., 2008). However, they do not express 
the cDC TF Zbtb46 (Meredith et al., 2012; Satpathy et al., 2012a), suggesting that these 
cells may simply be inflammatory MΦs or monocytes. Moreover, whilst both DCs and 
macrophages develop from a common precursor in the BM (MΦ-DC progenitors, MDPs) 
monocytes differentiate in response to specific cues via a distinct pathway (Geissmann et 
al., 2010b). Thus, these cells are not DCs per se but may be capable of Ag presentation in 
specific tissues and under certain conditions (Kamphorst et al., 2010), for example in the 
lung during viral infection (Aldridge et al., 2009) and allergic Th2 responses (Hammad et 
al., 2010; Plantinga et al., 2013). 
 
1.1.4 Flt3-L and GM-CSF: DC development versus homeostasis 
Fms-like tyrosine kinase 3 ligand (Flt3-L) is the major cytokine responsible for DC 
generation and turnover in vivo. Whilst granulocyte-MΦ colony-stimulating factor (GM-
CSF) can be used to differentate DCs in vitro (see Section 1.1.5), it does not seem to be 
essential for DC development in vivo. In the absence of GM-CSF or its receptor, there is 
only a minor reduction in cDC numbers and no change in the pDC population (Vremec et 
al., 1997). Furthermore, the slight reduction in total DC numbers in the absence of GM-
CSF appears to correlate with a concurrent reduction in spleen size and so probably does 
not reflect a specific defect in the DC compartment (Naik, 2008). In contrast, genetic 
deletion of Flt3-L leads to a dramatic loss of DC populations in all lymphoid and peripheral 
tissues, with approximately 90% reduction in DC numbers in the spleen and LN of Flt3-L 
deficient animals (Kingston et al., 2009; McKenna et al., 2000). pDCs display the most 
striking reduction in the absence of Flt3-L (Kingston et al., 2009; McKenna et al., 2000). 
Both MDPs and CDPs in the BM express Flt3 (D'Amico and Wu, 2003; Fogg et al., 2006; 
Naik et al., 2007; Onai et al., 2007), and both populations are depleted in the absence of 
Flt3-L (Kingston et al., 2009). Pre-DCs in the periphery are also Flt3+ and depend on Flt3-L 
for their further differentiation into the cDC subsets (Liu et al., 2009; Waskow et al., 2008). 
Flt3 signals via signal transducer and activator of transcription (STAT) 3, thus STAT3 
expression is also essential for DC development (Laouar et al., 2003).  
 
The combined loss of Flt3-L and GM-CSF leads to a more dramatic loss of cDC numbers 
in peripheral tissues compared to the reduction seen in mice that only lack Flt3-L (Kingston 
et al., 2009). In the absence of Flt3-L signalling, there is a 35% reduction in dermal DC 
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numbers, whereas in the skin of double-deficient animals, cDCs are reduced by 
approximately 75%. These findings are in agreement with recent suggestions that GM-
CSF is involved in cDC homeostasis in the periphery (Greter et al., 2012; King et al., 
2010). In the absence of GM-CSF, there is a reduction of CD103+ and CD11b+ cDCs 
numbers in the lung, skin and intestine (Greter et al., 2012; King et al., 2010; Kingston et 
al., 2009). GM-CSF is required for the survival of cDCs in the periphery: in the absence of 
GM-CSF signalling, cDCs are more pro-apoptotic, showing increased expression of 
caspase-3 and signs of mitochondrial fragmentation, as well as an increase in cells 
actively undergoing apoptosis (Greter et al., 2012). Signalling downstream of GM-CSF 
activates STAT5 followed by signalling pathways involved in DC maturation, activation and 
survival, including the NFκB and MAPK pathways (van de Laar et al., 2012). It is likely that 
these signalling events are required to maintain healthy cDCs in the periphery. In contrast, 
ligation of Flt3 activates STAT3 only (Laouar et al., 2003), with no impact on the NFκB 
pathway, therefore Flt3-L does not stimulate DC activation in the same way as GM-CSF 
(van de Laar et al., 2012). GM-CSF is also required for the expression of CD103 by tissue-
resident cDCs (Edelson et al., 2011; Greter et al., 2012; Zhan et al., 2011) and it has been 
suggested that CD103 expression may be required for full differentiation of this subset and 
for their capacity to cross-present Ag (Sathe and Wu, 2011; Zhan et al., 2011). Unlike 
cDCs, pDCs do not depend on GM-CSF, in fact, activation of STAT5 by GM-CSF actively 
inhibits pDC differentiation (Esashi et al., 2008).  
 
1.1.5 DCs generated in vitro 
Due to the scarcity of DCs in vivo (~1% of all cells in lymphoid tissues in the steady state 
(Merad and Manz, 2009)), many studies of DC biology make use of DCs generated in vitro 
from BM. The most commonly used BMDCs are those generated with GM-CSF (GMDCs) 
(Inaba et al., 1992; Lutz et al., 1999). Large numbers of DCs can be generated in vitro 
using GM-CSF, as differentiating cells proliferate in culture (Lutz et al., 1999). GMDCs are 
homogenously CD8α- and express high levels of CD11b (Brasel et al., 2000), however 
GMDCs are more closely related to monocytes and MΦs than CD11b+ cDCs in terms of 
their mRNA expression profile (Robbins et al., 2008). It has been suggested that GMDCs 
are more analogous to TipDCs or monocyte-derived DCs that develop under inflammatory 
conditions (Xu et al., 2007). However, TipDCs do not express the cDC-specific TF Zbtb46 
– most likely because they are monocytes/ MΦs rather than DCs, whereas GMDCs do 
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(Meredith et al., 2012; Satpathy et al., 2012a). Moreover, TipDCs develop in the absence 
of GM-CSF (Greter et al., 2012), demonstrating that these cells are entirely distinct from 
GMDCs generated in vitro. Given that GM-CSF is not involved in DC differentiation in vivo, 
it is perhaps not surprising that there is not a direct in vivo counterpart for GMDCs. 
Nonetheless, GMDCs have afforded researchers an invaluable tool with which to study DC 
biology and function.  
 
The fact that GM-CSF gives rise to a homogenous population of DCs is advantageous as 
it means that cells do not have to be sorted for full characterization of their phenotype and 
function. GM-CSF generates large numbers of cells that are generally in a low-activation 
state (i.e. expressing low-levels of MHC II, if grown carefully). The main advantage of 
these cells as a model for studying DCs, is that they most closely resemble cells that are 
generated from human blood-derived monocytes, using GM-CSF and IL-4 (Sallusto and 
Lanzavecchia, 1994), enabling direct comparisons between these cell types. 
 
Generation of BMDCs using Flt3-L gives rise to mixed cultures of pDCs and the cDC 
subsets, which are thought to be equivalent to those found in lymphoid organs in vivo 
(Naik et al., 2005; Naik et al., 2007). Although Flt3-L generated cDCs (FL-cDCs) do not 
express CD8α, an equivalent population can be identified that is CD24hi and CD11blo (Naik 
et al., 2005). Similarly to their in vivo counterparts, CD11b+ FL-cDCs express high levels of 
Sirpα (Naik et al., 2005). pDCs generated in vitro using Flt3-L have a similar expression 
profile of surface markers to their in vivo counterparts, with high levels of CD45R and 
Ly6C, and little or no CD11b on their surface (Brawand et al., 2002; Naik et al., 2005). FL-
pDCs are also capable of secreting high levels of IFN-I in response to Ag stimulation 
(Brawand et al., 2002; Naik et al., 2005), whilst CD24+ FL-cDCs alone display the ability to 
cross-present to CD8+ T cells (Naik et al., 2005). Similarly to their splenic counterparts, 
CD24+ cDCs cannot be generated from IRF8-deficient BM (Naik et al., 2005), whilst IRF4-
deficient cultures display a reciprocal deficit in CD11b+ cDCs (Suzuki et al., 2004). Both 
FL-cDC subsets express Zbtb46 (Meredith et al., 2012; Satpathy et al., 2012a). Thus, 
FLDCs provide a unique tool with which to study equivalents of all the major DC subsets 
present in vivo in the steady state. 
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1.1.6 DC migration from peripheral tissues to the dLN 
In order to interact with and prime naïve T cells, DCs that encounter Ag whilst patrolling in 
the peripheral tissues must first migrate to the dLN. cDCs leave the peripheral tissues and 
migrate via the afferent lymphatics (Alvarez et al., 2008). Much of our understanding of 
cDC migration comes from studies of DCs trafficking from the skin to the dLN, which 
demonstrate that successful transit is dependent on the chemokines CCL19 and CCL21, 
and their receptor CCR7 (MartIn-Fontecha et al., 2003; Saeki et al., 1999). Exposure to Ag 
and inflammatory mediators, such as IL-1β and TNFα, provides a strong stimulus for DCs 
to leave the tissues. However, a small number of DCs migrate constitutively in the steady 
state (Alvarez et al., 2008; Jakubzick et al., 2008). Although immature cDCs express only 
low-levels of CCR7 (Ricart et al., 2011; Ritter et al., 2004), the receptor and its ligands are 
still thought to be the primary mediators of steady state migration, as Ccr7-/- mice have a 
30-40% reduction in their LN DC populations in the absence of any inflammatory stimulus 
(Ohl et al., 2004).  
 
CCR7 expression is required for transmigration into the lymphatic lumen, enabling cDCs to 
dock with CCL21 on the lymphatic endothelium and enter via pores within the 
discontinuous laminin-expressing basement membrane, before crawling and paracellular 
entry, at junctions of lymphatic endothelial cells into the capillary lumen, (Pflicke and Sixt, 
2009; Tal et al., 2011). Once inside the initial lymph vessels, cDCs actively crawl along the 
endothelium, and are then transported passively in collecting lymphatics where the flow 
rate is higher (Tal et al., 2011). Although DC crawling requires engagement of adhesion 
molecules such as integrins, directional movement may still depend on CCR7-CCL21 
interactions (Shields et al., 2007). It is also thought that migrating DCs gain entry to the LN 
by following a gradient of CCL21, which is expressed at high levels in the LN paracortex 
(Nakano and Gunn, 2001). In support of this, in the absence of CCL21, DCs are unable to 
gain entry to the LN and instead accumulate in the subcapsular sinus on the outer edge of 
LNs (Mori et al., 2001). Clearly, CCR7 has an integral role at several stages of cDC 
migration from peripheral tissues to the draining LN. 
 
As highlighted above (section 1.1.2), pDCs do not migrate from the tissues to lymphoid 
organs in the lymph, but rather via the blood. An early study of pDCs indicated that these 
cells were highly concentrated around high-endothelial venules (HEV) in LNs (Cella et al., 
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1999), suggesting that they may enter via this route. pDCs can adhere to non-inflamed 
HEV, but it is only under inflammatory conditions, when endothelial cells upregulate 
CD62L, that they can transmigrate (Diacovo et al., 2005). Studies of CCR5-deficient cells 
indicate that this process requires pDC expression of CCR5 (Diacovo et al., 2005). 
 
1.1.7 Human DC subsets 
Most of our understanding of human DC subsets stems from studies of the DC subsets 
generated from, or found in, the blood due to the scarcity of samples from tissues. Human 
pDCs are lineage-negative (CD3- CD14- CD19- CD20- CD56-) and do not express CD11c, 
but are constiutively MHC II+ (Reizis et al., 2011). Other markers used to identify pDCs in 
humans include blood dendritic cell Ag (BDCA) 2, BDCA4 and CD123 (IL-3Rα) (Merad et 
al., 2013; Reizis et al., 2011). Human cDCs in the blood are identified as lineage-negative, 
but positive for CD11c and MHC II (Merad et al., 2013). In contrast to mice, in which 
circulating pre-DCs differentiate into mature cDC subsets in the periphery, human blood 
contains two fully differentiated cDC subsets that can be distinguished by their expression 
of the non-overlapping surface markers, CD1c (BDCA1) and CD141 (BDCA3) (Lindstedt et 
al., 2005; Merad et al., 2013). CD1c+ DCs are by far the predominant population in human 
blood (Mittag et al., 2011; Nizzoli et al., 2013)(Fig. 1.2).  
 
CD141+ human DCs are thought to be equivalent to the CD8α+/ CD103+ subset in mice 
(Jongbloed et al., 2010; Poulin et al., 2010; Robbins et al., 2008) (Fig. 1.2). As with CD8α+ 
cDCs in mouse, CD141+ human DCs express Clec9a on their surface (Jongbloed et al., 
2010; Poulin et al., 2010). Both murine CD8α+ cDCs and human CD141+ DCs display an 
enhanced ability to internalise apoptotic cells, and are the primary producers of IL-12 in 
response to TLR ligands (Iyoda et al., 2002; Jongbloed et al., 2010; Poulin et al., 2010; 
Reis e Sousa et al., 1997). Like CD8α+ cDCs in mouse, human CD141+ DCs efficiently 
cross-present to CD8+ T cells (Jongbloed et al., 2010; Poulin et al., 2010). It should be 
noted, however, that the CD1c+ subset can also cross-present and activate CD8+ T cells 
efficiently (Mittag et al., 2011; Nizzoli et al., 2013). As described above, development of 
murine CD8α+/ CD103+ cDCs depends on the TF Batf3 (Edelson et al., 2010; Hildner et 
al., 2008). Differentiation of human DCs in vitro from haematopoietic stem cells (HSCs)/ 
haematopoietic progenitor cells (HPCs) using a combination of Flt3-L and GM-CSF gives 
rise to a subset of CD141+ Clec9a+ DCs (Poulin et al., 2010). Blockade of Batf3 in these 
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cultures abolishes the development of this subset (Poulin et al., 2012), highlighting the 
developmental similarities of human CD141+ DCs to murine CD8α+ cDCs.  
 
Due to the restrictively small number of DCs that can be purified from human blood, DCs 
are often generated in vitro from CD14+ monocytes that are present at much higher 
numbers in human blood (Merad et al., 2013). GM-CSF is the primary differentiation factor 
used in these cultures, with the addition of different cytokines impacting on the phenotype 
of the DCs that are generated. GM-CSF together with IL-4 gives rise to a homogeneous 
population of monocyte-derived DCs (mo-DCs) that are CD1a+ and relatively immature, in 
terms of their surface expression of MHC and co-stimulatory molecules (Palucka et al., 
1998; Sallusto and Lanzavecchia, 1994). Mo-DCs generated with GM-CSF/ IL-4 also 
efficiently present Ag to T cells (Sallusto and Lanzavecchia, 1994). An alternative method 
for generating DCs uses HSCs/ HPCs from cord blood, rather than monocytes from 
venous blood. This culture method is more complex and involves two steps. Initially, 
HSCs/ HPCs are cultured for 7-11 days with Flt3-L, in combination with stem cell factor 
(SCF), IL-3 and IL-6 (Poulin et al., 2010). Cells are then re-cultured for the final 12-14 days 
of culture with Flt3-L, SCF, GM-CSF and IL-4 (Poulin et al., 2010). The DCs generated 
from these cultures include pDCs, CD1c+ and CD141+ cDCs - a major advantage of this 
method (Merad et al., 2013; Poulin et al., 2010). These cells also most closely resemble 
the DCs generated from murine BM in vitro using Flt3-L. 
 
1.2 DC Recognition of non-self and danger 
DCs express a range of pattern recognition receptors (PRRs) that have evolved to detect 
specific pathogen-associated molecular patterns (PAMPs) (Janeway, 1989; Kapsenberg, 
2003). Although it was originally presumed that PRRs would selectively recognise non-
self, they are also responsive to endogenous ligands, often components of damaged or 
necrotic cells, such as nucleic acids or heat-shock proteins, which act as danger signals 
following tissue damage (damage-associated molecular patterns, DAMPs) (Bianchi, 2007; 
Matzinger, 2002). It has been suggested that, although self-ligands can bind to the same 
receptors as PAMPs, the outcome of receptor ligation by danger signals may be distinct, 
initiating wound repair and healing rather than immune activation (Iwasaki and Medzhitov, 
2010). The PRRs expressed by DCs can broadly be categorised by their cellular 
localisation. The transmembrane PRRs include Toll-like receptors (TLRs) and C-type lectin 
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receptors (CLRs). A more recently identified class of PRRs are nucleic acid sensors found 
in the cytosol which include the retinoic acid-inducible gene I (RIG-I) -like receptors 
(RLRs).       
 
1.2.1 TLRs 
TLRs, which recognise an expansive range of PAMPs as well as DAMPs, were the first 
PRR family to be identified (Lemaitre et al., 1996; Vogel, 1998). TLRs are localised either 
to the plasma membrane or on endosomal/lysosomal membranes, with the surface 
membrane receptors primarily recognising microbial patterns that are expressed on the 
cell surface, whilst the intracellular TLRs recognise nucleic acid ligands (Table 1.1). Many 
TLRs require co-receptors to function fully, for example in order to recognise LPS, TLR4 
requires the myeloid differentiation factor 2 (MD2) as a co-receptor, which associates with 
the TLR4 homodimer on the cell surface or in the endolysosome (Shimazu et al., 1999). A 
number of synthetic TLR ligands have been developed that are recognised by specific 
TLRs. Synthetic ligands facilitate characterisation of cellular responses to the stimulation 
of a specific TLR in isolation, without the complexity of microorganisms, which often 
incorporate many different antigenic patterns. Synthetic ligands can also be used, or have 
the potential to be used, as adjuvants to enhance vaccine efficacy.  
Polyinosinic:polycytidylic acid (pI:C) is structurally similar to dsRNA and selectively 
activates TLR3. Resiquimod (R848) belongs to a family of anti-viral compounds that are 
agonists for TLR7 and TLR8 (Hemmi et al., 2002). Bacterial DNA that contains 
unmethylated CpG dinucleotides is highly immunostimulatory (Yamamoto et al., 2000), 
and immune activation in response to purified native or synthetic CpG is dependent on 
TLR9 (Hemmi et al., 2000).  
 
1.2.2 DC expression of TLRs 
DC subsets in human and mouse have distinct expression patterns of TLRs (Table 1.2 and 
1.3), which not only confers selective sensitivity to specific pathogens, but is also 
associated with the function of different DC populations. For example, pDCs selectively 
express very high levels of TLR7 and 9, allowing them to respond preferentially to viral 
challenge (Diebold et al., 2004; Takeuchi and Akira, 2010). Similarly, TLR3 is expressed 
only by CD8α+ cDCs in mice (Jelinek et al., 2011) and in the CD141+ DC population in 
humans (Hemont et al., 2013; Jongbloed et al., 2010; Poulin et al., 2010), which seems to 
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relate to the ability of these cell subsets alone to cross-present to CD8+ T cells. Although 
the expression patterns of human mo-DCs, pDCs and mDCs collectively have been known 
for a while (Iwasaki and Medzhitov, 2004; Schreibelt et al., 2010), it is only very recently 
that the specific expression patterns of CD1c+ and CD141+ DCs have been elucidated 
(Hemont et al., 2013) (Table 1.3). 
 
1.2.3 TLR adaptor proteins and downstream signalling 
Transcriptional activation occurs following ligation of TLRs, the specific genes that are 
activated being dependent on which TLRs are engaged and the adaptor proteins that are 
recruited. MyD88 is the adaptor protein for most TLRs, except for TLR3, which selectively 
recruits TRIF (Yamamoto et al., 2003). TLR4 signal transduction can also occur in a 
MyD88-independent manner via TRIF leading to IFN-β production (Yamamoto et al., 
2002). It is thought that activation of these two signalling pathways by TLR4 can occur 
sequentially (Takeuchi and Akira, 2010). The signalling events that occur downstream of 
MyD88 and TRIF are illustrated in Fig. 1.3.  
 
1.2.4 Activation of IFN-I expression downstream of TLRs 
Activation of both MyD88- and TRIF-dependent pathways in response to nucleic acid 
ligands triggers downstream signalling events leading to the stimulation of IFN-I gene 
expression (Honda and Taniguchi, 2006a). Transcription of IFN-I genes following TLR 
ligation is dependent on two IRFs – IRF3 and IRF7 - without which recruitment of 
chromatin modifiers and the transcriptional machinery to the promoter do not occur (Honda 
and Taniguchi, 2006a; Honda et al., 2005b). IRFs are activated by two kinases, TANK-
binding kinase (TBK)-1 and IKKε (Tseng et al., 2010)(Fig. 1.3). All IRFs contain a highly-
conserved DNA-binding domain, which recognizes a consensus DNA sequence known as 
the IFN-stimulated response element (ISRE) (Honda and Taniguchi, 2006b). This domain 
is found in the promoters of genes that sequence the IFN-I subsets themselves, as well as 
many other genes involved in immunity. IRF3 is constitutively expressed and resides in the 
cytosol in a latent state. Unlike IRF3, IRF7 is expressed only at low levels in most cells but 
is strongly induced by IFN-I signalling. IRF3 and IRF7 are highly homologous, and can 
form homo- or hetero-dimers following phosphorylation prior to translocation into the 
nucleus to initiate gene expression of IFN-I and other IFN-stimulated genes (ISGs) (Honda 
and Taniguchi, 2006b; Takeuchi and Akira, 2010).  
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MyD88 activates IFN-I production via a distinct signalling pathway downstream of TLR9. 
MyD88 interacts directly with IRF7 in the endosomal compartment. Following ligation of 
TLR9, IRF7 also interacts with TRAF6 and is activated in a MyD88-TRAF6 dependent 
manner (Honda et al., 2004; Kawai et al., 2004). It is likely that IRAKs and TRAF3 are also 
involved in this process, though their roles are less clear (Honda and Taniguchi, 2006b). 
Robust IFN-I gene induction in splenic pDCs is normal in IRF1 and IRF3-deficient mice, 
however this response is ablated in IRF7-deficient animals, demonstrating that IRF7 is the 
primary mediator of IFN-I in pDCs (Honda et al., 2005b). It was initially assumed that pDCs 
are able to produce such large amounts of IFN-I, unlike cDCs and other cells, because 
they constitutively express IRF7 to a higher level (Izaguirre et al., 2003; Prakash et al., 
2005). However, it is clear that spatio-temporal control of TLR9 signalling in pDCs also 
plays a role. In pDCs, CpG ligands are maintained in the endosome with the MyD88-IRF7 
complex for long periods, whilst in cDCs, CpG is rapidly transferred to lysosomal vesicles 
(Honda et al., 2005a). 
 
1.2.5 Negative regulation of TRIF function by alternative adaptors 
Activation of the adaptor proteins and their downstream signalling pathways is tightly 
controlled to prevent prolonged or unnecessary expression of pro-inflammatory mediators 
(Takeuchi and Akira, 2010). There is increasing understanding of these processes, which 
include negative regulation of specific adaptor proteins by other adaptors. Many of these 
interactions involve the downmodulation of TRIF signalling pathways. The most recently 
identified adaptor protein containing a TIR domain is SARM, which interacts directly with 
TRIF to inhibit NFκB and IRF-dependent gene expression (Carty et al., 2006). Since this 
interaction was identified, it has also been shown that MyD88 can negatively regulate 
TRIF, via two distinct mechanisms.  
 
The first of these was shown in a pI:C-dependent model of corneal inflammation, where 
the inflammatory response is activated downstream of TLR3-TRIF signalling, that MyD88-
deficient animals had exacerbated inflammation, including an increase in MΦ infiltration 
and CCL5 production (Johnson et al., 2008). MyD88 regulation of this pathway did not 
influence IRF3 function or directly act on NFκB. However, the MAP kinase c-Jun N-
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terminal kinase (JNK) was involved, as MyD88 knockdown significantly increased JNK 
phosphorylation in human corneal cells.  
 
MyD88 has also been shown to directly regulate IRF3 activity downstream of TRIF. In this 
pathway MyD88 associates with IRF3, preventing its phosphorylation by IKKε and 
resulting in reduced IFNβ production by pI:C-treated BMMΦs, however MyD88 did not 
affect TBK-1 activity (Siednienko et al., 2011). MyD88 inhibition of TRIF-IRF3 activation 
was also shown to inhibit CCL5 production by BMMΦs following their exposure to pI:C. 
MyD88-adaptor like (MAL) can also inhibit TRIF-mediated IFNβ production, albeit by a 
distinct pathway that does not affect CCL5. MAL associates with IRF7, inhibiting its 
phosphorylation and nuclear translocation (Siednienko et al., 2011). Thus, TRIF signalling 
pathways are controlled and downmodulated by a range of adaptor proteins using distinct 
mechanisms. 
  
1.2.6 Cytosolic nucleic acid sensors: The classical pathway of IFN-I induction 
It was shown some time ago that viral infection induces IFN-I production from a range of 
cell types, including non-immune cells, such as epithelial cells. This response is mediated 
by cytosolic PRRs that recognise nucleic acids (Desmet and Ishii, 2012). Cytosolic nucleic 
acid sensors are a large and growing family of PRRs, the best characterised of which are 
the RLRs and Nod-like receptors (NLRs). Of these, RLRs are more important for IFN-I 
production, particularly by myeloid cells, epithelial cells and cells of the central nervous 
system (Honda and Taniguchi, 2006a). Although RLRs are expressed by pDCs, they are 
not essential for IFN-I production by this cell type (Loo and Gale, 2011). The RLR family 
includes three members: RIG-I, MDA5 and LGP2. RIG-I and MDA5 consist of two N-
terminal CARD domains, a DExD/H-box RNA helicase domain and a C-terminal repressor 
domain (Takeuchi and Akira, 2009). It is the C-terminal regulatory domain of RLRs that 
bind nucleic acid ligands. RLRs catalyse ATP via the DExD/H helicase domain. This 
ATPase function is essential for IFN-I production by RLRs in all settings (Takeuchi and 
Akira, 2010). LGP2 lacks the CARD domains, which are essential for activating 
downstream signalling pathways (Loo and Gale, 2011). LGP2 is thought to be a positive 
regulator of the other two family members (Satoh et al., 2010). It has been shown that 
RIG-I can bind short ssRNA and dsRNA, with the presence of a 5’ triphosphate domain 
greatly increasing IFN-I production downstream of RIG-I, whilst MDA5 is activated by long 
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dsRNA (Desmet and Ishii, 2012; Takeuchi and Akira, 2010). AT-rich dsDNA can indirectly 
activate RIG-I, leading to IFN-I production, a process that is mediated by cytosolic RNA 
polymerase III, which utilises the DNA as a template for transcription to generate 5-ppp 
ssRNA that is detected by RIG-I (Ablasser et al., 2009; Chiu et al., 2009). RIG-I and MDA5 
can also recognise short self-RNAs that are cleaved by RNase L, and activation by these 
ligands can enhance IFN-I production during viral infection (Malathi et al., 2007).  
 
The adaptor protein downstream of RLRs is Interferon-β promoter stimulator 1 (IPS-1, also 
known as MAVS, CARDIF, VISA), which is located within the mitochondrial membrane 
(Kato et al., 2011; Kawai et al., 2005). Like RIG-I and MDA5, IPS-1 contains a CARD 
domain, with which it interacts with the cytosolic receptors (Kato et al., 2011; Kawai et al., 
2005). Activation of IPS-1 is essential for IFN-I production downstream of RLRs following 
exposure to RNA ligands, via TBK-1 and IKKε activation of IRF3 and IRF7 (Desmet and 
Ishii, 2012). The signalling events downstream of RLR ligation (and other cytosolic nucleic 
acid sensors) are shown in Fig. 1.4.  
 
RLRs are not the only cytoplasmic RNA helicases that recognise nucleic acid ligands. An 
increasing number of other DExD/H-box family members are being identified, which 
recognise a diverse range of nucleic acid ligands and utilise a variety of adaptor proteins. 
For example, the helicases DDX1, DDX21 and DHX36 form a complex that recognises 
dsRNA, and stimulates IFN-I induction in response to pI:C stimulation or viral infection 
(Zhang et al., 2011a). This interaction was demonstrated in GMDCs and is dependent on 
the adaptor molecule TRIF. A number of other cytosolic helicases utilise the RLR-
associated adaptor protein IPS-1 to activate IFN-I gene expression (Desmet and Ishii, 
2012), such as DDX3, which is constitutively expressed and recognises viral RNA 
(Oshiumi et al., 2010). Another adaptor molecule activated by these receptors is STING, 
which is associated with the endoplasmic reticulum and is also capable of IFN-I induction 
(Broz and Monack, 2013; Desmet and Ishii, 2012). One such cytosolic sensor that utilises 
this adaptor is the helicase DDX41, which was shown to recognise intracellular DNA in 






C-type lectin receptors can recognise a wide range of ligands, both pathogen-associated 
and self. They have been shown to play an important role in directly activating gene 
expression, as well as modulating the action of TLRs (Geijtenbeek and Gringhuis, 2009). 
CLRs are a group of receptors that are calcium-dependent and share a common 
carbohydrate-recognition domain, or C-type lectin-like domain (Kerrigan and Brown, 2010). 
A wide-range of CLRs are expressed by DCs and some are specifically associated with 
certain DC subsets. For example, Clec9a is expressed selectively by CD8α+ cDCs in 
mouse (Caminschi et al., 2008), and CD141+ DCs that are the human equivalent of this 
subset (Poulin et al., 2010). The CLRs expressed by DCs that act as PRRs primarily 
recognise mannose, fucose and glucan carbohydrate structures, which allows the 
recognition of a range of pathogens, including bacteria, viruses, fungi, and helminth 
parasites (Geijtenbeek and Gringhuis, 2009). Ligand-binding to CLRs leads to receptor 
clustering and to receptor phosphorylation by Src-family kinases, providing a docking site 
for the adaptor protein Syk, which initiates downstream signalling mediated by CARD9 
(Gross et al., 2006), including activation of the NFκB pathway (Kerrigan and Brown, 2010). 
Although CLRs can function in isolation to activate signalling pathways, it has also been 
shown that the CLR Dectin-1 can collaborate with TLRs 2, 4, 5, 7 and 9 to induce 
production of TNFα, CCL3 and CCL4 in an NFκB-dependent manner (Dennehy et al., 
2008), providing further evidence that PRRs should not only be considered in isolation. 
 
1.2.8 NFκB signalling in DCs 
The mammalian nuclear factor-κB (NFκB) family consists of five TFs that regulate 
inducible gene expression in a range of physiological processes. They play an essential 
role in orchestrating the activation of immune cells during an immune response and are 
integral to DC responses to Ag stimulation via PRRs, as well as cytokine signals (Hayden 
et al., 2006), such as GM-CSF. NFκB family members must dimerise to become 
functional, allowing the family to bind and modulate the transcription of a diverse range of 
genes (Gilmore, 2006).  
 
A family of inhibitory IκB proteins, which sequester inactive dimers in the cytoplasm, tightly 
regulates NFκB activity (Ghosh and Hayden, 2008). When the pathway is activated, the 
IκB protein is degraded and the NFκB complex enters the nucleus to modulate gene 
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transcription. The IKK complex consists of two kinases, IKKα and IKKβ, and the regulatory 
scaffold protein, IKKγ (NEMO) (Lawrence, 2009; Scheidereit, 2006). In the canonical NFκB 
pathway, IKKβ and IKKγ are required for the activation of NFκB complexes, whilst the non-
canonical pathway depends on the activity of IKKα (Hayden et al., 2006; Lawrence, 2009). 
Signalling downstream of MyD88 and TRIF, and other adaptor proteins, leads to the 
activation of canonical IKKβ-dependent NFκB complexes (Hayden et al., 2006). Binding of 
IL-1 and TNFα to their cognate receptors also activates the canonical NFκB pathway, 
while activators of the alternative pathway include CD40L binding to CD40 (Lawrence, 
2009).  
 
Little is known about the activation of signalling pathways in DCs following exposure to 
helminth Ag. It has been shown that NFκB1 is required for DC induction of Th2 responses 
(Artis et al., 2005), whilst others have demonstrated activation of the MAPK pathway 
following exposure to helminth Ags (Kane et al., 2004; Thomas et al., 2003). Yet, there 
remains much still to be uncovered about the role of these pathways in the polarisation of 
DCs towards Th2 induction.   
 
1.3 Antigen presentation by DCs 
The primary function of DCs is to process and present Ag to naïve T cells and to direct 
polarisation of Ag-specific adaptive responses (Kapsenberg, 2003; Steinman, 2012; Walsh 
and Mills, 2013). Key to this is the expression of MHC molecules on the surface of DCs, 
glycoprotein complexes that can bind and present peptide Ag to T cells (Villadangos and 
Schnorrer, 2007). MHC I complexes can be found on the surface of any nucleated cell and 
present Ag to CD8+ T cells (Neefjes et al., 2011). Expression of MHC II is restricted 
primarily to DCs, MΦ and B cells in the periphery, although it is also expressed by thymic 
epithelial cells (Li et al., 2005). During infection, MHC II can be upregulated on the surface 
of other innate cell populations, including basophils (Perrigoue et al., 2009; Sokol et al., 
2009) and eosinophils (Dardalhon et al., 2008; Shi, 2004). Ags on MHC II complexes are 
presented to CD4+ T cells, leading to the induction of T helper (Th) and T regulatory (Treg) 
cells (Kapsenberg, 2003; Villadangos and Schnorrer, 2007).  
 
With PRRs localised on the cell surface, in endosomes and within the cytosol, Ags both 
from within the cell (endogenous), and from the extracellular environment (exogenous) can 
! 40!
be sensed by DCs. It was originally thought that MHC I molecules presented only 
endogenous Ag, whilst MHC II bound and presented exogenous Ag (Neefjes et al., 2011). 
However, it has been shown in recent years that both classes of MHC molecules can 
present all forms of Ag. Analysis of MHC II-bound peptides has shown that a substantial 
number is derived from the cytosol (Dongre et al., 2001; Rudensky et al., 1991), indicating 
that it is not only MHC I molecules that present this class of Ag. Exogenous Ags can be 
presented on MHC I via cross-presentation, a function that is uniquely performed by 
CD8α+ cDCs and CD103+ cDCs in vivo (Desch et al., 2011; Hildner et al., 2008; Jung et 
al., 2002).  
 
In immature cDCs, MHC II is constitutively synthesised and loaded with peptide in 
endosomes, but complexes are only transiently delivered to the cell surface and are 
rapidly endocytosed and degraded (Wilson et al., 2004). In contrast, in mature cDCs, MHC 
II molecules are maintained on the cell surface and de novo generation of MHC II-peptide 
complexes is downregulated (Wilson et al., 2004), facilitating productive interactions with 
naïve T cells. pDCs do not downregulate the synthesis of new MHC II molecules following 
Ag exposure (Young et al., 2008). This leads to constant recycling of MHC II, thus pDCs 
are unable to maintain MHC II-peptide complexes on their surface for prolonged periods, 
with detrimental effects on T cell priming (Young et al., 2008). Endosomal proteases are 
also more active in pDCs, leading to rapid protein degradation, which prevents effective 
peptide loading onto MHC II (Young et al., 2008). Although these characteristics mean that 
pDCs are less able to present exogenous Ag to CD4+ T cells, they maintain the ability to 
present endogenous Ag on MHC I and MHC II following activation (Young et al., 2008), 
unlike cDCs, which may highlight an important function for pDCs to present to effector T 
cells in peripheral tissues.  
 
1.3.1 Signals involved in DC:T cell interaction 
Although the MHC-peptide complex initially mediates interaction between an Ag-loaded 
DC and a naïve T cell, other signals are also required to facilitate effective T cell 
polarisation. The ligation of the T cell receptor (TCR) by peptide-loaded MHC provides the 
first stimulatory signal, which determines Ag specificity, but it is T cell co-stimulation and 
co-inhibition, or ‘signal 2’, that directs T cell function and fate (Kapsenberg, 2003). 
Moreover, provision of signal 1 in the absence of appropriate signal 2 can lead to the 
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induction of T cell anergy - unresponsiveness to Ag, with a profound defect in T cell 
proliferation (Bour-Jordan and Bluestone, 2009; Jenkins and Schwartz, 1987). Signal 2 is 
provided by the interaction of co-stimulatory/ inhibitory molecules on the surface of DCs 
interacting with their cognate receptor/ ligand on the surface of T cells. These molecules 
often co-localise with the TCR on the T cell surface, synergising with signals via the TCR 
that promote or inhibit T cell polarisation and activation, often these signals are involved in 
the control of cell survival and proliferation (Chen and Flies, 2013). The third signal that 
directs T cell polarisation is generally cytokines provided by DCs and most likely also from 
other cells within the microenvironment. However, some co-signalling interactions are also 
sufficient to act as signal 3 (Chen and Flies, 2013).  
 
Co-stimulatory/inhibitory molecules primarily belong to either the immunoglobulin 
superfamily (IgSF) or the tumour necrosis receptor superfamily (TNFRSF). The most well 
known member of the IgSF is the receptor CD28, expressed on the surface of T cells 
(Linsley et al., 1993). The activatory ligands for this receptor are CD80 and CD86 
(Greenwald et al., 2005; Linsley et al., 1993). Other members of this family include the 
receptor/ ligand pair ICOS-ICOSL (Hutloff et al., 1999). Co-activatory members of the 
TNFRSF include CD40-CD154 (CD40L) (Caux et al., 1994), OX40-OX40L (Fillatreau and 
Gray, 2003; Ohshima et al., 1997) and RANK-RANKL (Anderson et al., 1997). The co-
stimulatory molecules expressed by DCs are upregulated on their surface following 
activation and CD28 is constitutively expressed by naive T cells, helping to ensure that 
DC:T cell interactions lead to productive polarisation of the T cell response (Chen and 
Flies, 2013; Kapsenberg, 2003) (Fig. 1.5).  
 
There are several levels of regulation of T cell co-signalling. As stated above, co-
stimulatory molecules are only upregulated on the surface of DCs following their activation 
by Ag, or in response to some inflammatory cytokines, such as TNFα. Following TCR 
ligation, the co-inhibitory receptor, CTLA-4, is released from intracellular compartments 
and transported to the site of ligation on the T cell surface (Egen and Allison, 2002; Linsley 
et al., 1996). Upregulation of CTLA-4 leads to the endocytosis and degradation of CD28 
(Berg and Zavazava, 2008). Like CD28, CTLA-4 binds to the ligands CD80 and CD86 
(Linsley et al., 1996). As well as transducing inhibitory signals following ligation by CD80 
and CD86, CTLA-4 can also capture these ligands, removing them from the surface of the 
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presenting cell and degrading them (Qureshi et al., 2011), further inhibiting co-stimulatory 
interactions. Another co-inhibitory molecule is PD-1, a member of the IgSF (Ishida et al., 
1992). It has been suggested that this receptor mediates anergy of CD8+ T cells (Chikuma 
et al., 2009; Tsushima et al., 2007). However, it may have a different role in controlling 
CD4+ T cell function, facilitating the induction of inducible Tregs (iTregs) in the periphery 
(Francisco et al., 2009; Qiao et al., 2012). A role for immature DCs in the induction of CD8+ 
T cell anergy, via their expression of PD-1 ligands and their interactions with CTLA-4, has 
been proposed (Probst et al., 2005a). DCs have also been implicated in the PD-1-
dependent induction of iTregs (Yogev et al., 2012). Thus, DCs play a central role in 
orchestrating activatory and inhibitory responses from T cells. 
 
1.3.2 CD4+ T cell subsets 
CD4+ T cells are activated only by professional APCs – restricted to those cell types that 
express MHC II, as the TCR repertoire on CD4+ T cells recognises Ag only in the context 
of the MHC II complex. Thus, CD4+ T cells are MHC II-dependent. CD4+ T cells are also 
MHC II-restricted as they can recognise Ag only when presented on MHC II. In 1986, 
distinct CD4+ T cell subsets were first described, based on differential cytokine production. 
These subsets were termed T helper 1 (Th1) and T helper 2 (Th2) cells (Mosmann et al., 
1986). Since then, these subsets have been further defined, based on the cytokines, cell 
signals and TFs required for their differentiation, as well as their distinct functions. 
Furthermore, a number of other distinct CD4+ T cell subsets have also been defined, 
including Th17 cells – named for the cytokines they produce – as well as T follicular helper 
(Tfh) cells and Tregs. Although it was once thought that these subsets were entirely 
distinct and terminally committed, there is a growing body of evidence that suggests that 
plasticity exists in vivo, allowing for some flexibility in T cell fate (Bluestone et al., 2009; 
Zhou et al., 2009) (Fig. 1.6). 
 
Th1 cells are defined by their production of IFNγ and are the primary mediators of the 
adaptive response against infection by bacteria, viruses and protozoa. IFNγ produced by 
Th1 cells has effects on many innate effectors, including stimulating the classical activation 
of MΦs to kill intracellular pathogens by various mechanisms including the production of 
nitric oxide (Walsh and Mills, 2013). IFNγ can also stimulate the activation of anti-viral 
responses and can enhance the functionality of CD8+ T cells during viral infection 
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(Platanias, 2005; Walsh and Mills, 2013). Th1 cells also provide B cell help, leading to the 
induction of antibody responses, particularly IgG2a, which is involved in opsonisation, 
complement fixation and virus neutralisation (Bluestone et al., 2009). Differentiation of Th1 
cells is generally dependent on IL-12, primarily from DCs (Hilkens et al., 1997; Macatonia 
et al., 1995). Polarisation of this subset can also be potentiated by IFNγ from NK cells and 
differentiated Th1 cells. IL-12-mediated Th1 differentiation requires signalling downstream 
of STAT4 (Thierfelder et al., 1996), and is dependent on the induction of the TF T-bet, 
which potently activates transcription of the IFNγ gene (Szabo et al., 2000). 
 
Th2 cells are induced during parasitic helminth infection and produce IL-4, IL-5, IL-9, IL-10 
and IL-13 (Pulendran and Artis, 2012). Th2 cells are also responsible for driving allergic 
responses in the airway (van Rijt and Lambrecht, 2001), and against food allergens (Berin 
and Mayer, 2009). The Th2 cytokines IL-4 and IL-13 stimulate alternative-activation of 
MΦs, which exhibit potent anti-inflammatory activity and have a role in wound healing and 
fibrosis (Murray and Wynn, 2011), playing an essential role in granuloma formation during 
helminth infection (Herbert et al., 2004). IL-13 production by Th2 cells acts directly on the 
epithelium during enteric helminth infection, enhancing smooth-muscle contractility and 
epithelial cell turnover, which can aid in helminth expulsion from the intestine (Anthony et 
al., 2007). IL-5 production by Th2 cells also activates eosinophils (EOS) and Th2 cells 
stimulate B cell production of IgE and IgG1 (Walsh and Mills, 2013). IL-4 signalling via 
STAT6 induces expression of the Th2-specific TF GATA-3 in naïve T cells, which then 
activates the IL-4 promoter (Kurata et al., 1999; Scheinman and Avni, 2009; Zheng and 
Flavell, 1997). IL-2 activation of STAT5 is also integral to Th2 differentiation (Cote-Sierra 
et al., 2004; Liao et al., 2008). However, it has been postulated that a number of different 
cytokines that activate STAT5, including thymic stromal lymphopoeitin (TSLP) and IL-7, 
could also provide this crucial signal (Rochman et al., 2009).   
 
Although DCs are required for Th2 induction in vivo (Hammad et al., 2010; Ohnmacht et 
al., 2010; Phythian-Adams et al., 2010), they do not produce IL-4 in response to Th2-
polarising Ags (Jankovic et al., 2004; MacDonald et al., 2001), nor do they need to 
produce IL-4 to prime Th2 responses (Jankovic et al., 2004; MacDonald et al., 2002a). 
Similarly, DC IL-10 is not required for this process (Perona-Wright et al., 2006a). However, 
DC expression of the co-stimulatory molecule CD40 is essential for Th2 induction 
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(MacDonald and Pearce, 2002), with CD40-CD154 interaction required for effective Th2 
development during murine S. mansoni infection (MacDonald et al., 2002b). Furthermore, 
DC expression of OX40L is necessary to maintain a sustained Th2 response (Jenkins et 
al., 2007). 
 
Although exogenous IL-4 is required to polarise Th2 cells in vitro, TCR signalling can 
induce low-level IL-4 production from T cells, which is sufficient to induce GATA-3 
expression (Yamane et al., 2005). Thus the IL-4 signal may well be cell-intrinsic, at least at 
the early stages of Th2 responses. It has been shown that IL-4 permeates responsive LN 
during helminth infection (Perona-Wright et al., 2010), which may function to enhance 
further Th2 induction. It has also been shown that Th2 cells can be polarised in vitro and in 
vivo without the ability of T cells to respond to IL-4, although they are generated at a lower 
frequency (Jankovic et al., 2000). This suggests that IL-4 may not be an essential signal 
for Th2 induction in all circumstances. 
 
Recent work has suggested that other innate cells may provide the polarising early IL-4 
signal. A candidate for this role is basophils, which can provide an early source of Th2 
cytokines in allergic responses to peptide/protein or hapten Ags (Otsuka et al., 2013; Sokol 
et al., 2008; Yoshimoto et al., 2009). Basophils may also provide an early source of IL-4 
during helminth infection (Ohnmacht et al., 2010; Perrigoue et al., 2009). It has been 
suggested that basophils can present Ag and prime Th2 cells (Perrigoue et al., 2009; 
Yoshimoto et al., 2009). However, while basophils do interact with T cells in the tissue, 
they do not interact with Ag-specific T cells in the LN, and can only produce IL-4 in a T 
cell-dependent manner (Sullivan et al., 2011). Further, basophils do express MHC II and 
can present peptide to Ag-specific T cells, but lack the machinery necessary to process 
and present complex Ag (Otsuka et al., 2013). Moreover, a number of studies have shown 
that basophils are redundant during Th2 priming (Hammad et al., 2010; Ohnmacht et al., 
2010; Phythian-Adams et al., 2010; Smith et al., 2012). Thus, this body of evidence 
discredits the idea that basophils are an essential APC population in the induction of Th2 
responses, or an essential early source of polarising IL-4.  
 
Innate lymphoid cells 2 (ILC2s), lineage-negative cells that were recently identified in the 
intestine and MLNs of mice infected with gastrointestinal helminths, and in the lungs of 
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mice in models of allergic airway responses, can also secrete Th2 cytokines during Th2 
responses (Fallon et al., 2006; Halim et al., 2012 
; Neill et al., 2010; Saenz et al., 2010). However, it has not been shown definitively that 
this population is involved in the induction of Th2 immunity, as well as at the effector stage.  
 
Whilst it cannot be denied that a number of innate cell populations play important roles 
during Th2 responses, it still remains unarguable that DCs are the primary cell type 
required for priming Th2 cells. It is still essentially unknown what the DC-derived signals 
are for Th2 induction. Thus, a major goal for the field is to understand the signals provided 
by DCs to T cells that are integral to the initiation of Th2 polarisation.   
 
Unlike Th1 responses, which are primarily characterised by T cell-derived IFNγ, there is a 
host of different Th2 cytokines, including IL-4, IL-5, IL-9, IL-10 and IL-13. It is reasonable 
to suggest that not all Th2 cells produce all these cytokines uniformly or simultaneously 
during a Th2 response. Rather, there is likely to be heterogeneity in the cytokines 
produced at different stages, at different sites and during different infection settings. For 
example, TGFβ can reprogram Th2 cells to IL-9-producing cells (Veldhoen et al., 2008). It 
has been suggested that IL-9+ Th cells represent a distinct subset (Dardalhon et al., 2008), 
but as yet no Th9-specific TF has been identified. Rather, it has been shown that IL-9 
production is dependent on IRF4 (Staudt et al., 2010) and PU.1 (Chang et al., 2010). PU.1 
is highly expressed by Th2 cells that have low-level IL-4 expression, and may enhance 
heterogeneity in Th2 cells by preventing GATA-3 from interacting with target loci (Chang et 
al., 2009; Chang et al., 2005). Thus, a switch to IL-9 production may reflect the plasticity of 
Th2 cells and their ability to respond to changes in the microenvironment. 
 
Tfh cells are a population of T cells that provide B cell help and are required for the 
formation of germinal centres (Crotty, 2011). Tfh secrete IL-21 and are defined by their 
surface expression of ICOS, PD-1, and CXCR5 (Crotty, 2011), a chemokine receptor that 
facilitates localisation within the B cell zone. Tfh are integral for the formation of germinal 
centres and provide B cell help (in the form of IL-21, CD40-L and ICOS-L) to facilitate 
class-switching and plasma cell formation (Tangye et al., 2013). The development of Tfh is 
dependent on the TF Bcl6 (Nurieva et al., 2009). IL-6 and IL-21 provide signal 3 for the 
differentiation of this T cell subset (Eto et al., 2011), whilst ICOS provides an essential 
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early signal to induce Bcl6 expression (Choi et al., 2011b). The exact cellular sources of 
IL-6 and IL-21 during Tfh differentiation are not yet known, although likely include DCs, B 
cells and T cells (Tangye et al., 2013). Studies suggest that Tfh may arise from already 
differentiated T effectors (Walsh and Mills, 2013). Indeed, with further evidence for the 
plasticity of T cell subsets, Tfh have been shown to differentiate from IL-4+ Th2 cells in the 
reactive LN in response to helminth Ag (Glatman Zaretsky et al., 2009). The primary IL-4-
producing population in the dLN during helminth infection is proposed to be Tfh (King and 
Mohrs, 2009; Liang et al., 2011). In agreement with the idea that there is heterogeneity in 
the cytokine profile of Th2 cells (Kelso et al., 1999), it has been suggested that, during 
helminth infection, IL-4+ T cells that do not express IL-13 are found in the B cell areas of 
the dLN, whilst in the tissues Th2 cells express a combination of IL-4 and IL-13, with IL-5 
primarily restricted to an IL-13+ subset (Liang et al., 2011). 
 
The existence of regulatory T cell populations (previously called suppressor T cells) had 
long been proposed, but research in this area fell out of favour due to an inability to define 
specific markers with which to identify this cell population (Basten and Fazekas de St 
Groth, 2008). Irrespective, it was known that CD4+ CD25+ T cells could provide protection 
from some inflammatory conditions, for example autoimmunity (Sakaguchi et al., 1995). 
Scepticism about existence of this cell type changed when the Treg-specific TF Foxp3 was 
identified (Fontenot et al., 2003; Hori et al., 2003). In the absence of Foxp3, there was 
found to be a deficiency in the thymic development of CD4+ CD25+ T cells (Fontenot et al., 
2003) and a significant increase in self-reactive T cells in the periphery (Kim et al., 2007). 
Thymically-derived Tregs are known as natural Tregs (nTregs), whilst regulatory T cells 
that develop in the periphery are described as inducible Tregs (iTregs). iTregs do not 
always express Foxp3, as is the case for Tr1 cells, which differentiate in response to IL-27 
and produce IL-10 (Awasthi et al., 2007). The maintenance of Tregs is dependent on IL-2 
(Fontenot et al., 2005), whilst TGFβ and retinoic acid have been shown to play a role in the 
differentiation of iTregs in the periphery (Chen et al., 2003; Cobbold et al., 2004; Coombes 
et al., 2007). Foxp3+ Tregs are induced in the steady state intestine in response to the 
microbiota and food Ags (Sun et al., 2007), a process that is dependent on intestinal DCs 
(Coombes et al., 2007; Sun et al., 2007). Tregs in this setting play an integral role in 
maintaining tolerance and preventing unnecessary immune activation against innocuous 
Ags (Pabst and Mowat, 2012).  
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A key factor that led to the discovery of Th17 cells was the finding that autoimmune 
disease was augmented in the absence of IFNγ, which at the time was thought to be the 
primary mediator of these responses (Harrington et al., 2005; Langrish et al., 2005). Th17 
cells were shown to be a separate lineage that was distinct from Th1/2 cells, with their 
development negatively regulated by IFNγ (Harrington et al., 2005; Langrish et al., 2005). 
Differentiation of Th17 cells is under control of the TF RORγt, and is dependent on STAT3. 
The cytokines TGFβ and IL-6, or IL-21, act as signal 3 for Th17 polarisation, whilst IL-23 
and IL-1β enhance Th17 development and functionality (Ivanov et al., 2006; Korn et al., 
2007; Walsh and Mills, 2013; Zhou et al., 2007). It has been shown that DCs are a crucial 
source of IL-6 for the polarisation of Th17 cells (Perona-Wright et al., 2009), it is also likely 
that DCs act as a source of IL-23 and IL-1β in this setting. There are a number of different 
sources of TGFβ in vivo, T cells, particularly Tregs, are one likely source (Li et al., 2007; 
Veldhoen et al., 2006), whilst T cells also likely provide IL-21, which may act in autocrine 
fashion (Nurieva et al., 2007). Th17 cells are thought to primarily function at mucosal sites 
(Muranski and Restifo, 2013). As such, in the steady state they are found primarily in the 
lamina propria (LP) of the intestine (Ivanov et al., 2006), but can readily be induced at 
other mucosal sites during infection (Muranski and Restifo, 2013). Consequently, Th17 
cells contribute to immune responses predominantly against a variety of extracellular 
bacteria and fungi in the gastrointestinal tract, airway, lungs and skin (Khader et al., 2009). 
Th17 cells produce large quantities of IL-17 and IL-22, which are taken up by epithelial 
cells (Khader et al., 2009), leading to production of antimicrobial peptides and chemokines 
that attract neutrophils and other granulocytes (Kumar et al., 2013) – cells that contribute 
to the clearance of bacterial and fungal pathogens (Khader et al., 2009). However, Th17 
cells are also involved in the pathogenesis of autoimmune disease in the central nervous 
system (Ivanov et al., 2006; Langrish et al., 2005), in asthma (Cosmi et al., 2011), and in 
severe immunopathology in the gastrointestinal tract and skin – such as colitis and 
psoriasis (Weaver et al., 2013).    
!
Counter-regulation and antagonism are key to balancing and maintaining CD4+ T cell 
responses. For example, T-bet suppresses transcription of the IL-4 and IL-5 genes (Szabo 
et al., 2000), whilst GATA-3 represses IL-12 induction (Ouyang et al., 1998). However, a 
growing body of evidence indicates a degree of plasticity within all T cell subsets, including 
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the ability in some contexts to co-express the subset-defining TFs and cytokines (Zhou et 
al., 2009). For example, during viral infection, stably committed Th2 cells can be 
reprogrammed to become GATA-3+ T-bet+ cells that co-produce IL-4 and IFNγ, these cells 
can persist for a period of months (Hegazy et al., 2010; Peine et al., 2013). It has recently 
been shown that stable GATA-3+ T-bet+ T cells are found in helminth infection, including 
murine models of S. mansoni and H. polygyrus (Peine et al., 2013). The authors suggest 
that these cells may function to provide both Type 1 and 2 inflammatory responses during 
helminth infection, whilst avoiding the severe immunopathology associated with highly Th1 
or Th2 skewed responses (Peine et al., 2013). 
 
It seems that Th17 cells may display the greatest degree of plasticity of all the T cell 
subsets. Whilst allergic airway disease is commonly thought of as Th2-mediated, it is 
increasingly understood that severe, steroid-resistant asthma is associated with high levels 
of IL-17 and neutrophilia in the asthmatic lung (Cosmi et al., 2011). In line with the fact that 
the allergic airway response is primarily a Th2 response, a subset of cells has been 
identified in mouse models and in human patients that co-express GATA-3 and RORγt, as 
well as Th2 and Th17 cytokines (Wang et al., 2010). It appears that context has a big 
impact on the phenotype of Th17 cells. Whilst they remain relatively stable during acute 
infection with the fungus Candida albicans, IL-17-producing cells can be induced by IL-23 
to secrete a range of other inflammatory cytokines, including IFNγ, during chronic 
autoimmune disease, such as experimental autoimmune encephalomyelitis (EAE) (Hirota 
et al., 2011). Human T cells can also display this IL-17/ IFNγ double-positive phenotype in 
vitro (Boniface et al., 2010). Given that both Th17 cells and Tregs depend on TGFβ for 
their differentiation, it is perhaps not surprising to find that there is also some crossover in 
these lineages. Even though Foxp3 inhibits IL-17 production (Zhou et al., 2008), Foxp3+ 
IL-17+ CD4+ T cells have been described both in vitro and in vivo in mouse and humans 
(Voo et al., 2009; Yang et al., 2008; Zhou et al., 2008). This degree of plasticity within the 
CD4+ T cell lineage demonstrates the complexity of the immune network and the versatility 
of the immune system to adapt to changes in the microenvironment. 
 
1.4 Intestinal myeloid populations 
The key feature of the intestinal immune system is its ability to maintain tolerance against 
dietary products and the microbiota, yet still provide protection from potential invaders 
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(Varol et al., 2010). Intestinal mononuclear phagocytes, including DCs and MΦs, are the 
crucial cell populations in this setting, maintaining intestinal homeostasis, whilst acting as 
pathogen sentinels capable of initiating a protective immune response (Coombes and 
Powrie, 2008; Varol et al., 2010). Studying intestinal myeloid populations presents 
significant challenges, as isolation of cells from the intestinal tissue is difficult, particularly 
under inflammatory and infection conditions. Additionally, the overlapping expression 
profiles of the surface markers on intestinal DCs and MΦs has led to confusion and 
conflicting reports on these distinct cell populations. Increasingly, however, a consensus is 
emerging and our understanding of these cells and their role in immune processes has 
improved significantly in recent times.  
 
1.4.1 Intestinal DCs 
Intestinal DCs are located in organised lymphoid tissues, such as Peyer’s Patches (PPs) 
and isolated lymphoid follicles (ILFs), as well as distributed throughout the villous lamina 
propria (LP) (Coombes and Powrie, 2008; Johansson-Lindbom et al., 2005; Scott et al., 
2011). DCs at these sites are further subdivided into specific subsets, based on their 
surface expression of CD11b and the integrin CD103 (αEβ7) (Bogunovic et al., 2009; 
Varol et al., 2010) (Fig. 1.7). Intestinal DCs constantly monitor the mucosa, capturing Ag 
and constitutively trafficking to the MLNs in the steady state (Cerovic et al., 2012). 
Interaction of T cells with intestinal DCs in the MLNs leads to the generation of gut-tropic T 
cells that upregulate the gut-homing markers CCR9 and α4β7 (Jaensson et al., 2008; 
Johansson-Lindbom et al., 2005), a process that is dependent on the ability of intestinal 
DCs to metabolise dietary retinoids to retinoic acid (RA) (Iwata et al., 2004). It was 
originally reported that CD103+ DCs are uniquely able to generate a gut-tropic T cell 
population (Jaensson et al., 2008). However, recent work has shown that CD103- CD11b+ 
DCs migrating from the intestine also have the capacity to confer gut tropism on 
differentiating T cells (Cerovic et al., 2012). This discrepancy may reflect the fact that 
Cerovic et al. restricted their analysis to the DC subsets migrating in the intestinal lymph, 
whilst previous studies tested the DC populations found in the MLNs, PPs or LP (Jaensson 
et al., 2008; Johansson-Lindbom et al., 2005). Presentation of innocuous Ag, such as 
dietary products or commensal bacteria, by intestinal DCs in the absence of an 
inflammatory stimulus does not lead to the initiation of an immune response but induces a 
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state of tolerance and immune unresponsiveness (Pabst and Mowat, 2012; Scott et al., 
2011; Worbs et al., 2006).  
 
Intestinal DCs, particularly CD103+ DCs, display a potent capacity to induce the generation 
of Foxp3+ Tregs in the steady state (Coombes et al., 2007), which may help to maintain a 
tolerogenic environment (Hadis et al., 2011). RA acts as a co-factor for the TGFβ-
mediated generation of Foxp3+ Tregs by intestinal DCs (Coombes et al., 2007). Intestinal 
DCs themselves may well provide a source of TGFβ for Treg induction, as CD103+ LP 
DCs express high levels of the TGFβ gene (Coombes et al., 2007). CD103+ MLN and LP 
DCs also express the αvβ8 integrin (Worthington et al., 2011), which converts the latent 
form of TGFβ to its active state (Mu et al., 2002). In the absence of αvβ8 on intestinal DCs, 
the normal population of intestinal Tregs is not maintained, leading to severe pathology 
(Travis et al., 2007). These properties are not shared by CD103+ DCs in other tissues, and 
seem to be imprinted on DCs by the gut itself (Scott et al., 2011). Intestinal epithelial cells 
may play a role in this, promoting a tolerogenic phenotype in gut DCs via their production 
of TGFβ, RA and TSLP (Iliev et al., 2009a; Iliev et al., 2009b). It has also been postulated 
that constitutive exposure to dietary metabolites and commensal-derived microbial 
components contributes to the conditioning of DCs and promotes a tolerogenic 
microenvironment in the steady state gastrointestinal tract (Scott et al., 2011). 
 
The intestinal DC subsets have distinct transcriptional requirements for their development, 
with the differentiation of the CD103+ CD11b- LP population (like the CD8α+ splenic cDC 
subset) dependent on Id2, IRF8 and Batf3 (Edelson et al., 2010; Ginhoux et al., 2009). 
The differentiation of the CD103+ CD11b+ LP DC population is dependent on IRF4 
(Persson et al., 2013). This subset of LP DCs also depends on Notch2 signalling for their 
development (Satpathy et al., 2013). As in other tissues, GM-CSF is required for CD103+ 
LP DC homeostasis (Greter et al., 2012) and Flt3-L is required for their differentiation 
(Bogunovic et al., 2009; Ginhoux et al., 2009). Like other CD11b+ DC subsets, the CD103- 
CD11b+ LP DC population is also deficient in CD11c-specific, IRF4-deficient animals in the 
steady state, although this subset is restored under inflammatory conditions (Persson et 
al., 2013).  
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Although CD103+ LP DC subsets are well known for their ability to polarise Foxp3+ Tregs, 
CD11c-specific IRF4-deficient mice have a selective deficiency in the intestinal Th17 
population, with further analysis demonstrating that the CD103+ CD11b+ LP DC subset is 
an essential source of IL-6 that is required for Th17 development in the intestine (Persson 
et al., 2013). This finding demonstrates that the intestinal DC subsets do not have discrete 
functions in controlling the intestinal immune system. Indeed, despite early studies 
suggesting that CD103+ DCs are the only LP DC subset to migrate to the MLN and 
polarise T cells (Schulz et al., 2009), comprehensive characterisation of cells in intestinal 
lymph highlights that the CD103+ CD11b+, CD103+ CD11b- and CD103- CD11b+/- LP DC 
subsets all migrate, and can be present in similar proportions to those found in intestinal 
tissue (Cerovic et al., 2012). Further to this, all of the LP DC subsets show some capacity 
to stimulate T cell proliferation and imprint gut tropism (Cerovic et al., 2012) (Fig. 1.9).  
 
A glaring omission in the characterisation of the LP DC subsets is any level of 
understanding of the role of these cells in active infection. This is an area of ongoing study 
for many groups. A very recent study has demonstrated that Notch2-dependent CD103+ 
CD11b+ LP DCs are an essential source of IL-23 during infection with the pathogenic 
bacteria, Citrobacter rodentium (Satpathy et al., 2013). Production of IL-23 by CD103+ 
CD11b+ DCs is essential for host survival. The roles that different intestinal DC subsets 
may play in the induction of Th2 responses is unknown. 
 
1.4.2 Macrophages in the intestine 
Many studies mistakenly characterise LP MΦs as a DC population, due to their mid- to 
high-level expression of the DC-associated marker CD11c (Bogunovic et al., 2009; 
Ginhoux et al., 2009; Niess and Adler, 2010; Niess et al., 2005). Initially, a population of 
CX3CR1+ DCs was identified in the LP (Niess et al., 2005). Expression of CX3CR1 (the 
fractalkine receptor) allows this cell population to interact with epithelial cells expressing 
CX3CL1 and to form dendrites, which traverse the epithelial layer and sample Ag from the 
lumen (Niess et al., 2005). However, further characterisation of this population revealed 
that CX3CR1+ myeloid cells are in fact MΦs, not DCs. This was demonstrated by the fact 
that the LP MΦ population has a distinct ontogeny to LP DC subsets, differentiating from 
monocytes in response to M-CSF, whilst the LP DCs develop from CDPs in a Flt3-L 
dependent manner (Bogunovic et al., 2009; Ginhoux et al., 2009; Varol et al., 2009). 
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Further, LP DC subsets express the cDC TF Zbtb46, whilst intestinal MΦs do not 
(Satpathy et al., 2012a). Importantly, CX3CR1+ MΦs do not migrate to the MLN and 
display poor T cell priming ability (Cerovic et al., 2012; Schulz et al., 2009). However, to 
add to the confusion surrounding this issue, CX3CR1 expression is not restricted to LP 
MΦs alone, as some LP DCs can also express this marker, although at much lower levels 
(Bain et al., 2012; Cerovic et al., 2012). Thus, CD64, or FcγR1, is increasingly being used 
as an alternative marker to CX3CR1 to differentiate between LP DCs and MΦs, as it 
appears to be expressed selectively by the MΦ population (Bain et al., 2012; De Calisto et 
al., 2012; Tamoutounour et al., 2012).  
 
What is the function of LP MΦs, which do not migrate (at least in the steady state), and 
therefore do not contribute to T cell priming? As highlighted above, LP MΦs are capable of 
sampling Ag from the lumen (Niess and Reinecker, 2005), perhaps providing a source of 
Ag for LP DCs to present to T cells in the MLN (Schulz and Pabst, 2013; Varol et al., 
2010), for tolerance induction in the steady state or to aid the induction of the adaptive 
response during active infection (Niess and Reinecker, 2005). Human intestinal MΦs are 
highly phagocytic (Smythies et al., 2005) and CX3CR1+ MΦs in mouse are found adjacent 
to the intestinal epithelium, whilst LP DCs reside in the core of the villus (Schulz et al., 
2009). These characteristics are all in agreement with the Ag-sampling function of LP 
MΦs. It has also been suggested that these cells may function to take up and destroy free 
Ag, before it is capable of activating an unnecessary immune response (Persson et al., 
2010). 
 
Although the initial generation of gut-tropic Tregs occurs in the MLNs, under the control of 
intestinal DCs, their full differentiation depends on their migration to the intestinal mucosa, 
where they undergo further expansion under the influence of IL-10-producing CX3CR1+ 
MΦs (Hadis et al., 2011), indicating an important role for LP-resident MΦs in maintaining 
immune tolerance in the steady state. The production of IL-10 by LP MΦs depends on 
their expression of CX3CR1 (Hadis et al., 2011), further demonstrating the importance of 
the epithelial cell layer in the induction and maintenance of immune tolerance. Similarly to 
LP DC subsets, intestinal MΦs have a tolerogenic phenotype in the steady state and are 
refractory to TLR stimulation (Bain et al., 2012; Denning et al., 2007; Monteleone et al., 
2008). Whether this phenotype is maintained during infection remains to be determined. 
! 53!
However, gene expression analysis of LP-resident MΦs demonstrates that this cell 
population displays a non-inflammatory profile in a DSS-dependent model of colitis 
(Zigmond et al., 2012).  
 
In the steady state, the LP MΦ population is renewed by Ly6Chi CX3CR1lo monocytes 
recruited from the blood (Bain et al., 2012; Varol et al., 2009). However, under 
inflammatory conditions this process is not maintained and inflammatory monocytes 
accumulate (Bain et al., 2012; Zigmond et al., 2012). This occurs both in models of colitis 
(Bain et al., 2012; Platt et al., 2010; Tamoutounour et al., 2012; Zigmond et al., 2012) and 
during infection with the parasitic protozoan species Toxoplasma gondii (Grainger et al., 
2013). Unlike steady state LP MΦs, inflammatory monocytes in the colitic large intestine 
are responsive to TLR stimulation, producing higher levels of inflammatory mediators, 
such as IL-6, TNFα and nitric oxide (Bain et al., 2012; Tamoutounour et al., 2012; Zigmond 
et al., 2012). Tamoutounour et al. (2012) demonstrated that inflammatory monocytes also 
accumulate in the MLNs and can polarise Th1 IFNγ+ cells. The authors suggested that 
inflammatory monocytes could orchestrate the inflammatory T cell response in this setting 
as inflammation develops in CCR7-deficient animals, indicating that migrating DCs do not 
play a role (Tamoutounour et al., 2012). In contrast, Zigmond et al. (2012) demonstrated 
that inflammatory monocytes acquire expression of the DC TF Zbtb46, are capable of 
migrating in intestinal lymph, and can stimulate T cell proliferation. The discrepancies in 
the findings of these groups may relate to the use of different colitis models: the T cell 
transfer model (Tamoutounour et al., 2012) vs. DSS-induced inflammation (Zigmond et al., 
2012). Nonetheless, both of these studies propose a role for monocytes in priming T cells 
under inflammatory conditions, suggesting that infiltrating innate cell populations can 
directly control the adaptive immune response. In contrast, in T. gondii infection, infiltrating 
inflammatory monocytes in the small intestinal LP (SI LP) regulate the expansion of 
infiltrating neutrophils and dampen immunopathology in the gut (Grainger et al., 2013), 
suggesting that there is diversity in the impact of monocytes on intestinal inflammation 
depending on context. 
 
Yet to be addressed is the role of these cells, or LP-resident myeloid cell populations, in 
the immune response against parasitic helminth infection in the intestine, a unique setting 
where AAMΦs are essential (Herbert et al., 2004; Herbert et al., 2010). In Litomosoides 
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sigmodontis infection (where the adult worms reside in the pleural cavity (Le Goff et al., 
2000), resident MΦs become alternatively-activated. Further, an increase in MΦ numbers 
at the infection site is due to the proliferation of the resident population, under control of IL-
4 signalling (Jenkins et al., 2011). In this setting, there is only a very minor influx of 
inflammatory monocytes, relatively late in infection. Thus the role of myeloid cells, 
including their proliferation/recruitment, activation and interaction with other cell types, may 
be entirely different during Th2 infections and inflammation than even the limited 
descriptions that currently exist in Th1/17 infection settings. 
 
1.5 Type I IFN 
Although IFN-I provides the first line of defence against viral infection, this family of 
cytokines has broad and wide-reaching influence on a range of immune mechanisms, and 
is capable of activating the expression of several hundred to over a thousand different 
genes (de Veer et al., 2001; Der et al., 1998; Lanford et al., 2006). Further, IFN-I plays a 
unique role in the immune system, due to its ability to influence both innate and adaptive 
immunity.  
 
1.5.1 Activation and signalling downstream of IFNAR 
IFN-I is a large cytokine family in humans and mice, comprising 12 IFNα subtypes (IFNα1-
13, IFNα1 and IFNα13 are identical), IFNβ, IFNε, IFNκ and IFNω (Piehler et al., 2012). 
Despite the size of this family, all subtypes bind to a common receptor – IFNAR, a 
heterodimer comprised of IFNAR1 and IFNAR2 subunits (Platanias, 2005). IFNAR1 has 
low affinity, and IFNAR2 high affinity, for their ligands (de Weerd and Nguyen, 2012). The 
IFNα subtypes display 70-80% sequence homology and share around 35% homology with 
IFNβ (Genin et al., 2009). The affinity each IFN-I subtype has for its receptor, the stability 
of the ternary complex formed by ligand binding, and the number of receptors present on 
the cell surface, all impact on the gene expression profile that follows IFNAR ligation (de 
Weerd and Nguyen, 2012; Kalie et al., 2008; Levin et al., 2011; Piehler et al., 2012). The 
genes activated by IFN-I also depend on the range of IFN-I subtypes that are present, as 
distinct Ags stimulate production of a specific suite of IFN-I family members (Genin et al., 
2009; Hillyer et al., 2012).  
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IFNAR2 has three isoforms, transcribed from the same gene by alternative splicing (de 
Weerd and Nguyen, 2012). The most well characterised isoform, IFNAR2c, exists in a long 
transmembrane form with a complete intracellular domain (de Weerd and Nguyen, 2012). 
This isoform is required for optimal IFNAR signalling and induction of anti-viral responses 
(Cohen et al., 1995). IFNAR2b is a short transmembrane form, which lacks the intracellular 
domain, and there is some suggestion that this form may act as a dominant negative, or 
decoy, receptor (Gazziola et al., 2005; Pfeffer et al., 1997). IFNAR2a is a soluble isoform, 
it has been shown that it can inhibit binding of IFN-I to IFNAR1-IFNAR2c, and may 
antagonize downstream signalling, however, this has so far only been documented in vitro 
(Hardy et al., 2001). 
 
Signalling downstream of IFNAR is dependent on Janus activated kinase (JAK) and STAT 
activity. IFNAR1 is constitutively associated with the JAK tyrosine kinase 2 (TYK2), whilst 
IFNAR2 associates with JAK1 (de Weerd and Nguyen, 2012; Platanias, 2005). The 
receptor-associated JAKs become autophosphorylated and activated following ligand-
dependent rearrangement and dimerisation of the receptor subunits (Platanias, 2005). The 
activated receptor-associated JAKs then phosphorylate STATs, which form homo- or 
heterodimers and translocate to the nucleus to regulate gene transcription, binding to 
specific sites in the promoters of ISGs (de Weerd and Nguyen, 2012; Piehler et al., 2012). 
The STATs activated by IFN-I include STAT1, STAT2, STAT3 and STAT5 (Platanias, 
2005).  
 
Following ligation of IFNAR, a homodimer of STAT1 and STAT2 can form a complex with 
IRF9 called IFN-stimulated gene factor 3 (ISGF3), which binds to IFN-stimulated response 
elements (ISREs) in the promoter regions of ISGs (Platanias, 2005) (Fig. 1.8). This 
transcriptional activator is particularly important in potentiating the IFN-I signal, as it 
stimulates the transcription of the IRF7 gene, itself an essential TF for the induction of the 
full family of IFNα subtypes (Marie et al., 1998; Sato et al., 1998). STAT complexes that do 
not recruit IRF9 bind to IFNγ-activated site (GAS) enhancer elements in gene promoters, 
activation of which can be induced by both IFN-I and IFNγ (Gonzalez-Navajas et al., 2012; 
Platanias, 2005). Some genes have only ISREs or only GAS elements, whilst others have 
both elements, thus a combination of different STAT-containing complexes may be 
required for optimal transcription of a particular gene.   
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IFNAR ultilises a number of other signalling pathways to alter gene transcription and 
cellular function, including MAPK and activation of a CRK-dependent pathway. The 
adaptor protein CRK-like (CRKL) associates with TYK2 and becomes phosphorylated 
following ligation of IFNAR (Ahmad et al., 1997). Activated CRKL then forms a complex 
with IFN-I-activated STAT5, this complex translocates to the nucleus and binds GAS 
elements to activate ISGs (Fish et al., 1999) (Fig. 1.9a). Phosphorylation of CRKL also 
leads to the activation of C3G – a guanine-nucleotide exchange factor (GEF), which 
faciliatates the activation of the GTPase Rap1 (Raaijmakers and Bos, 2009) (see Fig. 
1.9a). Rap1 and its downstream effectors are major players in the regulation of integrin 
activation, and therefore cell adhesion, migration and cell-cell interactions (Boettner and 
Van Aelst, 2009; Ebisuno et al., 2010; Hogg et al., 2011).  
 
Of all the MAPK pathways, it seems that p38 is the most important for mediation of IFN-I-
activated signals (Platanias, 2005). Phosphorylation of p38 leads to its activation; this 
process is dependent on a three-kinase relay system, which involves MAPKKK 
phosphorylating and activating MAPKK, which lastly activates MAPK, itself also a kinase 
(Zhang and Dong, 2005) (Fig. 1.9b). Activated p38 subsequently regulates activation of 
multiple downstream effectors, including MAPK-activated protein kinase 2 (MAPKAPK2), 
MAPKAPK3, mitogen- and stress-activated kinase 1 (MSK1) and MAPK-interacting protein 
kinase 1 (MNK1) (Platanias, 2005). 
 
1.5.2 DC sources of IFN-I 
pDCs are often described as “professional” IFN-I producers because of their ability to 
respond to viral challenge, particularly via TLR7/9, with rapid and robust IFN-I production 
(Reizis et al., 2011). Other cell types, including cDCs, respond to viral infection with a 
much lower level, but more prolonged, IFN-I signal. This raises the question of why we 
need a dedicated cell type for an IFN-I response. The rapid yet transient IFN-I signal from 
pDCs may provide a necessary stimulus to activate an immune response, whilst avoiding 
excessive uncontrolled inflammation that could prove damaging in the long-term. This is 
advantageous in viral infection because many viruses need to be detected and controlled 
within a matter of hours to prevent dangerous cell damage or rapid replication that is 
difficult to curtail, and can lead to T cell exhaustion (Swiecki et al., 2010). The role of pDCs 
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as a source of IFN-I is not restricted to antiviral responses, however, as they can also 
respond to self nucleic acid ligands that are released following tissue injury. For example, 
pDC production of IFN-I is key to orchestrating immune activation and wound healing 
following damage to the skin (Gregorio et al., 2010). Thus, pDCs function primarily as 
immune sentinels and IFN-I producers, with antigen-presentation to T cells a secondary 
concern.  
 
1.5.3 Impact of IFN-I on DC function 
A number of studies have suggested a role for IFN-I in controlling DC turnover and survival 
in vivo. Purified CD11c+ cells from the spleen of IFNAR-deficient mice are more resistant to 
apoptosis in vitro, whilst systemic IFNα administration augments DC turnover (Mattei et al., 
2009). These findings suggest that IFN-I may promote DC apoptosis. Indeed, IFN-I can 
induce expression of pro-apoptotic molecules and caspases by BMDCs and splenic cDCs 
(Fuertes Marraco et al., 2011; Mattei et al., 2009; Yen and Ganea, 2009), whilst systemic 
pI:C and LCMV infection – both potent stimulators of IFN-I – lead to a significant depletion 
of cDCs in the spleen (Fuertes Marraco et al., 2011). During viral infection, pDCs also 
upregulate caspases and pro-apoptotic proteins, undergoing IFNAR-dependent cell death 
(Swiecki et al., 2010). This enhancement of pDC turnover may serve to prevent excessive 
IFN-I-mediated cell activation; similarly, a reduction in cDC numbers would also help to 
curtail an immune response. Thus, the interplay between IFN-I and DCs is complex, and 
the effects of IFN-I on DC function multi-faceted. 
  
Whilst pDC IFN-I acts as a short, sharp signal to cells in the surrounding 
microenvironment, cDCs produce low-level IFN-I that acts as an autocrine stimulus to 
enhance cDC function (Montoya et al., 2002). For example, optimal IL-12 production by 
GMDCs and human mo-DCs following TLR stimulation depends on an endogenous IFN-I 
signal (Gautier et al., 2005). In the absence of functional IFNAR, or following IFNAR 
blockade, the ability of DCs to produce both IFN-I and IL-12 is severely compromised. This 
effect was seen in DCs exposed to pI:C and R848, which stimulate TLR3/ cytosolic nucleic 
acid sensors, and TLR7/8 respectively, but also following stimulation with LPS alone or in 
combination with pI:C/ R848 (Gautier et al., 2005). In the absence of IFNAR signalling in 
vivo, splenic or LN cDCs also display a more muted level of surface activation in response 
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to systemic pI:C treatment, and their ability to prime naïve CD4+ T cells is severely 
impaired (Kurche et al., 2012; Longhi et al., 2009).  
 
1.5.4 DC IFN-I and activation of immune responses against pathogens  
As suggested by the work described above studying cDC responses to LPS, cDC IFN-I 
also has a role to play in immune activation against bacteria infection. IFN-I signalling is 
required for protection against infection by a range of bacterial species, including group B 
streptococci (GBS), pneumococci and Escherichia coli (Mancuso et al., 2009). In the case 
of GBS, cDCs are the primary source of IFN-I, utilising a distinct TLR7/ IRF1-dependent 
pathway to initiate IFN-I production (Mancuso et al., 2009). The importance of cDC-derived 
IFN-I in this setting was demonstrated in TLR7-deficient and IRF1-deficient animals, which 
are highly susceptible to GBS infection (Mancuso et al., 2009). GMDCs also produce IFNβ 
following exposure to fungal pathogens, including Candida species and Saccharomyces 
cerevisiae (Biondo et al., 2011; Bourgeois et al., 2011; Del Fresno et al., 2013). In the 
absence of the IFN-I response, mice infected with C. albicans are unable to control fungal 
growth and are more susceptible to infection than wild-type (WT) animals (Biondo et al., 
2011; Del Fresno et al., 2013). This susceptibility is associated with a reduction in 
neutrophil and CD4+/CD8+ T cell infiltration (Del Fresno et al., 2013).  
 
A systemic IFN-I signal is required for DC mobilisation during Plasmodium infection 
(Guermonprez et al., 2013). This involves a complex pathway where IFN-I regulates uric 
acid production by infected erythrocytes, these uric acid crystals trigger Flt3-L release from 
mast cells, and Flt3-L facilitates the expansion of the CD8α+ cDC population, which greatly 
enhances the magnitude of the CD8+ T cell response. Cross-presentation by CD8α+ cDCs 
is essential for CD8+ T cell priming during viral infection and in anti-tumour responses 
(Hildner et al., 2008). The ability of CD8α+ cDCs to cross-present and activate CD8+ T cells 
depends on their ability to respond to IFN-I, at least in the context of viral infection (Le Bon 
et al., 2003; Pinto et al., 2011), and in immune rejection of tumours (Diamond et al., 2011; 
Fuertes et al., 2011), demonstrating the importance of IFN-I for optimal DC function in 




1.6 Helminth infection 
1.6.1 Schistosome infection 
200 million people worldwide, primarily in tropical and subtropical regions, are chronically 
infected with schistosome parasites (Wilson et al., 2007). Schistosome infection is 
predominantly a problem for developing countries in the tropics, however, the increase in 
foreign travel to these areas and the fact that this is a water-borne disease, mean that 
more Westerners are also being exposed to infection. Schistosomes are intravascular 
trematodes and are unusual helminths because of the fact that they can cause severe 
disease, which can be lethal (Gryseels et al., 2006). Three parasite species cause most 
cases of human schistosomiasis: Schistosoma mansoni, Schistosoma haematobium and 
Schistosoma japonicum (Dunne and Cooke, 2005; Gryseels et al., 2006). It is estimated 
that around 280,000 deaths a year in sub-Saharan Africa are due to S. mansoni and S. 
haematobium infection (Pearce and MacDonald, 2002).  
 
Schistosoma cercariae are shed by the intermediate host, freshwater snails, and can 
survive for up to 72h in the water, seeking the skin of a suitable definitive host (Gryseels et 
al., 2006). Following penetration of the skin, larvae migrate in the blood via the lungs to the 
perivesical (S. haematobium) or mesenteric (other species) vasculature, where they 
develop into adult worms and pair-up (Wilson and Barnes, 1977). Around 30-32 days after 
infection, female worms begin to release eggs (Pellegrino et al., 1962), and it is estimated 
that the female worms of the African species (S. mansoni and S. haematobium) lay 
hundreds of eggs a day (Gryseels et al., 2006; Moore and Sandground, 1956; Wilson et 
al., 2007). Following worm pairing, female worms begin to express a TGFβ family member, 
S. mansoni Inhibin/Activin (SmInAct), in their reproductive tract (Freitas et al., 2007). This 
molecule is also expressed in eggs laid by female worms, and is essential for development 
of the parasite embryo and reproductive success of the adult worm (Freitas et al., 2007). It 
takes approximately 6 days for S. mansoni eggs to fully mature once they have been laid 
(Pellegrino et al., 1962), and from around day 42 of infection eggs are detectable in the 
faeces (Moore and Sandground, 1956). S. mansoni eggs must pass from the vasculature 
into the intestinal lumen in order to exit the host (Pearce and MacDonald, 2002), whilst S. 
haematobium eggs traverse the bladder wall and are excreted in the urine (Gryseels et al., 
2006). S. mansoni eggs are also swept from the vasculature into the liver by the flow of 
blood. Eggs trapped in the liver cause extreme pathology and can lead to gross periportal 
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fibrosis and hypertension (Wilson et al., 2007). Severe morbidity is associated with the 
egg-specific Type 2 inflammation and granulomas in the gut and liver tissues (S. mansoni) 
or the urogenital tract (S. haematobium) (Dunne and Cooke, 2005).  
 
The fibrotic response in S. mansoni infection is initiated by and dependent on CD4+ T cells 
(Phillips et al., 1977), leading to the generation of collagen-rich granulomas that 
encapsulate eggs trapped in the tissue, sequestering egg products (Pearce and 
MacDonald, 2002). Granulomas are primarily made up of immune cells, including CD4+ T 
cells, EOS and MΦs (Pearce and MacDonald, 2002; Weinstock and Boros, 1983). Around 
the onset of egg deposition a strongly Th2-polarised immune response develops, and it is 
Ags released by the eggs themselves that initiate this response (Grzych et al., 1991; 
Pearce et al., 1991). In the absence of the Th2 cytokines IL-4 and IL-13, the 
granulomatous response is curtailed in the liver and the intestine, leading to severe Th1-
skewed inflammation in the intestine, a breakdown of intestinal barrier function and an 
increase in mortality (Fallon et al., 2000). In mice that are deficient in these Th2 cytokines 
severe haemorrhagic lesions develop in the mucosa of the small intestine (Brunet et al., 
1997; Fallon et al., 2000), which may allow the translocation of commensal bacteria from 
the intestinal lumen, with death likely caused by cytokine-induced septic shock (Fallon et 
al., 2000; Wilson et al., 2007). IL-4 is also required to protect against severe liver damage 
(Brunet et al., 1999; Brunet et al., 1997), in the absence of the granulomatous response, 
there is toxic leakage of egg components into the tissue, this leads to necrosis, as 
hepatocytes are susceptible to egg-derived toxins (Pearce and MacDonald, 2002; Wynn et 
al., 2004). The importance of IL-4 and IL-13 in the development of granulomas during S. 
mansoni infection is further demonstrated by the fact that this response is also curtailed in 
the absence of the IL-4 receptor α subunit (a component of the IL-4 and IL-13 
receptor)(Jankovic et al., 1999) and STAT6-deficient mice (activated downstream of IL-4 
and IL-13 receptors)(Kaplan et al., 1998). The Th2 response not only prevents the 
development of this severe pathology, but is also required for the successful transit of 
eggs through the intestinal tissue (Fallon et al., 2000). In IL-4-deficient and IL-4/IL-13-
deficient animals, eggs cannot successfully traverse the intestine and become trapped in 
the intestinal wall, leading to a dramatic reduction in the number of eggs present in the 
faeces (Fallon et al., 2000). This demonstrates the importance of a functional Th2 
granulomatous response not only for the protection of the host, but also to mediate the 
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successful trafficking of parasite eggs out of the host. A functional T cell response is also 
required for the generation of antibodies that protect from the hepatotoxicity of parasite 
excretory/ secretory products (Doenhoff et al., 1981), such as omega-1 (Dunne et al., 
1981), a highly immunostimulatroy molecule secreted by S. mansoni eggs (Everts et al., 
2012; Everts et al., 2009; Steinfelder et al., 2009).   
 
Similarly to Il4-/-/Il13-/- mice, study of S. mansoni infected LysMCreIL-4Rα-/flox mice, which are 
unable to respond to IL-4/13 in the neutrophil and macrophage compartment, display an 
increased Th1 response, and severe intestinal damage leading to bacterial translocation 
and sepsis (Herbert et al., 2004). This phenotype is not dependent on neutrophils, rather 
demonstrating the importance of alternatively-activated MΦs (AAMΦs) in the intestinal 
response (Herbert et al., 2004). This is in agreement with an earlier finding that the 
majority of cells within intestinal granulomas are MΦs (Weinstock and Boros, 1983).  
 
These studies in mice that are deficient in Th2 responses demonstrate that Th2 immune 
activation is host protective and is required for wound healing following the damage 
caused to organs by egg transit. However, there is no real evidence that this response is 
able to kill or expel schistosome worms, whereas in intestinal helminth infection, the Th2 
response is more effective in bringing about parasite expulsion (Anthony et al., 2007). This 
suggests that the localisation of schistosomes is key to their longevity and to the failure of 
the Th2 response to successfully target such intravascular parasites for destruction or 
removal.     
 
The peak of the Th2 response during murine S. mansoni infection is around d56 of 
infection (Pearce and MacDonald, 2002). From d84 onwards this acute Th2 response 
gives way to a more regulatory phenotype (Dunne and Cooke, 2005). This timepoint is 
also characterised by T cell exhaustion, whilst Th2 cell numbers are not reduced, these 
cells display an inability to proliferate (Taylor et al., 2009). The regulatory phenotype in 
chronically infected mice is characterised by downmodulation of the granulomatous 
response in the liver and the colon, but not the small intestine (Weinstock and Boros, 
1981). Downmodulation of this response in the colon is associated with a reduction in 
CD4+ T cell infiltration and reduced collagen deposition in granulomas, likely caused by a 
significant decrease in Th2 cytokines in the tissue environment (Turner et al., 2011). 
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Regulation of granuloma formation in the colon is mediated by Tregs and an increase in 
TGFβ (Turner et al., 2011). Tregs also prevent the development of severe pathology in the 
liver (Layland et al., 2007), by both IL-10 dependent and independent mechanisms 
(Baumgart et al., 2006; Hesse et al., 2004). However, IL-10 production is not restricted to 
Tregs as CD4+ T effectors and innate cells are important sources of IL-10 during S. 
mansoni infection (Dewals et al., 2010; Hesse et al., 2004). Whilst IL-10 and TGFβ are 
essential regulators of the immune response in the liver (Herbert et al., 2008), it has been 
demonstrated that Arginase-I production by AAMΦs is a primary regulatory factor in the 
small intestine, and is essential for preventing excessive tissue injury (Herbert et al., 2010; 
Pesce et al., 2009). 
 
Many people suffering from chronic schistosomiasis also display downmodulation of 
immune mechanisms, demonstrated by a reduction in lymphocyte responsiveness to Ags 
from different schistosome lifecycle stages in individuals chronically infected with S. 
mansoni (Ottesen et al., 1978). The schistosome-specific IL-5 and IFNγ responses of 
peripheral blood mononuclear cells (PBMCs) from individuals reinfected with S. 
haematobium after drug treatment are also reduced compared to uninfected subjects 
(Grogan et al., 1998), whilst infected individuals living in an area where S. mansoni is 
endemic also display a reduction in IFNγ responses compared to “endemic normals” 
(those who are egg-negative) (Viana et al., 1994). PBMCs from individuals who are 
chronically infected with S. mansoni also display a reduction in their ability to produce IFNγ 
(de Jesus et al., 1993; Zwingenberger et al., 1989). In agreement with this regulatory 
phenotype, PBMCs purified from S. haematobium infected children display increased 
schistosome-specific IL-10 production (Meurs et al., 2011; van den Biggelaar et al., 2000). 
However, the pro-inflammatory cytokine response to TLR2 ligands is enhanced, 
suggesting that suppression of the host immune system in schistosome-infected 
individuals is not total (Meurs et al., 2011). As such, systemic IL-4, IL-10 and IL-13 levels 
are reduced in S. haematobium infected individuals, however IL-2 and IFNγ in the serum 
of these subjects is elevated compared to those that are egg-negative (Milner et al., 2010).  
 
In agreement with findings from mouse models of schistosome infection (Brunet et al., 
1997; Fallon et al., 2000), asymptomatic schistosomiasis in humans is associated with 
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elevated IL-5, whilst those suffering from severe hepatosplenic disease display high levels 
of IFNγ, TNFα and nitric oxide (Mwatha et al., 1998).  
 
Despite the downregulation of immune function in chronically infected individuals, 
immunity to schistosome infection does eventually develop. Children in schistosome 
endemic areas are heavily infected, whilst adults living in the same areas show low or no 
detectable signs of infection (Butterworth et al., 1988; Chandiwana and Woolhouse, 1991). 
This is the case despite equal exposure of adults and children to water heavily infested 
with schistosome larvae (Kabatereine et al., 1999). The development of immunity occurs 
at an earlier age in individuals living in areas where transmission is high, suggesting that 
resistance to reinfection develops after a certain number of transmissions (Woolhouse et 
al., 1991). However, there also seems to be adult-intrinsic immunity to schistosomes that 
children lack. This is illustrated by the development of acquired immunity within 3 years of 
adults being exposed to schistosomes, whilst children under the same conditions remain 
susceptible to reinfection (Naus et al., 1999; Stelma et al., 1993).  
 
The exact nature of the protective immune response has not been identified. However, 
enhanced antibody responses, particularly IgE and IgG1 (Black et al., 2010; Demeure et 
al., 1993; Mutapi et al., 1998; Pinot de Moira et al., 2010), have been associated with 
resistance to reinfection (Hagan et al., 1991; Mutapi et al., 2008). It has been suggested 
that this protective antibody response is stimulated by the death of adult worms, providing 
an antigenic stimulus that generates antibodies to inhibit worm fecundity (Mitchell et al., 
2012; Woolhouse and Hagan, 1999). The average lifespan of worms is around 5-10 years 
(Fulford et al., 1995); the decline in disease prevalence in adults coincides with the time at 
which worms acquired in childhood would naturally begin to die (Black et al., 2010). By 
treating individuals with the anti-schistosome drug praziquantel, the protective immune 
response is boosted by drug-induced worm killing and resistance develops more quickly 
(Black et al., 2010; Mutapi et al., 1998).  
 
1.6.2 Immune recognition of schistosome eggs 
Egg deposition during S. mansoni infection stimulates a switch from a mixed Th1-Th2 
immune response to a dominant Th2-polarised immune response (Grzych et al., 1991; 
Pearce et al., 1991). Indeed, S. mansoni soluble egg Ags (SEA) provide a potent stimulus 
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for Th2 responses in vivo (Okano et al., 1999). Furthermore, following exposure to SEA, 
GMDCs, purified splenic DCs and human mo-DCs efficiently prime Th2 cells both in vitro 
and in vivo (de Jong et al., 2002; Jankovic et al., 2004; MacDonald et al., 2001). Despite 
this, there is very little change in the surface phenotype of the DC populations examined in 
these studies following exposure to SEA (de Jong et al., 2002; Jankovic et al., 2004; 
MacDonald et al., 2001). Nor do DCs respond to SEA exposure with high-level cytokine 
secretion (MacDonald et al., 2001). Irrespective of this, DCs are both sufficient and 
necessary for Th2 induction against schistosome egg Ags, most clearly shown using 
CD11c depletion during murine infection (Jankovic et al., 2004; MacDonald et al., 2001; 
Phythian-Adams et al., 2010). Studies using GMDCs have demonstrated the importance of 
CD40, MHC II and NFκB for the induction of SEA-specific Th2 responses (Artis et al., 
2005; MacDonald et al., 2001; MacDonald et al., 2002c), and are integral to our 
understanding of the mechanisms involved in DC priming of all Th2 responses, 
irrespective of their Ag-specificity. These studies have also shown that DC-derived IL-4 
and IL-10 are not essential for this process (MacDonald and Pearce, 2002; Perona-Wright 
et al., 2006a), whilst DC expression of OX40L is required to ensure sustained survival of 
SEA-specific Th2 responses (Jenkins et al., 2007). 
 
SEA is a complex mix of Ags, the majority of which are proteins, with over a thousand 
proteins identified (Mathieson and Wilson, 2010; Meevissen et al., 2011). Many of these 
are glycoproteins (Meevissen et al., 2011), which have been found to have 
immunostimulatory properties and bind to surface receptors on DCs. The glycosylation of 
these Ags seems integral to their ability to polarise Th2 responses, as, when SEA is pre-
treated to remove glycans, Th2 activation is reduced (Faveeuw et al., 2002; Okano et al., 
1999). Indeed, an SEA-derived glycan moiety, lacto-N-fucopentaose III (LNFPIII), binds to 
TLR4 on DCs, and can polarise Th2 responses (Okano et al., 2001; Thomas et al., 2003). 
Activation of distinct signalling pathways downstream of TLR4 may explain the ability of 
LNFPIII to induce Th2 responses following TLR4 ligation, despite the strongly Th1-
polarised response elicited by the interaction of LPS with this receptor. TLR4 stimulation 
by LPS leads to the activation of three MAPK kinases (ERK, p38 and JNK) and prolonged 
NFκB stimulation, whilst LNFPIII activates ERK alone and NFκB only transiently (Thomas 
et al., 2005). It has been postulated that these differences in signalling events may be 
orchestrated by the use of distinct co-receptors by the bacterial and helminth ligands.  
! 65!
Where LPS binds TLR4 in the presence of CD14, it may well be the CLR DC-SIGN that 
provides the necessary co-receptor in the case of LNFPIII (Hokke and Yazdanbakhsh, 
2005).  
 
Two glycoproteins, IPSEα-1 and omega-1, are major components of S. mansoni egg 
excretory/ secretory products (Dunne et al., 1991; Schramm et al., 2006). IPSEα-1 induces 
IgE production in vivo, which activates Ag-independent IL-4 production from basophils 
(Schramm et al., 2007) – a potential early source of IL-4 during S. mansoni infection. 
Omega-1 is a T2 ribonuclease, whose uptake by DCs is facilitated by a CLR, the mannose 
receptor (MR) (Everts et al., 2012; Everts et al., 2009; Steinfelder et al., 2009). Native 
purified or recombinant omega-1 is a potent inducer of Th2 responses, although omega-1 
depleted SEA still retains Th2-polarising capacity (Everts et al., 2009; Steinfelder et al., 
2009). Omega-1 appears to inhibit protein synthesis by degrading messenger and 
ribosomal RNA, and its ability to polarise DCs towards Th2 responses is dependent on its 
function as an RNase (Everts et al., 2012). Omega-1 is not the only glycoprotein found in 
SEA that binds to a CLR on DCs, as other components of SEA have also been shown to 
bind to DC-SIGN and the macrophage galactose-type lectin, as well as MR (Meevissen et 
al., 2011; van Liempt et al., 2007). Following ligation of these receptors by SEA, the CLRs 
are rapidly internalised and targeted towards MHC II-containing endosomes, suggesting 
that these SEA ligands are presented to T cells (van Liempt et al., 2007).        
 
It is not only SEA-derived glycoproteins that play a role in polarising Th2 responses, as the 
schistosome-derived lipid phosphatidylserine (PS) polarises human mo-DCs towards Th2 
induction, via TLR2, when cells are co-pulsed with LPS (van Riet et al., 2009). However, 
another study has demonstrated that scishtosome-derived PS led to the generation of IL-
10-producing T cells by human mo-DCs (van der Kleij et al., 2002). It has also been 
proposed that dsRNA ligands present in SEA bind to TLR3 (Aksoy et al., 2005), 
(discussed further in chapter 3). Despite the identification of a number of SEA-derived 
TLR-binding ligands, a number of studies have reported no requirement for MyD88, TLR2, 
TLR3 or TLR4 in the induction of schistosome-specific Th2 responses (Jankovic et al., 
2004; Kane et al., 2004; Layland et al., 2005; Vanhoutte et al., 2008). Further to this, SEA 
and its components inhibit DC responses following TLR activation by bacterial ligands, 
such as LPS, or by whole bacteria, reducing the upregulation of MHC II and co-stimulatory 
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molecules, as well as IL-12 production, induced by these classical stimuli (Cervi et al., 
2004; Kane et al., 2004; Perona-Wright et al., 2012; Steinfelder et al., 2009). This process 
may occur by the downmodulation of signalling pathways by SEA, particularly NFκB and 
MAPK (Kane et al., 2004). However, SEA stimulates potentiated ERK signalling from 
human mo-DCs, which leads to the activation of c-Fos, a transcriptional repressor of IL-12 
(Agrawal et al., 2003). A recent study investigated whether SEA modulates the response 
of human mo-DCs to LPS by the inhibition of mTOR, a key metabolic pathway that 
integrates signalling responses to growth factors and nutrients, and is essential for DC 
growth and optimal function (Salmond and Zamoyska, 2011). However, whilst mTOR 
inhibitors skew DC responses towards Th2 and modulate LPS responses, neither omega-
1 nor SEA appear to alter the activity of the mTOR pathway (Hussaarts et al., 2013).     
 
There are a number of open and interesting questions in the world of schistosome 
research that remain unanswered. These include a fuller understanding of the immune 
mediators involved in the protective response active in individuals who have acquired 
resistance to reinfection. There is also still much that is unknown about the role of DCs in 
the orchestration of immune responses during schistosome infection. Over the past ten or 
so years, our understanding of the processes involved in DC-mediated immune activation 
against schistosomes has improved significantly (Perona-Wright et al., 2006b). However, 
there are a number of unknowns surrounding DC interactions with schistosome Ags, and 
how these shape consequent immune activation. Whilst we know that DCs are essential 
for optimal Th2 induction against S. mansoni (Phythian-Adams et al., 2010), it is not yet 
clear which DC subset(s) are involved in orchestrating this response, or indeed, whether 
any DC subsets found in vivo inhibit or regulate the developing Th2 response. A number of 
important schistosome egg Ags have been identified that stimulate Th2 polarisation 
(Everts et al., 2009; Schramm et al., 2006; Steinfelder et al., 2009), however there are 
likely to be other egg Ags that interact with PRRs on DCs that are yet to be identified. 
There is also still further work to be done to characterise the intracellular responses of DCs 
following exposure to schistosome Ags – what are the gene expression changes and 
which signalling pathways are modulated following the binding of schistosome Ags to 
PRRs? How do these changes affect DC phenotype and function? Furthermore, how do 
schistosome egg Ags modulate DC responses to bacteria, above and beyond the 
modulation of protein synthesis by omega-1? How does inhibition of protein synthesis by 
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omega-1 skew DCs towards Th2 polarisation? Despite continuing work in the area, a bone 
fide DC-derived signal 3 that is integral to Th2 polarisation has yet to be identified. 
Although IFN-I have been shown to play a role in a variety of settings, in immune 
responses against a range of pathogens, the role of this pluripotent cytokine family in Th2 
responses has not been investigated. Thus, there are still lots of exciting areas of research 
to explore before our understanding of DC-schistosome interactions is complete.    
 
1.6.3 Heligomosoides polygyrus infection 
H. polygyrus is an intestinal nematode parasite, common in wild mouse populations, and 
widely used as a laboratory model of intestinal helminth infection. It is related to human 
hookworms and nematodes that afflict livestock (Maizels et al., 2012b). The third larval 
stage is infective and larvae enter the host orally, invading the small intestinal wall within 
24h and remaining in the submucosa for ~8d, undergoing two molts in that time (Bryant, 
1973; Reynolds et al., 2012). Adult worms emerge and feed on intestinal tissue (Bansemir 
and Sukhdeo, 1994), coiling around the villi of the small intestinal epithelium. At this stage 
worms mate and egg production begins. Although H. polygyrus worms start to be expelled 
from the host around 4 weeks after infection, they can persist within the host for many 
months, resulting in chronic infection (Monroy and Enriquez, 1992). Persistence is 
measured by determining the number of eggs released in the faeces and counting the 
worms that remain in the small intestine (Reynolds et al., 2012).  
 
Impaired worm expulsion in severe combined immunodeficient (SCID) mice demonstrates 
that the adaptive immune system has an important role in orchestrating this response 
(Hashimoto et al., 2009). Anti-CD4 treatment results in an increase in worm fecundity 
(Urban et al., 1991a), whilst transfer of T effectors (CD4+ CD25-) from the MLN of 
chronically infected mice leads to lower worm burden in recipient animals (Hashimoto et 
al., 2009). These studies demonstrate the importance of CD4+ T cells in controlling 
expulsion of this intestinal nematode. CD4+ T cell production of IL-4 is the primary 
mediator that promotes worm expulsion and limits egg production during H. polygyrus 
infection (Svetic et al., 1993; Urban et al., 1991b). The exact mechanisms of worm 
expulsion are not known, but likely involve both innate effectors and non-immune cells 
(Reynolds et al., 2012). Processes that may be involved in H. polygyrus expulsion include 
the ‘weep and sweep’ response, which is characterised by an increase in luminal fluid and 
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smooth muscle contractility in the intestine (Anthony et al., 2007). Mast cells are also 
thought to be major players in H. polygyrus expulsion (Behnke et al., 2003).  
 
CD4+ Foxp3+ Treg numbers increase dramatically in the MLN during infection with H. 
polygyrus (Finney et al., 2007; Rausch et al., 2008). Treg induction likely benefits both the 
parasite and host. A TGFβ-like molecule secreted by H. polygyrus drives Treg 
differentiation, and inhibition of TGFβ during infection causes a reduction in worm burden 
(Grainger et al., 2010), suggesting that induction of Tregs aids worm persistence. 
Depletion of Tregs early in infection also leads to enhanced Th2 responses and increased 
intestinal pathology, intimating that Tregs also provide protection to the host (Rausch et 
al., 2009).  
 
Similarly to S. mansoni infection, depletion of CD11c+ cells during H. polygyrus infection 
inhibits the induction of the Th2 response in the MLN (Smith et al., 2011), highlighting the 
essential role of DCs in activating the adaptive immune response against this intestinal 
helminth. Studies have shown that CD80 and CD86 signalling are essential to optimal IL-4 
induction and the Th2 response (Greenwald et al., 1997; Lu et al., 1994), whilst OX40L is 
also required to promote IL-4 production from T cells during H. polygyrus infection (Ekkens 
et al., 2003). 
 
1.7 Immune recognition of bacteria 
Heat-killed preparations of the Th1/Th17-polarising gram-negative bacteria Salmonella 
typhimurium (St) and the gram-positive bacteria Propionibacterium acnes (Pa) are used in 
this thesis as a counterpoint to the Th2-polarising SEA. St is an anaerobic intracellular 
pathogen, which, when live and unattenuated, causes severe diarrhoeal disease (Garai et 
al., 2012). Recognition of St is mediated entirely via TLRs, as BMMΦs lacking both MyD88 
and TRIF do not respond to heat-killed St (Arpaia et al., 2011). TLR2, TLR4 and TLR5 
mediate the majority of St recognition and an additional role for TLR9 was confirmed using 
TLR2, TLR4 and TLR9 double and triple knock out mouse strains (Arpaia et al., 2011). St 
flagellin is recognised by TLR5 (Feuillet et al., 2006). Recognition of St by the intracellular 
TLRs, TLR7 or TLR3 has also been suggested, as the use of an inhibitor of endosome 
acidification blocked the remaining TNFα induced by St in TLR2-TLR4-TLR9 combined 
knockout BMMΦs (Arpaia et al., 2011).  
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Pa is the most abundant bacterial species in acne lesions (Jugeau et al., 2005). Pa-
sensing is dependent on TLR2, with no requirement for TLR1, TLR4 or TLR6 for the 
induction of Pa-specific IL-12 from human monocytes (Jugeau et al., 2005; Kim et al., 
2002). St and Pa potently activate GMDCs, inducing upregulation of MHC II and co-
stimulatory molecules, and stimulating the secretion of a range of pro-inflammatory 
cytokines, including IL-12, IL-6 and TNFα (Perona-Wright et al., 2009; Perona-Wright et 
al., 2012). Both St and Pa-experienced GMDCs efficiently induce strain-specific IFNγ and 

























1.8 Thesis aims 
Broadly, the work detailed in this thesis aimed to dissect the role of different DC subsets in 
the induction of Th2 responses and identify the importance of IFN-I in Th2 immunity. 
 
Key questions: 
How do cDC and pDC subsets respond to stimulation with the potently Th2-
polarising soluble egg Ags (SEA) from S. mansoni? 
– Does exposure to SEA alter the surface phenotype of murine cDCs and pDCs 
generated in vitro using Flt3-L? 
– Do FL-cDCs and pDCs produce SEA-specific cytokines? 
– Is the phenotype displayed by FL-cDCs following exposure to SEA distinct from 
GMDCs? 
 
Can Flt3-L-dependent DCs polarise SEA-specific Th2 responses?  
– Do FLDC subsets migrate efficiently to the dLN? 
– On what factors do FLDCs depend for Th2 polarisation? 
– Is IFN-I signalling required for FLDC Th2 induction? 
 
Is IFN-I active during Th2 responses in vivo? 
– Do splenic cDCs and human blood-derived DCs display a similar phenotype to 
FLDCs following exposure to SEA? 
– Is systemic IFN-I detectable in murine and human S. mansoni infection? 
– Is IFN-I signalling involved in the development of the immune response during 
murine models of helminth infection?  
 
How are schistosome-specific Th2 responses orchestrated in the intestine? 
– How are intestinal DC subsets affected by S. mansoni infection? 
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Table 1.2 TLR expression by mouse DC subsets 










TLR1 ++ ++ + + 
TLR2 ++ ++ + + 
TLR3 ++ - - - 
TLR4 + ++ - ++ 
TLR5 - ++ + + 
TLR6 ++ ++ + + 
TLR7 - ++ ++ + 
TLR9 + + ++ + 
 
Table 1.3 TLR expression by human DC subsets 









TLR1 ++ ++ ++ + 
TLR2 + ++ - ++ 
TLR3 ++ - - + 
TLR4 - ++ - ++ 
TLR5 - ++ - + 
TLR6 ++ + ++ ++ 
TLR7 - + ++ - 
TLR8 + ++ + + 






pDC Monocyte Pre-DC 
CD8α+ or 
CD103+ cDC 


























Figure 1.1 Myeloid cell development 
TFs involved in development are included in green, growth factors in red. The early 
developmental events occur in the BM. The MΦ-DC progenitor (MDP) gives rise to monocytes 
and the common-DC precursor (CDP). CDPs can differentiate into pDCs or the cDC precursor, 
pre-DCs. pDCs are fully differentiated in the BM and migrate to the periphery via the blood. Pre-
DCs migrate via the blood to the periphery, where they can differentiate into the cDC subsets. 
Monocytes are also found circulating in the blood, giving rise to MΦs in the periphery. Under 
inflammatory conditions, monocytes can also give rise to a population of DC-like cells that 
produce high levels of TNFα and iNOS (Tip-DCs). GMP = Granulocyte-MΦ progenitor. Figure is 
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Figure 1.2 DC subsets in human and mouse 
This figure depicts the surface markers associated with the different DC subsets in mouse and 
human, and their characteristics and functions. The TFs associated with each subset are also 
shown, including the cDC TF, Zbtb46. The pDC TF, E2-2, has been shown to be active in human 
pDC homeostasis (Ghosh et al., 2010). Batf3 knockdown studies in human CD141+ DCs suggests 
that this TF is active in this subset (Poulin et al., 2012). It is not yet known whether the other TFs are 





Figure 1.3 TLR signalling pathways 
This figure includes the signalling pathways downstream of the main TLRs. Adapted from 



















































































































RNA polymerase III DNA 
Figure 1.4 Signalling pathways of the cytosolic helicase nucleic acid sensors involved in the 
IFN-I response 
All of these nucleic acid sensors share a common helicase domain but use a range of different 
adaptor proteins. The RLRs, MDA5 and RIG-I signal via IPS-1, which is associated with the 
mitochondrial membrane. The RLRs recognise RNA ligands. RNA polymerase III can convert DNA, 
including self DNA, into dsRNA ligands that can be recognised by RIG-I. DDX41 is one of a growing 
family of cytosolic sensors that utilises the adaptor protein STING. DDX1-DDX21-DHX36 co-operate 
to recognise dsRNA and induce IFN-I production downstream of TRIF. Figure is adapted from 
Takeuchi and Akira (2010) and Broz and Monack (2013), including data from Zhang et al. (2011).  
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Figure 1.5 DC-T cell interactions 
The ligands and receptors expressed by DCs and T cells that facilitate their interaction and form part 
of the immunological synapse. Co-stimulatory molecules are depicted in red, co-inhibitory molecules 
in blue. Stimulatory and inhibitory signals impact on the turnover and function of T cells. Adapted 
from Chen and Flies (2013) 
T cell  DC 
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Figure 1.6 T cell subsets and T cell plasticity 
Highlighted in red are the cytokines involved in the differentiation of the different T cell subsets. IFNγ 
can enhance the polarisation of Th1 cells, but is not produced by DCs. The TFs associated with each 
T cell subset are depicted in green. There is some plasticity in T cell fate, with reports that Th1 and 
Th2 cells can be converted to the alternative subset. Under certain conditions, iTregs can be 
converted to Th17 cells, and Th17 cells can display characteristics of the Th1 lineage. It has also 
been shown that Tfh cells produce Th2 cytokines in the reactive LN during helminth infection.   



















Figure 1.7 Intestinal DCs and MΦs 
LP DC subsets and MΦ surface markers and TFs (bold) (A). The characteristics of LP DC subsets and 
MΦs. ? signifies no data currently available. Data collated from Bogunovic et al. (2009), Cerovic et al. 
(2012), Coombes et al. (2007), Ginhoux et al. (2009), Greter et al. (2012), Hadis et al. (2011), 
Johansson-Lindbom et al. (2005), Persson et al. (2013), Satpathy et al. (2013), Schulz et al. (2009), 
Varol et al. (2010).  
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Figure 1.8 IFNAR activation of JAK-STAT dependent signalling 
Binding of IFN-I leads to reorganisation and heterodimerisation of the receptor subunits, IFNAR1 and 
IFNAR2, leading to the autophosphorylation of the receptor-associated JAKs, TYK2 and JAK2. The 
activated kinases then phosphorylate STATs. The formation of a STAT1-STAT2 heterodimer, with the 
addition of IRF9, leads to the formation of a complex called IFN-stimulated gene factor 3 (ISGF3). 
This complex can bind to a region upstream of IFN-stimulated genes (ISGs) called the IFN-
stimulated response element (ISRE). STAT complexes that do not recruit IRF9 (primarily STAT1, 
STAT2, STAT3 and STAT5) can bind to IFNγ-activated sites (GAS) found in the promoter regions of 
ISGs. Some genes have both ISRE and GAS elements in their promoter region, whilst others only 
have one. Thus, different STATs, and consequently different IFN-I subtypes, are required for their 














































Figure 1.9a CRKL-mediated signall ing 
downstream of IFNAR 
Following activation of TYK2, STAT5 and CRK-like 
(CRKL) are phosphorylated. These proteins form a 
complex that translocates to the nucleus and can 
bind certain GAS elements upstream of certain 
ISGs. Activation of CRKL also facilitates the 
guanine-nucleotide-exchange (GEF) activity of 
C3G, leading to the conversion of RAP1-GDP to 
RAP1-GTP. This activates the GTPase, allowing it 
to interact with and activate effector molecules 
involved in cell adhesion and migration.    
GAS 
Figure 1.9b Activation of MAPK p38 
downstream of IFNAR 
I F N A R - a c t i v a t e d J A K s r e g u l a t e t h e 
phosphorylation of GEFs, which leads to the 
activation of a MAPKKK, leading to the 
downstream activation of MAPKK3 & MAPKK6, 
which directly phosphorylate p38, resulting in its 
activation. Activated p38 regulates activation of 
multiple effectors, including MAPK-activated 
protein kinase 2 (MAPKAPK2), MAPKAPK3, 
mitogen- & stress-activated kinase 1 (MSK1) & 
MAPK-interacting protein kinase 1(MNK1). 
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Chapter 2. MATERIALS AND METHODS 
2.1 Mice, infections and in vivo experiments 
2.1.1 Mice 
C57BL/6, CBA, BALB/c, Ab-/- (C57BL/6)(Grusby et al., 1991), B-Act dsRed 
(C57BL/6)(Vintersten et al., 2004), Cd40-/- (C57BL/6)(Ensminger et al., 2001), CD45.1 
(C57BL/6), CX3CR1eGFP (C57BL/6)(Jung et al., 2000), CD11c.DOG 
(C57BL/6)(Hochweller et al., 2008), Ifnar1-/- (C57BL/6)(Hwang et al., 1995), Il10-/- 
(C57BL/6)(Kuhn et al., 1993), IL-10eGFP (Kamanaka et al., 2006) x KN2 (Mohrs et al., 
2005)(C57BL/6), IL-13eGFP (Neill et al., 2010) x KN2 (C57BL/6), KN2 (C57BL/6), 
Ly5.1xOTII (C57BL/6)(Barnden et al., 1998), Myd88-/-/Trif-/- (C57BL/6), Myd88-/- 
(C57BL/6)(Adachi et al., 1998), Trif-/- (C57BL/6)(Yamamoto et al., 2003), Tlr9-/- 
(C57BL/6)(Hemmi et al., 2000) mice were maintained under specific-pathogen free 
conditions at the University of Edinburgh Animal Facilities. Ly75-/- (C57BL/6)(Guo et al., 
2000) mice were maintained under specific-pathogen free conditions at the Burnet Institute 
Animal Facilities, Melbourne, Australia. Ifnar1-/- and littermate control bone marrow was 
originally a generous donation from Dr. Caetano Reis e Sousa, London Research Institute, 
CRUK. Dr Reis e Sousa also generously provided mice to set up an Ifnar1-/- mouse colony 
at UoE. All experiments were approved under a Project License granted by the Home 
Office (U.K.) and conducted in accordance with local guidelines. 
 
2.1.2 Subcutaneous injections into feet 
BMDC transfer: WT or knockout BMDCs were cultured as below (section 2.3 and 2.4), 
with SEA, St or in medium alone. 5 x 105 BMDCs were injected subcutaneously into the 
feet of recipient WT C57BL/6 mice (2.5 x 105 per foot), as previously described (Cook et 
al., 2012). 7 days following transfer the draining popliteal LNs were harvested. Single cell 
suspensions of LN cells (1 x 106 cell/ml) were cultured in X-vivo 15 medium (Lonza) 
containing 2mM L-Glutamine and 50 mM 2-ME (Invitrogen) in 96 well plates at 37°C in a 
humidified atmosphere of 5% CO2 with or without 15µg/ml SEA, or 1µg/ml St. 
Supernatants were harvested from the cultures after 72h and cytokine production 
assessed by ELISA. 
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BMDC tracking: dsRed or CD45.2 BMDCs were cultured as below (section 2.3 and 2.4), 
with SEA, St or in medium alone. 2 x 106 BMDCs were injected subcutaneously into the 
feet of recipient WT C57BL/6 or CD45.1 mice (1 x 106 per foot), this DC dose was based 
on unpublished optimization experiments performed by lab members (Rachel Lundie, Alex 
Phythian-Adams), that allowed optimal visualisation of transferred cells within the first 72h 
following injection. 24, 48 or 72h following transfer the draining popliteal LNs were 
harvested. 2 pLNs from each group were collected and prepared for microscopy, to 
prevent loss of the dsRed signal, pLNs were prepared as described in section 2.7.4.  
 
For flow analysis, pLNs were digested at 37°C for 30 min with 1.75 Wunsch Units/ml 
Liberase TI (Roche Diagnostics) and 80 Kunitz Units/ml DNase I type VI (Sigma) in HBSS 
(Sigma) containing 50U/ml penicillin and 50µg/ml streptomycin (Invitrogen). 100µl 0.1M pH 
7.3 EDTA (Gibco) stop solution per ml was then added and the tube topped up with DMEM 
containing 50U/ml penicillin and 50µg/ml streptomycin. The resulting suspension was then 
passed through a 70µm cell strainer to obtain a single cell suspension, and cells counted 
and resuspended for use. Cells were then stained for analysis by flow cytometry.  
 
For egg injections: The mice were immunised s.c. in the top of each rear foot with 2,500 
eggs in 50µl PBS or with 50µl of PBS alone, as described (Phythian-Adams et al., 2010).  
 
2.1.3 SEA intravenous injections 
Mice were injected intravenously with 50µg of SEA in 200µl PBS or with 200µl PBS alone. 
Spleens were harvested 12h later and diced, before being digested as above (section 
2.1.2, BMDC tracking) for 15 min. This dose was chosen to approximate the dose of SEA 
used to stimulate BMDCs in vitro (25µg/ml). The blood volume of a mouse is estimated to 
be 77-80µl/g (Jackson Laboratory), which for a 20-25g mouse is 1.5-2ml, thus 50µg 
equates to roughly 25µg/ml. Optimisation experiments using 50 or 100µg of SEA 
demonstrated that the lower dose was sufficient to elicit a phenotype from splenic DCs 
within 12h of administration. An intravenous route of delivery was chosen to maximize the 
amount of Ag that would reach the spleen.   
 
Low-density cells were enriched using NycoDenz (1.077g.cm3; Axis-Shield) density 
gradient separation and non-DC lineage cells were coated with biotinylated mAbs against 
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murine CD2, CD3ε, CD49b, mIgM and erythrocytes (Ter-119), and depleted using MyOne 
Streptavidin Dynabeads (Dynabeads Mouse DC Enrichment Kit; Invitrogen). This 
purification protocol was optimised in the MacDonald Laboratory (Rachel Lundie et al., 
manuscript submitted). CD11chi B220- cDCs were then sorted from B220+ CD11cmid pDCs 
using a BD FACs Aria II. Approximately 100,000 cDCs were sorted directly into 1ml 
aliquots of Trizol (Invitrogen) and snap frozen on dry ice.  
 
2.1.4 S. mansoni infection 
Cercariae were shed from patent S. mansoni infected B. glabrata snails by placing the 
snails in pond water under a heat lamp for 50 minutes. A sample of cercariae was counted 
in a 1:1 dilution of Lugol’s iodine solution under a dissection microscope. Female C57BL/6 
mice were anaesthetised with 0.01ml/g of 0.25ml Domitor (Janssen) and 0.19ml Vetalar 
(Pfizer) mixed in 2.6ml PBS (Sigma). For MLNX experiments, male mice were 
anaesthetized with 0.1ml/g of 0.5ml Vetalar and 0.25ml Rompun (Bayer) mixed in 4.25ml 
H20 (Sigma).!Fur was removed from abdomen with clippers, and animals taped to a pre-
warmed heat pad to help maintain body temperature during the procedure. A stainless 
steel ring was taped over the shaved part of the abdomen, 40-180 cercariae were placed 
into the ring in 200µl of pond water, with an additional 200µl of pond water added on top. 
Cercariae were allowed to penetrate for 30 minutes, following this time, steel ring and 
remaining cercariae were removed from the animals, and animals were revived by a 
subcutaneous injection of 0.1ml of 0.04ml antisedan diluted in 0.96ml PBS (Sigma). 
Following infection animals were monitored with weights measured 3 times a week starting 
at week 5. On d49 or 56 organs were harvested following CO2 asphyxiation. 
 
2.1.5 Serum collection 
Blood was collected non-terminally via puncture of the submandibular vein using a 26-
gauge needle. When blood was collected at experimental endpoints, mice were first 
anaesthetised by a 100µl subcutaneous injection containing 50µl 100 mg/ml Vetlar (Pfizer) 
and 50µl 1 mg/ml Domitor (Janssen), and blood was taken from the brachial artery before 
mice were culled by a Schedule 1 method. Blood was collected into Microtainer tubes 
(BD), which were spun at 13,000 rpm at 4 °C for 10 minutes. Serum was removed from the 
pellets and frozen at -80 °C until use. 
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2.1.6 H. polygyrus infection  
Mice were infected with 200 H. polygyrus L3s in 200µl of dH2O by oral gavage, using a 24-
gauge feeding needle, as previously described (Hewitson et al., 2011). Organs were 
harvested on d7 of infection following cervical dislocation.  
 
2.1.7 SEA/ S. mansoni egg gavage  
Mice were gavaged with 10-100µg SEA, 2500 S. mansoni eggs in PBS or PBS alone. 
MLNs were harvested 7d later and single cell suspensions prepared and restimulated with 
15µg/ml SEA, 16.65µg/ml αCD3 (prepared in house) or in medium alone, as described in 
section 2.1.2, BMDC transfer. Supernatants were harvested from the cultures after 72h 
and cytokine production assessed by ELISA. 
 
2.1.8 Subserosal injection of S. mansoni eggs  
Prior to surgery, mice received analgesia, Rimadyl (Pfizer) 1:100 dilution of stock, 0.075ml 
per 10g body weight and Vetergesic 1:10 dilution of stock, 0.015ml per 10g body weight. 
Mice were placed under general anaesthetic using Isoflurane in oxygen and abdomen fur 
removed with clippers. Skin was sterilised using 70% ethanol, a short (~1cm) midline 
incision was made in the skin and then in the peritoneal wall. The intestine was then 
removed from the abdomen using cotton buds and placed on gauze soaked in saline. To 
inject, the intestine was gently gripped with tweezers and an insulin needle used to pierce 
the outer lining of the intestine. 1000 S. mansoni eggs in PBS or PBS alone were injected 
into the subserosa. This dose of eggs was chosen as an approximation of the average 
daily egg dose that a mouse might be exposed to, with ~4-5 fecund worm pairs producing 
~300 eggs per day. The intestine was returned to the abdomen, and the peritoneal wall 
closed by suturing. The skin was sealed using surgical staples. Simon Milling and 
members of his laboratory at the University of Glasgow developed this experimental 
protocol. In CD11c depletion experiments, mice were injected intraperitoneally with 16ng/g 
of DTx dissolved in H20 daily, from 2d prior to surgery and 6d after. This dose was adapted 
from Phythian-Adams et al. (2010), where 8ng/g of DTx was administered daily. A 16ng/g 
dose was found to be safe and more effective than 8ng/g (Alex Phythian-Adams, 
unpublished findings). Organs were harvest 7d after subserosal egg injection and 
prepared as described in section 2.2.1.  
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2.1.9 Mesenteric lymphadenectomy  
Mice received analgesia prior to surgery and were anaesthetised as above (section 2.1.8). 
The protocol is very similar to that described for rats by Milling et al. 2006 and was further 
adapted for use in mice by Simon Milling’s laboratory. The intestine was exposed as in 
section 2.1.8 and the MLN carefully excised using tweezers, mice were then closed up as 
above. After 10d, surgical staples were removed. 28d after surgery mice were infected 
with S. mansoni cercariae as described in section 2.1.4.  
 
2.2 Parasitology and pathology of helminth infected mice 
2.2.1 S. mansoni worm counts 
Following CO2 asphyxiation, the hepatic portal vein was cut and mice perfused by injecting 
saline solution into the heart. This perfusate was collected from infected animals in order 
to enumerate the number of worms flushed out of the mesenteric veins. Samples were 
spun at 400xg for 15 min and excess perfusate removed with a stripette. The remaining 
blood/ worm mixture was diluted in 3 ml of 1x FACS fix/ lysis solution (BD). After 
incubating for 2 min, this mixture was rinsed through a 40µm cell strainer using PBS. The 
sieve was then inverted on a petri dish and rinsed again with PBS to remove any worms. 
Female and male worms could then be identified using a dissection microscope. Females 
were identified as longer thinner and often darkened by haemozoin. Males were fatter, 
shorter and much lighter in colour than females.  
 
2.2.2 S. mansoni egg counts 
To determine the number of parasite eggs present in the liver and intestine, tissue 
samples were weighed before being digested overnight at 37°C using 4% KOH dissolved 
in H2O. The numbers of eggs present in 100µl of digested tissue could then be determined 
using a microscope. For each sample, the average count from 3x 100µl samples was 
calculated. The number of eggs per gram of tissue could then be extrapolated, taking into 
account the weight of the tissue sample and the total tissue weight when harvested.  
 
2.2.3 Hepatomegaly and splenomegaly of S. mansoni infected mice 
After CO2 asphyxiation, the mouse weight, and liver and spleen weights were recorded. 
Hepatomegaly and splenomegaly could then be calculated, defined as spleen and liver 
size as a proportion of total body weight of naïve and infected animals. 
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2.2.4 Egg and worm counts from H. polygyrus infected mice 
Faecal egg counts: Faeces were weighed and left to form a homogenous solution in 2ml 
of distilled H2O. An equal volume of saturated NaCl was added, and the resulting solution 
loaded to fill one chamber of an egg counting slide (McMaster 2 cell counter; Hawksley). 
Eggs within the grid were enumerated using a light microscope, and eggs per gram of 
faeces were calculated using the following calculation: 
 
Eggs/ g of faeces: egg count x 26.67* 
                                faeces mass (g) 
 
*calculated as: volume of liquid faeces dissolved in (4 ml) 
                                    chamber volume (0.15ml) 
 
Worm counts: The small intestine was collected from infected animals on d28 of infection, 
cut open and washed in PBS. The number of worms present in the intestinal lumen was 
then enumerated. Egg and worm counts were performed as per standard procedures 
(Camberis et al., 2003). 
 
2.3. Cell isolations 
2.3.1 Leukocyte isolation from MLNs, spleen and liver 
Single cell suspensions were prepared following protocols previously published by the 
MacDonald Laboratory (Phythian-Adams et al., 2010) and as above in sections 2.1.2 and 
2.1.3. For liver preparations, tissues were diced and digested for 45 min as described 
above. Liver leukocytes were isolated by centrifugation in 33% Percoll (GE Healthcare), 
followed by filtration through a 40µm cell strainer to remove contaminating S. mansoni 
eggs before RBC lysis. Single cell suspensions from all tissues were then prepared for 
flow analysis or cells (Liver and MLN: 1 x 106 cell/ml; spleen: 2 x 106 cell/ml) were cultured 
in X-vivo 15 medium (BioWhittaker) containing 2mM L-Glutamine and 50mM 2-ME 
(Invitrogen) in 96 well plates at 37°C in a humidified atmosphere of 5% CO2 with or without 
15µg/ml SEA. Supernatants were harvested from the cultures after 72h and cytokine 
production assessed by ELISA.  
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2.3.2 Small intestinal lamina propria cell isolation 
The protocol used to isolate LP cells is based on protocols from the laboratories of Fiona 
Powrie and William Agace, and was adapted for helminth-infected guts by John Grainger 
(Belkaid Laboratory, NIH, USA). These adaptations include addition of dithiothreitol!(DTT) 
to combat the high levels of mucus present in the intestine during helminth infection. The 
small intestine was isolated, and PP manually dissected. The gut was longitudinally slit 
open in ice cold 3% medium (RPMI-1640 (Sigma) plus 3% FCS (Sigma), 1% Penicillin/ 
Streptomycin (Gibco) and 20mM HEPES (Gibco)), and the intestinal contents was 
removed by gently scraping along the length of the gut. Gut was diced into Shake medium 
(RPMI-1640, plus 1% Penicillin/ Streptomycin, 20mM HEPES and 2mM EDTA). Samples 
were manually shaken for 30 seconds, after which contents was poured through a tea 
strainer (Sainsbury’s), with liquid flow through discarded. Gut pieces were collected, and 
placed back into fresh Shake medium. The shake/draining process was repeated a further 
2 times, after which intestinal pieces were placed into DTT medium (3% medium 
supplemented with 1% FCS, 0.5mM EDTA (Gibco) and 14.5µg/ml DTT (Sigma-Aldrich)). 
Samples were stirred on a Variomag magnetic stir plate (Thermo Scientific) for 15 min at 
37 °C. Following stirring, the mixture was poured through tea strainers, and gut pieces 
placed back into fresh Shake medium. Samples were manually shaken/drained three 
times as described earlier, after which intestinal pieces were placed into digest medium 
(RPMI-1640, plus 1% Penicillin/ Streptomycin, 20mM HEPES, 1% L-Glutamine, 0.1% β-
mercaptoethanol, 5mg DNase and 5mg Liberase). Intestines were further diced manually, 
and stirred on the magnetic stir plate for 24 min at 37 °C. Following stirring, digestion was 
stopped by adding 30 ml of 3% medium. Gut pieces were mashed through a 70µM, then a 
40µM cell strainer in 3% medium. Cells were then resuspended in X-Vivo medium for 
restimulation or prepared for flow analysis. 
 
2.3.3 T cell isolation for DC:T cell co-culture 
Spleen, mesenteric, brachial and inguinal lymph nodes were pooled, crushed through 
gauze to release cells, centrifuged at 1200g for 5 minutes at room temperature, RBCs 
were lysed using RBC lysis buffer (Sigma), cells were washed and stained with CD4-APC 




2.4 In vitro bone marrow DC differentiation 
2.4.1 Bone marrow preparation 
Tibias and fibulas of the hind legs of mice were collected into ice cold PBS (GMDCs) or 
complete RPMI (FLDCs), bones were then sterilised in 70% Ethanol (Sigma) for 3 
minutes, before washing with PBS/ cRPMI, to remove all ethanol. Individual bones were 
selected, the ends of the bone were removed using a scalpel and 5ml of PBS/ cRPMI was 
injected through the bone using a 5ml syringe (BD) and a 21G needle (BD), flushing the 
bone marrow into a 50ml falcon tube (BD). Flushed bone marrow samples pooled from all 
bones collected were then disrupted by repeatedly passing through a 23G needle (BD). A 
sample of BM was mixed in a 1:1 dilution with trypan blue and the numbers of HSCs 
present were counted based on estimated size.  
 
2.4.2 Heat-inactivation of foetal calf serum  
The foetal calf serum serum (FCS) used in BMDC medium was placed at 58ºC for 50 
minutes to heat inactivate it prior to use. Heat inactivation was used to denature the 
components of the complement cascade in the serum that could damage the cells being 
cultured or prepared. 
 
2.4.3 Flt3-L BMDC culture 
FLDCs were cultured essentially as in Naik et al. (Naik et al., 2010), flushed BM was RBC 
lysed and 1.5 x 105/ml bone marrow cells were resuspended in complete Flt3-L medium 
(RPMI-1640 (Sigma) containing 10% FCS (Hyclone/Sigma), 2mM L-Glutamine (Gibco), 
50U/ml penicillin and 50µg/ml streptomycin (Invitrogen) 50mM 2-Mercaptoethanol 
(Invitrogen), plus 200ng/ml rFlt3-L (Peprotech). Flasks were cultured at 37°C in a 
humidified atmosphere of 5% CO2 for 8 days without feeding. On day 8 cells were 
harvested, and re-suspended in fresh medium containing 50ng/ml FLT3L for in vitro 
stimulations, see section 2.4.  
 
Optimisation experiments were performed initially to select the optimal concentration for 
plating of BM cells for FLDC generation, 1.5 x 105/ml was found to yield the best returns 
and healthy cells. A number of different FCS batches from different sources were also 
tested prior to characterisation experiments. Hyclone was found to provide the highest 
yield of live, immature cells. However, during the project it was necessary to batch-test a 
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new source of FCS. Sigma was chosen on this occasion, based on cell yield, lowest 
activation status and cost. Thus there is some variability in cell culture methods, however, 
the cells grown from Hyclone and Sigma FCS were found to be relatively comparable. 
 
2.4.4 GM-CSF BMDC culture 
Bone marrow (BM)-derived dendritic cells (DC) were prepared following protocols 
previously published from the MacDonald laboratory (MacDonald et al., 2001). 2 x 106 
bone marrow cells were seeded in 10ml complete medium (RPMI-1640 (Sigma) containing 
20ng/ml rGM-CSF (Peprotech), 10% FCS (Hyclone/Sigma), 2mM L-Glutamine (Gibco), 
50U/ml penicillin and 50µg/ml streptomycin (Invitrogen)). Cells were cultured at 37°C in a 
humidified atmosphere of 5% CO2. On day 3, 10ml of complete medium was added, on 
days 6 and 8, 9ml of media was gently (to avoid undesired activation of cells) aspirated 
and replaced with 10ml of fresh complete medium, cells were harvested gently on day 10. 
Immature d10 BMDCs were resuspended in fresh medium containing 5ng/ml GM-CSF for 
in vitro stimulations, see below (section 2.4).  
 
Due to the sensitivity of BMDCs to movement and temperature, there is inherent variability 
in the basal activation status of the cells used in all BMDC experiments. This is particularly 
the case with GMDCs, which must be removed from the incubator during culture for 
feeding. The method to count HSCs in BM preparations is not precise and down to 
personal assessment of cell size, and as such there is also variability in the yield of cells 
after the differentiation period. Another confounding factor in the activation status of 
BMDCs is that FCS is not a uniform preparation due to its biological nature. To minimise 
the variation in BMDCs on account of FCS (and growth factors), we spend a considerable 
amount of time batch-testing from various companies to ensure we get comparable 
growth, and then bulk-buy the FCS, Flt3-L and GM-CSF batch that provides the highest 
yield, lowest activation status, at the lowest price. However, as outlined above, it is some 
times unavoidable that some changes are made to the reagents used. 
 
2.5 In vitro stimulations and functional assays 
2.5.1 Preparation of Ags 
Propionibacterium acnes (Pa) is an anaerobic bacterium and was grown by the lab of 
Professor Ian R Poxton (Microbial Pathogenicity Research Laboratory, UoE) before being 
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heat-killed and stored under sterile conditions at 4ºC. Heat-killed P. acnes was aliquoted 
and the concentration of protein per ml was determined for each aliquot using a Bradford 
(coomassie) protein assay and a known BSA standard. 
 
Attenuated Salmonella typhimurium strain SL3261 was supplied by Dr. Maurice Gallagher 
(UoE) was heat-killed and stored under sterile conditions at 4ºC prior to use. The heat-
killed S. typhimurium was aliquoted and the concentration of protein per ml was 
determined for each aliquot using a Bradford (Coomassie) protein assay and a known BSA 
standard.  
 
Eggs were purified from the livers of mice infected with 180 S. mansoni cercariae. Livers 
alone are used as a source of eggs to limit the amount of endotoxin contamination that 
may occur from using tissues of mice, it was felt that the bacterial load of intestines would 
be too high to make this tissue a viable source of eggs.  Livers were harvested on d49 of 
infection from mice. C57BL/6 mice were used to avoid allogeneic responses following 
antigen challenge of C57BL/6 experimental mice with eggs or SEA purified and prepared 
from livers. Livers were washed in ethanol prior to being minced and then digested 
overnight at 37°C with 1.47U/ml Collagenase D, in the presence of Penicillin/ Streptomycin 
and Polymyxin B Sulphate, in an attempt to limit bacterial contamination. Digested livers 
were then washed twice before being mashed to break up any remaining liver fragments. 
Following a wash with PBS, the remaining pellet was resuspended in PBS and overlayed 
on a 33% Percoll gradient. The gradient was spun at 1400 RPM and the upper layers of 
the Percoll gradient removed to leave the eggs in a pellet at the bottom of the tube. Eggs 
were washed with PBS, counted and then frozen at -80°C. Soluble egg antigen from S. 
mansoni was prepared in-house as previously described (MacDonald et al., 2001). The 
stored eggs were thawed and transferred to a Tenbroeck 7 ml tissue grinder to which 5 ml 
sterile PBS was added. The eggs were then carefully homogenised using a twisting and 
grinding motion. After ~20 rotations, egg disruption was checked. This was repeated ~15 
times on ice until 95% of the eggs were disrupted. The homogenate was transferred to a 
15 ml tube and spun at 2800 xg for 15 min at 4ºC. The supernatants were transferred to 1 
ml micro-centrifuge tubes and spun at 16,000 xg for 10 min. The pooled supernatants 
were filter sterilised through a 0.45µm filter. The SEA protein concentration was 
determined using a Bradford (Coomassie) protein assay and a known BSA standard. The 
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SEA was aliquoted and stored at -80ºC. 
 
SEA prepared in the lab has been tested using the Limulus assay to assess potential 
endotoxin contamination, which demonstrated that there is no activation of Limulus by our 
SEA, thus any LPS contamination is below the level of detection of this assay. Further to 
this, GMDCs are extremely sensitive to LPS and we do not see any surface activation or 
cytokine production from these cells when cultured with SEA. Any batch that did activate 
an inflammatory cytokine response from these cells would be immediately discarded. 
Since 2002, only one batch from the lab has needed to be discarded.    
 
2.5.2 DC Exposure to Ag 
BMDCs were cultured for 6 or 18h in the presence or absence of SEA (25µg/ml), Pa 
(10µg/ml), St (5µg/ml) or CpG-A (1µg/ml, ODN 1585 (Invivogen)). Ag concentrations were 
based on published studies (Jenkins et al., 2007; Perona-Wright et al., 2012), that had 
previously shown these concentrations to be effective for Th2 polarisation by BMDCs, in 
the case of SEA, or Th1/Th17 priming by BMDCs following exposure to St/Pa. 6h Ag 
exposure was used for gene expression analysis, and 18h culture for assessment of 
surface phenotype and cytokine production. For the timecourse experiment described in 
section 3.2.4, BMDCs were cultured in the presence or absence of Ag for between 3 and 
24h. The results from the timecourse experiment were used to guide the length of time 
cells were cultured for gene expression analysis, as this experiment was used to evaluate 
gene expression at different timepoints, as well as surface phenotype and cytokine 
production. It was found that IFN-I genes were activated by SEA from 6h onwards.   
 
2.5.3 DC: OT II co-cultures 
This assay was set up following protocols from the MacDonald laboratory, as previously 
described (Cook et al., 2012). For CFSE dilution assays CD4+ OT II TCR Transgenic T 
cells were purified from spleen and LN using CD4+ Dynabeads (Invitrogen) following the 
manufacturer’s protocol. T cells were labelled with 5 µM CFSE (Invitrogen) for 15 min at 37 
°C, excess CFSE was allowed to leach from the cells prior to culture with 5 x 104 WT or 
Ifnar1-/- BMDCs in the presence of 0.01µg/ml OVA323-339 or 5µg/ml OVA protein (Sigma) 
which had been endotoxin depleted in-house. Cultures were incubated at 37°C for 4 days 
prior to assessment of CFSE dilution by flow cytometry. 
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2.5.4 DC: T cell co-cultures  
This assay was set up following protocols from the MacDonald laboratory, as previously 
described (Cook et al., 2012). 50,000 IL-10eGFP- x KN2 CD4+ or IL-13eGFP- x KN2 CD4+ 
T cells were cultured in 96 well plates for 3d with 2,500 WT or Ifnar1-/- BMDCs, 1µg/ml 
anti-CD3 (produced in-house) and with or without IL-4 (20 ng/ml, Peprotech).  
 
2.5.5 DC chemotaxis assay 
The method used to assess DC chemotaxis using a transwell assay was based on that 
described by Wendland et al. (2011), and was adapted for BMDCs to measure chemotaxis 
following exposure to Ag. Optimisation experiments were performed to establish which 
serum-free medium could be used for the assay, whilst limiting any effects on cell health or 
maturation status. Optimisation experiments were also used to establish the number of 
BMDCs to use per well, so that enough cells would be present in the migrated population 
for thorough analysis of surface phenotype by flow cytometry. WT or Ifnar1-/- BMDCs were 
cultured overnight in the presence or absence of SEA as described in section 2.5.2. Cells 
were washed and resuspended in X-Vivo medium (Lonza). 400µl of medium containing 0, 
25, 100, 250nM of CCL21 was added to the bottom chamber of a transwell plate. 1 x 106 
cells in 100µl of medium were placed in the top chamber of each transwell. Cells were 
incubated at 37°C for 3h. After 3h, the medium in the bottom chamber was harvested, and 
the bottom of the transwell insert washed to remove any adhered cells. Cells were then 
washed and stained for flow analysis and the MACSQuant (Miltenyi) used to acquire flow 
data and calculate the number of each DC subset present per sample. The MACSQuant 
was used as this machine takes up a specific volume per sample and calculates a cell 
count in known volume to provide a total cell count that should be more accurate than any 
generated by BD machines. 
 
2.5.6 TLR reporter cell assay 
The TLR reporter assay was performed by members of Hermilijn Smits laboratory (LUMC, 
Leiden, Netherlands). HEK293-TLR3 and HEK293-CD14/TLR4 cells were maintained in 
DMEM culture medium, supplemented with 10% FCS, 10mg/ml ciprofloxacin and 5mg/ml 
puromycin. For stimulation, cells were seeded at 3.5 x 104 cells/well in 96-well flatbottom 
plates and were stimulated the next day. For stimulation of HEK-293-CD14/TLR4 cells, 
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12.5% supernatant of MD-2 transfected cells was added. IL-8 production was measured in 
supernatants after 22 hours using a commercial kit (Sanquin), as per the manufacturer's 
instructions. 
 
2.6 Human samples 
2.6.1 Human DC isolation and generation 
Preparation and stimulation of human DCs was performed by Bart Everts (University of 
Washington, USA). PBMCs were isolated by Ficoll-Hypaque density gradient 
centrifugation from heparinised venous blood of healthy Western volunteers. CD141+ DCs 
were purified from PBMCs using the BDCA3/ CD141+ DC isolation kit (Miltenyi Biotech). 
CD1c+ DCs were purified from the CD141-depleted PBMCs using the BDCA1/CD1c+ DC 
isolation kit (Miltenyi Biotech). Subsequently, to maximize cell yield pDCs 
(BDCA4/CD123+) were isolated from the flowthrough of the mDC isolation by using BDCA-
4 Dendritic Cell Isolation Kit (Miltenyi Biotec).  
 
Monocytes were isolated from the same healthy volunteers as above by CD14+ MACS 
isolation (Miltenyi Biotec) and were cultured in RPMI medium supplemented with 10% 
FCS, 50ng/ml human rGM-CSF (Invitrogen), and 25U/ml human rIL-4 (R&D Systems). On 
day 3, culture medium including the supplements was replaced, and on day 6, immature 
mo-DCs were stimulated with the indicated Ags. 
 
Freshly isolated DCs or mo-DCs (2 x 104 cells/well in 200µl) were cultured in complete 
RPMI-1640 medium containing 10% FCS, 100U/ml penicillin, and 100mg/ml streptomycin 
and supplemented with 500U/ml GM-CSF or 10ng/ml IL-3 (both Strathmann) for CD1c+ 
mDCs and pDCs respectively. DCs were cultured in the presence or absence of SEA 
(50µg/ml), R848 (1µg/ml, Invivogen), CpG-B 2006 (1µg/ml, Invivogen) or pI:C (100µg/ml, 
Axxora). After 40h cells and supernatants were harvested. 
 
2.6.2 Human serum samples 
Venous blood was obtained from 36 people (mean age 32 years and 9 months) from a 
Kenyan cohort, living in an area in which Schistosoma mansoni infection is endemic. 
Infection with S. mansoni was determined by faecal egg counts, using the mean count of 2 
slides counted from 3 consecutive samples (see Table 2.1). Preparation of serum samples 
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was performed by members of David Dunne’s laboratory (University of Cambridge). See 
Table 2.1 for details of cohort. 
 
2.7 Analytical techniques 
2.7.1 Flow cytometry 
For viability staining: Cells were surface-stained for CD11c and CD45R as detailed 
below (without the addition of Live/Dead). Cells were washed once in Annexin V buffer 
(Life Technologies) and then stained in 50µl of Annexin V buffer plus 7-AAD (Life 
Technologies) and Annexin V-PE (Life Technologies) at a 1:250 dilution for 10 min in the 
dark at room temperature. 150µl of buffer was then added and cells run directly on the 
FACS machine. 
 
For surface staining: Cells were washed in PBS and stained with LIVE/DEAD Aqua or 
Blue (Invitrogen) at a 1:500 (Blue) or 1:1000 (Aqua) dilution in 10µl of PBS, for 10 min at 
room temperature. Surface markers and FcR block (αCD16/CD32, 2.4G2, produced in-
house) were then added to cells in 50µl of FACS buffer, for 20 min at 4°C, at the 
concentrations indicated in Table 2.2.  
 
For intracellular cytokine staining: For restimulation prior to intracellular cytokine 
staining, 2 x 106 cells were plated in a 96-well round bottom plate (Costar) and stimulated 
with 0.5µg/ml PMA (Sigma-Aldrich) and 1µg/ml Ionomycin (Sigma-Aldrich), with 10µg/ml 
Brefeldin A (Sigma-Aldrich) included for the 3h, at 37°C with 5% CO2.  
 
After restimulation with PMA/Ionomycin/Brefeldin, cells were stained with LIVE/DEAD and 
surface markers as described above. Cells were washed three times in FACS buffer, and 
fixed for 20 min at 4°C in Cytofix/Cytoperm (BD Bioscences). Following fixation, cells were 
washed three times in Perm/Wash (BD Biosciences) and stained with antibodies in 50µl of 
Perm/Wash (BD Biosciences) at the concentrations indicated in Table 2.5 for 20 min at 4 
°C. Isotype matched control antibodies were used on a pooled sample. Foxp3 staining was 
performed using the eBioscience Foxp3 staining kit, as per the manufacturer’s instructions. 
Marker expression was measured on FACSCanto (BD Biosciences) or LSRII (BD 




2.7.2 Enzyme-linked immunosorbent assays (ELISAs) 
Mouse cytokine ELISAs were performed on culture supernatants using paired mAb (See 
Table 2.3) purified in house, purchased from eBioscience, BD Pharmingen or PBL, and 
recombinant cytokine standards purchased from PeproTech or PBL. The TNFα ELISA was 
perfomed using a DuoSet ELISA development kit (R&D systems). Primary/capture 
antibodies were coated onto 96 well plates (NUNC) in a volume of 50µl in PBS overnight 
at room temperature (TNFα, IL-1β, IFNα, IFNβ) or 4°C (IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-
12p70, IL-13, IL-5, IL-4, IL-17). Plates were blocked using 10% NCS in PBS for >1h. 
Supernatants and doubling dilutions of recombinant protein standards were added to 96 
well plates in a volume of 50µl, in duplicate where possible, single wells were used in 
situations where supernatant or plate space was limiting. Secondary/detection antibodies 
were added in a volume of 50µl in 10% NCS/PBS, and allowed to bind for 1h at 37 °C (IL-
4, IL-10, IL-13), 1h at room temperature (IL-12p40, IL-12p70, IL-5, IL-6, IL-17) or 2h at 
room temperature (TNFα, IL-1β, IFNα, IFNβ). Streptavidin-peroxidase was added to all 
plates, except for IFNα/β, in a volume of 50µl and incubated at 37°C for 30 min. 50µl 
horse-radish peroxidase-conjugated rabbit IgG (Bethyl) was added to IFNα/β plates for 1h 
at room temperature (1.7µg/ml). 100µl of the colorimetric substrate of peroxidase, TMB 
(Sigma), was added to each well, following development of blue colour, reaction was 
stopped by addition of 0.18M H2SO4 acid (Sigma). Between steps, plates were washed 
using PBS 0.05% Tween-20 (Sigma). See Table 2.3 for reagent details. 
 
Human DC supernatants were analysed for IFNα production by ELISA. The ELISA was 
used as per the manufacturer’s instructions (MabTech).   
 
2.7.3 CBA 
Cytokines present in sera or cell supernatants were assayed using a CBA flex set (BD 
Biosciences), using cytokine-conjugated beads and PE-detection reagent as per the 
manufacturer’s instructions (Wendland et al.) or at 1/5 of the manufacturer’s recommended 
concentrations (mouse). Samples were run on a Canto II or a FACSJazz (BD) and data 



























Sample preparation and microscopy analysis was performed by Jess Borger (UoE). For 
dsRed BMDC tracking experiments, lymph nodes were fixed in 4% PFA, incubated 
sequentially in 15% and 30% sucrose solutions overnight to quench residual PFA and then 
mounted in O.C.T embedding medium (Sakura). This was done to ensure that the dsRed 
signal was maintained. Thin section confocal microscopy was performed on 25 µm 
cryostat sections, which were fixed in ice cold acetone for 10 min, then incubated 
overnight with TCRβ and CD4 antibodies conjugated to fluorescein (eBioscience, UK) and 
CD45R (B220) antibody conjugated to Alexa647 (BD Biosciences, UK). Slides were 
washed extensively in PBS-T, 1x PBS then water and nuclei were stained with DAPI 
supplemented ProLong Fade Gold (Invitrogen) mounting media. Samples were imaged on 
the Leica SP5 II (Leica Microsystems) with lasers exciting with the 405, 488, 543 and 
633nM laser lines and under the 40x and 63× objectives, using LAS AP software (Leica, 
! 98!
USA). Data was rendered and analysed using Volocity software (Improvision). 
 
2.7.5 RNA isolation and qPCR 
RNA was recovered from cells or tissues following suspension in the phenol-based 
product TRIzol (Invitrogen). Total RNA from liver tissue was isolated using the RNeasy 
Mini Kit (Qiagen).  
 
For DC samples, phase separation of DNA/protein and RNA was performed using 
Chloroform. RNA was precipitated using 2-propanol, visualization of RNA pellet was 
enhanced by addition of glycogen (Ambion) during precipitation. 75% ethanol was used to 
wash RNA, prior to air-drying and resuspension in RNase free DEPC water (Ambion).  
 
0.1-0.25µg RNA was used for the synthesis of cDNA using Superscript-III and oligo-dT 
(Invitrogen). Relative quantification was performed by qPCR analysis using the Roche 
Light Cycler 480, with LightCycler SYBR Green I master mix (Roche). Five serial 1:4 
dilutions of a positive control sample of cDNA were used to create standard curves. 
Expression was normalised to the housekeeping genes (gene expressed constitutively for 
the maintenance of cellular function) glyceraldehyde3-phosphate dehydrogenase Gapdh 
(for DCs) or Ubiquitin (for tissue samples). For primer sequences used see Table 2.4. 
Rachel Lundie performed the RT-PCR analysis on liver samples.  
 
2.8 Statistical analysis 
Statistical analyses were carried out using GraphPad Prism 6 software. Student’s T tests 
were employed to determine significant differences between sample groups. In chapter 3, 
Figure 3.2, ANOVA and Tukey’s multiple comparison tests were used to identify statistical 
differences between groups. In situations where only two replicate wells or individual 
animals were used, statistical tests are not valid and as such have not been used. For 
correlation analyses, Pearson r tests were done on parametric data, and Spearman r tests 






Table 2.1 Human Subjects  
YOB = Year of birth; Sex: 0 = female, 1 = male; epg = Eggs/ g faeces 
Colour code: Egg negative, Medium egg load, High egg load 
ID YOB Sex epg 
022-08 1987 0 0.0 
032-01 1960 0 0.0 
051-02 1982 1 0.0 
059-01 1967 1 0.0 
069-02 1976 0 0.0 
091-01 1968 1 0.0 
110-01 1968 1 0.0 
173-06 1990 1 0.0 
173-07 1980 1 0.0 
183-01 1972 0 0.0 
222-07 1977 0 0.0 
231-04 1989 1 0.0 
005-01 1959 1 126.7 
026-04 1989 0 113.3 
060-03 1966 1 113.3 
087-03 1991 0 120.0 
106-05 1990 1 140.0 
113-08 1984 0 110.0 
114-01 1970 1 120.0 
117-05 1981 0 106.7 
123-03 1990 1 136.7 
236-05 1973 0 100.0 
002-06 1992 1 873.3 
004-03 1993 0 1496.7 
015-04 1991 1 613.3 
025-04 1990 1 473.3 
038-06 1990 1 513.3 
109-04 1991 1 476.7 
112-07 1969 1 630.0 
120-03 1984 1 766.7 
177-02 1969 0 246.7 
178-01 1965 0 380.0 
193-07 1984 1 483.3 
218-06 1986 0 193.3 
280-02 1988 1 466.7 




Table 2.2 Flow antibodies 
Antigen Clone Isotype Host Conjugate Titration Manufacturer 
CCR5 HM-CCR5 IgG Ar Ham AF488 1:200 eBioscience 
CCR7 4B12 IgG2a κ Rat APC 1:50 Biolegend 
huCD2 S5.5 IgG2a Mouse PE 1:200 Invitrogen 
CD4 RM4-5 IgG2a κ Rat APC, AF700, 
FITC 
1:800 eBioscience 
CD8 53-6.7 IgG2a κ Rat PECy7 1:800 BioLegend 
CD103 2E7 IgG Ar Ham Bio, FITC, 
PerCP/Cy5.5 
1:50 eBioscience 
CD11b M1/70 IgG2b κ Rat FITC, AF780 1:600 BioLegend 
CD11c N418 IgG Ar Ham AF647, 
AF780, PE 
1:200 eBioscience 
CD19 1D3 IgG2a κ Rat AF450, PE, 
PECF594 
1:200 BioLegend 
CD24 M1/69 IgG2b κ Rat PECy7 1:1000 Biolegend 
CD25 7D4 IgM κ  Rat PerCP/Cy5.5 1:200 Biolegend 
CD40 3/23 IgG2a κ Rat PE, FITC 1:200 BD Pharmingen 
CD45 30-F11 IgG2b κ Rat AF700 1:400 eBioscience 
CD45.1 A20 IgG2a κ Mouse FITC 1:200 eBioscience 
CD45.2 104 IgG2a κ Mouse PE 1:100  
CD45R (B220) RA3-6B2 IgG2a κ Rat AF450, APC, 
BV650 
1:200 eBioscience 
CD80 16-10A1 IgG2 κ Ar Ham APC, PE, 
PerCP/Cy5.5, 
BV605 
1:600 BD Pharmingen 
CD86 GL-1 IgG2a κ Rat FITC, BV650, 
PECy7 
1:200 BD Pharmingen 
F4/80 BM8 IgG2a  Rat PECy7, FITC 1:400 BioLegend 
Foxp3 FJK-16s IgG2a κ Rat AF450 1:200 eBioscience 
IFNAR1 MAR1-5A3 IgG1 κ Mouse PE 1:200 Biolegend 
IL-4 11B11 IgG1 Rat PE 1:200 BioLegend 
IL-5 TRFK5 IgG1 Rat PE 1:200 BD Pharmingen 
IL-13 eBio13A IgG1 κ Rat AF488 1:200 eBioscience 
IFNγ XMG1.2 IgG1 κ Rat AF450 1:200 eBioscience 
Gr1 
(Ly6C+Ly6G) 
R86-8C5 IgG2b κ Rat PerCP/Cy5.5, 
BV570 
1:400 BD Pharmingen 
Ly6C HK1.4 IgG2b Rat BV570 1:400 Biolegend 
Ly6C AL-21 IgM Rat APC 1:400 BD Pharmingen 
Ly6G 1A8 IgG2a κ Rat AF780 1:200 BD Pharmingen 
MHC II (I-A/ I-E) M5114 IgG2b κ Rat PerCP/Cy5.5, 
FITC 
1:1600 eBioscience 
MHC II (I-A/ I-E) M5115 IgG2b κ Rat AF450 1:800 eBioscience 
Siglec F E50-2440 IgG2a κ Rat PE 1:200 BD Pharmingen 
Streptavidin    PerCP/Cy5.5 1:1000 eBioscience 







Table 2.3 ELISA reagents 
Primary Antibodies 
Specificity Conjugation Clone Host Concentration Manufacturer 
IL-1β Purified B122 Ar Ham 4µg/ml eBioscience 
IL-4 Purified 11B11 Rat 2µg/ml Homegrown 
IL-5 Purified! TRFK5 Rat! 2µg/ml! Homegrown 
IL-6 Purified! MP5-20F3 Rat! 2µg/ml! Homegrown 
IL-10 Purified! JES16-E3 Rat! 1µg/ml! eBioscience 
IL-12 p40 Purified! C15.6 Rat! 2µg/ml! eBioscience 
IL12 p70 Purified! 9A5 Rat! 2µg/ml! BD 
IL-13 Purified! Ebio13A Rat! 2µg/ml! eBioscience 
IL-17 Purified! TC11-18H0 Rat! 0.5µg/ml! BD 
IFNα Purified! RMMA-1 Rat 2.5µg/ml! PBL 
IFNβ Purified! RMMB-1 Rat 2.5µg/ml! PBL 
IFNγ Purified R4-6A2 Rat 2µg/ml Homegrown 
TNFα Purified! Duoset DY410  0.8µg/ml! R&D 
Recombinant Standards 
IL-1β Recombinant   20ng/ml eBioscience 
IL-4 Recombinant!   20ng/ml Peprotech 
IL-5 Recombinant!   20ng/ml! BD 
IL-6 Recombinant!   20ng/ml! Peprotech 
IL-10 Recombinant!   50ng/ml BD Pharmingen 
IL-12 Recombinant!   20ng/ml Peprotech 
IL-13 Recombinant!   50ng/ml Peprotech 
IL-17 Recombinant!   20ng/ml eBioscience 
IFNα Recombinant!   20ng/ml PBL 
IFNβ Recombinant!   112ng/ml PBL 
IFNγ Recombinant!   50ng/ml Peprotech 
TNFα Recombinant!   0.4ng/ml R&D 
Secondary Antibodies (Biotinylated) 
IL-1β Biotin Polyclonal sera Rabbit 0.3µg/ml eBioscience 
IL-4 Biotin! BVD6-24G2 Rat 0.25µg/ml BD 
IL-5 Biotin! TRFK4 Rat! 0.3µg/ml eBioscience 
IL-6 Biotin! MP5-32C11 Rat! 0.5µg/ml eBioscience 
IL-10 Biotin! SXC-1 Rat! 0.2µg/ml BD 
IL-12/23 p40 Biotin! C17.8 Rat! 0.2µg/ml eBioscience 
IL-13 Biotin! Polyclonal sera Rabbit 0.1µg/ml Peprotech 
IL-17 Biotin! TC11-8H4.1 Rat 0.25µg/ml BD 
IFNα Biotin! Polyclonal sera Rabbit 0.78µg/ml  PBL 
IFNβ Biotin! Polyclonal sera Rabbit 0.078µg/ml PBL 
IFNγ Biotin! XMG1.2 Rat 0.2µg/ml BD 













































































3.0 FLT3-L DEPENDENT BMDC RESPONSES TO SCHISTOSOME EGG 
ANTIGENS 
3.1 Introduction 
The use of CD11c-depletable mice has revealed that DCs are essential for the generation 
of Th2 immunity in response to both helminth parasites and allergens (Hammad et al., 
2010; Phythian-Adams et al., 2010; Smith et al., 2012). There is an extensive literature 
examining how DCs respond to Th2-inducing pathogens, particularly the egg stage of S. 
mansoni, and this has primarily utilised murine BMDCs generated in vitro in response to 
GM-CSF. These studies have shown that Th2 induction requires DC expression of CD40 
and NF-κB, whilst OX40L functions to amplify the response (Artis et al., 2005; Jenkins et 
al., 2007; MacDonald et al., 2002c). In the case of CD40, in vivo infection experiments with 
gene-deficient mice support these conclusions (MacDonald et al., 2002b; Straw et al., 
2003). This indicates that reductionist studies with in vitro-derived DCs can model and 
inform the more challenging task of assessing DC:T cell interactions in multiple tissues 
(the skin, lungs, liver, intestine, draining lymph nodes) that occur over the course of S. 
mansoni infection. Despite this, the nature of the polarising signal provided by DCs that 
instructs Th2 differentiation remains unknown, although DC secretion of the classical Th2 
polarising cytokine IL-4, or the Th2 and regulatory cytokine IL-10, is not required (Jankovic 
et al., 2004; MacDonald and Pearce, 2002; MacDonald et al., 2001).  
 
Addition of GM-CSF to bone marrow cultures leads to the generation of a homogenously 
CD11chi MHC II+ CD8α- cell population (Inaba et al., 1992; Lutz et al., 1999), that most 
closely resemble fully-differentiated monocyte-derived CD11b+ DCs in vivo (Robbins et al., 
2008). GMDCs have been, and continue to be, a very useful primary DC model, as it is 
possible to generate large numbers of cells in vitro using GM-CSF. Another advantage of 
GMDCs is that they are a single DC subtype so there is no need to sort or purify subsets. 
However, GM-CSF does not govern DC development in vivo (Naik, 2008; Waskow et al., 
2008), thus it does not seem that GMDCs have any direct counterpart in mice in the 
steady state. It now seems more likely that GM-CSF is required for DC homeostasis and 
survival in vivo rather than as a DC growth factor (Greter et al., 2012). Hence, GMDCs fail 
to represent the level of heterogeneity seen in the DC populations present in lymphoid 
organs, or in peripheral tissues in the steady state.  
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More recently, it has been demonstrated that murine BMDCs can be generated in vitro 
using Flt3-L (Brasel et al., 2000; Brawand et al., 2002), which is the primary DC 
differentiation factor in vivo (D'Amico and Wu, 2003; Kingston et al., 2009; Waskow et al., 
2008). Unlike GMDCs, cDCs generated in vitro with Flt3-L have clear steady state 
equivalents in vivo. Flt3-L gives rise to two in vitro cDC subsets which have similar 
properties to the cDC populations found in the spleen (Brasel et al., 2000; Naik et al., 
2005). Flt3-L also generates a subset of plasmacytoid DCs (pDCs), these cells share 
many characteristics with their in vivo counterparts (Brawand et al., 2002; Naik et al., 
2005). 
 
In contrast to the large number of studies using GMDCs, there are currently no published 
studies investigating how Flt3-L derived BMDCs (FLDCs) respond to either schistosome 
antigens, or those from other helminth species. Because of the dichotomy in the roles of 
these two growth factors in DC biology (differentiation vs. maintenance of DCs, steady 
state vs. inflammatory DC phenotype), we hypothesised that FLDCs would respond to 
helminth antigen in a manner distinct from GMDCs. As such, this first chapter will address 
how FLDCs respond to the strongly Th2-polarising egg-antigens from S. mansoni, and 
compare and contrast their responses to a Th1/17-polarising bacterial stimulus. We have 
performed a comprehensive analysis of the phenotype of FLDCs following exposure to 
SEA. This includes characterisation of the expression level of MHC II and co-stimulatory 
markers, molecules that are essential for T cell polarisation. We have also assessed the 
cytokine output of FLDCs in response to SEA. The findings from these studies have been 
surprising, with the cytokine response in particular providing novel insights into the 
responses of different DC subsets to SEA. This has led us to investigate the PRRs that are 
involved in SEA-sensing by DCs, and may facilitate important developments in our 




3.2.1 Identification of DC subsets in a Flt3-L bone marrow culture 
As FLDC generation was a relatively new technique in the lab, we first sought to identify 
the DC subsets present in our Flt3-L BM cultures. The protocol used to generate FLDCs 
was based on that of Naik et al. (2010), who have published extensively on these cells 
(Naik et al., 2005; Naik et al., 2007; Xu et al., 2007), and have shown that 8-9d culture of 
BM with Flt3-L generates fully-differentiated CD11c+ cells with the functional 
characteristics of DCs (Naik et al., 2005).  BM cells were cultured with Flt3-L for 8d, before 
being replated and cultured for a further 18h (Fig. 3.1A). The presence of the different DC 
subsets was then analysed by flow cytometry. Over 95% of live-singlet cells were CD11c+ 
(Fig. 3.1B). Within the CD11c+ population, two distinct DC subpopulations could be 
identified by their differential expression of CD45R (Fig. 3.1B). The CD45R+ pDCs 
comprised approximately 30% of the CD11c+ population, however this did vary between 
cultures (20-45%). The CD45R- cDCs, which made up a greater proportion of the culture 
(50%), could be further subdivided into CD11bhi CD24lo (CD11b+ cDCs) and CD11blo 
CD24hi (equivalent to CD8α+ cDCs, referred to as CD24+ cDCs from now on) populations 
(Fig. 3.1B). There was a small proportion, around 20%, of CD11chi cells that were not 
clearly definable as CD45R+ pDCs or CD45R- cDCs. They may be the in vitro equivalents 
of a cell population identified in the spleen that are a developmental stage of cDCs, these 
cells downregulate expression of CD45R during differentiation (Segura et al., 2009). This 
may explain a minority of cells expressing intermediate levels of CD45R (Fig. 3.1B). 
Having confirmed the presence of pDCs, CD24+ and CD11b+ cDCs in our FLDC cultures, 
we next assessed their responses to Ag. 
 
3.2.2 SEA stimulates an intermediate level of phenotypic activation in conventional 
FLDCs 
To determine how FLDCs respond to helminth Ag, BM cells were differentiated with Flt3-L 
for 8 days and then cultured overnight in the presence or absence of SEA (Fig. 3.2A). A 
heat-killed preparation of the attenuated Salmonella typhimurium strain SL3261 (St) was 
used as a Th1/17-inducing control. Unless otherwise stated, these characterisation 
experiments use bulk FLDC cultures that are a mixture of the cDC subsets and pDCs. 
There is no doubt that it would have been preferable to sort the FLDCs into pure 
populations. However, this was technically impractical due to the amount of flow-sorting 
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that would have been required to obtain the numbers of cells needed for every experiment. 
We also found that flow sorting could have a detrimental impact on the survival and 
phenotype of our cells. In our initial experiments we focused on the surface phenotype of 
cDCs versus pDCs and did not breakdown our characterisation to include the different 
cDC subsets. This was primarily because of limitations in the number of markers we were 
able to analyse on our FACS machines at the time. More recently we have been able to 
extend our flow panel and have characterised the responses of the cDC subsets to SEA, 
which are detailed in section 3.2.7. 
 
As expected, FL-cDCs upregulated expression of MHC II and the co-stimulatory molecules 
CD40, CD80, and CD86 in response to St (Fig. 3.2B), this was also evident in a significant 
increase in gMFI of these markers (Fig. 3.2C). FL-pDCs also upregulated these molecules 
when stimulated with St (Fig. 3.2B-C). However, their expression level of MHC II and 
CD40 was approximately 15 fold lower than St-stimulated cDCs, whilst that of CD80 and 
CD86 was 80 and 25 fold lower respectively. More tellingly, only CD86 was significantly 
upregulated on pDCs exposed to St, compared to medium alone (Fig. 3.2C). Furthermore, 
in the absence of any Ag stimulation, pDCs had a much lower basal level expression of 
these markers compared to cDCs (Fig. 3.2B-C).  
 
From our previous work with GMDCs, we predicted that SEA would induce little to no 
change in FLDC activation phenotype (Jenkins et al., 2007; MacDonald et al., 2001; 
Perona-Wright et al., 2006a). Surprisingly, however, SEA caused a marked increase in 
MHC II and co-stimulatory molecule expression, which was also evident in a significant 
increase in gMFI (Fig. 3.2B-C). In fact, MHC II expression levels on SEA and St-stimulated 
FL-cDCs were equivalent. FL-pDCs displayed no significant upregulation of expression of 
MHC II, CD40, CD80 or CD86 in response to SEA (Fig. 3.2B-C). 
 
Thus SEA appeared capable of generating an intermediate level of FL-cDC phenotypic 
activation. This is in contrast with results previously obtained using GMDCs, which are 
essentially unresponsive to SEA (MacDonald et al., 2001; Perona-Wright et al., 2012). 
This finding led us to next investigate whether SEA exposure also affected cytokine 
production by FLDCs. 
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3.2.3 SEA stimulates IFN-I secretion from FLDCs 
In order to assess FLDC cytokine production in response to SEA or St, ELISAs were 
performed on cell supernatants from cells cultured overnight with these Ags. In line with 
the marked phenotypic activation of FLDCs following exposure to St (Fig. 3.2), the 
bacterium also stimulated high-level secretion of the inflammatory cytokines IL-1β, IL-6, IL-
12p40, IL-12p70 and TNFα (Fig. 3.3A), all mediators of Th1 and/or Th17 immunity 
(Kapsenberg, 2003; Muranski and Restifo, 2013). By contrast, SEA elicited much lower 
levels of these cytokines from FLDCs, although significant upregulation of IL-6 and IL-
12p40 was noted when compared to medium alone controls (M, Fig. 3.3A). St also 
induced the secretion of IL-10 from FLDCs, which was not the case for SEA-pulsed cells 
(Fig. 3.3A).  
 
In line with the initial identification of their in vivo counterparts as ‘IFN-producing cells’ 
(Perussia et al., 1985; Trinchieri and Santoli, 1978), FL-pDCs produce large amounts of 
IFN-I in response to viral and synthetic TLR ligands (Brawand et al., 2002; Naik et al., 
2005). FL-cDCs can also secrete IFNα following stimulation with bacterial or viral 
preparations, albeit at lower levels (Brawand et al., 2002). Thus, we measured IFN-I 
production by these cells, and found they secreted high levels of IFNα3 and IFNβ in 
response to the TLR9 ligand, CpG ODN 1585 (Fig. 3.3C). Similarly, St also stimulated 
IFNα production by FLDCs (Fig. 3.3B), whereas IFNβ production was at a lower level and 
more variable, only being detectable on occasion (none detected in the experiment shown 
in Fig. 3.3B).  
 
Whilst the response of these cells to bacterial and TLR agonists was as expected, we 
were extremely surprised to find that SEA was also a robust stimulus for IFN-I production 
(Fig. 3.3B) by FLDCs. SEA induced both IFNα3 (at a level similar to St) and IFNβ 
subtypes.  
 
3.2.4 The kinetics of FLDC activation and IFN-I production in response to SEA 
Since the above findings assessed the responses of FLDCs only after 18h of Ag 
stimulation, we next performed a timecourse study to determine the kinetics of the FLDC 
response. Bulk FLDCs were cultured with or without Ag and supernatants from triplicate 
wells were harvested after 3, 6, 12, 18 or 24h stimulation. Cells were also stained for 
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analysis of surface marker expression by flow cytometry at 3, 6, 18 and 24 h. For 
simplicity, Fig. 3.4A focuses on cDC expression of CD40 only at these timepoints. 
However, these data are also representative of the kinetics of CD80 and CD86 expression. 
Expression levels of these activation markers in FL-pDCs exposed to SEA/ St was 
negligible. 
 
cDCs cultured in medium alone displayed a basal expression level (gMFI 300-400) of 
CD40 on their surface that was largely unchanged over a 24h period, and the total 
percentage of CD40+ cells actually decreased over time (Fig. 3.4A). In stark contrast, at 
the earliest timepoint analysed (3h), essentially 100% of cDCs activated with St were 
already CD40+, with a high level of CD40 expression on their surface (Fig. 3.4A). After 3h 
of SEA exposure, both the proportion of FL-cDCs that were CD40+, and the level of CD40 
expression, was increased compared to unstimulated cells. Despite this, SEA activated 
cDCs expressed almost 10-fold lower levels of CD40 than St exposed cells at this early 
timepoint (Fig. 3.4A). The proportion of cDCs expressing CD40 between 6 and 18h 
remained stable in the St cultures, with a stepwise increase in geoMFI at each timepoint 
(Fig. 3.4A). After 24h, however, the expression level of CD40 had started to drop on cells 
exposed to St, and there was a minor decrease in the proportion of cells expressing this 
marker. This suggests that the St response may be downregulated at later timepoints. The 
kinetics of the cDC response to SEA were somewhat different because the percentage 
and level of CD40 expression continued to rise between 6-24h, to the extent that by 18h 
>99% of cells were CD40+, and remained so at the 24h time point (Fig. 3.4A). This 
suggests that, as SEA appears to stimulate a lower level of activation when compared to 
St, the response develops slower and may peak later. 
 
Culture supernatants were collected over the timecourse for ELISA analysis of FLDC 
cytokine secretion levels. As with phenotypic activation, IFNα release in response to St 
was significantly above background at the earliest timepoint (3h, p=0.0034, Fig. 3.4B), and 
peaked between 6-9h. In this experiment, no IFNβ was detected in the supernatants of St-
pulsed cells at any timepoint. Again, the response to SEA was slower. Significant but low 
levels of IFNα3 were detectable above background at 6h (p=0.0008), and IFNβ at 9h, 
following SEA exposure (p=0.0147, Fig. 3.4B). However, most SEA-specific IFN-I was 
secreted between 6-12h of Ag stimulation. Levels of St-induced IFNα and SEA-IFNβ 
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seemed to be reduced at later timepoints (Fig. 3.4B). Together, these data suggest that 
the kinetics of both the phenotypic activation and IFN-I response of FLDCs to SEA is 
different to that generated by bacterial exposure, with potential consequences for co-
ordination of downstream T cell responses. 
 
3.2.5 FLDCs generated from 3 different mouse strains have the same phenotypic 
and cytokine response to SEA 
Using cells generated from C57BL/6 BM, we found that IFN-I was secreted in response to 
SEA stimulation by FLDCs, and that cDCs particularly became activated by exposure to 
this helminth Ag preparation. To address whether this is a general feature of the murine 
FLDC response to helminth Ag, the phenotype of FLDCs generated from the BM of two 
other commonly used laboratory mouse strains (BALB/c and CBA) was also assessed 
(Fig. 3.5A). 
 
Both SEA-pulsed BALB/c and CBA FL-cDCs displayed the intermediate activation level 
previously seen with BL/6 cells, with the gMFI of the co-stimulatory molecules being 
highest following St stimulation, but SEA inducing significantly above-background levels 
(Fig. 3.5B). GMFI levels for MHC II were more variable between wells, and so less easily 
interpreted. There was no significant difference in the gMFI of MHC II or CD40 on SEA-
pulsed cells from the 3 strains. However, BALB/c FL-cDCs expressed significantly more 
CD80 (BL/6 and CBA: p<0.0001) and CD86 (BL/6: p=0.0003, CBA: p=0.0051) than cells 
from the other strains (Fig. 3.5B). CBA expression of CD80 (p=0.0042) and CD86 
(p=0.0003) was also significantly elvated compared to BL/6 cells exposed to SEA.   
 
SEA stimulated significant IFNα production by FLDCs from all three mouse strains (Fig. 
3.5C). The exact concentrations of IFNα3 secreted varied between strains, with a mean 
concentration of 0.55ng/ml from BL/6, 1.23ng/ml from BALB/c and 0.82ng/ml from CBA 
cells (Fig. 3.5C). Again, the BALB/c output was significantly higher than the other strains 
(BL/6: p=0.0001, CBA: p=0.0031), and CBA IFNα levels were also significantly above 
BL/6, in response to SEA (p=0.0008). In this experiment, the level of IFNα production from 
St-pulsed cells was much lower than SEA levels, and CBA secretion was around 
background. Together, these data indicate that the responses of FLDCs to SEA represent 
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a consistent phenotype across mouse strains. We next investigated whether any facets of 
this response were shared with GMDCs. 
 
3.2.6 GMDCs phenotypic activation and IFN-I secretion does not occur in response 
to stimulation with schistosome egg Ag 
As described in the introduction to this chapter, a large number of published studies have 
examined the responses of GMDCs to SEA, none of which have reported a marked 
phenotypic response from these cells. In agreement with this, we found significant 
upregulation of MHC II and co-stimulatory molecule expression on GMDCs only following 
overnight exposure to the bacterial stimuli St or Pa (the heat-killed gram-positive 
bacterium, P. acnes)(Fig. 3.6A-B). Similarly, no significant IFN-I secretion was detected in 
the supernatants of cells that had been exposed to SEA (Fig. 3.6C). These data indicate 
that, although capable of phenotypic activation and IFN-I production in response to 
bacterial stimulation, GMDCs do not respond to SEA in this way. 
 
3.2.7 Differential activation of FL-cDC subsets by SEA 
Thus far, this chapter has distinguished between the responses of cDCs and pDCs to SEA 
based on their surface expression of CD45R. However, as discussed in section 3.2.1, FL-
cDCs are composed of both CD11bhi CD24lo and CD11blo CD24hi cells, equivalent to in 
vivo CD11b+ and CD8a+ cDCs, respectively. For simplicity, the CD11bhi population will be 
referred to as CD11b+ cDCs, and the CD24hi as CD24+ cDCs. We assessed the response 
of the individual cDC subsets to SEA by FACS analysis of unsorted bulk FLDC cultures, 
and found clear differences in basal activation, as well as in the response to SEA. CD11b+ 
cDCs expressed a significantly higher basal level of CD40 (p<0.0001) and CD80 
(p=0.0001, Fig. 3.7A-B) than the CD24+ subset. SEA-stimulated expression of these 
markers was also higher on CD11b+ cDCs than CD24+ cells, with gMFI for CD40 
(p=0.0199) and CD80 (p<0.0001) 2 and 4-fold greater respectively than on the CD24+ 
subset (Fig. 3.7B). It should be stated, however, that following SEA exposure, both these 
markers were significantly upregulated on the CD24+ subset compared to unstimulated 
cells (CD40: p=0.0007; CD80: p=0.0003) (Fig. 3.7B). Moreover, whilst CD11b+ cDCs 
upregulated CD80 to a greater extent than the CD24+ subset in response to SEA, CD24+ 
cDC expression of CD40 increased 4-fold in comparison to just a 2-fold increase on 
CD11b+ cDCs (Fig. 3.7C). This suggests that both cDC subsets are responsive to SEA 
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stimulation but with some differences in their surface phenotype. There was no significant 
difference in MHC II expression between any groups in this experiment. 
 
To determine the cellular source of the IFN-I produced by FLDCs in response to SEA, the 
three different FLDC subsets were FACS-sorted, stimulated for 18h with Ag, and then cell 
supernatants analysed for cytokine production. This revealed that only the CD24+ cDCs 
produced significant levels of IFNα3 above background levels (p<0.0001, Fig. 3.7D). No 
IFNβ was detected from any cells in this experiment. Since neither pDCs nor CD11b+ 
cDCs produced IFNα in response to SEA, this suggests that the receptor-signalling 
pathway involved in the IFN-I response is selectively expressed by CD24+ cDCs over other 
subsets.  
 
3.2.8 Receptor-signalling pathways involved in the FLDC IFN-I response to SEA  
IFN-I production in response to pathogen Ags is mediated by PRRs, primarily by cytosolic 
nucleic acid sensors, such as RIG-like receptors (RLRs) or by transmembrane TLRs 
(Honda and Taniguchi, 2006a). To investigate which receptor-signalling pathways may be 
important in SEA-specific IFN-I induction by FLDCs, we began by addressing the role of 
TLRs. Two key adaptor proteins for relaying TLR-mediated signalling are MyD88 and 
TRIF, and so we assessed IFN-I production by Myd88-/-/Trif-/- FLDCs, in response to SEA. 
This revealed that SEA induces IFNα3 in a MyD88/TRIF-dependent fashion (Fig. 3.8B). 
This finding suggested that RLRs were unlikely to play a central role in the IFN-I response, 
as a distinct adaptor molecule, IPS-1, mediates downstream signalling from RLRs (Kawai 
et al., 2005). 
 
To investigate the exact TLR responsible for this signalling, we measured responses in 
WT and TLR9-deficient FLDCs, since TLR9 (which recognises unmethylated CpG 
sequences in dsDNA and is MyD88-dependent) is the TLR most closely associated with 
IFN-I production by DCs (Kadowaki et al., 2001a; Kadowaki et al., 2001b). However, bulk 
cultures of Tlr9-/- FLDCs produced comparable concentrations of IFNα3 to WT cells 
(p=0.1671, Fig. 3.8C), indicating no major role for TLR9 in this case. Remarkably, MyD88-
deficient, TRIF-sufficient cells showed a significant enhancement in SEA-specific IFNα3 
compared to WT cells (p=0.0003, Fig. 3.8D), which clearly demonstrates that MyD88 is a 
negative regulator of the SEA-induced IFN-I response. Equally clear was the complete 
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ablation of IFNα secretion by Trif-/- FLDCs in response to SEA (p=0.0084, Fig.  3.8D), 
demonstrating that the IFN response is dependent on TRIF signalling. TRIF relays signals 
from TLR3 and TLR4 (Yamamoto et al., 2003; Yamamoto et al., 2002), suggesting 
involvement of one or both of these receptors in the IFN-I response to SEA. However, 
there are additional PRRs involved in the induction of this response, as Ly75-/- FLDCs 
(deficient in the CLR CD205) displayed a significant (p=0.0290), though only partial, 
reduction (40% of WT levels) in IFNα production after exposure to SEA (Fig. 3.8E). 
Together, these findings indicate that SEA interaction with FLDCs stimulates a complex, 
multi-faceted signalling cascade, one of the downstream outcomes of which is SEA-
specific IFN-I production.  
 
In order to determine whether SEA contains a TLR3 ligand, we tested for binding to a 
number of TLR reporter cell lines, in collaboration with Hermelijn Smits (LUMC, 
Netherlands). TLR3 activation by SEA was only 2-fold above medium background levels 
(demonstrated by IL-8 induction), this was approximately 6-10 fold lower than that induced 
by the known TLR3 ligand polyI:C (Fig. 3.9). Perhaps most tellingly, there was no 
discernible increase in TLR3 activation with increasing dose of SEA (Fig. 3.9). The TLR4-
reporter cell line illustrates that there is a level of activation of TLR4 by SEA. However, 
TLR4 activation was downmodulated at a high dose of SEA, with a reduction in TLR4 
activation at 50µg/ml compared to 10µg/ml (Fig. 3.9). Thus, more work is required to 
identify the exact PRRs that contribute to SEA-specific IFN-I production, as well as the 














• FL-cDCs displayed an intermediate level of surface activation in response to SEA, 
which includes a marked upregulation in MHC II expression and co-stimulatory 
molecules (Fig. 3.2), although not to the level of classical activation seen in 
response to a bacterial stimulus 
• FL-pDCs responded to Ag stimulation with only very minor changes in the markers 
associated with activation (Fig. 3.2) 
• The FLDC response to SEA was characterised by an almost complete lack of 
cytokine production (Fig. 3.3A), with the exception of IFN-I (Fig. 3.3B) 
• Both CD11b+ and CD24+ FL-cDCs were activated by SEA, but CD24+ cDCs were 
the source of SEA-specific IFN-I (Fig. 3.7) 
• In agreement with published reports, GMDCs did not become phenotypically 
activated in response to SEA, nor did they secrete IFN-I in response to this 
helminth Ag (Fig. 3.6) 
• The SEA IFN-I response was dependent on both TRIF and DEC205, but was 



















The aim of the work detailed in this chapter was to address how Flt3-L generated BMDCs 
respond to SEA, the highly Th2-polarising egg Ags from the parasitic helminth S. mansoni. 
Although Flt3-L is the primary DC growth factor in vivo, most of the in vitro studies 
investigating DC responses to SEA have focused on GMDCs. Up to this point, the 
phenotype of FLDCs following exposure to helminth Ag had not been described. The DCs 
differentiated in vitro by Flt3-L are comprised of subsets that are equivalent to those found 
in lymphoid organs in the steady state, thus providing a model with which to study DC 
responses to SEA that is more relevant to the in vivo setting. This work demonstrated that 
FL-cDCs upregulated the markers associated with T cell priming following exposure to 
SEA, an intermediate level of surface activation in comparison to a bacterial stimulus. 
pDCs expressed only very low-levels of MHC II and co-stimulatory molecules but did 
display significant upregulation of CD40 and CD86 in response to SEA. Although the 
cytokine output from FLDCs in response to SEA was very low, we have identified that the 
CD24+ FL-cDC subset uniquely produced IFN-I following exposure to SEA. This IFN-I 
response was dependent on the PRR adaptor protein TRIF, and optimal IFN-I output also 
required FLDC expression of the CLR CD205. In contrast, we failed to detect any IFN-I 
production by GMDCs exposed to SEA. Thus, the responses of FLDCs to SEA are 
somewhat distinct from those of GMDCs.   
 
3.3.1 FLDC activation by SEA 
In agreement with previous work (MacDonald and Maizels, 2008; MacDonald et al., 2001), 
we found that C57BL/6 GMDCs fail to respond to SEA phenotypically with little change in 
surface expression of MHC II, CD40, CD80 or CD86 compared to unstimulated cells. In 
complete contrast, our studies with Flt3-L in vitro differentiated cDCs have indicated that 
SEA can stimulate an intermediate level of activation, as evidenced by a significant 
increase in MHC II, and a minor elevation in co-stimulatory molecule expression (Fig. 
3.2B-C). Nevertheless, activation levels remain low in SEA exposed FLDCs, compared to 
those ‘classically’ activated by bacterial stimulation (Fig. 3.10).  
 
As highlighted in the introduction to this chapter, FLDCs have been lauded as a model of 
DCs present in steady state lymphoid organs (Naik et al., 2005; Naik et al., 2007), 
suggesting that their responses to SEA in vitro may be representative of the phenotype of 
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their in vivo counterparts. A study by Straw et al. (2003) is, to date, the only published 
study that has tried to characterise the activation phenotype of DCs in vivo during patent 
S. mansoni infection. This paper analysed the surface expression of MHC II, CD40, CD80 
and CD86 on MACS-purified CD11c+ cells from the spleens of mice at different time points 
during infection. This CD11c+ cell population in the spleen would likely contain resident 
CD8α+ and CD8α- cDCs (equivalent to the CD24+ and CD11b+ cDCs in the FLDC culture 
respectively (Naik et al., 2005)), as well as pDCs (Naik et al., 2007). Whilst the authors 
saw an increase in MHC II, CD40 and CD80 expression over the course of infection on all 
CD11c+ cells, this did not rise significantly above naïve levels until a relatively late 
timepoint (days 49-56), and CD86 expression did not vary significantly at any timepoint of 
infection (Straw et al., 2003).  
 
Our findings from FLDCs stimulated with SEA suggest we would expect to see DC 
activation around the commencement of egg deposition (from around d28 post-infection), 
but Straw et al. (2003) did not detect this. One possible explanation is that their initial 
analysis of splenic DCs included all CD11c+ cells within the spleen, and did not separate 
the DC subsets. As we, and others (Asselin-Paturel et al., 2001; Brawand et al., 2002), 
have demonstrated, pDCs express only very low levels of MHC II and co-stimulatory 
molecules, which may influence interpretation of the readout for bulk CD11c+ cells ex vivo. 
In unpublished work from our lab (Rachel Lundie et al.), we have assessed the activation 
status of cDCs and pDCs in different tissues over the course of S. mansoni infection. This 
work has indicated that DC responses to infection are quite distinct in different tissues, 
with splenic cDCs only displaying a significant increase in CD40 expression compared to 
naïve animals around d56 of infection. However, we have not completed a comprehensive 
analysis of the activation of the different cDC subsets. 
 
Straw et al. (2003) did assess the activation status of CD8α+ and CD8α- splenic cDCs 
during S. mansoni infection. In contrast to our findings with the FLDC subsets, where we 
saw a higher basal level of surface activation on CD11b+ cDCs (the CD8α- 
equivalents)(Fig. 3.7A-B), a greater proportion of the splenic CD8α+ cDCs from naïve mice 
expressed CD40, CD80 and CD86. Straw et al. found that the CD8α- subset expressed 
only MHC II at a higher level than the CD8α+ cDCs in the spleen of naïve animals. On d56 
of infection the CD8α- subset displayed a greater fold increase in CD80 expression 
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compared to the CD8α+ subset, whilst CD40 upregulation was more pronounced on CD8α+ 
cDCs (Straw et al., 2003). These findings are in agreement with our analysis of the 
responses of the CD24+ and CD11b+ FL-cDC subsets to SEA stimulation (Fig. 3.7C). 
However, the proportion of splenic cDCs that had upregulated MHC II and co-stimulatory 
molecule expression at this timepoint of S. mansoni infection seemed lower than is seen 
from FL-cDCs exposed to SEA in vitro. 
 
Low to moderate DC activation in the spleen may be due to low-level Ag exposure in this 
tissue, compared to FL-cDCs in the in vitro setting. Similarly, sustained exposure to 
schistosome Ags in the spleen may only occur at later timepoints of infection when 
substantial tissue damage has been caused in the liver and intestine. We have termed the 
response of FL-cDCs to SEA an “intermediate activation phenotype”, and this may be too 
subtle to be clearly detectable in vivo during infection. It is also worth noting that our 
studies of FLDCs in vitro examine the responses of these cells in isolation, whilst the in 
vivo setting is within a much more complex environment, including cell populations that 
regulate DC activation. During S. mansoni infection in particular, a large component of the 
immune response is regulatory, including an increase in Tregs, and activation of IL-10-
producing Teffectors and innate cell populations (Dewals et al., 2010; Herbert et al., 2008; 
Hesse et al., 2004). The response of splenic DCs to synchronous delivery of schistosome 
Ag, without the additional complexity of active infection, will be addressed directly in 
chapter 5. 
 
Straw et al. (2003) restricted their analysis of DC phenotype to the spleen. However, the 
tissues that are predominantly affected by S. mansoni infection are the liver and intestine, 
and their dLN. This is because the immune response is primarily directed at parasite eggs, 
which become lodged in the liver and traverse the intestinal wall, causing severe damage 
(Wynn et al., 2004). For this reason, it may be more applicable to compare FLDC 
activation to the phenotype of DCs from these tissues during S. mansoni infection. In 
agreement with our findings with FL-cDCs, data from our lab indicates that cDCs in the 
liver significantly upregulate their expression of CD40 from d28 of infection onwards 
(Rachel Lundie et al., unpublished data). Not only that, hepatic pDCs also upregulate 
expression of co-stimulatory molecules during infection. This agrees with our data from 
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SEA-pulsed FL-pDCs, which do become activated by SEA.  However, both in vitro and in 
vivo pDCs express much lower levels of these markers than cDCs.  
 
Our data raises the question of why Flt3-L and GM-CSF-dependent DCs respond so 
differently to SEA. One possible explanation is that GMDCs have a higher basal level of 
activation or maturation prior to exposure to helminth Ag, and this masks the intermediate 
level of activation induced by such stimuli. By contrast, this is readily detectable in the less 
mature FL-cDCs. In support of this, GMDCs have a higher granularity and size compared 
to FLDCs, and they also produce much larger concentrations of IL-12, TNFα and IL-10 in 
response to bacterial stimulation (Xu et al., 2007), consistent with a more activated 
phenotype. However, it is not the case that GMDCs have a higher basal level of 
expression of MHC II or the co-stimulatory molecules, with the exception of CD80 (Fig. 
3.2B-C and Fig. 3.6A-B), as has been shown in a published comparison of GMDCs and 
FLDCs (Xu et al., 2007). Thus, it seems more likely that the differences we see in the 
response of GMDCs and FLDCs to SEA are more related to differential expression of 
receptor-signalling pathways, and the activation of particular pathways triggered by GM-
CSF itself.  
 
Ligation of the GM-CSF receptor leads to the activation of STAT3, STAT5 and NFκB 
(Ebner et al., 2003; Feldman et al., 1997; Laouar et al., 2003). NFκB activation in particular 
is essential for effective APC function, regulating MHC II and co-stimulatory molecule 
expression (Yoshimura et al., 2001). Ligation of Flt3, however, does not directly activate 
NFκB (van de Laar et al., 2012), whilst STAT3 is essential for DC differentiation in 
response to Flt3-L (Laouar et al., 2003; Onai et al., 2006). STAT3 has been shown to 
interact with NFκB, leading to inhibition of NFκB-dependent responses, such as iNOS 
production (Yu et al., 2002). Thus, it is possible to speculate that, in the absence of Ag 
stimulation, NFκB is largely inactive in FLDCs. NFκB expression is essential for optimal 
Th2 induction following SEA stimulation of GMDCs (Artis et al., 2005), however, NFκB 
activation was not detectable in GMDCs at early timepoints after exposure to SEA (Kane 
et al., 2004). This suggests that GM-CSF-dependent activation of NFκB enables effective 
SEA-specific Th2 polarisation by GMDCs. NFκB activation is tightly controlled, with NFκB 
itself initiating transcription of the negative regulator IκBα, which binds to NFκB, 
dissociating it from DNA and returning it to the cytoplasm in an inactive form (Natoli and 
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Chiocca, 2008). Gene transcription by NFκB is also terminated by degradation of NFκB 
subunits by ubiquitin ligases (Natoli and Chiocca, 2008). Thus, it could be that GM-CSF 
activation of NFκB renders this pathway unresponsive in GMDCs following exposure to 
Ags, such as SEA, that stimulate only low-level activation of signalling pathways. For this 
reason, we see no discernible change in GMDC surface phenotype in response to SEA. In 
contrast, it is reasonable to speculate that NFκB is activated in FLDCs following SEA 
exposure, leading to an upregulation in MHC II and co-stimulatory molecules. This could 
be assessed by Western blot analysis for NFκB subunits following SEA stimulation of 
FLDCs. 
 
One way to definitively address the differences between FLDCs and GMDCs would be to 
perform in-depth gene expression analysis with a microarray-based approach. A study that 
looked at the effect of SEA on gene expression in GMDCs indicated that only 29 genes 
were significantly altered by SEA, in comparison to 551 by LPS (Kane et al., 2004). Our 
lab has also carried out microarray analysis of SEA-stimulated GMDCs, which revealed 
that only a small number of genes were up- or downregulated in response to SEA (Peter 
Cook et al., manuscript submitted). Microarray analysis of mRNA expression by FLDC 
subsets would allow us to confirm the changes we have seen at the level of cytokine 
secretion and surface protein upregulation, and also allow a more broad assessment of 
other significant changes in FLDCs that are induced by SEA.  
 
Intriguingly, analysis of the responses of FLDCs from 3 different mouse strains suggests 
that the mouse strain, BALB/c, may be more responsive to SEA than cells generated from 
C57BL/6 or CBA BM (Fig. 3.5). Early studies of the immune responses of different mouse 
strains suggested that BALB/c mice had a more “pro-Th2” phenotype (Locksley et al., 
1999). However, there are a number of factors involved in this dominant Th2 phenotype, 
including a defect in Th1 induction in BALB/c mice, as well as an imbalance in Treg 
homeostasis (Sacks and Anderson, 2004). Studies of strain differences in response to 
infection with the gastrointestinal helminth H. polygyrus demonstrate that there are a 
number of genetic polymorphisms that influence the immune response in BALB/c mice, 
which include MHC II haplotype (Reynolds et al., 2012). Thus, it is difficult to discern 
exactly why there are differences in the responsiveness of FLDCs from different mouse 
strains to SEA. However, it is clear that an intermediate level of surface activation and IFN-
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I production in response to SEA are traits common to FLDCs from the three mouse strains 
tested. 
 
A timecourse analysis of FLDC phenotype and cytokine production following SEA or St 
stimulation revealed that the development of the FLDC response to SEA (and potentially 
other helminth and Th2-polarising Ags) was slower to develop, but may be more 
prolonged, than that induced by the bacterium St (Fig. 3.4). DC phenotypic responses to 
St stimulation were already well developed after a 3h culture, whilst SEA-exposed cells did 
not show a comparative level of activation until after 18-24h (Fig. 3.4A). In agreement with 
these findings, it has been shown (albeit with GMDCs) that LPS stimulation leads to 
phosphorylation of the MAPK family members p38, JNK and ERK within 10min, and NFκB 
activation after 30min of Ag exposure (Kane et al., 2004). In contrast, SEA-pulsed GMDCs 
displayed only transient and low-level activation of p38 and ERK, and no discernible effect 
on JNK or NFκB within the 60min period analysed. These findings suggest that ligation of 
TLRs by bacterial Ags, such as the TLR4 ligand LPS, which is expressed by the gram-
negative bacterium S. typhimurium, leads to rapid and intense activation of downstream 
signalling pathways. This leads to changes in DC phenotype within 3h of Ag stimulation 
(Fig. 3.4A). In contrast, the downstream effects of SEA exposure seem to be slower to 
influence DC phenotype, and the activation of signalling pathways more subtle (Artis et al., 
2005). The slower kinetics in FLDC maturation in response to SEA stimulation may mean 
that the induction of Ag-specific T cell activation occurs later. Migratory responses of 
FLDCs to SEA and St will be assessed in the next chapter, however, from this data it may 
be hypothesised that migration of SEA-stimulated DCs would also be delayed compared to 
St-pulsed cells, with two distinct waves of DC migration from periphery to LN, fast induced 
by St, and slow induced by helminth Ag.! 
!
A facet of DC activation that the timecourse experiment in Fig. 3.4 does not address is 
how long cell responses are maintained following a more transient Ag activation, given that 
it is possible that exposure to Ag in vivo would be more short-lived. This could be 
addressed with a shorter Ag pulse, followed by washing and replating of cells for a period 
of time prior to assessment of their phenotype. However, during infection with helminths, 
such as S. mansoni, parasites are constantly releasing antigenic material, whether in the 
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form of excretory/ secretory products or eggs; thus, it is entirely possible that DCs in 
affected tissues will be exposed to Ag continuously or for prolonged periods. 
 
3.3.2 The FLDC IFN-I response to SEA: A complex receptor-signalling pathway? 
The IFN-I signature we have detected in FLDCs responding to SEA is not an entirely novel 
finding; earlier studies by Trottein et al. described an IFN-I response by DCs to live 
schistosome eggs. Their 2004 study analysed the gene expression profiles of D1 cells (an 
immortalised splenic DC cell line (Winzler et al., 1997)) in response to schistosome eggs 
or larval Ags (SLA). They described an “inflammatory” gene expression profile from DCs 
exposed to schistosome eggs that was not seen in response to SLA (Trottein et al., 2004). 
This profile included the upregulation of a number of IFN-responsive genes, and an 
increase in IFNβ mRNA, although the authors did not demonstrate egg-specific secretion 
of IFN-I protein from D1 cells. These findings were regarded as controversial at the time, 
with many in the field suggesting LPS contamination of the egg preparation a probable 
cause. Such an explanation was supported by the abnormally high production of the 
inflammatory cytokines IL-12/23p40 and TNFα by D1 cells in response to egg stimulation 
(Trottein et al., 2004). Based on results described in this chapter, we would now argue 
that, whilst this excessive production of IL-12/23p40 and TNFα may be a response 
peculiar to this DC cell line, our work with FLDCs suggests that an IFN-I signature is a 
reproducible response to schistosome egg Ag by DC subsets that are equivalent to those 
resident in lymphoid organs.  
 
An additional area for discussion is the description by Trottein et al. of an IFN-I signature 
as “inflammatory”. IFN-I is a cytokine that has pleiotropic effects in vivo, whilst capable of 
enhancing inflammatory responses in some settings, high concentrations of IFN-I act to 
limit IL-12, and consequently IFNγ, production (Trinchieri, 2010). It has also been 
suggested that low-level IFN-I signalling is integral to maintaining function of a wide range 
of immune cells (Gough et al., 2012). A study analysing the gene expression profile of D1 
cells to different stimuli indicated that IFNα treatment actually stimulates a gene 
expression profile more consistent with an anti-inflammatory phenotype (Torri et al., 2010). 
IFN-I undoubtedly has a central role in activating innate and adaptive immune responses 
to viral and bacterial infection (Fitzgerald-Bocarsly and Feng, 2007; Gonzalez-Navajas et 
al., 2012; MacMicking, 2012). However, a number of studies have also highlighted an 
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important role for IFN-I in the regulation and augmentation of DC function. For example, 
IFN-I is required specifically by CD8α+ cDCs for induction of functional anti-tumour 
responses from CD8+ T cells (Diamond et al., 2011; Fuertes et al., 2011). It has been 
suggested that both splenic and BMDCs (GMDCs) express IFN-I message basally, and 
that they require IFN-I responsiveness for optimal activation and function (Kurche et al., 
2012; Montoya et al., 2002). A role for IFNα has also been described in mediating optimal 
DC turnover in vivo (Mattei et al., 2009). 
 
Furthermore, it is an oversimplification to suggest all IFN-I function in the same 
“inflammatory” manner, as they represent such a large and diverse protein family with both 
mouse and humans having 12 different IFNα subtypes, alongside IFNβ, IFNε, IFNκ and 
IFNω (Pestka et al., 2004). In human PBMC-derived myeloid cells different cell types 
respond to specific TLR ligands, such as CpG and pI:C, with a cell-specific IFNα subtype 
expression profile (Hillyer et al., 2012). Currently our understanding of the SEA-specific 
IFN-I profile from FLDCs is restricted to IFNα1 (at the mRNA level), and IFNα3 and IFNβ 
(protein secretion). All IFN-I subsets bind at the same site on their shared receptor, 
IFNAR, forming a complex of similar structure (Piehler et al., 2012). However, differential 
IFN-I activities are determined by the lifetime and binding affinity of each subset (Piehler et 
al., 2012). More thorough gene expression analysis is required to address whether other 
IFN-I subtypes are activated by SEA, which may provide insights into their role in helminth 
infection. 
 
No mouse is currently available that has been genetically altered to be deficient in all 16 
IFN-I genes, and the likelihood of a degree of functional redundancy means that single 
deficiency may be compensated for by other family members. Although there are no single 
deficiency mice currently available for IFNα, Ifnb-/- animals have been generated 
(Erlandsson et al., 1998). The authors of this study examined the IFN-I response of IFNβ-
deficient mouse embryo fibroblasts (MEFs) following viral challenge, these cells were 
unable to produce IFNβ or IFNα in response to Sendai virus infection, illustrating the 
importance of the IFNβ signal for IFNα induction. Thus, it would be informative to 
investigate the response of IFNβ-deficient FLDCs to SEA stimulation, to assess whether 
IFNα production by CD24+ cDCs was also ablated. As an alternative approach, many 
studies into IFN-I function utilise Ifnar1-/- mice to elucidate the role of IFN-I. The IFN-I 
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receptor, IFNAR, is a heterodimer made up of IFNAR1 and IFNAR2 subunits and deletion 
of the Ifnar1 gene leads to a loss of function and a failure of all IFN-I (α and β) to activate 
downstream effector functions (Hwang et al., 1995). Mouse and human DC subsets 
express IFNAR (Diamond et al., 2011; Severa et al., 2006), and so are responsive to IFN-
I. Study of IFNAR-deficient DCs indicates that IFN-I can act on DCs in an autocrine 
manner (Montoya et al., 2002), which may explain aspects of our data that would 
otherwise be puzzling. In the timecourse experiment it seemed that concentrations of both 
IFNα and IFNβ secreted in response to Ag stimulation were reduced after longer culture 
times, and no IFNβ was detected from FLDCs exposed to St (Fig. 3.4B). It is likely that this 
is the result of uptake of IFN-I by cultured cells.  
 
Assessment of IFNα production by cells selectively lacking the adaptor proteins MyD88 
and TRIF indicate contrasting roles for these molecules in the SEA-specific IFN-I response 
(Fig. 3.8D) (Fig. 3.11). The requirement for TRIF for IFN-I production by FLDCs may 
suggest a role for TLR3 or TLR4, which can signal through this adaptor (Yamamoto et al., 
2002). TRIF (TIR-domain-containing adaptor-inducing interferon-β) was originally 
characterised for its role in the activation of IFNβ downstream of TLR3 (Yamamoto et al., 
2003; Yamamoto et al., 2002). Two kinases have been identified which phosphorylate the 
TFs IRF3 and 7 in a TRIF-dependent manner, leading to transcription of IFN-I genes: IKKε 
and TBK-1 (Fitzgerald et al., 2003; Sato et al., 2003; Sharma et al., 2003). IRF3/ 7 
homodimers and IRF3-IRF7 heterodimers activate transcription of a large number of 
genes, including the genes for IFN-I subtypes (Honda and Taniguchi, 2006b). The role of 
this IRF-dependent pathway in the FLDC response to SEA could be definitively shown 
using Irf3-/- and Irf7-/- BM to generate DCs. 
 
It is clear that MyD88 is not required for the induction of SEA-induced IFN-I, but instead 
actively inhibits this process (Fig. 3.8D). This phenomenon has been previously reported in 
other, non-helminth settings, demonstrating that MyD88 can negatively-regulate pathways 
downstream of TLR3 activation by at least two distinct mechanisms. Exacerbation of TRIF-
dependent inflammation, initiated by pI:C treatment of mouse corneas in MyD88-deficient 
mice highlighted that MyD88 negatively regulates TLR3/TRIF signalling and subsequent 
CCL5 release by downregulating the activity of the MAP kinase, JNK (Johnson et al., 
2008). The increase in CCL5 output in MyD88-deficient animals led to increased infiltration 
! 123!
of inflammatory cells. A more recent study indicated that MyD88 could also inhibit 
phosphorylation and activation of IKKε, (but not TBK-1) which limits TRIF-dependent IRF3 
activation and resultant CCL5 and IFNβ production following pI:C treatment of BMMΦs 
(Siednienko et al., 2011). This inhibition is specific to TLR3 signalling and does not affect 
LPS-induced TLR4-dependent pathways (Siednienko et al., 2011), which gives further 
weight to our hypothesis that SEA-specific IFN-I occurs via TLR3 and not TLR4. These 
studies also highlight that production of the leukocyte chemoattractant, CCL5, by SEA-
pulsed FLDCs should be investigated.  
 
Despite our hypothesis that the IFN-I response is TLR3-mediated, there is little evidence 
from a TLR3 reporter cell line that this receptor is strongly activated by SEA. The IL-8 
production in response to SEA was much lower than was stimulated by the synthetic TLR3 
ligand, pI:C (Fig. 3.9). This may reflect differences in the amount of stimulus added. It 
should also be noted that, whilst pI:C is a pure TLR3 ligand, SEA is a complex mixture of 
Ags, the majority of which are proteins, and the majority of those being heavily 
glycosylated (Jang-Lee et al., 2007; Mathieson and Wilson, 2010). There is likely to be a 
much smaller nucleic acid content, only some of which may bind TLR3. Thus a fairer 
comparison would require a titration of pI:C concentrations, as well as a comprehensive 
assessment of the nucleic acids present in SEA.  
 
The reporter cell line results also indicated a degree of TLR4 activation by SEA (Fig. 3.9). 
This may in part be due to low-level LPS contamination, as SEA is prepared from eggs 
purified from the livers of S. mansoni infected mice. However, SEA induces only very low-
level secretion of IL-12, IL-6 and TNFα (Fig. 3.3A), cytokines associated with LPS 
stimulation, indicating that any LPS present in SEA has a minimal effect on these aspects 
of FLDC activation. Further, the absence of an SEA IFN-I response from GMDCs (Fig. 
3.6C) indicates that IFN-I induction is unlikely to be down to LPS stimulation of TLR4, as 
GMDCs express high levels of this receptor and respond readily to LPS stimulation 
(Boonstra et al., 2003). LPS contamination could be quantified definitively using the 
limulus amoebocyte lysate (LAL) assay (Young et al., 1972), however, our BMDC studies 
should provide a reliable readout of LPS contamination, as we would expect to see surface 
activation and cytokine production if endotoxin was present in our SEA. The presence of 
an egg-derived TLR4 ligand should not be ruled out, however. Studies of the rodent filarial 
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nematode, Acanthocheilonema viteae, have identified ES-62, a glycoprotein present in 
parasite excretory/ secretory products, which binds TLR4 (Goodridge et al., 2005). 
Moreover, a glycan, lacto-N-fucopentaose III (LNFPIII), present in SEA acts via TLR4 
(Thomas et al., 2003). GMDCs exposed to LNFPIII stimulated IL-4 production from TCR 
Tg OTII T cells, and this response was absent with TLR-deficient GMDCs. This highlights 
that TLR4 ligands exist in SEA and initiate Th2 induction. Thus, analysis of TLR3- and 
TLR4-deficient FLDC responses is crucial, in order to identify which TLR is the inducer of 
SEA IFN-I. RNase treatment of SEA prior to FLDC stimulation may also help determine 
whether this response is dependent on SEA-derived dsRNA ligands, which are recognised 
by TLR3. In order to selectively target dsRNA ligands present in SEA it necessary to use 
an RNase that acts specifically on dsRNA, such as a member of the RNase III family 
(MacRae and Doudna, 2007).  
 
A published study has previously identified dsRNA ligands from live schistosome eggs that 
activate TLR3 (Aksoy et al., 2005). The authors suggested two possible reasons for the 
presence of dsRNA in parasite eggs. Transcriptomic analysis of the different lifecycle 
stages of S. mansoni indicates that the parasite expresses genes involved in RNA 
interference, which creates dsRNA as a method of post-transcriptional gene silencing 
(Verjovski-Almeida et al., 2003). Aksoy et al. (2005) also indicated that the schistosome 
genome contains large numbers of transposons, which are both transcribed and show 
secondary structure that could include formation of double-stranded RNA.  
 
A number of papers have identified microRNAs in S. mansoni that may have a role in 
controlling parasite gene expression (de Souza Gomes et al., 2011; Simoes et al., 2011), 
and it may be these that were identified as schistosome dsRNAs in earlier studies. 
MiRNAs are short, non-coding RNAs that bind to messenger RNAs, providing post-
transcriptional regulation of genes. It has been demonstrated that miRNAs can act as 
ligands for murine TLR7 and human TLR8, which recognise single-stranded RNA (Fabbri 
et al., 2012). MiRNAs are formed from dsRNA precursors, and mature miRNAs bind to 
complementary sequences in target mRNAs (Winter et al., 2009). The cellular machinery 
that is involved in RNAi also plays a role in the processing of miRNAs, and these proteins 
have been identified in adult schistosomes and eggs (Gomes et al., 2009; Krautz-Peterson 
and Skelly, 2008; Verjovski-Almeida et al., 2003). The ability of schistosomes to perform 
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RNAi has not been definitively shown. However, a number of studies have identified 
miRNAs in the S. mansoni genome, as well as their likely gene targets (de Souza Gomes 
et al., 2011; Gomes et al., 2009; Simoes et al., 2011), suggesting that the parasite utilises 
this pathway to regulate gene expression (Cheng and Jin, 2012). It has not yet been 
investigated whether pre-microRNAs or mRNA-bound miRNAs could provide ligands for 
host TLR3 activation.  However, they should be considered as potential dsRNA ligands 
that could be present in schistosome egg preparations. 
 
Another TRIF-dependent PRR that recognises dsRNA has recently been identified. This 
sensor is a complex made up of the RNA helicases DDX1, DDX21, and DHX36, and is 
localised within the cytosol (Zhang et al., 2011a). Similarly to our observations of the SEA 
response, stimulation of this receptor by pI:C led to low-level IFN-I secretion. Involvement 
of this receptor in the induction of SEA-specific IFN-I could explain the failure of SEA to 
activate TLR3. However, this receptor complex was identified in GMDCs (Zhang et al., 
2011a), which is in conflict with our finding that these cells are unable to produce IFN-I in 
response to SEA. As yet it has not been demonstrated that this RNA helicase complex is 
active in other DC subsets. Thus, analysis of TLR-deficient FLDC IFN-I production 
following SEA exposure is essential to identify which TRIF-dependent PRR is required for 
this response. 
 
SEA may also be inducing IFN-I through a TRIF-independent pathway, in support of which 
we have shown that CD205 has a partial role (Fig. 3.8E). A recent study has indicated that 
signalling downstream of another C-type lectin receptor, Dectin-1, can activate IFN-I 
production from DCs, this process being dependent on the adaptor protein, Syk (Del 
Fresno et al., 2013). The induction of IFNβ was also dependent on IRF5, whilst IRF3 and 
IRF7 had no role. This suggests that CLR ligation could initiate IFN-I production directly in 
response to SEA. The importance of these receptors in SEA-sensing has already been 
demonstrated (Everts et al., 2012; Meevissen et al., 2010; Meevissen et al., 2011). The 
role of this pathway in IFN-I induction downstream of SEA stimulation could be 




If TRIF-dependent IFN-I activation is mediated by TLR3, the question remains how these 
ligands are made available to FLDCs in vitro. It has been shown that a potent Th2-
polarising component of SEA is omega-1 (Everts et al., 2009; Steinfelder et al., 2009), a 
glycoprotein whose activity is dependent on both its glycan components, which permit 
cellular uptake via MR, and its RNase activity, which causes the degradation of host 
mRNA and subsequent inhibition of protein synthesis (Everts et al., 2012). Although we do 
not yet know whether omega-1 or MR are involved in the IFN-I response of FLDCs to SEA, 
it is possible that there are other RNases in SEA, whose uptake is mediated by CD205, 
which could release SEA-derived dsRNA fragments within cells that could then act as 
TLR3 ligands (Fig. 3.11). It is also possible that SEA-derived RNases could generate 
dsRNA ligands from host cell-intrinsic nucleic acids. However, dsRNAs are not a feature of 
mammalian gene expression, nor are mammalian cells capable of RNAi, so it may be 
unlikely that dsRNA self-ligands could be generated by RNase activity. The potential 
requirement for RNases in the generation of ligands, and the dependency on CLRs to 
transport SEA-derived RNases into DCs (Everts et al., 2012), may explain why negligible 
TLR3 activation was recorded by direct SEA stimulation of TLR3-transfected cells (Fig. 
3.9). Alternatively, it has been shown that RNA polymerase III can convert DNA to dsRNA 
ligands that can be recognised by RIG-I, leading to IFN-I production (Ablasser et al., 2009; 
Chiu et al., 2009). It is possible that schistosome egg DNA could be converted to a ligand 
that is recognised by a TRIF-dependent PRR. If this mechanism does occur, it seems 
unlikely that TLR3 would be involved, given that this receptor is localised to endosomes, 
whilst RNA polymerase III is active in the cytosol (Chiu et al., 2009).   
 
The Th2-promoting activity of omega-1 was found to be MyD88/TRIF-independent 
(Steinfelder et al., 2009), however this study looked only at GMDC responses to this SEA-
derived glycoprotein. We plan to address how FLDCs respond to omega-1 whether it is 
capable of inducing IFN-I from FLDC subsets, and whether Th2 induction by omega-1 
stimulated FLDCs requires IFN-I signalling.  
 
As well as its strongly Th2-polarising characteristics, omega-1 was also shown to inhibit 
LPS-induced IL-12/23p40 and p70 production (Everts et al., 2009; Steinfelder et al., 2009). 
The ability of SEA to inhibit bacterial-induced IL-12 has been well documented (Cervi et 
al., 2004; Kane et al., 2004; Kane et al., 2008), and shown to be independent of TLR2, 
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TLR4 and MyD88 (Kane et al., 2008). This process is almost wholly dependent on omega-
1 (Everts et al., 2009) and may be mediated via its ability to inhibit protein synthesis 
(Everts et al., 2012). Alternatively, omega-1 may induce IRF3 activation, which can then 
bind directly to the IL-12b promoter, preventing IRF5 binding and inhibiting gene 
transcription (Koshiba et al., 2013; Negishi et al., 2012), These published studies focus on 
IRF3 activation downstream of RLRs rather than TRIF-mediated IRF3 activity, and the role 
of RLRs in SEA-sensing has yet to be assessed. However, it is possible that this may also 
occur following TRIF-induced activation of IRF3. The role of IRF3 in the control of 
bacterial-stimulated IL-12 from FLDCs and GMDCs should be assessed using IRF3-
deficient cells.  
 
Infection of Tlr3-/- mice with S. mansoni has revealed that the receptor is not involved in 
control of infection or pathology (Vanhoutte et al., 2008). There was no alteration in 
parasite burdens or granuloma size on d49 of infection. Moreover, there was an 
enhancement of Th2 cytokine output from splenocytes from Tlr3-/- S. mansoni-infected 
mice, following αCD3 stimulation. This may suggest that TLR3-dependent DC-derived IFN-
I plays only a minor role in patent infection. Alternatively, we would suggest that the ability 
of DCs to respond to IFN-I produced by other cellular sources during infection might be 
more important than their own ability to produce it in a TLR3-dependent manner. The 
importance of DC IFN-I responsiveness will be addressed in chapters 4 and 5.  
 
3.3.3 Distinct responses to SEA from different DC subsets 
A potential role for TLR3 in mediating the DC IFN-I production in response to SEA is in 
agreement with our discovery that SEA-specific IFN-I is produced exclusively by the 
CD24+ cDC subset (Fig. 3.7D and Fig. 3.10). It has been shown that CD24+ cDCs, the 
CD8α+-equivalents, are the only population of FLDCs that express TLR3 at the mRNA and 
protein level (Jelinek et al., 2011; Naik et al., 2005). These papers also illustrated that 
TLR3 expression in vivo is restricted to the CD8α+ cDC subset and the closely related 
CD103+ DCs. CD24+ cDCs do express TLR4, albeit at a lower level than TLR3, (Naik et al., 
2005). Further to this, GMDCs have only negligible expression levels of TLR3 receptor 
(Jelinek et al., 2011), providing a plausible explanation for why these cells do not secrete 
IFN-I in response to SEA, but do so following bacterial stimulation (Fig. 3.6C). It has also 
been shown that STAT5 activation downstream of the GM-CSF receptor inhibits IRF7 
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expression (Esashi et al., 2008), which is essential for sustained IFN-I production, 
particularly IFNα (Honda et al., 2005a). This provides a further physiological explanation 
for the paucity of IFN-I production by Ag-stimulated GMDCs. 
 
It should be noted that CD205 is selectively expressed on CD8α+ cDCs in vivo (Vremec et 
al., 2000), in agreement with its involvement in the SEA IFN-I response, which was unique 
to CD24+ FL-cDCs. Thus, it would be useful to confirm that, of the FLDC subsets, CD24+ 
cDCs alone express CD205. Due to the fact that the CD11b+ FL-cDC subset did not 
produce IFN-I in response to SEA, but did become activated (Fig. 3.7A-B), it seems likely 
that TLR3 activation is not uniquely required for the upregulation of MHC II and co-
stimulatory molecules in response to SEA. We do not yet know, however, why CD11b+ 
cDCs have a higher basal level of expression of activation markers compared to CD24+ 
cDCs. This may again relate to gene expression differences, which would be revealed by 
mRNA profiling. 
 
One potential criticism of the experimental approach taken in this chapter is that, in 
keeping with the vast majority of the referenced studies using FLDCs, we have determined 
the response of mixed cultures of DC subsets, rather than analysing the individual subsets 
in isolation. As such, we cannot exclude the possibility that the presence of one subset 
may alter the response of another. Nevertheless, it remains possible that DC subset 
crosstalk may also occur in vivo. Multiple attempts at FACS sorting FLDCs revealed that 
the technique led to unacceptably high cell death (particularly for pDCs), an increase in 
basal activation levels, and often a loss of detectable IFN secretion. Because of this, we 
decided to limit pre-sorting to experiments that require only low cell numbers, such as the 
in vitro functional assays that will be discussed in the next chapter. Sorting was also 
performed to ascertain the cellular source of SEA-stimulated IFN-I (Fig. 3.7D). We would 
like to be able to verify the result of this experiment using ICC. However, because IFN-I 
specific ICC has poor sensitivity, and the amounts of IFN-I we are hoping to detect are 
quite low, this proved technically difficult.   
 
In conclusion, data in this chapter reveals that schistosome egg antigens induce the cDC 
subsets generated by Flt3-L to display an intermediate surface activation phenotype. This 
phenotype is distinct from that displayed by GM-CSF-derived cells. We have found that 
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CD24+ cDCs have a unique ability to produce IFN-I in response to schistosome egg Ags, 
and this process is dependent on TRIF-signalling and negatively regulated by MyD88. 
Having defined this unexpected phenotype, we then went on to address the T cell priming 








































Figure 3.1 BMDC subsets generated in vitro using murine Flt3-L. 
BM cells were cultured for 8d with 200ng/ml Flt3-L before being re-
plated on d8 and cultured overnight at a final concentration of 2x106 
cells/ml. On d9, DC subsets present in the culture were analysed by 
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Figure 3.2 SEA stimulation induces an intermediate level of 
phenotypic activation in FL-cDCs.  
FLDC cultures were stimulated for 18h with 25µg/ml SEA or 5µg/ml St 
and their expression of MHC II, CD40, CD80 and CD86 assessed by 
flow cytometry (B), gMFI of these markers was also assessed (C). Data 
representative of >5 experiments, performed in triplicate. Statistical 
differences calculated using ANOVA and Tukey multiple comparisons 


























































































































































Figure 3.3 FLDCs secrete significant levels of Type I IFN in response to 
SEA stimulation, with background levels of inflammatory cytokines.  
Bulk FLDC cultures were stimulated for 18h with 25µg/ml SEA, 5µg/ml St or 
1µg/ml CpG, and cytokine levels in supernatants assessed by ELISA (A-C). 
Data representative of >5 experiments, performed in triplicate. **P<0.01, 

















































































































* ** *** **
3h 6h 9h 12h 18h 24h
Figure 3.4 The kinetics of FLDC responses to SEA.  
Mixed FLDC cultures were stimulated for 3-24h with 25ng/ml SEA or 5ug/ml 
St, phenotypic activation of cDCs was assessed by flow cytometry (A) and 
cytokine production measured by ELISA (B). Values in blue on plots equate to 
gMFI of CD40 expression, gate and corresponding value represents 
percentage of positive cells (A). One representative plot shown, of 3 replicate 
wells (A). Data representative of 2 independent experiments, done in triplicate. 
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Figure 3.5 FLDCs from different mouse strains show comparable 
responses to SEA.  
FLDCs were generated using BM from C57BL/6, BALB/c or CBA mouse 
strains, cells were stimulated overnight with Ag on d8 of culture and their 
surface phenotype analysed by flow cytometry, gMFI of activation markers 
was calculated (B). ELISA was performed on cell supernatants to measure 
levels of IFNα3 (C). Statistical difference between strains following exposure 
to SEA only are shown, where they exist. *P<0.05, **P<0.01, ***P<0.001, 
























































































































































































Figure 3.6 Unlike FLDCs, GMDCs fail to display clear activation in 
response to SEA.  
Cells were cultured overnight in the presence or absence of SEA (25µg/
ml), St (5µg/ml) or Pa (10µg/ml), cells were stained and analysed for 
their surface expression of MHC II and co-stimulatory molecules (A), 
gMFI for these markers was also recorded (B). IFN-I levels were 
ascertained by ELISA (C). Data representative of 3 (C) and 5 (A-C) 





























































































































Figure 3.7 Differential response of FL-cDC subsets to SEA.  
FLDCs were cultured overnight with or without SEA and their level of phenotypic 
activation elucidated by flow cytometry (A), gMFI for activation markers was 
recorded (B), and fold change in gMFI compared to basal levels was calculated for 
SEA stimulated cells (C). FLDC subsets were FACS sorted on d8 of culture before 
being replated and stimulated overnight with Ag, IFNα levels in cell supernatants 
was measured by ELISA (D). Data representative of 3 (A-C) and 2 (D) experiments, 










































































Figure 3.8 FLDC IFN-I production in response to SEA is regulated by 
MyD88, and promoted by TRIF and CD205 signals. 
WT, Myd88-/-/Trif-/- (B), Tlr9-/- (C), Myd88-/-, Trif-/- (D) or Ly75-/- (CD205-
deficient, E) FLDCs were cultured overnight in the presence or absence of 
SEA, cell supernatants were collected and analysed for IFNα secretion by 
ELISA. Data representative of 5 (B), 4 (C-D) and 3 (E) experiments. 
*P<0.05, **P<0.01, ***P<0.001. Significance levels in D. denote the 











































Figure 3.9 IL-8 production by TLR3 
or TLR4-expressing cell lines 
following Ag stimulation 
HEK cells stably expressing either 
TLR3 or TLR4/MD2 were cultured with 
or without Ag. Cell supernatants were 
col lected after 22h and ELISA 
performed to establish IL-8 production. 
Data represented as fold induction of 
IL-8 compared to medium alone. 
Representative of single wells for SEA 
TLR3, pI:C TLR3 and LPS TLR4, 
duplicate wells for SEA TLR4.  



































Figure 3.10 BMDC responses to SEA and St 
Changes in BMDC phenotype following overnight exposure to SEA or St. It should be 
noted that there is some low-level IL-12p40 and IL-6 production from FLDCs exposed to 
SEA, which most likely is produced by cDC subsets.   
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Figure 3.11 Potential PRR pathways in SEA sensing and IFN-I induction 
TRIF is an essential component in the activation of the IFN-I response against SEA in FLDCs. 
As yet, we have not identified which PRR signals via TRIF to stimulate this response. 
Candidates include TLR3 and a cytosolic nucleic acid sensor, both of these receptors 
recognise nucleic acid ligands. Optimal IFN-I production in response to SEA also requires the 
CLR CD205. It is possible that CD205 can directly activate IFN-I transcription, as has been 
demonstrated downstream of dectin-1. Alternatively, CD205 may facilitate the internalisation of 
a bioactive SEA component, capable of generating nucleic acid ligands for other PRRs. It is 
likely that the kinases TBK and/ or IKKε, and IRFs, are involved in the signalling cascade that 
leads to the activation of IFN-I genes. MyD88 negatively regulates the IFN-I response, most 









4.0 FLDC ACTIVATION OF TH2 RESPONSES – A ROLE FOR TYPE I IFN 
4.1 Introduction 
The primary role of DCs is to present Ag to naïve T cells in the secondary lymphoid organs 
(SLO) in order to initiate adaptive immune responses (Alvarez et al., 2008; Kapsenberg, 
2003). In the tissues, DCs act as sentinels, collecting antigenic material before trafficking, 
via the lymphatic system, to the SLO to interact with lymphocytes. Thus, efficient and 
accurate migration is key to DC function. cDC migration to the LN is a complex, multi-step 
process, requiring detachment from structural elements within the tissues, followed by 
entry to, and then transit in, the afferent lymphatics (Alvarez et al., 2008). Trafficking of 
cDCs via the lymphatics is thought to be dependent on their expression of the chemokine 
receptor CCR7 (Tal et al., 2011), under inflammatory conditions and in the steady state 
(Ohl et al., 2004). Given that CCR7 is important for cDC migration during inflammation and 
in the steady state, it is likely that this receptor plays a role in DC migration in Th2 settings, 
however, the chemokine receptor-ligand requirements for cDC migration to the dLN 
following exposure to Th2-polarising Ags has not been addressed. In contrast to 
conventional DC subsets, pDCs are thought to primarily gain access to LN via the blood 
system, but only under inflammatory conditions (Diacovo et al., 2005).  
 
A published study indicated that FLDCs could migrate effectively to the dLN following 
subcutaneous injection (Xu et al., 2007). However, the authors did not address whether 
both FL-cDCs and FL-pDCs reached the dLN via this route. It was also not shown exactly 
where FLDCs were localised within the dLNs. This is a particularly pertinent question in 
the context of Th2 induction in response to helminths, as a recent study suggested that 
during infection with the gastrointestinal parasite H. polygyrus, DC:T cell interactions occur 
outside of the T cell zone (Leon et al., 2012), contrary to what may have been expected.  
 
In this chapter, we have used an adoptive transfer model to address these issues in the 
context of SEA stimulated FLDCs, with confocal microscopy providing an ideal technique 
to identify DC localisation within the dLN. Xu et al. (2007) did not demonstrate that FLDCs 
could prime adaptive responses following injection and, up to now, there have not been 
any published studies to address whether FLDCs can polarise Th2 responses against 
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helminth Ag. Thus, this chapter also focuses on the ability of FLDCs to prime SEA-specific 
T cell responses in vivo.  
 
In vitro studies indicate that FL-cDCs can effectively present OVA to OTII TCR Tg CD4+ T 
cells, resulting in T cell proliferation and cytokine production, to a comparable level to that 
induced by GMDC or purified splenic subsets (Brasel et al., 2000; Naik et al., 2005; Xu et 
al., 2007). Unlike FLDCs, SEA-specific Th2 induction by GMDCs has been studied 
extensively (MacDonald and Maizels, 2008). Experiments detailed in this chapter aim to 
redress the balance, investigating the surface markers and signalling molecules required 
for Th2 induction by FLDCs in vivo.  
 
In chapter 3, an SEA-specific IFN-I response from FLDCs was described. Several studies 
have suggested that expression of the IFN-I receptor, IFNAR, is required for optimal DC 
function (Kurche et al., 2012; Mattei et al., 2009; Montoya et al., 2002). However, these 
studies have focused wholly on the importance of IFNAR for DC function in non-Th2 
settings. Thus, the final part of this chapter examines the importance of IFN-I 
responsiveness for effective Th2 induction by FLDCs, using both in vitro and in vivo 




















4.2.1 FLDC Migration in vivo 
An assay commonly used in our lab to assess the T cell priming capacity of BMDCs 
involves adoptive transfer of Ag-pulsed cells into naïve recipients (Cook et al., 2012; 
MacDonald et al., 2002c; Perona-Wright et al., 2012). The response generated by 
transferred cells is evaluated by quantifying the T cell cytokine output from Ag-restimulated 
dLN cells. The requirement for GMDC MHC II expression (MacDonald et al., 2001) 
strongly indicates that transferred DCs migrate to the draining LNs to interact with 
responding T cells, though this has never formally been experimentally addressed. 
 
Before investigating the priming ability of FLDCs, we first addressed whether they were 
able to migrate effectively to the dLN following transfer. For this experiment, FLDCs were 
generated from the BM of dsRed mice; these mice express red fluorescent protein under 
control of the actin promoter, thus all cells fluoresce red. dsRed DCs were injected into 
each hind foot and the dLNs were harvested at 24 or 48h after injection. These timepoints 
were assessed because most surviving cells should reach the LN within the first few days 
(Tal et al., 2011; Xu et al., 2007). Prior to transfer, cells were activated overnight with SEA 
or St, or cultured in medium alone. 24h after injection, CD11c+dsRed+ cells were 
detectable by flow cytometry in the dLNs of recipient mice, and this population was present 
regardless of prior stimulation (Fig. 4.1B). CD11c+dsRed+ cells were also detectable in the 
dLNs of recipients in all groups at 48h (Fig. 4.1B) post-injection. These findings 
demonstrate that FLDCs are capable of efficient migration to the draining LNs of recipient 
mice following adoptive transfer. No consistent differences in the kinetics of migration 
between the three conditions were found across independent experiments. 
 
At each timepoint, dLNs were also collected and prepared for analysis by confocal 
microscopy. Fig. 4.1C depicts representative images from 48h after injection. DsRed+ cells 
were detected in dLN sections from all groups at this timepoint, and were mainly localised 
in areas where TCRβ+ CD4+ cells were abundant (Fig. 4.1C). At higher magnification it was 
also possible to see dsRed cells in close association with CD4+ cells (Fig. 4.1C, right 
panel). These data illustrate that transferred cells localised to the T cell zone of the 
recipient dLNs, and suggest that DCs likely interact with T cells within that area.  
 
! 144!
At all timepoints analysed, we were unable to detect any CD45R+ (B220+) dsRed+ cells in 
dLN sections from mice in any groups (Fig. 4.1C). Similarly, we did not see any CD45R+ 
CD11c+ dsRed+ cells by flow cytometry. Failure to detect any CD45R+ transferred cells by 
either of these techniques suggests that pDCs did not reach the popliteal LNs following 
subcutaneous injection. pDCs are not thought to traffic via the lymphatics, instead entering 
lymphoid tissues from the blood via HEV, in a CCR7-independent manner (Diacovo et al., 
2005). In accordance with this, FL-pDCs expressed only negligible levels of CCR7, 
regardless of whether they were stimulated with Ag or not (Fig. 4.2A-C). In stark contrast, 
upwards of 95% of CD24+ cDCs (the CD8α+ equivalents) and CD11b+ cDCs expressed 
CCR7 in response to overnight culture in the presence of St (Fig. 4.2A-B). This was a 
significant increase compared to cells cultured in medium alone, where less than 20% of 
CD11b+ cDCs and around 5% of CD24+ cells were CCR7+ in the absence of Ag. Following 
18h exposure to St, cDC subsets also had significantly higher levels of CCR7 on their 
surface than cells in medium alone, measured by gMFI (Fig. 4.2B). The mean gMFI of 
CCR7 on St-stimulated CD24+ cDCs was 4810, marginally higher than on CD11b+ cells 
whose mean gMFI for this marker was 2880, representing a significant (p=0.0098) 
difference in CCR7 expression between these subsets. 
 
Exposure of FLDCs to SEA did not induce CCR7 expression to the level that was detected 
in response to St (Fig. 4.2A-C; expression levels were approximately 55- and 15-fold lower 
on CD24+ and CD11b+ cDCs, respectively). Less than half of CD11b+ cDCs were CCR7+ 
after SEA exposure, and an even smaller proportion of CD24+ cells expressed this 
chemokine receptor in response to SEA (Fig. 4.2A-B). Nevertheless, both subsets did 
display a significant increase in percentage positive and gMFI for CCR7, compared to cells 
cultured in medium alone.  
 
The migration of pDCs via HEVs requires their expression of CCR5 (Diacovo et al., 2005), 
thus we investigated the expression level of this receptor on the surface of FL-pDCs (Fig. 
4.2D). pDCs did not express this receptor at high levels and the proportion of CCR5+ cells 
actually went down in response to Ag stimulation. The cDC subsets also expressed only 




4.2.2 FLDCs can effectively prime Ag-specific T cell responses 
Having established that FL-cDCs were able to traffic efficiently to the dLN following 
adoptive transfer, we then assessed their ability to prime Ag-specific T cell responses in 
vivo. Cells were cultured with or without Ag overnight then adoptively transferred as 
before. We transferred the mixed DC culture generated by Flt3-L rather than pure 
populations of the different subsets, so as to avoid the negative impact that FACS sorting 
had on the cells. To purify enough cells for transfer would have required a prohibitively 
large number of cells at the outset, as well as an extended length of time on the FACS 
sorter, likely leading to a further reduction in cell viability. Moreover, the migration 
experiments indicated that pDCs did not migrate to the pLNs and so were unlikely to 
contribute in this model. 7d after injection, dLN were harvested and cells restimulated with 
Ag in vitro. It was clear that FL-DCs cultured in the presence of SEA prior to transfer 
successfully primed Ag-specific Th2 response as high levels of IL-4, IL-5, IL-10 and IL-13 
were measured in supernatants from restimulated dLN cells (Fig. 4.3B). Additionally, 
FLDCs exposed to SEA prior to transfer induced IL-17 and IFNγ production, although, 
unlike the Th2 cytokines, secretion of these was not significantly above background levels 
(Fig. 4.3B). FLDCs cultured with St effectively generated an Ag-specific Th1/Th17 
response following transfer, characterised by significant levels of IL-17 and IFNγ 
production upon restimulation of dLN cells, whilst Th2 cytokines were undetectable (Fig. 
4.3C). The St-specific response also included a regulatory aspect, as IL-10 was elevated 
in the supernatants of restimulated LN cells (Fig. 4.3C).  Together, these findings illustrate 
that FL-cDCs successfully generated Ag-specific T cell responses in the dLN following 
adoptive transfer. 
 
4.2.3 FLDC priming of SEA-specific Th2 responses requires MHC II and CD40 
expression 
Previous in vivo experiments with GMDCs have established that SEA-specific Th2 
induction by DCs is dependent on their expression of MHC II, CD40 (MacDonald et al., 
2001; MacDonald et al., 2002c), whilst DC-derived IL-10 has no role in this process 
(Perona-Wright et al., 2006a). Although it was clear that FL-cDCs were able to prime Th2 
responses, our findings from chapter 3 illustrated that FL-cDCs display a distinct 
phenotype from GMDCs when exposed to SEA. For this reason, we undertook to establish 
whether the published findings for GMDCs were valid for FLDCs.  
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Firstly, transfer of FLDC derived from H2-ab-/- mice (Ab-/-, lacking a subunit of MHC II) into 
WT recipients confirmed that SEA-specific Th2 induction by FLDCs was dependent on 
their expression of MHC II, as H2-ab-/- cells failed to prime levels of IL-4, 5 and 13 
significantly above background (Fig. 4.4B). No IL-10 was detected from restimulated pLN 
cells in any group in this experiment. Cd40-/- FLDCs displayed an impaired ability to 
generate SEA-specific Th2 responses, though the reduction in IL-5 and IL-13 compared to 
WT did not reach significance due to variability in the WT cytokine levels (Fig. 4.4C). 
Finally, FLDC induction of SEA-specific Th2 responses did not require DC-derived IL-10 
as Th2 cytokine levels generated by WT and Il10-/- DCs were comparable (Fig. 4.5). Taken 
together, these experiments reveal that Th2 induction by FLDCs, in common with GMDCs, 
is dependent on their expression of MHC II and CD40, but that DC-derived IL-10 has no 
major role in this process. 
 
4.2.4 A central role for IFN-I in Th2 induction by FLDCs 
In chapter 3, it was shown that CD24+ cDCs secrete IFN-I in response to SEA exposure. A 
number of studies have suggested a role for IFN-I in maintaining DC function, often in an 
autocrine manner (Montoya et al., 2002). We wanted to investigate whether the SEA-
specific IFN-I signal was required for optimal FLDC function. As discussed previously, the 
expansive nature of the IFN-I family means it is not feasible to knock out or block IFN-I 
production, so instead we addressed the more general question - if FLDCs were unable to 
respond to any IFN-I signal, could they still prime effectively in a Th2 setting? To do this, 
WT or IFNAR-deficient FLDCs were cultured overnight with SEA and adoptively 
transferred into WT recipients. Notably, Ifnar1-/- FLDCs displayed a severe impairment in 
their ability to prime SEA-specific IL-4, IL-5, IL-10 and IL-13 (Fig. 4.6), with the levels of all 
Th2 cytokines remaining at baseline levels. Production of SEA-specific IFNγ was not 
significantly affected, whilst only very low levels of IL-17 were detected. This result 
indicated that IFN-I receptor expression by FLDCs is critical for their ability to generate 
SEA-specific Th2 responses in vivo.  
 
4.2.5 IFNAR-deficient FLDCs display defective responses to SEA stimulation 
In order to investigate why Ifnar1-/- FLDCs were unable to prime in vivo Th2 differentiation 
we first assessed their in vitro response to SEA treatment. SEA exposure did not induce 
the intermediate activation phenotype characteristic of WT cells in Ifnar1-/- FLDCs, with 
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cDCs showing reduced MHC II expression compared to WT cells (Fig. 4.7A). Strikingly, 
the gMFI of CD40 and CD86 on Ifnar1-/- FL-cDCs following SEA exposure was barely 
above background levels and was significantly lower than on WT cells cultured with SEA 
(Fig. 4.7A). Surface phenotype was not the only aspect of the Ifnar1-/- FLDC response that 
was affected, as receptor-deficient cells also secreted significantly less IFNα3 in response 
to SEA than WT cells (Fig. 4.7B).  
 
Signalling downstream of IFNAR results in sustained production of IFN-I (Malmgaard et 
al., 2002; Marie et al., 1998). Similarly, there are a large number of other interferon-
stimulated genes (ISG) whose transcription is dependent on signalling via IFNAR. We 
reasoned that the SEA-induced IFN-I would act in an autocrine manner, and so assessed 
the expression levels of other ISGs by FLDCs after a short (6h) culture with SEA. We 
found that SEA stimulated a significant increase in the expression of two well-known ISGs 
– Ifit1 and Mx1 in WT FLDCs (Fig. 4.7C). SEA-induced upregulation of these genes was 
not evident in Ifnar1-/- FLDCs. In addition, baseline expression of these ISGs by 
unstimulated medium control Ifnar1-/- cells was reduced compared to WT controls (Fig. 
4.7C). Thus, in the absence of functional IFNAR, not only were FLDC phenotypic 
responses to SEA abrogated, but the induction of the IFN-I signature was also curtailed. 
 
4.2.6 IFNAR-deficient FLDCs develop normally with only minor differences in subset 
composition  
To address whether the reduced ability of Ifnar1-/- FLDCs to be activated by SEA and 
prime Th2 responses was due to impaired DC generation or viability we compared the 
viability of WT and IFNAR-deficient FLDCs. Unstimulated Ifnar1-/- FLDCs had comparable 
viability to WT cells, with a similar percentage of live cells and equivalent proportions of 
cells undergoing apoptosis (Fig. 4.8B). In the experiment depicted here there was a small 
but significant increase in viable IFNAR-deficient cells after overnight culture with SEA. 
However this was subject to variability across experiments. It should be highlighted that 
FLDCs have quite a high level of apoptosis, which has not previously been reported (Fig. 
4.8B).  
 
The percentage of live-singlet cells that expressed CD11c was comparable between WT 
and Ifnar1-/- FLDCs (Fig. 4.8C). Within the CD11c+ population, Ifnar1-/- Flt3-L cultures had 
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significantly less CD45Rhi pDCs than WT and a consequent increase in the proportion of 
CD45Rlo cDCs (Fig. 4.9A). There were also changes in the composition of the CD45Rlo 
cDC compartment in Ifnar1-/- cultures, with approximately double the proportion of the 
CD24+ cDCs, whilst the percentage of CD11b+ cDCs dropped by one fifth (Fig. 4.9B). It is 
clear that Ifnar1 is not required for generation of FLDCs. However the lack of functional 
receptor expression on BM precursors did have some effect on the populations generated 
by Flt3-L.  
 
4.2.7 In the absence of TLR signalling FLDCs cannot prime Th2 responses 
Having established that Ifnar1-/- FLDCs displayed no major impairment in development or 
survival, but showed some differences to WT FLDCs, we attempted to establish whether 
an inability to secrete IFN-I was the key factor in this response. As shown in chapter 3, 
Myd88-/-/Trif-/- FLDCs also fail to secrete IFN-I (Fig. 3.8A). For this reason, we assessed 
whether Myd88-/-/Trif-/- FLDCs showed a similar deficiency in SEA-driven Th2 induction in 
vivo. This revealed that Th2 induction, as well as IFNγ (no IL-17 was detected), was 
completely ablated in the absence of the TLR adaptor proteins (Fig. 4.10B). This result 
may suggest that IFN-I production by FLDCs following exposure to SEA is essential for 
their ability to prime Th2 responses, however, it cannot be ruled out that other defects in 
Myd88-/-/Trif-/- FLDC function are responsible for their inability to prime SEA-specific Th2 
responses. 
 
4.2.8 IFNAR-deficient FLDCs prime normal T cell activation in vitro  
To directly address whether Ifnar1-/- FLDCs had a specific defect in their ability to interact 
with T cells, we used a more reductionist in vitro model of T cell priming. In the absence of 
an SEA-specific Tg T cell model, it was necessary to use the OVA system to investigate 
the activation of naïve CD4 cells (Barnden et al., 1998; Murphy et al., 1990). First, we used 
OTII TCR Tg CD4+ T cells to assess the ability of FLDCs to induce Ag-specific T cell 
proliferation, as this assay provides a good measure of Ag uptake, processing and 
presentation. FLDCs were FACS sorted on day 8 of culture to provide a pure cDC 
population. We excluded pDCs on the basis that they do not appear to play a role in the in 
vivo transfer model. Sorted cDCs were cultured with CFSE-labelled OTII TCR Tg T cells in 
the presence or absence of OVA peptide (pOVA) or whole OVA protein (OVA). Both WT 
and Ifnar1-/- FL-cDCs successfully stimulated T cell proliferation in the presence of OVA 
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peptide, with almost 100% of T cells having undergone at least one round of division after 
96h of culture (Fig. 4.11B). Similarly, all but a very small percentage of T cells proliferated 
when OVA protein was present, regardless of whether the presenting DCs were WT or 
Ifnar1-/- (Fig. 4.11C). Since whole OVA protein must be processed to generate peptides to 
be presented on MHC II, this indicates that Ifnar1-/- FL-cDCs are not inherently defective in 
Ag processing and presentation.   
 
We next addressed whether Ifnar1-/- FL-cDCs had a specific deficiency in their ability to 
polarise Th2 responses in vitro. As OTII TCR Tg T cells produced little to no T cell 
cytokines following culture with OVA or pOVA, to specifically assess Th2 priming we 
activated a polyclonal T cell population with anti-CD3 in the presence of IL-4 (Cook et al., 
2012). Although IL-4 acts as a Th2-polarising agent in these cultures, DCs are also 
essential, and there is no Th2 induction in their absence. Polyclonal CD4+ T cells were 
FACS sorted from KN2xIL-13eGFP (Fig. 4.12) or KN2xIL-10eGFP (Fig. 4.13) reporter 
mice. Cells from these mice express human CD2 (huCD2) on their surface when IL-4 is 
secreted (Mohrs et al., 2005), and produce GFP when IL-13 (IL-13eGFP mice) or IL-10 
(IL-10eGFP mice) message is transcribed. In the absence of exogenous IL-4, very few T 
cells expressed huCD2 (Fig4.12B) or IL-13eGFP (Fig. 4.12C). With the addition of IL-4 
there was a significant increase in the percentage of huCD2+ and IL-13eGFP+ cells, and 
this was the case in the presence of either WT or Ifnar1-/- cDCs (Fig. 4.12B-C). Similarly, 
IL-10eGFP expression was induced by exogenous IL-4 with either WT or IFNAR-deficient 
cDCs (Fig. 4.13). This assay demonstrates that IFNAR-deficient FL-cDCs can effectively 
facilitate T2 polarisation in the presence of IL-4.  
 
4.2.9 A migration defect in IFNAR-deficient FL-cDCs?  
We had generated a growing body of evidence that Ifnar1-/- cDCs could still function 
effectively as APCs in vitro, despite defective responses to SEA and an inability to prime T 
cell cytokine production in vivo. As well as eliciting upregulation of MHC II and co-
stimulatory molecules, SEA also caused significant increase in CCR7 expression on a 
proportion of FL-cDCs, primarily CD11b+ cDCs (Fig. 4.2A-B and Fig. 4.14, WT data for 
both figures are from the same experiment). As with other surface markers, SEA-specific 
CCR7 expression on Ifnar1-/- cDCs was significantly reduced compared to WT cells (Fig. 
4.14). This was particularly apparent with CD11b+ cDCs, as both the percentage of CCR7+ 
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cells, and the CCR7 gMFI, were at baseline levels on Ifnar1-/- cells exposed to SEA 
(Fg4.14B-C). This suggests that functional IFN-I signalling may be required for effective 
FLcDC migration to the draining LN following adoptive transfer.  
 
To compare migration of WT and Ifnar1-/- DCs we decided to first assess their chemotactic 
activity in an in vitro transwell assay of chemotaxis. DCs were cultured overnight with or 
without SEA, and then washed and resuspended in serum-free medium. This was done 
because components of FCS, which is normally present in FLDC cultures, can activate 
chemokinesis and block responsiveness to chemokines.! Cells were placed in the top 
chamber of transwells, with the bottom chamber containing varying concentrations of the 
CCR7 ligand, CCL21 (Fig. 4.15A). We expected that CCR7-expressing cells in the upper 
section would be attracted by CCL21 and traverse the permeable membrane into the lower 
chamber. After 3h incubation cells present in the lower chamber were stained and 
analysed by a MACSQuant flow cytometer that can provide accurate cell counts. These 
were used to calculate the chemotactic index of the various DC subsets from the different 
conditions (Fig. 4.15A). 
 
In the presence of CCL21, the number of WT CD24+ and CD11b+ cDCs that traversed the 
membrane increased by approximately 4-fold compared to medium alone (Fig. 4.15B). 
However, there was no further dose-dependent increase in migration with increasing 
concentrations of CCL21 (Fig. 4.15B). Only unstimulated CD11b+ Ifnar1-/- cDCs displayed a 
significant defect in transmigration compared to WT, with a chemotactic index that was 
two-fold lower in the presence of CCL21 than WT cells (Fig. 4.15B). Prior exposure to SEA 
seemed to reduce the number of WT CD24+ cDCs that transmigrated. However, the 
chemotactic index of Ifnar1-/- CD24+ cDCs, and both WT and IFNAR-deficient CD11b+ 
cDCs was unaffected by SEA.  
 
The unreliability of this transwell assay as a measure of migratory capacity was highlighted 
by the fact that pDCs were detectable in all conditions (Fig. 4.16A), despite only 0.5-1.5% 
of pDCs expressing CCR7 (Fig. 4.16B). This suggests that the presence of pDCs in the 
bottom chamber is due to random movement and not chemotaxis. This finding indicated 
that another method of measuring DC migration was required to analyse the role of IFNAR 
in this process. 
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We had previously found that adoptive transfer of dsRed+ cells provided an in vivo assay 
for DC migration (Fig. 4.1). In the absence of an Ifnar1-/- x dsRed cross, we attempted this 
assay using CD45.2+ FLDCs transferred into CD45.1+ naïve recipients. Initially, by 
analysing the size of the CD45.2+ CD11c+ population present in the dLN by flow cytometry 
we thought that this could provide a good measure of migration. However, injection of cells 
caused infiltration of a CD45.1+ CD45.2+ population that could be found in the CD45.2+ 
CD11c+ gate of injected animals (Fig. 4.17B-D). Once this autofluorescent population was 
excluded, it was possible to identify a WT CD45.1- CD45.2+ CD11c+ population in the dLN 
of some recipient mice, for example animal 1 (Fig. 4.17C), but not others (animal 2, Fig. 
4.17D), suggesting that not all injections had resulted in successful migration. In addition, 
no CD45.2+ cells were detectable in dLN sections analysed by confocal microscopy.  
 
4.2.10 GMDCs do not require Ifnar1 expression to effectively induce Th2 responses 
Although GMDCs did not secrete IFN-I in response to SEA stimulation (Fig. 3.6C), a 
published study suggested that they too require IFN-I responsiveness to be able to 
stimulate optimal OVA-specific T cell proliferation in vitro (Montoya et al., 2002). However, 
the authors did not address whether Ag-specific cytokine output from T cells was affected 
in the presence of IFNAR-deficient GMDCs. We found that WT and Ifnar1-/- GMDCs 
generated comparable SEA-specific Th2 cytokine responses in the dLN of recipient mice 
(Fig. 4.18A). In fact, IL-4 levels elicited by IFNAR-deficient cells were significantly 
increased compared to WT (Fig. 4.18A). Similarly to IFNAR-deficient FL-cDCs, Ifnar1-/- 
GMDCs had no defect in their ability to stimulate Ag-specific proliferation from OTII TCR 
Tg T cells in the presence of OVA protein or peptide (Fig. 4.18B), or to generate a Th2 
profile from reporter T cells in the IL-4-dependent in vitro assay described in section 4.2.8 
(Fig. 4.18C-D). Induction of IL-10eGFP by IFNAR-deficient GMDCs was significantly 
increased compared to WT cells (Fig. 4.18E). These data clearly show IFN-I is not 
required for GMDCs to function as APCs in a Th2 setting either in vitro or in vivo. 
 
Despite a previous report that IFNAR-deficient splenic DCs are more resistant to apoptosis 
(Mattei et al., 2009), as with FL-cDCs, we found no difference in the viability of Ifnar1-/- 




Differential expression of the IFNAR may explain why FLDCs, but not GMDCs, depend on 
IFN-I for their function. Whereas only 20% of GMDCs expressed IFNAR1 on their surface 
in the presence or absence in Ag (Fig. 4.19B), some 80% of FL-cDCs were IFNAR1+ in the 
absence of Ag stimulation (Fig. 4.19A). As professional IFN-I producing cells, almost 100% 
of pDCs expressed IFNAR1 in the basal state (Fig. 2.19A). Both the percentage of 
IFNAR1+ FLDCs and the gMFI of IFNAR1 expression were significantly decreased on 
BMDCs in the presence of Ag (Fig. 4.19A and C). This may reflect downregulation or 
degradation of the receptor following stimulation, which has been reported in studies of 
human monocyte-derived DCs (Severa et al., 2006), and in mouse and human fibroblasts 
(Qian et al., 2011). The antibody used in our experiments was a blocking antibody, 
however (Sheehan et al., 2006), thus reduced staining may reflect the fact that IFNα/β is 























• FL-cDCs migrate to the dLN following adoptive transfer (Fig. 4.1), forming 
productive DC:T cell interactions to polarise an SEA-specific Th2 response (Fig. 
4.3B) 
• FL-pDCs do not reach the pLN after transfer (Fig. 4.1) 
• Th2 priming by SEA-activated FL-cDCs is dependent on MHC II and CD40 
expression (Fig. 4.4) 
• Functional IFNAR signalling is required for FL-cDCs to prime effectively (Fig. 4.6) 
• IFNAR-deficient FL-cDCs fail to become activated (Fig. 4.7A), generate an IFN-I 
signature (Fig. 4.B-C) or upregulate CCR7 (Fig. 4.14) in response to SEA 
• T cell priming by IFNAR-deficient FL-cDCs is not defective in vitro (Fig. 4.11-13) 























In this chapter we set out to investigate the capacity of FLDCs to prime SEA-specific Th2 
responses, and the possible involvement of IFN-I in this process. For the first time, we 
have shown that SEA activated FLDCs effectively migrated to the dLN following adoptive 
transfer, where they capably induce a Th2 response. Another novel finding of our studies 
of FLDC SEA-specific Th2 priming was that induction of this response was dependent on 
DC expression of IFNAR. However, FLcDC function was not curtailed in vitro in the 
absence of functional IFNAR. This suggests that IFNAR-deficient FLcDCs may have 
defective migration in vivo, identifying a role for IFN-I in migration and Th2 priming by Flt3-
L dependent cDCs.   
 
4.3.1 Migration and priming by FLDCs  
FACS and microscopy analysis following transfer of dsRed cells demonstrated that FLDCs 
migrated efficiently, with cells from all conditions detectable in the dLN 24h after transfer. 
Although cDCs cultured in medium alone or in the presence of SEA expressed much lower 
levels of CCR7 than cells exposed to St (Fig. 4.2A-C), there was no difference in the 
kinetics of cell migration (Fig. 4.1B-C). This was somewhat surprising, since we expected 
that the high level of CCR7 expression (essentially 100%) by FLDCs following exposure to 
SEA would give them a migratory advantage. One possible explanation for this 
discrepancy is that FLDCs cultured overnight with St have reduced migratory capacity. In a 
transwell assay involving transmigration of D1 cells (an immortalised DC cell line from 
mouse spleen, generated from cells with dendritic morphology that expand in response to 
GM-CSF) through an endothelial cell layer, the migratory capacity of LPS-stimulated DCs 
peaked at 4h, but by 18h transmigration was much reduced (Granucci et al., 1999). 
However, the findings of Granucci et al. (1999) are in conflict with our work that 
demonstrates that cells cultured in the presence of St still express high levels of CCR7 
after 18h (Fig. 4.2), suggesting a capability to migrate at later timepoints. One way to test 
whether migratory capacity is reduced at 18h would be to culture FLDCs with Ag for a 
shorter period prior to transfer (4h), and compare the migration of these cells to FLDCs 
cultured with Ag for 18h. 
 
Confocal microscopy analysis of recipient dLNs demonstrated that FL-pDCs did not reach 
the dLN when injected subcutaneously (Fig. 4.1C). It is possible that FL-pDCs 
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downregulated expression of CD45R following transfer, which would explain why we were 
unable to detect dsRed+ cells that co-expressed CD45R. However, there is no evidence in 
the literature that pDCs alter their expression of CD45R. pDCs do not migrate via the 
afferent lymphatics, as cDCs do, but rather via the blood (Diacovo et al., 2005). Thus, 
perhaps more likely, the route of injection in this experiment did not provide pDCs easy 
access to the blood system. It is also possible that FL-pDCs migrating via the blood 
system only appeared in the LN at timepoints later than was analysed here. 
 
If transferred FL-pDCs had disseminated systemically in the circulatory system it is 
possible that these cells migrated to the spleen. In our experiments, the accumulation of 
transferred cells in the spleen was not assessed. However, as shown by Diacovo et al. 
(2005), although pDCs can attach to noninflamed HEV, an inflammatory stimulus is 
required for them to gain entry. For this reason, we may only be able to visualise pDCs in 
lymphoid organs following co-injection of an inflammatory stimulus, such as LPS or CpG. 
Even so, the process of pDC transmigration via HEVs requires CCR5 (Diacovo et al., 
2005), which was not obviously expressed on our in vitro differentiated FL-pDCs (either 
basally, or following exposure to SEA or St; Fig. 4.2D). The absence of pDCs in the dLN 
following adoptive transfer suggests that they are unlikely to have a role in priming T cell 
responses there in this model, although it is possible they may play a role at the injection 
site. 
 
FACS analysis clearly showed that FL-cDCs could migrate efficiently to the dLN, with 
confocal microscopy confirming that the majority localised to the T cell zone (Fig. 4.1C). 
Contrary to the finding of Léon et al. (2012) that DCs localise to the edges of the B cell 
zone during H. polygyrus infection, most dsRed+ cells were situated well within the T cell 
zone. This discrepancy may reflect the fact that our experiments analysed the localisation 
of transferred cells cultured with Th2-polarising Ag rather than in vivo DCs responding to 
helminth infection. Alternatively, DC localisation may be site-specific (popliteal LN vs. 
MLN) or pathogen/Ag-specific (SEA vs. H. polygyrus).   
 
High magnification revealed that, in some cases, dsRed+ DCs were very closely 
associated with CD4+ cells, suggesting that transferred cells present Ag to T cells of the 
dLN. In agreement with this hypothesis, FLDCs cultured in the presence of SEA prior to 
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transfer induced Ag specific Th2 responses (IL-4, 5, 10 and 13), detectable seven days 
after transfer. Conversely, cells exposed to St prior to transfer induced significant Ag-
specific IL-10, IL-17 and IFNγ (Fig. 4.3C), but no IL-4, IL-5 or IL-13 was detectable. Thus 
FLDCs induce appropriate polarised T cell responses to helminth and bacterial Ag 
following adoptive transfer in vivo.  
 
FLDC bulk cultures were capable inducers of an SEA-specific Th2 response following 
transfer. However, what is clear when comparing the cytokine output from several 
experiments is that this response can be quite variable (Fig. 4.3-4.6). Flt3-L cultures are 
heterogeneous (Fig. 3.1) and the proportions of the different subsets they generate can 
vary between experiments. This may explain why IL-4 and IL-5 output ranged from 
0.05ng/ml to 3ng/ml. Other reasons for experiment-to-experiment variability include 
differences in the age or sex of mice used, although every effort was made to avoid these 
variables when possible. It is also likely that there was variability in the length of time that 
DCs were exposed to Ag, as well as the length of time between harvesting LNs and 
putting LN cells into culture, similarly, the amount of time that LN cells were in culture may 
not be exactly 72h for each replicate experiment. However, this kind of variability in 
absolute cytokine levels is the norm rather than the exception in ex vivo/ in vitro systems 
that use primary cells and complex Ag mixes. More importantly, the patterns of cytokine 
production are robust and reproducible despite some variability. WT DCs exposed to SEA 
prior to transfer reproducibly polarise Th2 cytokine production in the dLNs, cytokines that 
are not induced by unstimulated DCs or cells exposed to a bacterial stimulus. DCs can 
induce some level of IFNγ and IL-17 production following exposure to SEA, however, this 
is uniquely associated with strong induction of Ag-specific Th2 cytokines. 
 
4.3.2 The role of IFN-I in Th2 induction by FLDCs 
Initial experiments revealed that FLDC Th2 induction was similar to GMDC in that it 
required MHCII and CD40, but one clear difference was that FLDC (but not GMDC) SEA-
specific Th2 induction was dependent on IFN-I responsiveness. In our adoptive transfer 
model, Ifnar1-/- FLDCs displayed a complete failure to prime SEA-specific Th2 responses, 
whilst the Th1 facet of this response was unaffected (Fig. 4.6). Unravelling exactly why 
these cells were ineffective in this model proved less straightforward. Part of the 
explanation for this may be that IFN-I signalling was clearly essential to the ability of FL-
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cDCs to generate the intermediate level of surface activation characteristic of WT cells, as 
CD40 and CD86 expression on Ifnar1-/- cells exposed to SEA were barely above 
background (Fig. 4.7A).  
 
Similarly, SEA-specific IFN-I output was not maintained in the absence of IFNAR (Fig. 
4.7B). This is likely due to the breakdown of the IFN-I feedback loop, which governs 
sustained IFNα/β production via IFNAR (Honda and Taniguchi, 2006a). Jak/STAT 
signalling downstream of IFNAR initiates transcription of hundreds of other ISGs, thus the 
action of this receptor controls a vast array of cellular processes besides IFN-I production 
(Gonzalez-Navajas et al., 2012). Because IFN-I readily binds to its surface receptor soon 
after secretion (Piehler et al., 2012), it can be very difficult to detect soluble protein in 
supernatants by ELISA. For this reason, transcription analysis of ISGs can provide a 
useful biomarker for an IFN-I signature. We have identified a number of ISGs that are 
upregulated by FLcDCs following 6h culture with SEA, including Ifit1 and Mx1 (Fig. 4.7C). 
Both of these genes were found to be upregulated in a microarray of D1 cells cultured with 
live schistosome eggs (Trottein et al., 2004). In accordance with Trottein et al., we found 
that expression of these genes was abolished in the absence of functional IFNAR (Fig. 
4.7C). As a next step in our work, a similar microarray approach to assess changes in 
gene expression in SEA-stimulated FLDC subsets, and their reliance on IFNAR, would 
provide a more comprehensive picture of ISG expression by these cells.  
  
Understandably, the field of study around ISGs has thus far focused primarily on their role 
as antiviral effectors (Diamond and Farzan, 2013; Schoggins and Rice, 2011; Schoggins 
et al., 2011). However, the broad range of the ISG response suggests they are likely to 
have as yet unidentified function in DCs in a number of settings, which would be inhibited 
in Ifnar1-/- cells. For example, members of the IFIT family can inhibit protein translation by 
binding to the initiation factor eIF3 (Diamond and Farzan, 2013). As such, a study with a 
murine macrophage cell-line that overexpressed IFIT2 found that IL-6 and TNFα 
production in response to LPS stimulation was inhibited (Berchtold et al., 2008). Omega-1, 
an RNase present in SEA, has already been shown to condition DCs for priming Th2 
responses by repressing protein synthesis (Everts et al., 2012), demonstrating that this 
process contributes to the Th2-polarising ability of this immune-dominant component of 
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SEA. Thus, it is possible that induction of IFITs by SEA may function to limit translation 
and enhance Th2 induction. 
 
The failure of IFNAR-deficient cells to induce SEA-specific Th2 responses did not appear 
to be linked to any substantial developmental or survival abnormalities (Fig. 4.8 and Fig. 
4.9). A small number of studies do suggest that IFN-I regulate DC differentiation and 
survival, with Mattei et al. (2009) finding that Ifnar1-/- splenic DCs were more resistant to 
apoptosis in short-term culture. Mattei et al. also found impairment in in vitro GMDC 
differentiation from Ifnar1-/- BM; in contrast we have experienced no significant impact of 
IFNAR deficiency on GMDC or FLDC generation.  
 
Comparing apoptosis of WT and Ifnar1-/- cells illustrated that FLDCs are more prone to 
apoptosis (20-30% cDC in late apotosis; Fig. 4.8A-B) than GMDC (<5%; Fig. 4.18F), This 
suggests that, although Flt3-L is a key differentiation factor, DCs may require other factors, 
such as GM-CSF, for more long term survival. This could be assessed in vitro by the 
addition of GM-CSF to DC cultures during Ag stimulation. This difference may relate to the 
different STATs involved in FLDC and GMDC differentiation, with STAT3 activated by Flt3 
(Laouar et al., 2003), whilst GM-CSF function is primarily mediated by STAT5 (Feldman et 
al., 1997). It has been shown that GM-CSF-activated STAT5 can inhibit STAT3-mediated 
apoptosis induced by IL-21 in GMDCs (Wan et al., 2013). GM-CSF activation of STAT5 
has also been shown to protect neural cells from apoptosis (Choi et al., 2011a).   
 
As Myd88-/-/Trif-/- FLDC secretion of IFNα was limited following SEA stimulation (Fig. 3.8B), 
we assessed the ability of these cells to prime in vivo Th2 responses, and found a similar 
complete ablation of SEA-specific T cell responses to what we had seen with Ifnar1-/- 
FLDCs  (Fig. 4.10B). This raises some interesting questions, as Th2 priming by both SEA 
and during S. mansoni infection is currently thought to be independent of MyD88 signalling 
(Pearce and MacDonald, 2002; Perona-Wright et al., 2006b). This conclusion was based 
on studies with MyD88-deficient animals for in vitro DC-Th2 polarisation assays, using 
sorted splenic cDCs, in the presence of SEA (Jankovic et al., 2004), as well during patent 
S.mansoni infection (Layland et al., 2005). Tlr3-/- mice infected with S. mansoni displayed 
no significant phenotype on d49 of infection (Vanhoutte et al., 2008), suggesting that TRIF 
is also not required for immune activation in this setting. However our results with double 
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deficient Myd88-/-/Trif-/- cells clearly show that these signals are required for schistosome-
induced Th2 induction and caution against drawing firm conclusions using only singly 
deficient mice. Based on this, it is important that the role of MyD88 and TRIF together, as 
well as separately, is assessed in S. mansoni infection. The ability of Myd88-/- and Trif-/- 
FLDCs to stimulate SEA-specific Th2 responses following adoptive transfer must also be 
addressed. 
 
Whilst Montoya et al. (2002) reported a reduction in the ability of IFNAR-deficient GMDCs 
to stimulate naïve T cell proliferation in vitro, we did not see this for either FL-cDCs (Fig. 
4.11) or GMDCs (Fig. 4.18B). In fact, Ifnar1-/- FL-cDCs could stimulate CD4+ T cell 
proliferation in response to whole OVA (Fig. 4.11C), indicating they have no major defect 
in Ag uptake, processing and presentation. Similarly, Ifnar1-/- cells were also proficient in 
generating hallmarks of a Th2 response from polyclonal T cells in an IL-4-dependent in 
vitro model (Fig. 4.12-13). Whilst this assay demonstrates that IFNAR-deficient FL-cDCs 
can facilitate Th2 polarisation driven by IL-4, this assay does not definitively show that 
these cells are capable of direct Th2 priming. In order to demonstrate this effectively, we 
require transgenic T cells with a TCR specific for a component of SEA, as SEA-specific 
Th2 polarisation cannot be detected from a polyclonal population of T cells in vitro. Using 
cytokine reporter mice to measure Th2 polarisation by SEA-exposed BMDCs following 
adoptive transfer has also so far proved unsuccessful (Peter Cook, unpublished data), 
however, it may be possible to optimise this technique to more directly measure Th2 
polarisation by IFNAR-deficient DCs.   
 
Comparison of GMDCs with FLDCs in the in vitro CD4+ T cell polarisation experiments 
revealed that GMDCs were much better at inducing IL-4 protein, as well as IL-13 and IL-10 
message expression (Fig. 4.12-13 and Fig. 4.19B). These Th2 cytokines were also 
detectable by ELISA in GMDC cultures (data not shown), as shown previously (Cook et 
al., 2012), but not in FLDC cultures. One possible explanation for this difference is the fact 
that FLDCs are more prone to apoptosis than GMDCs (Fig. 4.8 and Fig. 4.18F). 
Intriguingly, it has also been suggested that IL-2 can inhibit FLDC function, and that 
FLDCs differentiated in the presence of IL-2 are more susceptible to apoptosis when 
cultured in the presence of T cells (Lau-Kilby et al., 2011). Thus, it may be the presence of 
T cells themselves in these cultures that inhibits FLDC function. To address whether this is 
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the case, we could generate FLDCs using BM from mice that lack subunits of the IL-2 
receptor, for example Il2ra-/- (CD25-deficient) or Il2rb-/- animals, and so cannot respond to 
IL-2 stimulation (Fontenot et al., 2005; Suzuki et al., 1995; Willerford et al., 1995). It has 
been shown that GMDCs produce IL-2 at early timepoints after exposure to bacteria, such 
as E. coli (Granucci et al., 2001), and it has been suggested that this is important for T cell 
activation (Granucci et al., 2001; Zelante et al., 2012). However, whether or not FLDCs 
produce IL-2 basally or in response to Ag has not yet been addressed. Thus, it would be 
worthwhile to assess IL-2 production by FLDCs. If FLDCs produce less IL-2 than GMDCs, 
addition of recombinant IL-2 to in vitro T cell co-cultures may enhance T cell survival and 
polarization, with the caveat that if the findings of Lau-Kilby et al. (2011) are correct, then 
this may affect FLDC survival. 
 
The relatively poor performance of FLDCs in the in vitro polarisation assay may also reflect 
the fact that not all cDCs present in the culture are capable of priming Th2, as FLcDCs 
include both CD24+ and CD11b+ cDCs (Naik et al., 2005). There are currently no published 
studies that address the roles of different cDC subsets in helminth infection. However, our 
lab is actively investigating this through S. mansoni infection of Batf3-/- mice, which lack 
CD8α+ cDCs (Alex Phythian-Adams, Angela Marley). A number of studies have been 
published indicating that CD11b+ and monocyte-derived DCs selectively promote Th2 
differentiation in mouse models of allergy and airway inflammation (Hammad et al., 2002; 
Hammad et al., 2010; Plantinga et al., 2013). The importance of mo-DCs in these models 
is in agreement with our finding that GMDCs are better at polarising Th2 responses than 
FL-cDCs.  
 
Following the discovery that CD11b+ cDCs but not CD8α+ cDCs induce Th2 responses in 
the allergic setting (Plantinga et al., 2013), our working hypothesis is now that this subset 
may be the FL-cDC population that polarises Th2 responses. We have yet to test whether 
sorted CD11b+ cDCs perform better than the CD8α+ subset in the IL-4-dependent in vitro 
polarisation assay. Given that CD11b+ cDCs pulsed with SEA express higher levels of co-
stimulatory molecules (Fig. 3.A-B) and CCR7 (Fig. 4.2A-C), it is possible that they are the 
sole DC subset from the FLDC cultures responsible for priming in our adoptive transfer 
model. This would be difficult to address directly by transferring pure populations of FL-
cDC subsets because of the limited cell numbers recovered following FACS sorting. 
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Despite the issues surrounding FACS-sorting of FLDCs, it is necessary to do these 
experiments in order to fully address the role of the different DC subsets in SEA-specific 
Th2 induction. As cell return from flow sorting is so low, this may necessitate several 
smaller experiments, with fewer recipients per group. This could actually prove to be 
advantageous, providing a more robust statistical result, if multiple experiments were 
pooled. Magnetic-bead enrichment (MACS sorting), so far in our hands, has not provided 
pure enough populations from FLDC cultures, though it may be possible to refine this 
technique further to enhance purity. MACS sorting would be a preferable method of cell 
selection because it should be less damaging to cells than FACS.  An alternative approach 
would be to assess cell migration with the dsRed FLDCs and co-staining dLN sections with 
CD11b or CD24. As described in chapter 3, we have identified clear differences in the 
responses of CD8α+ FL-cDCs, CD11b+ cDCs and GMDCs to SEA exposure. This raises 
the possibility that cDC subsets have distinct functions in Th2 responses to schistosomes 
and other helminth infections.  
 
Since our data clearly shows that Ifnar1-/- FL-cDCs do not have any defect in priming T cell 
responses in vitro, this led us to investigate whether their failure to induce in vivo Th2 
responses is due to their inability to migrate to the dLN. This possibility is supported by the 
finding that SEA-pulsed Ifnar1-/- FL-cDCs, particularly the CD11b+ cDC subset, express 
much lower levels of CCR7 than WT cells (Fig. 4.14). Some studies have suggested that 
that IFN-I can influence DC migration, with Mattei et al (2009) also identifying reduced 
expression of Ccr7 mRNA by Ifnar1-/- GMDCs, and a resultant impairment in chemotaxis 
towards CCL21 and CCL19 by these cells in transwell assays. Whilst we were unable to 
detect any defect in the chemotaxis of Ifnar1-/- FL-cDCs in response to CCL21 (Fig. 
4.15B), the validity of this experimental model was called into question by the “chemotaxis” 
of (CCR7-negative) pDCs (Fig. 4.17).  
 
Although chemotaxis assays are often used in studies of cell migration, they are actually 
one of the more basic measures of in vitro cell migration, requiring only that the migrating 
cell can pass through a 5um pore in a collagen membrane. We based the amount of 
CCL21 on previous studies (25-250nM; (Wendland et al., 2011)), although much variation 
was noted in the literature. It may be the case that if we tested a wider range of CCL21 
concentrations, we may detect differences in migration, both between the different subsets 
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of DC, and between WT and Ifnar1-/- cells. This assay also requires that cells be 
maintained in serum-free medium due to the chemotactic potential of FCS, which can 
negate the effects of exogenous chemokines. Since we found that DCs did not perform 
well in serum-free RPMI 1640, we instead used X-VivoTM medium (Lonza) (Fig. 4.15-17). 
Because of the expense of X-Vivo medium, we initially differentiated DCs in standard 
RPMI supplemented with 10% FCS, before transfer into X-vivo medium for the chemotaxis 
assay. This caused a minor increase in cell activation levels, and so the assay may be 
improved by growing cells in X-vivo from the outset. 
 
Differentiation of human mo-DCs in the presence of IFNα leads to increased CCR7 
expression, and this enhances their adhesion to a lymphatic endothelial monolayer, 
resulting in increased chemotaxis (Rouzaut et al., 2010). This study also found enhanced 
migration of murine GMDCs differentiated in the presence of IFNα following their injection 
into the footpad, which was abolished by blockade of the adhesion molecule, LFA-1 
(Rouzaut et al., 2010). This suggests that, as well as CCR7 and other chemokine 
receptors, we should also investigate the expression of adhesion molecules on Ifnar1-/- FL-
cDCs. Although immobilised CCL21 is required for DCs to adhere to the lymphatic 
endothelium (Tal et al., 2011), and soluble chemokine gradients direct their movement 
(Schumann et al., 2010), adhesion molecules facilitate all of these processes. 
Furthermore, if adhesion molecule expression is greatly reduced on the surface of Ifnar1-/- 
FL-cDCs, we would not be able to detect this defect in our simplistic transwell assay, 
which does not require adhesion. Adhesion molecules are not only essential for entry of 
DCs into the dLN, but are also required for strong interactions between DCs and T cells at 
the immunological synapse (Lim et al., 2012).  
 
Maintenance of leukocytes in the LN is controlled by the signalling sphingolipid S1P and its 
receptor, S1PR1 (Cyster and Schwab, 2012). Downregulation of S1PR1 on cells prevents 
egress from the LN, and expression of the receptor is influenced by a number of factors, 
including the post-translational regulator CD69. Upregulation of CD69 on the cell surface 
leads to the internalisation and degradation of the S1PR1, inhibiting leukocyte egress 
(Cyster and Schwab, 2012). CD69 expression is upregulated by IFN-I, and in the absence 
of IFNAR signalling lymphocyte migration out of the LN is significantly increased (Shiow et 
al., 2006). Although CD69 upregulation is primarily associated with activated T and B cells, 
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it has been shown that GMDCs, splenic and Flt3L-generated cDCs and pDCs all 
upregulate CD69 following exposure to TLR ligands (Alari-Pahissa et al., 2012). It is likely 
in the absence of IFNAR signalling that CD69 expression would be reduced on FLDCs, 
which may alter their ability to downregulate the S1PR1, reducing the ability of IFNAR-
deficient cells to remain in the dLN. This may have a significant impact on the ability of 
transferred cells to interact with T cells effectively and to prime Ag-specific responses 
following transfer. Thus, analysis of adhesion molecules, CD69 and S1PR1 expression by 
Ifnar1-/- FL-cDCs is essential to our understanding of the role of IFN-I for FL-cDC function. 
 
An in vivo migration assay would clearly provide the most relevant result for our adoptive 
transfer model. We do not currently have an Ifnar1-/- x dsRed transgenic mouse that would 
allow us to replicate our experiments assessing WT FLDC migration (Fig. 4.2), although 
we are in the process of generating this cross. We found that CD45.2 DC transfer into 
CD45.1 recipients was unreliable (Fig. 4.18), primarily because we could not verify our 
FACS results with confocal microscopy. The major disadvantage of all adoptive transfer 
experiments is that a large number of cells must be injected, as very few reach the dLN 
(around 0.5-5%) (De Vries et al., 2003; Tal et al., 2011; Xu et al., 2007). Although exactly 
why this is the case is not known, it is likely that, of the cells that are successfully injected, 
very few make it into the afferent lymphatics (Tal et al., 2011). There is variability inherent 
in these experiments, as evidenced by our CD45.1/2 transfers (Fig. 4.18). Although we 
detected clear dsRed+ populations following adoptive transfer of FLDCs (Fig. 4.2B), to 
obtain enough events for FACS analysis it was necessary to pool the dLNs of up to 5 mice 
in these experiments. As such, it is difficult to draw conclusions about differences in 
migration kinetics between groups. In order to compare WT and Ifnar-/- FL-DC migration 
using dsRed cells, we will need to use individual mice to give statistical power, which 
should be possible as these cells are readily detectable by microscopy. 
!
It is possible that our tracking experiments using Ifnar1-/- x dsRed FLDCs will demonstrate 
no migration defect of IFNAR-deficient cells. A possible explanation for the inability of 
Ifnar1-/- FLDCs to induce a Th2 response is that IFNAR signalling in FLDCs is required for 
sustained Th2 polarisation but not for priming per se. This would explain why we see no 
defect in an in vitro polarisation assay, where Th2 induction is only measured at early 
timepoints (d3-4). On d7 following Ifnar1-/- FLDC transfer we are unable to detect any SEA-
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specific Th2 induction. In order to assess whether IFNAR is required for the maintenance 
of Th2 polarisation rather than priming, we need to assess whether the Th2 response is 
impaired at earlier timepoints after transfer, around d4-5 following DC injection. Similar 
published experiments have demonstrated that OX40L is required to maintain SEA-
specific Th2 induction but not for the initial priming of the Th2 response (Jenkins et al., 
2007). Such experiments would indicate whether IFN-I is required for FLDC survival in 
vivo, or to maintain contact with T cells, as suggested above.     
 
Together, our studies have demonstrated for the first time that cDCs differentiated with 
Flt3-L can generate SEA-specific Th2 responses following adoptive transfer in vivo, and 
that this Ag-specific polarisation is dependent on the expression of IFNAR (Fig. 4.6). 
However, GMDCs do not display the same dependence on IFN-I responsiveness for their 
function (Fig. 4.19A). This difference is likely due to the fact that a much smaller proportion 
of GMDCs express IFNAR1 on their surface, and at much lower levels (Fig. 4.20). This 
provides a clear explanation of why this receptor is so important to FLDC function, but not 
for GMDCs. This then raises the question of why GMDCs express much lower levels of 
this receptor. Perhaps GM-CSF provides myeloid cells with a survival/activation factor, 
overriding any requirement for additional activation via IFN-I. This hypothesis is supported 
by studies demonstrating that stimulation of the GM-CSF receptor itself activates signalling 
pathways that enhance DC survival and function (van de Laar et al., 2012), as detailed in 
section 3.3.1. By contrast Flt3 does not display the same capacity to activate these 
pathways (van de Laar et al., 2012), meaning that FLDCs, and perhaps Flt3-L dependent 
DC subsets in lymphoid organs, must depend on other signals (including IFN-I) to maintain 
or amplify their functionality. This may explain why splenic DCs survive less well in culture 
in the absence of IFNα/β (Mattei et al., 2009). Indeed, it has been postulated that IFN-I is 
an essential homeostatic factor for controlling signalling pathways and maintaining 
immune cell function (Gough et al., 2012). 
 
This dichotomy between IFN-I requirements for GMDCs vs. FLDCs raises the interesting 
question of whether IFN-I has a role in maintaining DC Th2 function in vivo, particularly 
during helminth infection. This may well depend on which DC populations and – perhaps 
more importantly – which tissues, are studied, at which timepoint in the development of the 
Th2 response (acute vs. chronic). With this in mind, the next chapter will investigate the 
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Figure 4.1 FL-cDCs effectively traffic to the draining LN following transfer into naïve 
recipients.  
DsRed FLDCs were stimulated overnight with soluble egg Ags from S. mansoni (SEA) or S. 
typhimurium (St), or cultured in medium alone (M), and injected subcutaneously into the feet of 
naïve recipients on d9. Draining popliteal LNs were harvested 24h or 48h later, stained and 
analysed for the presence of dsRed+ CD11c+ transferred cells by flow cytometry (B) or by confocal 
microscopy (C). Left panels in C. depicts 45x magnification of 15µm z-stacks, right panels show 63x 
magnification. Data representative of 2 independent experiments, plots in B represent pLN cells 













































































Figure 4.2 FL-cDCs upregulate CCR7 expression on their surface 
following Ag stimulation.  
Cells were cultured overnight with S. mansoni soluble egg Ags (SEA), S. 
typhimurium (St) or in medium alone (M), and their expression of chemokine 
receptors analysed by flow cytometry, histograms of CCR7 (A) and CCR5 
(D, pDCs only) expression, gating indicates percentage positive. 
Percentage of CD24+ and CD11b+ cDCs, and pDCs that stained CCR7+ (B) 
and gMFI of CCR7 expression on DC subsets (C). Data representative of 4 
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Figure 4.3 FLDCs pulsed with Ag can effectively stimulate Ag-specific T cell 
responses in vivo following transfer to a naïve recipient.  
Cells were cultured overnight in medium alone (M), or with SEA (B) or St (C), 
before being transferred into naïve recipients via subcutaneous injection. On d7 
after transfer, the draining popliteal LNs were harvested, dLN cells were plated 
with/without Ag for 72h. To assess the level of Ag recall response, ELISAs were 
performed on cell supernatants. Media background subtracted. Data representative 

















































































Figure 4.4 Optimal SEA-specific Th2 induction by FLDCs is dependent on their 
expression of MHC II and CD40. 
WT, MHC II-deficient (Ab-/- = H2-Ab-/-, B), or Cd40-/- (C) FLDCs were cultured overnight 
in the presence of SEA, or in medium alone (M), before being adoptively transferred 
into naïve hosts. dLN were harvested 7d later and restimulated with Ag, cell 
supernatants were then collected for analysis of T cell cytokine production by ELISA. 
Medium background subtracted. N.D = None detected. Data representative of 1 (B) and 
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Figure 4.5 SEA-specific Th2 induction 
by FLDCs does not require DC 
production of IL-10.  
WT or Il10-/- FLDCs were cultured 
overnight in the presence of SEA, or in 
medium alone (M), before being 
adoptively transferred into naïve hosts. 
dLN were harvested 7d later and 
restimulated with Ag, cell supernatants 
were then collected for analysis of T cell 
cytokine production by ELISA. Medium 
background subtracted. Data from 1 
























































Figure 4.6 FLDCs depend on IFN-I responsiveness 
for effective SEA-specific Th2 induction.  
WT or Ifnar1-/- FLDCs were cultured overnight in the 
presence of SEA, or in medium alone (M), before 
being adoptively transferred into naïve hosts. dLN 
were harvested 7d later and restimulated with Ag, cell 
supernatants were then collected for analysis of T cell 
cytokine production by ELISA.  Medium background 
subtracted. Data representative of 3 experiments. 





































































































































Figure 4.7 FLDC responses to SEA are curtailed in 
the absence of IRNAR1.  
WT or Ifnar1-/- FLDCs were cultured for 6h (C) or 
overnight (A-B) with SEA, or in medium alone (M). Cells 
were stained and the gMFI of surface marker expression 
on FL-cDCs analysed by flow cytometry (A). IFNα 
secretion in cell supernatants was quantified by ELISA 
(B). RT-PCR was performed on purified mRNA from 
FLDCs st imulated with Ag for 6h (C). Data 
representative of 3 experiments, 3 wells per condition. 
























































Figure 4.8 Ifnar1-/- FL-cDCs display comparable viability and CD11c 
expression levels to WT cells.  
Cells were cultured overnight in the presence or absence of SEA and their viability 
(A-B) and surface phenotype (C) analysed by flow cytometry. Cells gated on live 
singlets in C. Data representative of 3 (B) and >5 (C) experiments, 3 wells per 






































































Figure 4.9 Ifnar1-/- FLDC mixed cultures consistently contain fewer pDCs and a 
greater proportion of CD24+ cDCs than WT cultures. 
WT or IFNAR-deficient FLDCs were cultured overnight in the presence or absence of 
SEA and the proportions of cell subsets analysed by flow cytometry. Proportions of 
cDCs (CD11c+ CD45R-) and pDCs (CD11c+ CD45R+) (A). Proportions of cDC subsets 
(B): CD24+ cDCs (CD11c+ CD45R- CD24hi CD11blo) and CD11b+ cDCs (CD11c+ 
CD45R- CD24lo CD11bhi). Gated on live-singlet CD11c+ cells. Data representative of 3 




































































































Figure 4.10 Th2 induction by FLDCs is abrogated in the absence of TLR 
signalling.  
WT or Myd88-/-/Trif-/- FL-DCs were cultured overnight in the presence or absence of 
SEA, before being adoptively transferred into naïve hosts. dLN were harvested 7d 
later, cells were prepped and restimulated with Ag, cell supernatants were then 
collected for analysis of T cell cytokine production by ELISA. Medium background 
subtracted. No IL-17 detected. Data representative of 2 experiments, 5 mice per 






































































Figure 4.11 Ifnar1-/- FL-cDCs can capably present Ag 
and induce Ag-specific T cell proliferation in vitro.  
FL-cDCs were sorted on d8 of culture and cultured with 
CFSE-labelled OTII TCR Tg T cells with either OVA 
peptide (pOVA, B) or whole OVA protein (OVA, C). On d4 
of culture, T cell division was assessed by flow cytometry. 
Gray dashed line represents division of T cells in the 
absence of Ag. Data representative of 3 experiments, 5 






















































Figure 4.12 Ifnar1-/- FL-cDCs can support Th2 polarisation of T cells in 
vitro.  
FACS sorted FL-cDCs were cultured with FACS sorted IL-13eGFP-CD4+ T 
cells, in the presence or absence of anti-CD3 and IL-4. HuCD2 (B) and 
IL-13eGFP (C) expression on CD4+ T cells was assessed by flow 
cytometry after 72h of culture. Data representative of 3 experiments, 4-5 










 T cells 
72h 































































































Figure 4.13 Ifnar1-/- FL-cDCs can effectively induce 
IL-10 production in response to IL-4 stimulation in vitro.  
FACS sorted FL-cDCs were cultured with FACS sorted 
IL-13eGFP-CD4+ T cells, in the presence or absence of 
anti-CD3 and IL-4. IL-10eGFP expression on CD4+ T cells 
was assessed by flow cytometry after 72h of culture. Data 





















Figure 4.14 In the absence of functional IFNAR, CCR7 upregulation in 
response to SEA is reduced on FL-cDCs. 
WT or Ifnar1-/- FLDCs were cultured overnight with SEA, or in medium alone (M), 
CCR7 expression on CD24+ and CD11b+ cDCs was analysed by flow cytometry 
(A). The percentage of CCR7+ cells were calculated (B, positive gating as in 
Fig4.2) and the gMFI for CCR7 recorded (C). Data representative of 3 
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Figure 4.15 Only unstimulated Ifnar1-/- CD11b+ FL-cDCs show an impairment in 
an in vitro chemotaxis assay.  
Following overnight culture in the presence or absence of SEA, FLDCs were washed 
and resuspended in serum-free medium before being plated in the upper chamber of 
a transwell. The bottom chamber, separated from the top section by a permeable 
membrane, contained either 0, 25, 100 or 250nM of CCL-21. After 3h at 37C, any 
cells in the bottom chamber were collected, stained and counted by flow cytometry. 
The chemotactic index of the CD8α+  and CD11b+ cDCs (B) was calculated based on 
cell counts provided by a MACSQuant. Data from 1 experiment, 3 wells per condition.  
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Figure 4.16 FL-pDCs transmigrate in a transwell in vitro assay.  
FL-DCs were cultured overnight with or without Ag and the transwell assay 
performed as previously described. Cells in the bottom chamber of the transwell 
were stained, and cell counts and CCR7 expression analysed by flow cytometry 
(B). Cell counts were used to calculate chemotactic index (A). Data from 1 
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Figure 4.17 Adoptive transfer into CD45.1 recipients is not a sensitive 
enough method to measure CD45.2 FLDC trafficking to the dLN. 
Following overnight Ag stimulation, CD45.2 FLDCs were transferred into naïve 
CD45.1 recipients. 48h following injection, dLN were harvested and analysed by 
flow cytometry and microscopy for the presence of CD45.1- CD45.2+ CD11c+ cells 
(B-D). Animal 1 (C) and 2 (D) both received transferred cells. Data representative 
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Figure 4.18 GMDCs do not depend on IFNAR expression for their ability to polarise 
Th2 responses. 
GMDCs were cultured overnight with SEA, or in medium alone (M), before being adoptively 
transferred into naïve recipients. 7d after injection dLNs were harvested and cells were 
restimulated with Ag. Cell supernatants were collected for analysis of T cell cytokine 
production by ELISA (A). GMDCs were cultured with CFSE-labelled OTII TCR Tg T cells 
with either OVA peptide (pOVA) or whole OVA protein (OVA). On d4 of culture, T cell division 
was assessed by flow cytometry (B). GMDCs were cultured with FACS sorted IL-13eGFP-
CD4+ or IL-10eGFP-CD4+ T cells, in the presence or absence of anti-CD3 and IL-4. HuCD2 
(C), IL-13eGFP (D) and IL-10eGFP (E) expression on CD4+ T cells was assessed by flow 
cytometry after 72h of culture. Cells were cultured overnight in the presence or absence of 
SEA and their viability analysed by staining with Annexin-V and 7-AAD (F). Data 
representative of 2 (F) or 3 experiments (A-E), 5 animals per group (A) and 3-5 wells per 
group (B-F). *P<0.05, **P<0.01, ****P<0.0001.  









































































































































































Figure 4.19 Surface expression of IFNAR1 by BMDCs. 
BMDCs were cultured overnight in medium (M), with or without SEA or St, cells were 
then stained and their surface expression of IFNAR1 assessed by flow cytometry. The 
percentage of cells that were IFNAR1+ (A-B) and IFNAR1 gMFI were calculated (C-D). 
Data representative of 3 experiments *P<0.05, ***P<0.001, ****P<0.0001. In A. and B., 
significance value represents significant difference in proportion of IFNAR1+ cells 




















































































5.0 THE ROLE OF TYPE I IFN IN TH2 RESPONSES AGAINST HELMINTHS 
5.1 Introduction 
In the preceding chapters, BMDC studies identified an SEA-specific IFN-I signature, 
suggesting a role for IFN-I in Th2 settings. In agreement with this, we found that IFNAR-
deficient Flt3-L-dependent BMDCs were unable to prime SEA responses following 
adoptive transfer, however, there was no discernible defect in the function of IFNAR-
deficient FLDCs in vitro. Further, GM-CSF-dependent BMDCs did not share this 
requirement for IFNAR signalling for induction of SEA-specific Th2 responses. DC 
development in vivo is dependent on Flt3-L (McKenna et al., 2000), but GM-CSF also 
plays a role in cDC homeostasis in peripheral tissues (Greter et al., 2012; Kingston et al., 
2009). Thus it was difficult to predict whether cDC subsets in vivo would also depend on 
IFN-I for optimal Th2 induction.  
 
Given that IFN-I is primarily associated with the activation of Th1, particularly, anti-viral 
responses, it is intriguing to find that it may play a role in the induction of Th2 responses. 
So far, however, we have shown only that IFN-I and functional IFNAR are required for 
SEA-specific Th2 priming by FLDCs. We wanted to expand on this, by investigating the 
IFN-I signature of DCs challenged in vivo with SEA and the development of egg-specific 
responses in IFNAR-deficient mice. This will provide insights into the relevance of our 
findings from previous chapters but does not address whether IFN-I is involved in the 
development, or regulation, of immune responses during active infection.  
 
It is not yet known whether IFN-I is active during helminth infection, or what influence, if 
any, IFNAR signalling may have on the development of helminth-induced immune 
responses. Investigating the role of IFN-I and IFNAR during S. mansoni infection has 
implications for our understanding of the processes involved in Th2 induction in this murine 
model of helminth infection, which has been integral to our understanding of immune 
processes activated against such parasites that provoke a strong Th2 response, but also 
elicit severe immunopathology (MacDonald and Maizels, 2008; Perona-Wright et al., 
2006b; Phythian-Adams et al., 2010). Perhaps more importantly, such studies also inform 
our understanding of immune responses during S. mansoni infection in humans, an 
important cause of severe chronic disease in tropical regions (Pearce and MacDonald, 
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2002; Wynn et al., 2004). To this end, we have begun to examine the role of IFN-I in 
human DC responses to SEA, as well as investigating whether IFN-I production is 
detectable during human disease.  
 
Studies examining the role of IFN-I and IFNAR in immune responses during active 
infection with a range of mircroorganisms, including viruses, bacteria and protozoan 
parasites, have demonstrated that this cytokine family can enhance immune activation 
against pathogen attack, but can also have a negative impact on the outcome of infection. 
Ifnar1-/- mice were first characterised for their inability to control viral infection (Hwang et 
al., 1995; Muller et al., 1994). Since then, IFNAR has been shown to have many roles in 
antiviral defence, which go beyond the initial induction of intracellular responses. IFNAR 
signalling is integral to effective adaptive immune activation during viral infection, as 
functional CD8+ T cell responses are dependent on IFN-I (Aichele et al., 2006; Thompson 
et al., 2006; Wang et al., 2012). The requirement for IFN-I for optimal CD8+ T cell 
responses is not always cell-intrinsic, as cross-presentation and priming by CD8α+ cDCs 
also relies on DC IFN-I responsiveness (Le Bon et al., 2003; Pinto et al., 2011). However, 
studies of chronic viral infections in IFNAR-deficient mice have shown that IFN-I can also 
be detrimental to the host, preventing viral clearance in persistent infection, as a result of 
chronic IFNAR signalling which can limit CD4+ T cell function and IFNγ production (Teijaro 
et al., 2013; Wilson et al., 2013). 
 
The influence of IFNAR is not limited to antiviral immunity, however, as this pathway also 
influences immune responses against bacterial and parasite infection. Studies in IFNAR-
deficient mice indicate that IFN-I signalling can enhance host resistance to a range of 
bacteria, including Streptococci species and Escherichia coli (Mancuso et al., 2007). 
However, IFNAR can also act as a hindrance to effective immune activation against 
intracellular pathogens, inhibiting infiltration or function of innate effectors in Salmonella, 
Listeria and Trypanosoma infection (Brzoza-Lewis et al., 2012; Chessler et al., 2011; 
Robinson et al., 2012), and limiting Th1 responses in Leishmania infection (Xin et al., 
2010). IFN-I clearly impacts on immune mechanisms against microorganisms. However, 
the role it plays in helminth infections and other Th2 settings has yet to be investigated 
either in experimental models or in humans.  
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Although there is no published data on an IFN-I signature from human DCs exposed to 
helminth Ags, a number of publications have characterised the phenotype of blood DCs 
from schistosome-infected individuals. Myeloid DC and pDC numbers are reduced in the 
peripheral blood of S. haematobium-infected individuals in endemic areas (Everts et al., 
2010a; Nausch et al., 2012). DCs from infected people also express lower levels of HLA-
DR (MHC II) on their surface (Everts et al., 2010a), although CD86 and CCR7 expression 
levels are unchanged compared to cells from control (schistosome egg-negative) 
individuals (Everts et al., 2010a; Nausch et al., 2012). Myeloid DCs from infected subjects 
are less responsive to TLR ligands and display poor T cell activating capacity (Everts et 
al., 2010a), suggesting that DC function is impaired in human schistosomiasis. Like murine 
BMDCs, human monocyte-derived DCs (moDCs) cultured with SEA produce only very low 
levels of the inflammatory cytokines IL-6, IL-12p70 and TNFα (de Jong et al., 2002; van 
Riet et al., 2009). However, SEA-pulsed moDCs upregulate surface expression of OX40L 
and induce IL-4 production in T cell co-cultures, indicating that similarly to mouse DCs, 
human cells display only minor phenotypic changes in response to SEA but capably 
induce Th2 responses (de Jong et al., 2002).    
 
S. mansoni is widely used as an experimental model of human helminth infection for the 
study of Th2 development and ongoing type 2 inflammation (Allen and Maizels, 2011; 
Gause et al., 2013; Maizels et al., 2012b), however, we wanted to elucidate whether IFN-I 
and IFNAR had a similar impact on Th2 responses in other settings. For this reason, we 
have also examined the immune response of IFNAR-deficient animals during infection with 
H. polygyrus. H. polygyrus is an entirely enteric helminth and is used as a model of chronic 
human hookworm infection (Reynolds et al., 2012). Thus providing an alternative model 










5.2.1 Systemic SEA treatment induces gene expression changes in splenic cDCs 
We have found that cDCs generated in vitro using Flt3-L have an intermediate level of 
activation in response to SEA (Section 3.2.2, Fig. 3.2 and Fig. 3.4). Stimulation with SEA 
also induces an IFN-I signature from FL-cDCs (Section 3.2.3, Fig. 3.3 and Fig. 3.4), 
characterised by IFNα/β secretion and upregulation of a host of other ISGs (Section 4.2.5, 
Fig. 4.7). The cDC subsets generated by Flt3-L from murine BM have been shown to 
share the characteristics of splenic cDCs (Naik et al., 2005). Thus, we hypothesised that 
splenic cDCs would display a similar phenotype to FL-cDCs following exposure to SEA. To 
address this, and to examine the relevance of our in vitro findings to the in vivo setting, we 
injected mice intravenously with SEA and purified CD11c+ cells from the spleen 12h after 
treatment (Fig. 5.1A). Splenic cDCs were then FACS-sorted directly into Trizol aliquots, 
with purity above 95% (Fig. 5.1B-C). We decided to inject mice intravenously as this route 
of administration delivers Ag systemically, so SEA should reach the spleen relatively 
quickly. SEA rather than whole S. mansoni eggs were used in this model to make it as 
comparable as possible to the in vitro assay. It was difficult to hypothesise at what 
timepoint after SEA injection we might expect to see a change in surface phenotype or 
IFN-I production by DCs in the spleen, as we did not know the kinetics of Ag delivery to 
this site. For this reason we chose to focus on the gene expression profile of splenic cDCs, 
reasoning that any change in phenotype would be preceded by changes at the mRNA 
level.    
 
It should be noted that, due to the small numbers of DCs in the spleen and the nature of 
the purification steps used, spleens from 5 mice were pooled per group. For this reason, 
we concentrated our analysis on the phenotype of all cDCs, rather than on the individual 
cDC subsets present in the spleen. In gene expression analysis, each data point 
represents a replicate from 5-pooled spleens, not individual mice (each replicate being 
approximately 100,000 cells). Due to the small numbers of cells isolated in this 
experiment, surface phenotype was not assessed. 
 
We found that SEA treatment induced a significant upregulation of mRNA for CD40 and 
CD80 (Fig. 5.1D). The transcript for H2-Ab, a subunit of MHC II, was also upregulated 12h 
after SEA treatment (Fig. 5.1D). No signal for Ifnα1 or Ifnβ was detectable in mRNA from 
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splenic cDCs of PBS- or SEA-treated mice (not shown). We also did not detect any IFN-I 
in the serum of mice 12h after SEA injection, or in PBS-treated mice (not shown). 
However, transcripts for a number of ISGs were upregulated in splenic cDCs at this 
timepoint, including IFIT1, IFIT3 and MX1 (Fig. 5.1E). The upregulation of these genes 
suggests that splenic cDCs were activated by systemic SEA treatment and that an IFN-I 
signature is characteristic of both FL-cDCs and splenic cDCs. 
 
5.2.2 IL-10 and IFNγ production is curtailed in Ifnar1-/- mice but the Th2 response is 
unaffected following subcutaneous injection of S. mansoni eggs  
Having established that splenic cDCs respond to SEA treatment with a similar phenotype 
to cDCs generated in vitro with Flt3-L, we next wanted to address whether IFNAR is 
required for the induction of Th2 responses in vivo. A model of schistosome-specific Th2 
induction is subcutaneous injection of S. mansoni eggs into the hind feet of mice 
(Phythian-Adams et al., 2010). The resulting T cell response is analysed in the draining 
popliteal LN, and MLNs were taken as a distal LN control. To assess whether IFNAR plays 
a role in this response, S. mansoni eggs were injected into WT C57BL/6 or Ifnar1-/- mice 
and popliteal LNs were harvested 7d after egg injection (Fig. 5.2A). There was no defect in 
the induction of the Th2 response in Ifnar1-/- mice at this timepoint following egg injection 
as IL-4, IL-5 and IL-13 levels were comparable between WT and IFNAR-deficient animals 
(Fig. 5.2B). However, there was a significant reduction in IL-10 and IFNγ responses in the 
dLN of Ifnar1-/- mice (Fig. 5.2B).  
 
Whilst the Th2 cytokine response was comparable between groups, there was a significant 
reduction in cell infiltration into the dLN of Ifnar1-/- animals following egg injection (Fig. 
5.2C), suggesting a defect in immune activation. Analysis by flow cytometry revealed that 
the proportion of TCRβ+ cells in the dLN of IFNAR-deficient mice was significantly 
increased compared to WT (Fig. 5.2D); consequently, the percentage of CD4+ T cells was 
also elevated (Fig. 5.2D). However, the proportion of Foxp3+ CD25+ Tregs in Ifnar1-/- dLNs 
was not significantly altered (Fig. 5.2D). An increased percentage of CD4+ T cells in the 
dLN would mean that a greater number of these cells were present in culture wells during 
Ag restimulation, which could impact on the cytokine readout. For this reason, cytokine 
concentrations were adjusted to establish the amount secreted per 100,000 CD4+ T cells 
(Fig. 5.2E), providing a fairer comparison of cytokine production by WT and IFNAR-
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deficient mice. This analysis suggested that, as well as IL-10 and IFNγ, IL-13 production 
was also significantly reduced in Ifnar1-/- dLNs (Fig. 5.2E). These findings indicate that 
while IFNAR is required for optimal T cell responses following egg injection, it is not 
essential for Th2 induction in this model. 
 
5.2.3 IFN-I is elevated in the serum only at high doses of S. mansoni infection 
In order to assess whether IFN-I was elevated systemically during infection, we measured 
cytokine levels in the serum of animals on d56 after infection with different doses of S. 
mansoni cercariae (Fig. 5.3A). No IFNβ was detected in the serum of any mice in this 
experiment and IFNα3 levels were not significantly increased at any dose of infection (Fig. 
5.3B). 2 out of 4 animals infected with 160 cercariae did have elevated systemic levels of 
IFNα3 compared to naïve mice. However, the other mice in the 160 cercariae group did 
not share this phenotype, thus there was no statistically significant change in IFNα levels 
at this dose. The wide spread of the data in the 160 cercariae group demonstrates that 
more repeats are needed, and a larger sample size would enhance the statistical power of 
this analysis, this is the case for all cytokines analysed at this dose. Of the Th2-associated 
cytokines, IL-4 levels were significantly elevated at 40, 80 and 160 cercariae dose (Fig. 
5.3B). IL-13 was also above background levels in mice infected with 40 and 80 cercariae, 
but not at the 160 dose. However, IL-5 and IL-10 levels were not altered compared to 
naïve controls. The inflammatory cytokines also failed to show a consistent pattern, with 
no change in systemic IL-6 at any dose of infection, IL-12/23 p40 was elevated only at 80 
cercariae dose. IFNγ and IL-17 levels were above naïve at 20 and 80 cercariae dose, 
however these cytokines were more variable at the other doses of infection and so were 
not significantly elevated.  
 
These data were suggestive of elevated IFN-I at high doses of S. mansoni infection. 
However, we had not sampled enough animals to assess IFN-I reliably in this experiment, 
given the clear variability in the serum cytokine data within the 160 cercariae group. For 
this reason, we analysed the serum cytokine levels of a larger cohort of animals with high 
intensity infection (180 cercariae – Fig. 5.4A). These mice were killed on d49 because, at 
higher doses, animals can start to lose weight and may die before reaching d56 of 
infection. IFNα3 levels were elevated in the serum of 75% of infected mice, and the 
increase compared to naïve animals was highly significant (p=0.0001, Fig. 5.4B). Systemic 
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levels of IL-5 (p<0.0001) and IL-12p40 (p<0.0001) were also similarly increased in the 
serum of infected mice (Fig. 5.4B). IL-10, IL-17 and IFNβ levels were also significantly 
higher than in naïve serum, although these cytokines were at baseline in the majority of 
infected animals (Fig. 5.4B). IFNγ, TNFα, IL-4, IL-6 and IL-12p70 were not significantly 
elevated in the serum of mice on d49 following infection with 180 S. mansoni cercariae. 
Systemic IFNα levels from infected mice were compared with the IL-5 and IL-10 levels in 
the same samples; however, there was no correlation between an increase/ decrease in 
Th2 or regulatory cytokines and an increase in systemic IFNα (Fig. 5.4C). 
 
5.2.4 The role of IFNAR in the immune response against helminth infection 
We found that systemic IFNα/β levels were only significantly elevated at very high doses of 
S. mansoni infection. However, IFN-I production is often difficult to detect because IFN-Is 
are often secreted at relatively low-levels, or for a short period of time, and are taken up by 
a variety of cell types promptly following secretion. Our work with Flt3-L-dependent 
BMDCs suggests that IFNAR expression may be required for efficient priming of Th2 
responses (Chapter 4, Fig. 4.6). In S. mansoni infection, a dominant Th2 response is 
induced in response to egg deposition, which begins at around d28 of infection (Pearce 
and MacDonald, 2002). The Th2 response is detectable in infected tissues and draining 
LNs, including the liver and MLNs, from around d42 of infection (Grzych et al., 1991; 
Pearce et al., 1991). One of the most affected tissues is the liver because the majority of 
parasite eggs are swept into the hepatic blood system (Wynn et al., 2004). With IFN-I 
transcripts upregulated in the liver at d42 of infection with 40 cercariae (Fig. 5.5B, PCR 
performed by Rachel Lundie), this may suggest a role for IFNAR in the priming of T cell 
responses at this stage of schistosome infection. To address this, WT or Ifnar1-/- mice 
were infected with 40 S. mansoni cercariae and sacrificed on d42 of infection. This 
infection dose was chosen to ensure that this experiment was comparable to the 
timecourse infection study described above. Mouse weights were recorded from d35 of 
infection. The weights of both WT and Ifnar1-/- animals on d37 were reduced compared to 
d35 levels, with IFNAR-deficient mice losing slightly more weight. However, by d40 the 
weight change of all animals was comparable (Fig. 5.6B). Animal weights were assessed 
only for a short period during infection, thus a more extensive assessment of weight 




Before harvesting tissues, mice were perfused by injecting PBS into the heart, to expunge 
all blood from the organs. This process also flushes out most of the schistosome worms 
resident in the blood system. The perfusate was collected from infected animals and the 
number of adult worms was assessed. Ifnar1-/- animals had significantly fewer female 
worms than WT mice (Fig. 5.6C). However, although 3 of the IFNAR-deficient mice had no 
female worms in the perfusate (Fig. 5.6C), they were patently infected because 
schistosome eggs were detectable in all liver samples, and all but one gut sample (Fig. 
5.6D). This illustrates that manual perfusion is not successful at recovering all worms. 
Although there was a slight reduction in liver and gut egg counts in Ifnar1-/- mice, this did 
not reach statistical significance (Fig. 5.6D). This preliminary data will be bolstered by 
further repeats involving more animals, in order to ascertain if there is any consistent 
change in worm (and egg burden) or whether this result is merely a reflection of the 
inaccuracy inherent in the perfusion technique. 
 
Hepatomegaly and splenomegaly provide a general measure of pathology during 
schistosome infection. Both WT and IFNAR-deficient animals had significant 
hepatomegaly and splenomegaly, and there was no significant difference between infected 
groups (Fig. 5.6E). Thus, overall the data suggests no major difference in parasitaemia or 
pathology in infected IFNAR-deficient animals.  
 
Cells were purified from the liver and MLN of all mice and cultured with SEA in order to 
assess the recall response to egg Ags. In the liver, only SEA-specific IL-10 was 
significantly reduced in IFNAR-deficient mice; levels of IL-4, IL-5, IL-13 and IFNγ were 
equivalent between WT and Ifnar1-/- animals (Fig. 5.7B). Both IL-4 and IL-13 levels were 
significantly reduced in the MLN (Fig. 5.7C), whilst IL-10 and IL-5 were not significantly 
altered in the MLNs of infected Ifnar1-/- mice (Fig. 5.7C). Similarly to the liver, there was no 
change in IFNγ levels in the MLN of IFNAR-deficient animals (Fig. 5.7C). No IL-17 was 
detected from liver or MLN cells.  
 
Liver and MLN cell counts were comparable in both infected groups (Fig. 5.8A). However, 
MLNs were significantly smaller in naïve Ifnar1-/- animals (Fig. 5.8A). The percentage of 
CD4+ T cells present in each sample was calculated as the proportion of all live intact-
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singlets that were TCRβ+ CD4+ (using event counts from FACS data). To quantify the total 
number of CD4+ T cells in the liver or MLNs, the number of viable leukocytes was 
multiplied by the percentage of T cells as determined by flow cytometry. This analysis 
demonstrated that there was no significant alteration in the proportion, or actual number, of 
CD4+ T cells present in the liver or MLN of S. mansoni infected IFNAR-deficient animals 
(Fig. 5.8B-C). Further analysis of cell populations in these tissues indicated no significant 
differences in the proportions or total numbers of B cells (CD19+ B220+) or Treg (TCRβ+ 
CD4+ Foxp3+ CD25+) populations between infected groups (Fig. 5.8B-C). There may be a 
reduction in lymphocyte populations in the livers of naïve IFNAR-deficient mice. However, 
this needs to be assessed with a larger number of animals to allow for statistical analysis 
(Fig. 5.8B-C). Together, these data indicate that IFNAR was required for optimal Th2 
responses in the MLN on d42 of S. mansoni infection. In the liver, only IL-10 induction 
appeared to require IFNAR. 
 
Up to this point, all of our experiments had focused on the role of IFNAR in the induction of 
immune responses to schistosomes. To assess whether IFN-I signalling has an important 
function in other helminth settings, we infected WT or Ifnar1-/- mice with the murine 
gastrointestinal nematode parasite H. polygyrus. Infected groups had comparable egg 
counts on d14 and d21 of infection; however, d28 egg counts were significantly higher in 
the faeces of IFNAR-deficient mice (Fig. 5.9B). There was no significant difference in 
worm burden between infected groups on d28 (Fig. 5.9C). An increase in egg burden is a 
phenotype associated with a deficiency in the Th2 response to H. polygyrus (Maizels et al., 
2012a). Therefore, it was not unexpected to find that production of Th2 cytokines was 
reduced in the MLN of Ifnar1-/- mice on d7 of infection (Fig. 5.9D). IL-4 and IL-5 were 
significantly reduced, whereas IL-13 production was unaffected (Fig. 5.9D). Although the 
Th17 response was comparable between infected groups, Th1 induction was impaired in 
IFNAR-deficient animals, with a significant reduction in IFNγ levels in this group (Fig. 
5.9D). There was no significant difference in IL-10 between infected groups (Fig. 5.9D). In 
combination with the preliminary data from S. mansoni infection, it seems reasonable to 
conclude that IFNAR signalling is required for optimal induction of adaptive immune 
responses in helminth infection, particularly in the MLN, with some facets of the Th2 
response being more dramatically affected than others in the global absence of IFNAR.  
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5.2.5 Investigating the role of IFN-I in human responses to S. mansoni 
Having found that SEA treatment induces an IFN-I signature from murine Flt3-L-dependent 
cDCs in the spleen (Fig. 5.1E), as well as in vitro-generated FL-cDCs (Fig. 3.3B), we 
wanted to address whether any hallmarks of this response were detectable from human 
DCs following exposure to SEA. Bart Everts (University of Washington, USA) performed 
the purification and stimulation of human DCs for us. The DC subsets present in human 
blood – pDCs, CD1c+ cDCs (comparable to murine CD11b+ cDCs (Robbins et al., 2008)) 
and CD141+ cDCs (equivalent to CD24+ FLDCs/ splenic CD8α+ cDCs in mice (Jongbloed 
et al., 2010)), were purified from samples supplied by donors from a non-endemic area 
(U.S.A) and cultured overnight with SEA or TLR ligands (Fig. 5.10A). pDCs were 
stimulated with CpG, which is recognised by TLR9, as human pDCs express very high 
levels of this receptor and produce large quantities of IFN-I in response to exposure to this 
ligand (Hemont et al., 2013). As a positive control, CD1c+ DCs were stimulated with R848, 
a synthetic TLR7/8 ligand, having previously been reported to express TLR7/8 and to 
secrete IFNα following exposure to this Ag (Meixlsperger et al., 2013; Piccioli et al., 2007). 
CD141+ DCs express high levels of TLR3 and produce IFN-I in response to pI:C, a TLR3 
ligand (Jongbloed et al., 2010; Poulin et al., 2010), hence, this Ag was used as a positive 
control for this subset. Mo-DCs were also generated from monocytes isolated from these 
samples and stimulated with SEA or CpG. Mo-DCs have previously been shown to 
express TLR9 and produce IFNα in response to CpG (Hoene et al., 2006).  
 
Supernatants were shipped to us and we assessed the cytokines produced by these cells 
after overnight culture in the presence or absence of Ag. IFNβ production was not 
assessed, as the reagents for IFNβ quantification are prohibitively expensive. However, 
the assay used to measure IFNα detects all 12 human IFNα subtypes. No IFNα was 
detectable in the supernatants of any of the DC subsets cultured with SEA, either with 
cells directly purified from the blood, or from human mo-DCs generated from the same 
donor (Fig. 5.10B). IFNα was detected only in supernatants from pDCs responding to CpG 
(Fig. 5.10B). Human mo-DCs did not produce detectable levels of any other innate 




We did not detect any IFNα production from CD141+ DCs in response to pI:C, despite 
published reports of IFN-I production from this subset following pI:C exposure (Hemont et 
al., 2013; Jongbloed et al., 2010; Meixlsperger et al., 2013). However, it is in line with the 
findings of Jongbloed et al. (2010), who detected IFNβ secretion in response to pI:C, but 
not IFNα. No R848-induced IFNα was detected from CD1c+ DCs, however, this TLR7/8 
ligand stimulated high-level production of TNFα, IL-1β, IL-6, IL-10 and IL-12p70, as 
previously reported (Hemont et al., 2013) (Fig. 5.10B). IFNα secretion was also not 
detected from CpG-stimulated mo-DCs despite previous reports of IFN-I production by 
human mo-DCs in response to this ligand (Hoene et al., 2006) Fig. 5.10B).     
 
To our knowledge, information on the levels of IFN-I in S. mansoni-infected individuals has 
not been published. For this reason we analysed the serum IFNα levels of a sample of 
people who were part of a cohort from an endemic area in Kenya (samples from David 
Dunne, University of Cambridge). We had found that in a mouse model of S. mansoni 
infection, serum IFNα was elevated only at high doses of infection (Fig. 5.3). Thus, IFNα 
levels in the serum of individuals who had medium or high egg burden by faecal counts 
were compared to the serum levels of egg-negative individuals (Fig. 5.11A). There was no 
correlation between faecal egg counts and the amount of IFNα detected in the serum (Fig. 
5.11A). It is known that resistance to S. mansoni infection increases with age (Pinot de 
Moira et al., 2010) and the median age of egg-negative individuals was higher than those 
with high faecal egg counts. However, there was no correlation between IFNα levels in the 














• Splenic cDCs upregulated ISGs at the messenger RNA level in response to 
systemic SEA treatment (Fig. 5.1E) 
• Regulatory and Th1 cytokine production was reduced in the dLN of Ifnar1-/- mice 
following schistosome egg injection, whilst facets of the Th2 response were also 
downregulated (Fig. 5.2B & E). 
• In a mouse model of S. mansoni infection, IFN-I could be detected in the serum at 
high levels of infection intensity (Fig. 5.4B) 
• IFNAR-deficient mice display reduced Th2 cytokine responses in the MLN during 
S. mansoni (Fig. 5.7B) and H. polygyrus (Fig. 5.9D) infection 
• IFNα was not detectable in the supernatants of human mo-DCs or purified blood-
borne DCs following SEA stimulation (Fig. 5.10B) 
• Serum levels of IFNα were not significantly altered in S. mansoni infected 





Work presented in chapter 4 illustrates that expression of IFNAR is necessary for SEA-
specific Th2 induction by Flt3-L dependent BMDCs but is dispensable for, and may even 
inhibit, optimal Th2 induction by BMDCs generated using GM-CSF (Fig. 4.8A and Fig. 
4.8E). Although Flt3-L is an essential growth factor for DC differentiation in vivo (McKenna 
et al., 2000), and FLDCs represent DC subsets found in lymphoid tissues in the steady 
state (Naik et al., 2007), GM-CSF is also required to maintain DC populations in peripheral 
tissues (Greter et al., 2012; Zhan et al., 2012). Thus, we wanted to address whether IFN-I 
signalling would be required for schistosome-specific Th2 induction by DCs in vivo. It was 
essential to examine whether our findings using BMDCs had relevance to immune 
activation in vivo, as DCs will encounter Ag in a more complex microenvironment, 
including exposure to bystander Ags and other cell types, which may influence Th2 
development. In our adoptive transfer model, in vitro generated DCs are exposed to SEA 
prior to injection, thus their responses will be less influenced by the microenvironment. In 
vivo DCs are exposed to tissue-factors, for example TSLP, TGFβ or IL-10, produced by 
cells such as epithelial cells and Tregs, which may impact on their phenotype and function. 
This is particularly the case during patent helminth infection, where the immune system is 
exposed for prolonged periods to large quantities of Ag, from multiple lifecycle stages, 
often in the context of tissue damage caused by the parasite. Thus it was worthwhile to 
assess DC phenotype and the development of Th2 responses in the context of in vivo Ag 
challenge models, but also during patent helminth infection. Moreover, to date, there have 
been no studies examining the existence of an IFN-I signature in Th2 settings, or any work 
addressing whether IFN-I impacts on the development of Th2 responses during helminth 
infection.  
 
We began by characterising the gene expression profile of murine splenic cDCs following 
i.v. SEA injection, which demonstrated that, like FL-cDCs, these cells displayed an IFN-I 
signature in response to SEA. Although global expression of IFNAR was not required for 
SEA-specific Th2 induction in the dLN following subcutaneous challenge with S. mansoni 
eggs, we have demonstrated that optimal Th responses during murine models of helminth 
infection may depend on IFN-I signalling. We are also investigating whether there is a role 
for IFN-I in human disease. However, we have so far failed to identify an increase in 
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systemic IFN-I in S. mansoni infected individuals or IFN-I secretion by PBMC-derived 
human DCs in response to SEA.  
 
5.3.1 SEA-specific IFN-I from mouse splenic DCs, but not human blood-derived DCs 
Systemic SEA treatment allowed us to assess whether our findings from FL-cDCs 
responding in vitro were applicable to splenic cDCs responding in vivo. We chose to focus 
on the spleen because previous studies have described the similarities of splenic cDCs to 
Flt3-L generated BMDCs (Brawand et al., 2002; Naik et al., 2005). However, the primary 
effector sites for S. mansoni infection are the liver and intestines (Wynn et al., 2004), so a 
model to study the responses of DCs in the liver and liver-draining LNs and intestines and 
MLN to SEA/eggs would also be of real interest. Although we detected IFN-I production 
from FLDCs (Chapter 3, Fig. 3.3B), i.v. injection of mice with SEA did not induce elevated 
IFN-I levels in the serum (data not shown as no detectable IFN-I in any serum samples). 
There was also no detectable transcript for IFNα1 or IFNβ from splenic cDCs 12h after 
SEA injection (data not shown as no IFN-I transcripts were detected in any samples). It is 
possible that upregulation of IFN-I transcripts may occur earlier than the 12h timepoint 
analysed here. Further, we have yet to measure transcript levels for all the IFN-I subtypes, 
so it is also possible that other IFN-Is are upregulated at this timepoint. Nevertheless, a 
range of ISGs was significantly upregulated in splenic cDCs from SEA-injected mice (Fig. 
5.1E), indicating the activation of an IFN-I signature. Changes in the expression levels of 
H2-Ab, CD40 and CD80 mRNA also suggested that SEA may stimulate an activated 
surface phenotype in splenic cDCs (Fig. 5.1D), and future experiments will assess this 
comprehensively, using flow cytometry to assess surface phenotype. Together, these data 
suggest that splenic cDC responses to schistosome egg Ags in vivo are similar to those of 
FL-cDCs in vitro, resulting in upregulation of surface molecules associated with phenotypic 
activation, as well as IFN-I signalling. 
 
The splenic DC data presented here (Fig. 5.1D) is representative of two experiments 
performed in our clean animal unit. Several subsequent experiments were carried out to 
address whether the splenic cDC responses are dependent on IFNAR signalling, 
comparing gene expression profiles in cDCs from WT and Ifnar1-/- animals. However, 
these experiments were carried out in our quarantine facility, which has a lower health 
status, and PBS-treated animals had higher basal expression levels of the genes analysed 
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than those seen in our clean facility; consequently no SEA-specific phenotype was 
discernable in either WT or Ifnar1-/- mice (data not shown). For this reason we cannot 
definitively state that IFNAR is required for the response of splenic cDCs to SEA in vivo, 
and further experiments must be performed to confirm that the WT phenotype is robust. In 
future experiments, the gene expression profile of splenic DCs following systemic S. 
typhimurium treatment should also be assessed as a Th1 control. This will provide an 
interesting comparison of ISG induction in splenic DCs in response to a Th1 or Th2 
stimulus.  
 
Our DC purification technique requires 5 pooled spleens, which generates around 0.5-1 
million cDCs that were sorted directly into Trizol aliquots. These aliquots were kept 
separate for gene analysis rather than being pooled, providing technical replicates from 5 
pooled spleens. These internal replicates indicate that the gene expression data is reliable. 
However, for more rigorous statistical analysis of such data, multiple repeats must be 
performed. The statistical power of independent experiments could also be improved by 
using multiple 5-pooled replicates per condition. We have chosen to sort all cDCs together 
rather than split the cDC subsets. This was done because the CD8α+ subset in the spleen 
is quite a small proportion of the total cDCs (Shortman and Heath, 2010), and cell 
numbers were already limiting. However, it is possible that there are gene expression 
differences between the cDC subsets that could be investigated by scaling up the 
enrichment and sorting procedure.     
 
As well as characterising the responses of mouse splenic DCs to SEA, we wanted to 
investigate whether human DCs displayed any of the hallmarks of the IFN-I signature 
identified in mice following exposure to SEA. In these initial experiments, IFNα was not 
detectable in any of the supernatants from human DC subsets cultured with SEA (Fig. 
5.10B). Of the Flt3-L-generated murine subsets, we have found that the CD8α+ cDC-
equivalent is uniquely able to produce IFN-I following overnight culture with SEA. Hence, 
we may have expected to detect IFN-I production from CD141+ DCs, the human DC 
subset that has been shown to most closely resemble murine CD8α+ cDCs (Jongbloed et 
al., 2010; Poulin et al., 2010). This subset, unlike CD1c+ cells, expresses TLR3, and 
secretes IFNβ in response to the TLR3 ligand polyI:C (Hemont et al., 2013; Jongbloed et 
al., 2010). Jongbloed et al. (2010) did not detect IFNα mRNA from CD141+ DCs in 
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response to TLR ligands. However, a recent study of DC subsets in humanised mice 
demonstrated IFNα production from CD141+ DCs following exposure to dsRNA 
(Meixlsperger et al., 2013). Thus, this human DC subset, like its murine equivalent, can 
secrete IFN-I in response to nucleic acid ligands. More analysis is required to establish 
whether human DC subsets from the blood secrete IFNβ, or whether IFN-I mRNA levels 
are altered, following exposure to SEA. 
 
Similarly to murine DCs, human DCs express IFNAR on their surface (Severa et al., 2006), 
and so are able to take up, and are responsive to, IFN-I (Hillyer et al., 2012). Human 
myeloid DCs, and CD141+ DCs specifically, have been shown to upregulate ISG 
expression in response to TLR ligands, as well as in response to viral infection (Hillyer et 
al., 2012; Schulte et al., 2013). Although no secreted IFNα was detectable from human 
DCs following SEA exposure, it is possible that an ISG expression profile is activated in 
response to SEA, a possibility that we are actively pursuing. In support of this, the ISGs 
IFIT2 and IFIT3 have been identified as two genes upregulated by human DCs in 
response to omega-1 (Bart Everts, personal communication), a strongly Th2-polarising 
component of SEA (Everts et al., 2009; Steinfelder et al., 2009). We would like to compare 
and contrast the ISG expression profiles of murine and human DCs following omega-1 and 
SEA stimulation, to assess the similarities and differences of DC responses to these Ags. 
Thus, there is still much work to be done to fully characterise the IFN-I signature of human 
DCs in response to schistosome egg Ags. 
 
5.3.2 Serum IFN-I in mouse and human S. mansoni infection 
Serum IFN-I levels, particularly IFNα3, were elevated in mice after high dose infection with 
S. mansoni, but not at lower doses (Fig. 5.3-4). Although IL-5 and IL-10 were also 
upregulated in the serum of the majority of infected animals at a 180 cercariae dose (Fig. 
5.4B), there was no correlation between serum IFNα and the levels of these cytokines 
(Fig. 5.4C). This suggests that an increase in systemic IFNα is not associated with a 
significant increase or decrease in the Th2 or regulatory response.  
 
All animals in the 180 cercariae group were heavily infected, demonstrated by severe 
visible liver pathology. However, egg and worm counts from these animals were not 
performed so we do not yet know whether higher IFN-I production is associated with 
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greater infection load. Systemic IFN-I was elevated in 180 cercariae infected mice on d49 
of infection, however we have yet to examine whether IFN-I levels are significantly above 
background at other timepoints. Similarly, IFNα/β levels were not above naïve levels on 
d56 at doses of 20-160 cercariae (Fig. 5.3B). However, this does not rule out the 
possibility that IFN-I is upregulated at other stages of infection at lower doses. 
Furthermore, the dose experiments included only 4 mice per dose, due to the variability of 
systemic cytokine levels this is not enough animals to provide conclusive data. For this 
reason, it would be informative to determine serum cytokine levels over the course of 
infection, at different doses. This is a particularly pertinent question as we know that 
IFNα/β gene expression is upregulated in the liver at specific timepoints of infection: on 
d42 and d105 following infection with 40 S. mansoni cercariae (Fig. 5.5B), thus we may 
expect to see systemic levels of IFN-I elevated at these timepoints. For this reason, more 
comprehensive analysis of serum cytokines, with a larger sample size, is required at these 
timepoints and this dose (40 cercariae) to establish whether systemic IFN-I is also 
upregulated. However, it is conceivable that systemic IFN-I will not be elevated at these 
timepoints, despite an increase of IFN-I gene expression, because IFN-I may well be taken 
up by IFNAR-expressing cells in the tissue site. 
  
The gene expression data in the liver suggests that IFN-I may play a role in immune 
priming, as well as much later during infection on d105 (Fig. 5.5B). We do not yet know the 
role of IFN-I at this later timepoint. From d84 onwards the granulomatous response is 
downregulated in the liver (Wilson et al., 2007), thus it could be speculated that IFN-I is 
also involved in immune modulation. This could be addressed directly by using a blocking 
antibody against IFNAR to inhibit IFN-I signalling at this stage (see Section 5.3.4, below). 
We have also assessed the phenotype of IFNAR-deficient mice on d42 of infection (Fig. 
5.6-Fig. 5.8) and have serum samples from these animals so systemic IFN-I levels should 
be examined in these mice to address the role of IFNAR in this response. We would 
expect that in the absence of IFNAR, systemic IFN-I would be much reduced. 
 
In these studies, we have not yet addressed the question of what the cellular source(s) of 
IFN-I is in this setting, or why IFNα/β is only detectable in the serum at higher doses of 
infection. It is unlikely that a high level of IFN-I systemically can be attributed to DC IFN-I 
production alone. With a 180 cercariae dose of infection, the egg burden is large, leading 
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to tissue damage and pathology, primarily in the liver and intestine (Wynn et al., 2004). 
Tissue damage is likely to release large quantities of nucleic acids from damaged cells, 
providing ligands for TLRs that initiate IFN-I production. Moreover, it has been shown that 
DNA damage can induce IFNα production from fibroblasts (Brzostek-Racine et al., 2011), 
a similar response may be seen from epithelial cells or other cells that are damaged by 
egg transit. Severe damage to the intestine could also cause a breach of the mucosal 
barrier, allowing dissemination of bacteria, another source of IFN-activating TLR ligands, 
such as nucleic acid or LPS. However, if this was the case we would expect to see other 
cytokines associated with sepsis upregulated in the serum – there was no significant 
increase in IL-6, IL-12p70 or TNFα in these animals (Fig. 5.4B). All of these factors could 
potentially contribute to increased IFN-I levels in the bloodstream.  
 
Although IFN-I was elevated in the serum of heavily infected mice, we did not see a similar 
upregulation in systemic IFNα in humans infected with S. mansoni, even in individuals with 
high faecal egg counts (Fig. 5.11). This is perhaps not surprising, as it has been reported 
that people with chronic schistosome infection exhibit downmodulation of immune 
mechanisms (Grogan et al., 1998; Ottesen et al., 1978; Viana et al., 1994). For example, a 
study of a cohort from a schistosome-endemic area of Zimbabwe indicated that IL-4, IL-10 
and IL-13 levels in the serum were lower in S. haematobium egg-positive individuals when 
compared to egg-negative subjects (Milner et al., 2010). Individuals with patent S. 
haematobium infection had higher serum IL-2 and IFNγ levels than those classed egg-
negative. Our data from a small sample of individuals from Kenya suggests that circulating 
IFNα levels have no correlation with infection status (Fig. 5.11). Although we have not 
measured the levels of other cytokines in the serum samples, members of Prof. David 
Dunne’s lab have done this analysis. We plan to examine whether there is any correlation 
between IFNα levels and the systemic levels of other cytokines in these samples in due 
course. Ideally we would have measured these other cytokines ourselves to rule out any 
variability in the assay process, however the cost of the required reagents was prohibitive. 
 
Systemic IFNα levels were very low in all samples analysed (<5pg/ml), this introduces 
inherent variability to the dataset as levels are very close to the limit of detection. Further 
to this, while our IFNα readings are low, they are actually comparable to the median 
systemic IFNα levels recorded in individuals infected with hepatitis B (HBV) or C (HCV) at 
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the peak of viremia, which were 5.5pg/ml and 7.2 pg/ml respectively (Stacey et al., 2009). 
This is compared to a median baseline (level prior to infection) of 3.1pg/ml in HBV infected 
individuals and 4.7pg/ml in HCV patients (Stacey et al., 2009). Only 40-50% of individuals 
actually displayed elevation in systemic IFNα during hepatitis infection. This is despite the 
fact that IFN-I is believed to be essential for host survival in a mouse model of hepatitis 
(Cervantes-Barragan et al., 2007). Thus, it is not surprising that we saw no significant 
change in systemic IFNα levels in S. mansoni infected individuals.    
 
We have PBMC RNA samples from the same individuals whose serum was tested, so we 
can next assess ISG expression in human S. mansoni infection. This analysis will 
encompass all cell populations present in the blood and will not solely measure the IFN-I 
signature from DCs. However, it will provide insights into the level of IFN-I activation in the 
cells of infected individuals, and a starting point for subsequent studies on sorted specific 
cell types. 
 
5.3.3 The role of IFNAR in the T cell response to schistosome egg injection 
The data from our sole egg injection experiment in Ifnar1-/- mice are difficult to interpret at 
this stage without repeat experiments to compare to. On the face of it, only the Th1 and 
regulatory aspects of the T cell response were impaired in egg injected IFNAR-deficient 
animals (Fig. 5.2B). However, the increase in CD4+ T cell numbers in the dLNs of Ifnar1-/- 
mice most likely influenced cytokine output. Although Ifnar1-/- mice do not have any severe 
developmental abnormalities (Hwang et al., 1995), this does not rule out alterations to 
immune cell populations. When cytokine production was determined, taking into account 
the differences in proportions of CD4+ T cells, along with a reduction in IL-10 and IFNγ 
production, IL-13 levels were also reduced. A more reliable measure of T cell output is 
required to overcome the difference in T cell numbers. One such method would be to 
FACS sort CD4+ T cells from the dLN, and restimulate these cells with Ag in the presence 
of irradiated APCs. ICC of dLN T cells would also provide valuable information about the 
proportion of cytokine-producing cells in the pLN of WT and Ifnar1-/- mice. Members of the 
laboratory are currently in the process of optimising ICC protocols to assess SEA-specific 
cytokine production, however, the percentage of cytokine+ cells in these assays is much 
lower than can be achieved with a polyclonal stimulus like PMA/Ionomycin. However, we 
are also now using αCD28/αCD3 as an effective, more physiologically relevant polyclonal 
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stimulus for ICC. An additional way to assess T cell cytokine output in this setting would be 
to cross our IFNAR-deficient animals with the KN2 and IL-13-eGFP reporter lines, which 
would provide information on the levels of IL-4 secretion and IL-13 mRNA expression 
respectively. 
  
Egg injection into global IFNAR-deficient mice does not directly address the role of DC-
specific expression of IFNAR in the induction of the Th2 response against eggs. IFNAR is 
expressed on lymphocytes as well as myeloid cells (Diamond et al., 2011), so any 
alteration in the response cannot be directly attributed to an alteration in DC function. To 
address the importance of IFNAR expression of DCs it is necessary to analyse the T cell 
response following egg injection into CD11c-cre x IFNAR-flox mice. Chris Engwerda 
(QIMR, Brisbane, Australia) has these mice and members of his lab are in the process of 
performing these experiments for us. In our FLDC transfer experiments the SEA-specific 
Th2 response is absent on d7 following transfer of IFNAR-deficient cells (Fig. 4.6). Our 
hypothesis is that this inability to prime by transferred IFNAR-deficient FLDCs is due to 
defective DC migration. If DC migration is affected in global Ifnar1-/- mice, in the egg 
injection model there may well be a defect in Th2 priming at early timepoints after 
challenge – due to delayed migration – which is rescued by d7. Thus, we would like to 
compare the kinetics of the developing immune response following egg injection in WT 
and IFNAR-deficient animals by assessing Ag-specific cytokine production at earlier 
timepoints after injection.    
 
If our findings with FL-cDCs and GMDCs are applicable in vivo, different DC subsets may 
have a differential requirement for IFNAR. There are a number of different DC subsets that 
are mobilised from the skin following Ag challenge (Henri et al., 2010). It is likely that 
dermal DCs depend on Flt3-L for their differentiation (Kingston et al., 2009). However, 
whether or not GM-CSF is also involved in this process, or is required for dermal DC 
homeostasis, remains a contentious issue (Edelson et al., 2011; Ginhoux et al., 2009; 
Greter et al., 2012; King et al., 2010). This means that subcutaneous egg injection is a 
complex model for identifying the role of DC IFNAR expression in Th2 induction. We do 
not yet know which DC subsets are key to the induction of Th2 induction against S. 
mansoni eggs into the hind feet, however, depletion of all CD11c+ cells ablates the Th2 
response following subcutaneous egg injection (Phythian-Adams et al., 2010).  
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Preliminary data from subcutaneous egg injection in Batf3-/- mice (no CD8α+ cDCs (Hildner 
et al., 2008)) suggests that CD8α+ cDCs are not required for the induction of the egg-
specific Th2 response (Alex Phythian-Adams, Angela Marley). Use of zDC-DTR (DTx 
depletion of all cDCs expressing Zbtb46 (Meredith et al., 2012)) and pDC-DTR (DTR 
expression under the control of BDCA2 (Swiecki et al., 2010)) mice will enable us to 
directly assess the requirement for cDCs and pDCs in egg-specific Th2 induction following 
subcutaneous egg injection. Th2 induction during patent S. mansoni infection will also be 
assessed in these depletion models. Although we anticipate that findings from the egg 
injection model will be similar to active infection, there may well be tissue-specific 
requirements for certain DC subsets. For example, pDCs are found in high numbers in the 
liver in the steady state (~10% of all haematopoietic cells (Merad and Manz, 2009)) and 
we know that IFNα mRNA levels are selectively upregulated in the liver at d42 and d105 of 
S. mansoni infection (Fig. 5.5B), suggesting that pDCs may play a role in the induction and 
regulation of the immune response at this site. 
 
In the spleen, it is known that DCs depend on Flt3-L for their development, and do not 
require GM-CSF for homeostasis (Kingston et al., 2009; Waskow et al., 2008). As we have 
identified a similar SEA activation phenotype in FLDCs and splenic cDCs (Fig. 5.1D), it 
would make sense to build on this initial work and use a systemic route of egg challenge to 
examine the generation of Ag-specific T cell responses in the spleen of CD11c-Cre+/-
Ifnar1f/f mice, as well as in the pLN following subcutaneous administration of S. mansoni 
eggs. Comparing Th2 induction in these different tissues will further address whether there 
is a differential requirement for IFNAR expression by DCs resident in lymphoid organs 
versus peripheral tissues. As previously discussed, the tissues most affected by S. 
mansoni infection include the liver and intestine (Wynn et al., 2004), thus the induction of 
egg-specific responses in these organs and their dLN should also be assessed in IFNAR-
deficient animals. However, during both human and murine S. mansoni infection, there are 
detectable levels of circulating egg Ags in the blood. Thus, the spleen would be 
continuously exposed to high levels of Ag, if not directly affected by egg traffic, meaning 





5.3.4 Helminth infection in IFNAR-deficient mice 
A significant reduction in the number of female worms detected in the perfusate of S. 
mansoni infected Ifnar1-/- mice may suggest that development of patent infection is 
inhibited in these animals (Fig. 5.6C). However, the experiment must be repeated to verify 
this finding, particularly in light of the fact that animals lacking detectable worm pairs did 
have parasite eggs in the liver and intestine, illustrating the technical variability and 
limitations of manual perfusion. If the animals in the IFNAR-deficient group that had no 
detectable female worms are excluded, there is no significant difference in the total worm 
pairs between groups. For this reason, it is necessary to assess parasitology in follow-up 
experiments before any conclusions can be made about worm development in IFNAR-
deficient mice.   
 
A number of studies have examined the requirement for immune mediators for optimal 
worm development in the infected host. It is impossible to grow schistosomes in tissue 
culture, which is highly suggestive that these parasitic worms require cues from the host to 
develop (Pearce and MacDonald, 2002). Attempts to infect mice that have immune system 
defects, such as immunosuppressed animals, athymic mice and mice with severe 
combined immunodeficiency (SCID), demonstrate that worm fecundity is markedly 
reduced in the absence of a functional immune system (Amiri et al., 1992; Harrison and 
Doenhoff, 1983). Studies in Rag-/- mice (lack T and B cells) suggested that lymphocytes 
might be key to optimal worm fecundity, further characterisation of worm development in 
TCRβ-deficient and αCD4-treated animals demonstrated that it is CD4+ T cells that provide 
essential cues to developing worms (Davies et al., 2001). This is in agreement with 
findings from a previous study in IL-7-deficient mice where worm development was 
curtailed (Wolowczuk et al., 1999). Initially this result was interpreted as a demonstration 
that IL-7 acted directly to enhance worm development, however, it was later shown that 
the requirement for both IL-7 and IL-2 was for optimal CD4+ T cell functionality, on which 
worm development depends (Blank et al., 2006). The nature of the T cell-derived signal 
has yet to be established. It is known that S. mansoni parasites express a receptor that 
binds human TGFβ (Beall and Pearce, 2001). An early study also suggested that TNFα 
could rescue worm fecundity in SCID mice (Amiri et al., 1992), however, this was later 
found not to be an essential factor (Cheever et al., 1999). It is reasonable to suggest that if 
IFNAR signalling is required for optimal CD4+ T cell function, IFNAR-deficiency may impact 
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on worm development; however, this requires further work to establish whether there is a 
phenotype in these mice.      
 
Although Ifnar1-/- animals have no obvious developmental defects, there do appear to be 
some differences in the immune system of these animals compared to WT mice, with a 
significant increase in the size of the T cell compartment and ~25% more CD4+ T cells in 
the pLN, as well as a significant reduction in the cellularity of the MLN in naïve mice. An 
alternative way to investigate the role of IFNAR in helminth infection would be to 
administer the IFNAR1-blocking antibody, MAR1-5A3 (Sheehan et al., 2006), to WT mice. 
An advantage of this method is that the role of IFNAR could be assessed at different 
stages of S. mansoni infection by antibody administration at different timepoints, for 
example at the early stages of Th2 priming (d28-42) and in chronic infection (d84+). The 
effectiveness of this approach has been demonstrated in West Nile virus infection (Pinto et 
al., 2011). However, in this setting the researchers administered the antibody only once to 
block IFNAR function for 5 days. Thus we would need to assess whether the antibody 
could be given multiple times over a longer period during S. mansoni infection. The 
disadvantage of a blocking antibody is that the efficacy of treatment may not be 
comparable across all tissues. Although MAR1-5A3 could provide a good model to 
investigate the role of IFNAR, the most relevant experiment at this stage would be S. 
mansoni infection in CD11c-Cre+/-Ifnar1f/f mice to establish the importance of DC 
expression of this receptor. However, we do not currently have this mouse strain in order 
to perform these studies.  
 
In the liver of S. mansoni infected globally IFNAR-deficient mice, only the development of 
the IL-10 response was significantly reduced (Fig. 5.7B). A role for IFN-I and IFNAR in the 
induction of IL-10 has been identified in a variety of settings. For example, IFNAR is 
required for IL-10 production in the lung during influenza infection (Arimori et al., 2013). It 
has also been demonstrated previously that IFN-I is required for IL-10 induction in the liver 
specifically. In IFNAR-deficient mice immunised with a DNA-based vaccine, inflammatory 
CD8+ T cell responses were increased in the liver (Dikopoulos et al., 2005). However, 
hepatic Treg numbers were not altered in these animals. Instead, IFN-I was required for 
the induction of IL-10 production from CD4+ Foxp3- T cells. Similarly, we identified no 
deficit in Treg numbers in the livers of Ifnar1-/- mice during S. mansoni infection, 
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suggesting that a comparable mechanism may be required for IL-10 induction in this tissue 
during schistosome infection. 
 
Facets of the MLN T cell response were reduced in both S. mansoni and H. polygyrus 
infection of IFNAR-deficient animals (Fig. 5.7C and Fig. 5.9D), whilst the induction of the 
Th2 response was unaffected in the liver of S. mansoni infected mice (Fig. 5.7B). A 
selective impairment in LN responses may reflect our finding that Flt3-L dependent 
BMDCs are uniquely dependent on IFNAR for their function. If GM-CSF is, as reported, 
required for the homeostasis of DCs in peripheral tissues (Greter et al., 2012), and tissue-
resident DCs share the characteristics of GMDCs, these cells may be able to maintain T 
cell functionality in peripheral sites during helminth infection in the absence of IFNAR. To 
investigate this further, a comprehensive analysis of the Th2 response in the spleen, liver 
dLN and intestines of IFNAR-deficient mice during S. mansoni infection is required. The 
lifecycle stages of H. polygyrus that occur within the rodent are restricted entirely to the 
gastrointestinal tract of the host (Maizels et al., 2012a), thus examination of the immune 
response in the lamina propria during H. polygyrus infection will demonstrate whether or 
not T cell responses are also ablated in the tissue, as well as the MLN, of IFNAR-deficient 
mice.  
 
The possibility of a cell-intrinsic defect in T cell responses cannot be ruled out in helminth 
infection of global Ifnar1-/- mice. As discussed in the introduction to this chapter, IFN-I can 
directly influence T effector functions, and has also been shown to promote T cell survival, 
at least in vitro (Marrack et al., 1999). In 2 out of 3 H. polygyrus infected Ifnar1-/- mice, IL-
10 responses were above WT levels (Fig. 5.9D). Clearly, this result was not significant and 
the IL-10 response must be assessed further in future experiments. An increase in the 
regulatory response may be the cause of limited IL-4, IL-5 and IFNγ production seen in 
these 2 mice (Fig. 5.9D). Treg numbers are elevated in the MLN by d6-7 of H. polygyrus 
infection (Finney et al., 2007; Rausch et al., 2008), and this cell population plays a central 
role in controlling the effector response (Grainger et al., 2010). The proportion of Treg cells 
in the MLN of WT and IFNAR-deficient H. polygyrus mice should be assessed. In vitro 
studies have found that IFNα can inhibit Treg differentiation and function, both by acting on 
T cells directly and by altering DC activity (Golding et al., 2010; Pace et al., 2010). Thus, 
Treg function may be augmented in Ifnar1-/- mice infected with H. polygyrus, inhibiting T 
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effector responses. IL-10 production (Fig. 5.7B-C) and Treg numbers (Fig. 5.8B-C) were 
not increased in S. mansoni infected IFNAR-deficient mice, thus increased regulation does 
not likely account for the reduction in Th responses in this setting.  
 
The work detailed in this chapter has shown definitively that there are impairments in the 
induction of adaptive responses against helminths in the absence of IFN-I signalling. 
Whether or not this is due to DC dysfunction remains to be determined. The existence or 
otherwise of an IFN-I signature in human responses to helminths is an exciting new area 
of investigation for us. However, there is still much work to be done in this area, and in the 
in vivo mouse studies. Irrespective of this, the data we have generated now provides a 





Figure 5.1 Systemic SEA administration induces gene expression changes in splenic cDCs. 
Mice were injected intravenously with SEA or PBS, spleens were harvested 12h later and 
processed to enrich for DC subsets. Splenic cDCs were FACS sorted from enriched cells (B-C) and 
RT-PCR analysis of activation markers (D) and ISGs (E) performed on mRNA purified from sorted 
cells. Gene expression normalised to Gapdh expression. Data representative of 2 experiments, 



































































































Figure 5.2 There is no significant impairment in Th2 induction in the draining 
lymph node of Ifnar1-/- following S. mansoni egg injection. 
WT or Ifnar1-/- animals received 2500 eggs into the top of each hind foot. On d7 
following egg injection, the draining LN (Egg) were harvested, and the mesenteric LN 
(-) also harvested as a distal control. LN cells were counted (C), restimulated with SEA 
(B) or prepared for flow analysis (D). ELISAs were performed on cell supernatants after 
restimulation to assess the Ag-specific recall response (B). The proportion of T cells 
was calculated as the percentage of live-singlet cells that were TCRβ+, the proportion 
of CD4+ T cells as the percentage of TCRβ+ live-singlets that were CD4+, Treg 
percentages represent the proportion of CD4+ T cells that were also Foxp3+ CD25+ (D). 
Concentrations of T cell cytokines were calculated per 0.1 x106 CD4+ T cells (E). Data 
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Figure 5.3 Th2 and inflammatory cytokines are significantly elevated on d56 
of infection in the serum of animals infected with an 80 cercariae dose. 
Animals were infected with S. mansoni  cercariae and serum samples taken at d56 
of infection for assessment of cytokine levels by ELISA/ CBA (B). Data from 1 
experiment, 4 mice per group. *P<0.05, **P<0.01, ****P<0.0001. Significance in B 
compared to cytokine level at 0 cerc dose, data was logarithmically transformed 














































Figure 5.4 IFN-I levels are raised on d49 of infection in the serum of animals 
infected with 180 cercariae.  
Animals were infected with 180 S. mansoni cercariae and serum samples taken at d49 of 
infection for assessment of cytokine levels by ELISA/CBA (B). IFNα levels in the serum of 
infected mice were compared to IL-5/ IL-10 levels present in these samples (C).  No IL-13 
was detected. 20 mice per group, data combined from 2 experiments. *P<0.05, **P<0.01, 
***<0.001, ****P<0.0001. NS = No significant correlation. Correlations were calculated 





















































































































Figure 5.5 IFN-I mRNA levels are elevated on d42 and d105 of 
infection. 
Animals were infected with 40 S. mansoni cercariae and killed on d28, 
42, 56, 84 or 105. Liver samples were collected and RT-PCR analysis 
performed on purified mRNA (B). Expression of gene of interest 
compared to the housekeeping gene, ubiquitin. Data combined from 2 
experiments. Statistical analysis compares gene level compared to 
naïve mice (0). **P<0.01, ***<0.001, ****P<0.0001.  
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Figure 5.6 Ifnar1-/- S. mansoni-infected animals have reduced worm pairs on d42 of 
infection. 
Mice were infected with 40 cercs and weighed from d35 onwards (B). On d42 of 
infection, animals were sacrificed, weighed and heart perfusions performed. Spleens and 
livers were harvested and weighed. Female worms present in perfusate were counted. 
Egg counts were performed on liver and gut samples following overnight digestion (D). 
Animal and tissue weights were used to calculate hepato- and splenomegaly (E). Data 




















































































Figure 5.7 Ifnar1-/- S. mansoni-infected animals display defective Th2 
responses in the MLN on d42 of infection. 
Mice were infected with 40 S. mansoni cercariae and on d42 of infection, livers and 
MLNs were harvested. Liver (B) and MLN (C) cells were then restimulated with Ag 
and supernatants collected for ELISA. Medium background subtracted (B-C). Data 
from 1 experiment, 2 naïve livers pooled per replicate, giving 2 naïve replicates, 
4-5 individually prepared infected livers per group. MLN data represents 4-5 













































































































































Figure 5.8 WT and Ifnar1-/- S. mansoni-infected animals have comparable 
proportions and actual numbers of immune cell populations in the liver and MLN 
on d42 of infection. 
Livers and MLNs were harvested, cells counted (A) and cells were stained for analysis of 
cell populations by flow cytometry. Proportions of cell populations were calculated as a 
percentage of intact live-singlets (B). Actual numbers of cell populations was calculated 
from cell counts using percentages from flow analysis (C). Data from 1 experiment. 
***P<0.001. 
A. B. 









































































































































































































Figure 5.9 Ifnar1-/- mice infected with H. polygyrus, show increased egg 
burden at d28 of infection and a reduction in T cell cytokines in the MLN 
on d7. 
Animals were infected with L3 H. polygyrus larvae, at d14, d21 and d28 faeces 
were collected and egg counts performed (B). On d28 worms still within the 
small intestine were counted (C). On a separate set of animals, MLN were 
harvested and restimulated with Ag on d7 of infection. CBAs were performed 
on cell supernatants to assess cytokine production (D). Medium background 
subtracted in D. Data from 1 experiment, representative of 2 animals pooled 
(naïve groups) and 3 individual animals (infected groups). *P<0.05, **P<0.01.  
A. 
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Figure 5.10 IFNα is not secreted in response to overnight SEA stimulation by 
DC subsets derived from the PBMCs of Western donors. 
DC subsets and monocytes were MACS sorted from PBMCs, following purification of 
cells from whole blood. Monocytes were cultured for 8d with GM-CSF and IL-4 to 
generate moDC. Directly purified DCs or moDCs from the same donor were cultured 
overnight with or without Ag plus growth-factors (see Methods), supernatants for 
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Figure 5.11 Serum levels of IFNα did not correlate with S. 
mansoni faecal egg burden or age. 
Median ages for egg negative, medium egg burden and high egg 
burden individuals were 36.5, 30.5 and 25 years respectively. 
Sample size of 10 people per group, from a cohort in an endemic 
area of Kenya (courtesy of David Dunne). NS = No significant 
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6.0 SCHISTOSOME-SPECIFIC IMMUNE ACTIVATION IN THE SMALL 
INTESTINE  
6.1 Introduction 
During S. mansoni infection, Th2 activation is required for successful transit of parasite 
eggs out of the host, as well as for protection of the host from a dangerously Th1-skewed 
response (Brunet et al., 1997; Fallon et al., 2000; Jankovic et al., 1999). However, a 
balanced response to S. mansoni is essential, as excessive Th2 leads to severe fibrosis 
and increased mortality (Hoffmann et al., 2000). In the absence of IL-4, impaired egg 
migration results in their accumulation in the intestinal wall, leading to excessive 
inflammation at this site (Brunet et al., 1997; Fallon et al., 2000). A failure to control 
intestinal damage also likely leads to the breakdown of barrier function and translocation of 
bacteria in S. mansoni infected IL-4-deficient mice, leading to higher levels of systemic 
LPS and inflammatory mediators (Fallon et al., 2000). Thus, the generation of a functional 
Th2 response and the subsequent control of egg-induced pathology in the intestine is 
integral to host survival, but must also be regulated to avoid severe immune-mediated 
fibrosis. 
 
Although our lab has shown that DCs are required for induction of the Th2 response in the 
spleen and liver during S. mansoni infection, and the popliteal LN following S. mansoni 
egg injection (Phythian-Adams et al., 2010), the role of DCs in the intestinal immune 
response has not yet been assessed. Th2 immunity is critically involved in the 
development of granulomas around parasite eggs, protecting the host against toxic egg 
products and egg-mediated intestinal damage. However, excessive Th2 is also damaging, 
thus there are both regulatory and Th1 facets to the egg-specific response during S. 
mansoni infection (Herbert et al., 2008; Hoffmann et al., 2000; Phythian-Adams et al., 
2010). It is our hypothesis that DCs localised in the tissues that are directly affected by egg 
traffic – the liver and the intestine – play a vital role in orchestrating the immune response 
during S. mansoni infection.  
 
Studies have identified a role for CD103+ CD11b+ LP DCs and CX3CR1+ LP MΦs in the 
generation of Tregs in the steady state (Coombes et al., 2007; Hadis et al., 2011), whilst 
CD103+ CD11b+ LP DCs are also involved in Th17 generation and protective responses 
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against pathogenic bacteria (Persson et al., 2013; Satpathy et al., 2013). However, how 
intestinal DCs and MΦs respond during helminth infection is currently poorly defined, as is 
which specific DC subsets are involved in activating the immune response at this site. 
Experiments in this chapter use flow cytometry to characterise the myeloid populations in 
the LP during patent S. mansoni infection, with a view to future work that will investigate 
the functional role of these cells in priming or regulating Th2 inflammation in the intestine.   
 
In these studies we have focused on the small intestine, this was primarily to minimise the 
workload required for processing samples to ensure optimal cell survival. Both the large 
and small intestine have heavy egg burden during S. mansoni infection (Saoud, 1965; 
Tiboldi, 1979), and exhibit a granulomatous Th2 response during S. mansoni infection, 
downregulation of this response occurs at the chronic stage of infection in the colon, but 
not the small intestine (Turner et al., 2011; Weinstock and Boros, 1981).  
 
One of the long-term aims of the lab is to understand the role of the different gut-
associated DC subsets in the initiation of the egg-induced Th2 response. Whilst 
determining the phenotype of DCs in the intestinal tissues and the MLNs during S. 
mansoni infection was one approach we used to address this goal, we also aimed to 
develop a more controlled and reductionist model of synchronous egg exposure to 
complement the more complex active infection system. Such a model would allow analysis 
of DC phenotype at the earliest possible points following egg exposure, enabling 
identification of the specific DC subsets that initiate the egg-specific response in the 
intestines and MLNs. This analysis is more difficult in patent infection because it is 
impossible to know exactly when egg deposition begins and so precisely when DCs will 
first be exposed to and activated by egg Ags.  
 
Because of these potential complications with examining DC responses in actively infected 
mice, we developed a surgical model of synchronous egg delivery subserosally, directly 
into the intestinal tissue of non-infected animals. CD11c-depletable mice were utilised to 
directly address whether any egg-specific immune activation was dependent on CD11c+ 
cells, thus beginning to unravel the importance of DCs in the generation of egg-specific 
responses in a mucosal tissue site.  
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Following initial exposure to eggs, we hypothesise that the initiation of type 2 immunity 
requires DC migration from the intestinal tissue to the dLN. Although beyond the scope of 
this PhD, future experiments will use a surgical lymphatic cannulation approach to 
investigate this. This approach will enable characterisation of the cells migrating in 
intestinal lymph in response to either patent S. mansoni infection or subserosal egg 
injection. Lymphatic cannulation studies have generally only been carried out in veterinary 
studies of large animals (Pullinger et al., 2007; Thornbury et al., 1993) or rats (Cerovic et 
al., 2009; Milling et al., 2006; Pugh et al., 1983). However, a small number of groups have 
developed these techniques to allow micro-surgical cannulation of laboratory mice. 
Although it is possible to cannulate the intestinal lymph vessels, this approach provides 
only miniscule volumes of lymph for analysis (~0.2-0.4µl per mouse) (Schulz et al., 2009). 
As an alternative approach, following removal of the mesenteric lymph nodes, the thoracic 
lymph duct can be cannulated (Milling et al., 2010), yielding large numbers of DCs that are 
clearly migrating from the intestine, as these cells are not present in the lymph of animals 
that have not undergone mesenteric lymphadenectomy (Cerovic et al., 2012).  
 
The ability to collect large numbers of cells from the intestinal lymph of egg-treated or S. 
mansoni infected animals would allow us to go beyond characterisation of migrating DCs, 
to perform functional studies of these cells. However, to be able to carry out this approach 
during S. mansoni infection in future studies, we first needed to address whether 
mesenteric lymphadenectomy would be prohibitive to parasite development or to the 
generation of a functional immune response. For this reason, we characterised acute S. 
mansoni infection in mice lacking MLN, as detailed in this chapter.    
 
Thus, this chapter details a range of experiments designed to develop innovative new 
approaches to directly address the role of DCs in Th2 orchestration in the intestines and 
MLNs – relevant sites during S. mansoni infection. This chapter also provides the first 
insights into the phenotype of the intestinal DC compartment during S. mansoni infection. 
The egg injection model we have developed provides a relevant tissue in which to study 
the responses of Flt3-L dependent DC subsets to egg challenge in vivo. Furthermore, it 
will allow us to investigate whether IFN-I signalling is required for the induction of egg-




6.2.1 Myeloid cell populations in the small intestine of S. mansoni infected mice 
The DC populations resident in the LP of the steady state small intestine have been well 
characterised (Cerovic et al., 2012; Persson et al., 2013; Schulz et al., 2009; Varol et al., 
2010). Before investigating the phenotype and function of DC populations in response to 
schistosomes, we first sought to confirm we could replicate these results in naïve mice. 
Analysis was restricted to CD45+ cells (all haematopoietic cells, excluding erythrocytes and 
plasma cells) in order to remove any non-immune cell populations; autofluorescent 
SiglecF+ eosinophils were gated out as they express CD11b and other myeloid markers 
(Fig. 6.1A) (Bain et al., 2012). Gr-1+ (Gr-1 antibody recognises cells expressing Ly6C/G) 
cells were also gated out to exclude neutrophils and inflammatory monocytes. DC 
populations could be identified as F4/80- CD11c+ MHC II+ cells; the different DC subsets 
were delineated by their expression of CD11b and CD103 to give four defined subsets 
(Cerovic et al., 2012)(Fig. 6.1A). F4/80+ MHC II+ MΦs also expressed CD11c and high 
levels of the fractalkine receptor, CX3CR1 (Fig. 6.1A-B), in agreement with published data 
(Niess et al., 2005), and were CD103- (Fig. 6.1D). All of the CD11c+ MHC II+ populations in 
the LP expressed some level of the co-stimulatory molecules CD80 and CD86 in the basal 
state (Fig. 6.1E-F). Although LP MΦ are known for their high level expression of CX3CR1, 
the DC subsets present in the LP also expressed this marker to some degree, when 
compared to cells from a CX3CR1-eGFP- mouse (grey shaded histogram, Fig. 6.1D). The 
findings from these characterisation experiments demonstrated that our cell isolation 
techniques and staining protocols were in agreement with previous studies in naïve mice.  
 
Prior to investigating the functional role of myeloid cells in the small intestine during patent 
S. mansoni infection, we first characterised the populations present at different timepoints 
of infection (Fig. 6.2B). On d42, approximately 1-2 weeks after the commencement of egg 
deposition (Pearce and MacDonald, 2002), there was no discernible change in the total 
cell numbers recovered from the LP of infected animals, compared to naïve (Fig. 6.2C). 
The myeloid compartment in the small intestinal LP of infected mice was also comparable 
to naïve mice; there were similar numbers of DCs and MΦs in the LP (Fig. 6.2E), and no 
discernible influx of Ly6Chi CD11b+ inflammatory cells (Fig. 6.2D). The proportions of the 
different LP DCs subsets, delineated by their expression of CD11b and CD103, were 
unaltered on d42 of infection, compared to naïve animals (Fig. 6.2F).  
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There was also no discernible change in total cell numbers in the LP on d56 of S. mansoni 
infection (Fig. 6.3B). However, on d56 of infection, by which time the intestine is severely 
affected by egg-induced pathology (Turner et al., 2012), there were discernible changes in 
the myeloid population. At this stage, there was an influx of Ly6Chi CD11b+ inflammatory 
monocytes into the small intestine (Fig. 6.3C), however this was variable between animals. 
The inflammatory monocyte population were uniformly CD103-, but expressed variable 
levels of MHC II and F4/80 (Fig. 6.3G).  
 
The percentage of LP MΦs in each sample was calculated as the proportion of all live 
intact-singlets that were Ly6C- MHC II+ F4/80+ (using event counts from FACS data). To 
quantify the total number of MΦs in the SI LP, the number of viable leukocytes was 
multiplied by the percentage of MΦs as determined by flow cytometry. This technique is 
used throughout to calculate the percentage and total numbers of cell populations in 
infected tissues. Due to the low number of naïve samples in these experiments, it is not 
possible to perform reliable statistical analysis on the changes to the LP myeloid 
populations during infection. However, there was a marked decrease in the percentage of 
LP MΦ on d56 of infection, and in the absolute number of LP-resident MΦs in infected 
animals (Fig. 6.3C-D). A minor increase in the percentage of F4/80- CD11c+ MHC II+ DCs 
did not translate to a discernible alteration in this population when extrapolated to actual 
cell numbers (Fig. 6.3C-D).  
 
Of the different LP DC subsets, the only population that displayed marked change in 
absolute cell numbers was CD103+ CD11b+ DCs, with a dramatic reduction in this 
population on d56 of infection (Fig. 6.3E-F). This indicates that increasing egg burden in 
the intestine of S. mansoni infected mice (Turner et al., 2012) has marked effects on the 
myeloid cell populations in the small intestine, but does not affect all populations equally.  
 
On d42 of infection, there was no discernible change in the surface phenotype of LP DC 
subsets or LP MΦ, illustrated by comparable expression of CD40 by these cells from naïve 
and S. mansoni infected animals (Fig. 6.4A). However, there was a clear reduction in the 
expression of CD40 and CD86 on all DCs, as well as LP-resident MΦs, on d56 of infection 
(Fig. 6.4B-C). In particular, expression of CD40 on CD103- CD11b- LP DCs was markedly 
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reduced at this timepoint (Fig. 6.4B). It is clear that at the early stages of infection the 
myeloid population in the small intestine is largely unaltered by initial egg deposition. 
However, as infection progresses and egg-induced pathology becomes more severe, there 
are stark changes in the make-up of the myeloid compartment, including an inflammatory 
cell influx and down-regulation of activation markers on LP-resident populations. 
 
6.2.2 Subserosal egg injection: A model of synchronous egg delivery 
Oral administration of Ag is a relatively straight-forward way of challenging the intestinal 
immune system, but is also a route that can induce oral tolerance (Mowat, 2005).  As an 
initial approach to try to generate a more controlled mucosal Th2 response to schistosome 
eggs than active infection, we administered mice with schistosome eggs or varying doses 
of SEA by oral gavage and measured the induction of T cell responses in the MLN 7d later 
(Fig. 6.5A). Very little Ag-specific T cell cytokine production was detectable at this 
timepoint; no IL-5 or IL-13 was detectable, whereas IL-4, IL-10, IL-17 and IFNγ were 
present only at very low levels (Fig. 6.5B). Although at first viewing IL-4 and IL-10 levels 
induced following oral SEA administration appeared lower than the amounts produced by 
PBS-treated animals, this was not significant (Fig. 6.5B). IFNγ production was above 
background levels, but only at the highest SEA concentration or in mice receiving whole 
parasite eggs, this was also only a trend and non-significant in these groups (SEA 100µg: 
P=0.0870, Eggs: P=0.0832)(Fig. 6.5B). Analysis of the polyclonal response (stimulated by 
αCD3 treatment) indicated that, whilst administration of 50µg SEA enhanced the ability of 
MLN T cells to produce IL-5 and inhibited IFNγ, there was little evidence of a dose-
response to SEA (Fig. 6.5C). Egg administration also inhibited polyclonal IFNγ production 
by MLN cells (Fig. 6.5C). Induction of polyclonal IL-4, IL-10, IL-13 and IL-17 were not 
significantly altered in any condition, when compared to levels from control (PBS-treated) 
mice (Fig. 6.5C).   
 
As schistosome eggs are potent inducers of Th2 responses when administered by other 
routes (e.g. subcutaneously, i.p., i.v. to lungs (Chiaramonte et al., 1999; McKenzie et al., 
1999; Phythian-Adams et al., 2010; Sabin et al., 1996)), the muted response following oral 
administration indicated this does not provide a good route to generate an egg-specific 
response. This is perhaps not surprising given that, during patent infection, eggs transit 
from the mesenteric vessels through the serosal side of the gut into the lumen. Thus, this 
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route of egg administration is very different from normal egg transit. For this reason, we 
decided to develop an alternative method of egg delivery, which involved surgical 
exposure of the small intestine under general anaesthesia, followed by injection of eggs 
into the subserosa of the intestinal wall. This route of egg administration is more akin to 
the natural route of egg transit, though of course not perfect, given that some mechanical 
disruption of the tissue does occur. This model was developed in collaboration with Simon 
Milling’s lab at the University of Glasgow.  
 
In contrast to oral administration (Fig. 6.5), subserosal egg injection induced a strong T cell 
response in the MLN 7d after injection (Fig. 6.6B). Although IL-4 production was relatively 
low, there was significant Ag-specific IL-5, IL-13 and IL-10 secretion by MLN cultures from 
egg-injected mice, compared to animals injected with a PBS control (Fig. 6.6B). Some 
level of IL-17 and IFNγ was also induced, but at variable levels. Induction of an egg-
specific response was not restricted to the draining LN, as illustrated by Ag-restimulation of 
LP cells following egg injection. Significant levels of IL-4 and IL-5 were induced by egg 
injection, and LP cells also produced large quantities of IL-13 but the levels were more 
variable (Fig. 6.7B). IL-17 secretion was low-level but significant, whilst IL-10 and IFNγ 
production was variable between egg-injected animals (Fig. 6.7B). 
 
In order to assess cytokine production specifically by LP CD4+ T cells in response to 
subserosal egg injection, we carried out a pilot experiment assessing the expression of 
huCD2 by T cells from KN2 reporter mice was analysed by flow cytometry. These mice 
have an IL-4 allele replaced by human CD2, thus IL-4-producing cells can be identified by 
the expression of huCD2 on their surface (Mohrs et al., 2005). Although not reaching 
significance with these low numbers of mice in this initial experiment, 2 out of 3 egg-
injected animals displayed an increase in the proportion of huCD2+ CD4+ T cells in the LP 
(Fig. 6.7C). There was no significant difference in the percentage of huCD2+ CD4+ T cells 
present in the MLNs or PPs of PBS or egg-treated animals (Fig. 6.7D). To evaluate the 
production of other cytokines in the LP, in a separate pilot experiment ICC was performed 
following polyclonal stimulation with PMA/Ionomycin. Due to the low numbers of animals 
and the variability in cytokine production between mice in this initial experiment, there was 
no significant increase in IL-4, IL-5 and IL-13 production by LP CD4+ T cells following egg 
injection (Fig. 6.8B-C). However, these Th2 cytokines were strongly induced in some mice 
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following egg injection, which was not seen in animals in the PBS-treated group. Fig. 6.8B 
depicts plots from animals where the subserosal egg injection was deemed successful, 
based on the percentage of TCRβ+ CD4+ cells expressing the Th2 cytokines, IL-4, IL-5 and 
IL-13. The proportion of intestinal CD4+ T cells expressing IFNγ did not change (Fig. 6.8B-
C), and there was no discernible alteration in the percentage of CD4+ T cells in the MLN 
producing any of the cytokines that were assessed (Fig. 6.8C).   
 
The above experiments, especially Ag-specific restimulations, show that subserosal 
schistosome egg injection clearly initiates a strong Th2 response in the small intestine. To 
begin to address the role of DCs in this response, we used CD11c-DOG mice to establish 
whether CD11c+ cells are required. CD11c-DOG mice express a BAC transgene that 
includes the human diptheria toxin receptor under control of the CD11c promoter, 
administration of diptheria toxin (DTx) leads to the depletion of CD11c-expressing cells 
(Hochweller et al., 2008). DTx can be administered to CD11c-DOG mice for up to 12 days 
with effective ablation of CD11c+ cells (Hochweller et al., 2008). CD11c+ cells were 
depleted daily for 2 days prior to and 6 days following subserosal egg injection, and 
tissues were harvested on day 7. LP and MLN CD11c+ DC populations were almost 
completely ablated in DTx-treated animals (Fig. 6.9B & D). Due to poor tissue preps in this 
experiment, the CD103- LP DC populations could not be detected in PBS-treated animals 
in this experiment (Fig. 6.9B). In line with a published study using CD11c-DTR mice (Varol 
et al., 2007), the CD11c+ LP MΦ population was also depleted in CD11c-DOG mice (Fig. 
6.9B-C). Induction of egg-specific IL-4, IL-5, IL-10, IL-13 and IFNγ, but not IL-17, was 
dramatically ablated in the MLN of DTx-treated mice (Fig. 6.10), indicating that effective 
polarisation of this response is dependent on CD11c+ cells. Together, this work 
demonstrates that subserosal egg injection robustly induces an egg-specific Th2 response 
in the LP and the MLN, and this is dependent on CD11c+ cells.  
 
6.2.3 The development of patent S. mansoni infection and the immune response are 
normal in the absence of MLN 
The next steps in this project will be to determine the identity of the CD11c+ cells that we 
have shown to be critical in the intestinal response to schistosome eggs (Fig. 6.10).  As 
introduced above, we plan to help define which CD11c+ cell type is key for induction of the 
egg specific Th2 response by cannulating the lymph draining the intestine, and 
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characterising the types of cell that migrate from these tissues, their activation status and 
function (Cerovic et al., 2012). For this surgical technique, prior to cannulation, the 
mesenteric lymph nodes are excised, in order to shunt the intestinal flow into the thoracic 
duct, which can then be cannulated (Milling et al., 2006). As a first important step towards 
future cannulation experiments, in order to assess whether mesenteric lymphadenectomy 
(MLNX) would have any debilitating effect on the development of the parasite or the 
immune response during S. mansoni infection, we infected mice with cercariae 28 days 
after surgical removal of the MLN. From d35 post-infection, the weight of infected animals 
was monitored because severe disease is associated with significant weight loss 
(MacDonald et al., 2002b). In fact, both groups of infected mice actually gained weight 
over the course of infection, with the MLNX group even gaining significantly more weight 
than their intact counterparts (Fig. 6.11B). Mice were killed and parasitaemia assessed on 
d56 of infection. Both infected groups had comparable worm burdens (Fig. 6.11C), and 
there was no difference in egg counts in the liver or intestine (Fig. 6.11D), or in the number 
of eggs produced per worm pair (Fig. 6.11E). The development of hepatomegaly and 
splenomegaly was comparable in intact and MLNX infected mice (Fig. 6.11F). These 
findings suggest that S. mansoni parasites develop normally in mesenteric 
lympadenectomised animals. Finally, MLNX mice produced Th2 responses that were 
indistinguishable from intact animals, with comparable IL-4, IL-5, IL-10 and IL-13 
production in the liver (Fig. 6.12B) and spleen (Fig. 6.12B), and with IL-13 actually 
significantly upregulated in the spleen in the MLNX group. No IL-17 or IFNγ was detected 
in either group of infected mice. These data demonstrate that the immune response is 
intact in MLNX mice infected with S. mansoni. There was no impact on the total number of 
cells present in the liver or spleen of naïve or infected MLNX mice (Fig. 6.13A and Fig. 
6.14A). MLNX did have some impact on the numbers of lymphocytes present in these 
tissues, however, with a minor but significant increase in the number of CD4+ T cells in the 
liver of infected MLNX mice (Fig. 6.13C), and in the spleen of naïve MLNX animals (Fig. 




• There was no discernible change to small intestine LP myeloid cell populations on 
d42 of S. mansoni infection (Fig. 6.2 & Fig. 6.4A)  
• However, by d56 of infection there was an influx of inflammatory monocytes (Fig. 
6.3A-B) and a reduction in the CD103+ DC populations (Fig. 6.3A&C)  
• The LP-resident APC populations also down-regulated their expression of 
activation markers at this stage of infection (Fig. 6.4B-C) 
• Oral administration of schistosome eggs or SEA does not induce a detectable Th2 
response in the MLN (Fig. 6.5) 
• Subserosal egg injection stimulates an adaptive immune response in the MLN (Fig. 
6.6) and LP (Fig. 6.7), primarily characterised by production of Th2 cytokines   
• The induction of this response is dependent on CD11c+ cells (Fig. 6.10) 
• S. mansoni parasites developed a patent infection in MLNX mice (Fig. 6.11), and a 




The small intestine is a major site of Ag challenge and inflammation during schistosome 
infection.  Our long-term goal is to address the importance of specific DC subsets and IFN-
I in induction, maintenance and regulation of immunity and inflammation in the intestines. 
The results presented in this chapter represent the beginning of this work, providing a solid 
foundation for future studies investigating the role of intestinal DCs in the induction of the 
immune response to S. mansoni eggs.  
 
Successful purification of DCs from the intestine of infected mice is complicated, due both 
to high levels of mucus production and egg-induced intestinal pathology, which together 
results in excessive cell death. These techniques were not standard in our lab so we spent 
some time optimising the isolation of live cells from murine intestinal tissues during S. 
mansoni infection. We showed that during acute S. mansoni infection LP DC subsets did 
not display increased surface activation, and may in fact have a more muted activation 
level as infection progresses.  
 
We then developed a more controlled approach to be able to dissect the immune response 
to schistosome eggs delivered synchronously to the intestine.  Direct challenge with eggs 
injected into the serosa of the small intestine induced a strongly Th2 polarised cytokine 
response in both the MLN and the intestinal tissue itself, and the induction of this response 
was dependent on the presence CD11c+ cells. This novel model of egg deposition in the 
intestine will enable future studies to directly assess the phenotype and function of the 
different DC subsets during induction of the egg-specific response.  
 
Analysis of S. mansoni infection in mesenteric lymphadenectomised mice demonstrated 
that parasite development and immune activation occurs normally in the absence of the 
MLN. This important preliminary finding will now allow characterisation and functional 
studies of the cell subsets that are mobilised from the intestine during infection, through 





6.3.1 Downmodulation of myeloid cell activation with progressive S. mansoni 
infection  
The myeloid populations identified in the steady state LP appeared identical to the subsets 
previously described in the literature (Fig. 6.1)(Bogunovic et al., 2009; Varol et al., 2010). 
As well as identifying the more abundant CD103+ CD11b+ and CD103+ CD11b- DC 
subsets, we also identified CD103- CD11b- LP DCs, a population that is often overlooked, 
perhaps because of its low-level expression of CX3CR1 (Cerovic et al., 2012). These cells 
could be mistaken for MΦs. However, it has been shown that they are present in intestinal 
lymph (Cerovic et al., 2012). Key to the APC function of DCs is their ability to migrate 
efficiently to the draining LN following exposure to Ag, in order to present Ag to naïve T 
cells resident in the LN, and to polarise adaptive immune responses, MΦs do not display 
the same migratory capacity (Geissmann et al., 2010a; Randolph et al., 2008), and are not 
present in intestinal lymph (Cerovic et al., 2012). CD103- CD11b+/- DCs isolated from the 
small intestine of naïve mice can prime T cells effectively and expand in response to Flt3-L 
(Cerovic et al., 2012). However, it still needs to be shown definitively whether the CD11b- 
DCs alone can prime. Although the highest level of expression of CX3CR1 is found on LP 
MΦ, DC subsets in the LP also express this marker to some degree (Fig. 6.1C) (Cerovic et 
al., 2012). Given that CX3CR1 can only be reliably identified using GFP-reporter mice, it is 
clear that it does not provide an ideal tool for delineation of the myeloid populations in the 
LP of e.g. gene deficient mice. Recent studies have identified CD64 (FcγR1) as a more 
discriminating marker of intestinal MΦ (Bain et al., 2012; Tamoutounour et al., 2012), 
which should be used in future experiments.  
 
CX3CR1hi cells in the small intestine LP were initially described to be a DC population 
(Niess et al., 2005). However, more recent studies have revealed these cells to be MΦ, a 
non-migratory population derived from monocytes in response to M-CSF (Bogunovic et al., 
2009; Schulz et al., 2009). Functional studies performed by Schulz et al. demonstrated 
that, whilst CX3CR1+ LP MΦs readily take up Ag in vivo, they are unable to prime Ag-
specific CD4+ T cells at all, and stimulate only low-level proliferation of CD8+ T cells. 
Nevertheless, this population may be important in Ag sampling from the intestinal lumen 
(Niess et al., 2005; Schulz et al., 2009), which may help to maintain immunoregulation in 
the tissues in the steady state (Bain et al., 2012; Murai et al., 2009), and aid in bacterial 
clearance following infection with pathogenic species such as S. typhimurium (Niess et al., 
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2005). However, priming of S. typhimurium-specific T cell responses still relies on DCs, not 
MΦs (Bogunovic et al., 2009). High expression levels of MHC II (Fig. 6.1B), as well as co-
stimulatory molecules, often with a higher gMFI than the DC subsets (Fig. 6.1E-F & Fig. 
6.3), illustrate the potential for LP MΦ to interact with T cells in the intestinal tissue. Thus, 
the MΦ population should not be ignored when considering the role of myeloid populations 
in the LP.  
 
There was no measurable alteration in the myeloid cell populations present in the LP on 
d42 of S.mansoni infection (Fig. 6.2D-F), indicating that initial egg deposition does not 
cause a significant efflux of DCs. This finding is in agreement with the hypothesis 
presented in chapter 3, that SEA-stimulated DCs traffic to the dLN at a similar rate to 
steady state DC migration. At this timepoint of infection, there was also no discernible 
increase in the expression level of co-stimulatory molecules on LP DCs or MΦs (Fig. 
6.4A). Future cannulation studies will allows us to study the DCs leaving the intestinal 
tissue following egg challenge.  As this population should include Ag-experienced cells, it 
will be interesting to assess their surface phenotype in comparison to the LP DC 
populations as a whole. Assessment of DCs present in the MLN during S. mansoni 
infection will also provide information on the phenotype of Ag-experienced cells, as a large 
proportion of the DCs in the MLN will have migrated from the intestinal tissue (Jakubzick et 
al., 2008; Satpathy et al., 2013). However, this data must be used with caution, as it is 
difficult to identify which cells have migrated from those that are resident in the MLN.    
 
From our work with FL-cDCs (Chapter 3), we would perhaps have expected an 
upregulation of co-stimulatory molecules on LP DC subsets during S. mansoni infection. 
However, by comparison of gMFI data for the expression of CD40 and CD80 by 
unstimulated CD24+ FL-cDCs (Fig. 3.7B) and CD103+ CD11b- LP DCs from a naïve mouse 
(Fig. 6.4), it is clear that the basal expression level of these markers is 3-6 fold higher on 
the LP-resident subset than on FLDCs. Although this is not a direct comparison as these 
experiments were carried out independently, this may explain the failure of egg deposition 
in the intestine to induce DC activation, as the basal activation level of DCs in vivo in this 
tissue site appears higher than the surface phenotype stimulated in FLDCs by SEA in 
vitro. Another possibility is that the intestines are, by necessity, a more highly regulated 
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tissue than the spleen, with constitutively high levels of TGFβ, IL-10 and Tregs. This may 
keep in check any activation in response to eggs and egg Ags.   
 
By d56 of infection, there were marked changes in the myeloid populations in the LP that 
were not seen at the earlier timepoint, and this may reflect the dramatic increase in 
intestinal egg burden at this stage (Turner et al., 2012), as well as increased inflammation 
and tissue damage (Pearce and MacDonald, 2002). An influx of CD11b+ Ly6Chi 
inflammatory monocytes was observed in the LP by d56 of S. mansoni infection (Fig. 6.3A-
B). Similar inflammatory monocyte influxes have been described in both colitis models and 
during infection with parasitic protozoa in the small intestine (Grainger et al., 2013; Platt et 
al., 2010; Zigmond et al., 2012). There was a stark reduction in CD103+ CD11b+ DCs in the 
LP by d56 of infection (Fig. 6.3C). This unexplained phenomenon has been described 
previously in the inflamed LP (Grainger et al., 2013). CD103+ CD11b+ DCs are thought to 
be the primary LP population that migrates to the MLN and primes CD4+ T cells 
(Bogunovic et al., 2009; Schulz et al., 2009).  As such, they represent the majority of DCs 
present in intestinal lymph (Cerovic et al., 2012). It is therefore possible that this population 
is mobilised from the LP by d56 of schistosome infection. This could be tested simply by 
comparing the proportions and numbers of this DC subset present in the MLN, i.e. is there 
an increase in CD103+ CD11b+ DCs by d56 of infection? Cannulation studies at this stage 
of infection would also indicate whether there was an increase in mobilisation of this 
subset. The reduction in CD103+ CD11b+ DCs may also reflect a disruption in the turnover 
of LP DCs during infection, as CD103+ DCs are replaced by precursors recruited from the 
blood more frequently than CD103- subsets (Bogunovic et al., 2009).  
 
A reduction in numbers of CD103+ DCs in the SI LP may impact on the development of T 
cell responses at this site, particularly Treg differentiation, as the CD103+ DC subset 
preferentially induces Treg differentiation in the steady state (Coombes et al., 2007), 
although it is not yet known if this is also the case during helminth infection. Work from 
Yasmine Belkaid’s lab also demonstrates a reduction in Treg numbers in the small 
intestine during protozoal infection (Oldenhove et al., 2009), along with loss of CD103+ 
DCs (Grainger et al., 2013). This suggests that Treg numbers may be reduced in the small 
intestine during S. mansoni infection, although this hypothesis needs testing directly. A 
study of the granulomatous response in the colon identified an increase in Treg numbers 
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during chronic infection (Turner et al., 2011). However, nTreg numbers are not altered in 
the MLN during S. mansoni infection (Baumgart et al., 2006). Weinstock et al. have 
previously demonstrated that granulomas in the ileum are much smaller than other 
intestinal granulomas, a finding which may suggest a tissue-site specific impairment of the 
normally ‘florid’ acute granuloma response, this may relate to the highly regulatory 
phenotype of the ileum (Powrie, 2004), and would contrast with the hypothesis that Treg 
responses are deficient at this site during the acute stage of S. mansoni infection. Thus, a 
comprehensive study of the numbers of Tregs in the small intestine over the course of S. 
mansoni infection is required, as well as functional characterisation of these cells in this 
setting. A study of Tregs on d63 of S. mansoni infection has shown that Foxp3+ cells are 
localised around the periphery of granulomas in the intestine, although the authors do not 
state what site(s) in the intestine was included in this analysis (Layland et al., 2010).  
 
An influx of CD11b+ Ly6Chi monocytes, as seen by d56 of S. mansoni infection, is primarily 
associated with an exacerbation of intestinal inflammation (Platt et al., 2010; Zigmond et 
al., 2012). However, a recent study indicates that this cell population can also regulate 
innate immune activation, limiting neutrophil-mediated pathology in the intestine in a 
prostaglandin E2 (PGE2) -dependent manner during Toxoplasma gondii infection (Grainger 
et al., 2013). It is not yet known whether infiltrating monocytes promote or limit 
inflammation and immune responses in the helminth-infected intestine, or whether they 
can influence DC phenotype and function. Intriguingly however, PGE2 has also been 
shown to inhibit retinoic acid production by DCs (Stock et al., 2011), which is required for 
Treg differentiation in the steady state intestine (Coombes et al., 2007). This may explain 
the reduction in Treg numbers during protozoan infection in the small intestine (Oldenhove 
et al., 2009). In support of the hypothesis that CD103+ DC function is impaired during 
parasite infection, preliminary data from our lab indicates that activity of RALDH, the 
enzyme responsible for retinoic acid (RA) generation, is down-regulated in the CD103+ 
DCs that remain in the SI LP on d49 of S. mansoni infection in mice infected with 180 
cercariae (Lucy Jones and LMW). It should be noted that it has not yet been shown that 
CD103+ DCs function to promote Treg differentiation in helminth infection, or whether RA, 
and RA-producing cells, play an entirely different role in these settings. It is likely that the 
function of CD103+ DCs may change following exposure to helminth Ags, particularly in 
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light of recent studies that have shown these cells are involved in Th17 polarisation 
against pathogenic bacteria (Persson et al., 2013; Satpathy et al., 2013).  
 
It cannot be ruled out at this stage that changes in the numbers and phenotype of myeloid 
cell populations described on d56 of S. mansoni infection may be caused by cell damage 
or death, given that there is severe immunopathology at this stage of infection, which may 
render cells more susceptible to death during tissue preparation and cell isolation. For this 
reason, it would be informative to assess the proportions of myeloid cells undergoing 
apoptosis from the intestine of naïve mice, and from the tissues of animals at different 
stages of S. mansoni infection. Further, these characterisation experiments need to be 
repeated with larger sample sizes to enable statistical analysis of the observed changes.   
 
Studies of inflammatory monocytes have primarily focused on the effect they have on Th1/ 
Th17 immune responses within the intestine. However, recent studies have also 
highlighted that in some settings these cells can downregulate Ly6C expression, and 
subsequently migrate in the intestinal lymph towards the MLNs. These cells can also 
induce Ag-specific T cell proliferation in vitro (Zigmond et al., 2012). For this reason, a 
potential role of these cells in T cell polarisation during S. mansoni infection should not be 
overlooked. Again, this can begin to be addressed by characterising the cell populations 
migrating from the intestine to first determine if they are present in the intestinal lymph 
during infection. 
 
The importance of intestinal epithelial cells (IECs) in orchestrating the immune response 
against gastrointestinal helminths has been demonstrated (Artis and Grencis, 2008; Cliffe 
et al., 2005), and this includes production of tissue factors such as TSLP, IL-25 and IL-33 
which promote Th2 induction and worm expulsion (Humphreys et al., 2008; Rimoldi et al., 
2005; Saenz et al., 2010; Zaph et al., 2007). It is therefore possible that increasing egg-
induced damage around d56 of S. mansoni infection elicits cytokine secretion from IECs 
that influence DC activation. TSLP directly induces human DCs to produce IL-10 and 
enhances costimulatory molecule expression, (Rimoldi et al., 2005), resulting in increased 
Th2 responses (Rimoldi et al., 2005; Soumelis et al., 2002). As such, more likely 
candidates for down-regulating DC activation in the intestine during S. mansoni infection 
are TGFβ and IL-10. TGFβ is produced by both IECs (Zeuthen et al., 2008), and DCs 
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themselves, particularly by the CD103+ DC populations (Coombes et al., 2007). IEC-
derived TGFβ, in conjunction with IEC-TSLP, have been shown to induce a tolerogenic 
phenotype from DCs, at least in vitro (Zeuthen et al., 2008).  
 
Blockade of both TGFβ and IL-10 indicate that production of these regulatory cytokines 
plays an important role in protecting against severe liver damage during S. mansoni 
infection (Herbert et al., 2008). IL-10 production from T effectors and innate cells, as well 
as Tregs, is integral to the regulation of aberrant immune activation in the liver of S. 
mansoni infected mice (Dewals et al., 2010; Hesse et al., 2004). However, inhibition of IL-
10 and TGFβ did not in fact lead to exacerbation of intestinal immunopathology (Herbert et 
al., 2008). The authors suggested that control of aberrant immune activation in the 
intestine is controlled by alternatively-activated MΦs (Herbert et al., 2004), and went on to 
demonstrate the importance of Arginase-I production by AA MΦs in suppressing 
inflammation in the gut during acute S. mansoni infection (Herbert et al., 2010; Pesce et 
al., 2009). Arginase-I functioned to limit production of pro-Th1/ Th17 cytokines such as IL-
12/IL-23p40 and IL-6 (Herbert et al., 2010), and also served to inhibit T cell turnover 
(Pesce et al., 2009). Thus, it is possible to imagine that Arginase-I, which is also produced 
by DCs (Chang et al., 2013) could additionally limit DC activation and promote immune 
regulation. Whilst Herbert et al. (2010) investigated the importance of Arginase-I during S. 
mansoni infection using Arginase-I deficient BM chimeras, this does not address the 
importance of DC-derived Arginase-I and whether this may play a role in regulating 
immune activation in the intestine during infection.   
 
Whether or not the Ly6Chi inflammatory monocytes that are recruited to the intestine 
during S. mansoni infection become alternatively-activated remains to be determined. It is 
also possible that intestinal AAMΦs induced during S. mansoni infection are derived from 
proliferation of the CX3CR1+ LP-resident MΦ populations. In this regard, in infection with 
the filarial nematode, Litomosoides sigmodontis, infiltrating monocytes do not contribute to 
the generation of AAMΦ in the infection site until relatively late in infection, if at all (Jenkins 
et al., 2011). Nevertheless, in schistosome infection we did not detect an influx of Ly6Chi 
inflammatory monocytes until d56 of S. mansoni infection, and studies indicate that AAMΦ 
are essential for protection at earlier timepoints than this (Herbert et al., 2004; Herbert et 
al., 2010), implying that CX3CR1+ LP MΦs are likely to be the primary cell population 
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contributing to the pool of AAMΦs in the intestine in acute infection. If this were the case, 
this would highlight an important protective role for CX3CR1+ LP MΦs in Th2 inflammation 
in helminth infection. One way to address this would be to investigate the presence of 
CX3CR1+ cells in the intestinal granulomas of CX3CR1-GFP mice by microscopy. Given 
that these cells are also ablated by DTx treatment of CD11c-DTR mice (Varol et al., 2007), 
it may also be possible to assess the importance of these cells in granuloma formation 
during S. mansoni infection in DTx-treated CD11c-DOG mice. The obvious downside to 
this method is that DCs would also be depleted.  
 
6.3.2 DC-dependent Th2 induction in the small intestine following subserosal egg 
injection 
As an initial approach to try to develop a more controlled model of schistosome egg Ag 
exposure in the intestines, we tried oral administration of SEA or schistosome eggs. 
However, preliminary experiments using a range of SEA doses or 2500 eggs, failed to 
elicit a Th2 response in the MLN 7d after oral gavage (Fig. 6.5B). Since we did not perform 
a full time course analysis, it remains possible that we missed the peak of Th2 response. 
However, the lack of any detectable IL-13 or IL-5, coupled with an actual decrease in IL-4 
and IL-10, suggests this is unlikely to be the case (Fig. 6.5B). This is consistent with oral 
administration leading to the generation of tolerance against SEA/ eggs, rather than 
priming immune activation (Pabst and Mowat, 2012). In retrospect, this seems like an 
obvious outcome of oral administration of S. mansoni eggs/ SEA. However, there is some 
indication that this route of egg/ SEA delivery can enhance polyclonal Th2 (Fig. 6.5C) – 
perhaps a reflection of the Th2 ‘adjuvant’ ability of SEA.   
 
Subserosal egg injection proved to be a much more successful route of Ag challenge in 
the intestine, generating an egg-specific response in the draining LN (Fig. 6.6B) and in the 
LP tissue itself (Fig. 6.7B). Although there was only low-level IL-17 and IFNγ production 
stimulated by egg injection, particularly in the MLN, the IL-17 response in the LP was 
significantly above background (Fig. 6.7B). This reflects the fact that both Th17 and IL-17-
producing innate cells are constitutively present in the LP in the small intestine (Cua and 
Tato, 2010; Ivanov et al., 2006; Takatori et al., 2009).  
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In contrast to the data from the SEA restimulation of MLN cells (Fig. 6.6), there was no 
detectable Th2 cytokine production above background from MLN CD4+ T cells by ICC (Fig. 
6.8C) or using the KN2 reporter mice (Fig. 6.7D). This may be due to the use of PMA/ 
Ionomycin to stimulate cytokine production, which is a very potent stimulator of all 
lymphocytes and may cause the death of Ag-specific T cells that are already activated, 
due to overstimulation. A much more relevant ICC protocol would use SEA to restimulate 
Ag-specific cells, however, production of cytokines following in vitro SEA restimulation is of 
course much lower than with a polyclonal stimulus, and there may not be enough Ag-
specific T cells present to provide a reliable readout. An alternative method is to inject 
brefeldin prior to killing experimental mice, any T cells that are producing cytokines in the 
tissues will maintain their cytokine intracellularly, which may be detectable after isolation. 
However, this may also impact on the survival of cells during processing. Our preliminary 
KN2 data suggests that this reporter may be useful for identifying IL-4 production in the 
LP; however, there was no hint of huCD2+ cells in the MLN. More extensive use of IL-4/ 
10/ 13-GFP reporters, in conjunction with the KN2 mice, would allow us to assess whether 
there are cells present in the MLN and LP that are capable of making Th2 cytokines, 
without using any kind of stimulus, which can have artifactual effects on the cytokine 
readout.  
 
We have some preliminary ICC and KN2 data that suggests that CD8+ T cells and B cells 
do not make Th2 cytokines following subserosal egg injection, however, reporter mice will 
enable us to do a more comprehensive analysis of this. There are also a number of other 
cell populations whose contribution to cytokine production in response to subserosal egg 
injection or during S. mansoni we have not yet considered. These include ILC2s, which 
have been shown to be active in the intestine during helminth infection, acting as a source 
of Th2 cytokines, particularly IL-13 (Fallon et al., 2006; Neill et al., 2010; Saenz et al., 
2010). Other cell types to investigate for a role in cytokine production in the intestine are 
γδ T cells, NK cells and intraepithelial lymphocytes (IELs). A large proportion of IELs are 
γδ T cells, these cells are primarily associated with IFNγ production, but have been shown 
to produce IL-4 under specific culture conditions in vitro (Caccamo et al., 2013). Further, 
these cells are expanded during infection with the intestinal helminth Trichinella spiralis 
(Bozic et al., 1998), although their production of cytokines during helminth infection has not 
been shown. Similarly to γδ T cells, NK cells produce IFNγ during viral and bacterial 
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infection, but have also been shown to produce IL-13 during infection with T. spiralis 
(McDermott et al., 2005), however, this population was characterised in SCID mice so it is 
difficult to know what contribution these cells make in immunocompetent mice.     
 
Whilst surgery and subsequent microinjection into the intestinal tissue and manipulation of 
the organ may cause some level of immune activation, PBS injected control mice lacked 
any detectable response. As microinjection is a technically demanding procedure, it is 
perhaps not surprising to find variation in cytokine responses between mice (Fig. 6.6B & 
Fig. 6.7B). This may also account for the variability in the data from our attempts to 
characterise the T cell response in the LP. The LP is a very fragile tissue to work with and 
dead/dying cells can affect the readout. Thus, there is a suggestion that huCD2 expression 
on CD4+ T cells is increased in the LP (Fig. 6.7C), but this did not reach significance (Fig. 
6.7C). Similarly, the ex vivo restimulation ICC readout was also very variable (Fig. 6.8C). 
In a proportion of animals that received S. mansoni eggs subserosally, elevated levels of 
Th2 cytokines were detectable (Fig6.8B-C). It is hypothesised that these mice may have 
been more successfully dosed with eggs than those animals where no change in Th2 
cytokine levels were detectable. To test this, it would be beneficial to perform egg count 
from the intestine to compare the antigen load between different mice. Thus our data 
strongly suggests that subserosal egg injection is a good technique to induce Th2 cytokine 
production from CD4+ T cells in the intestinal tissue, but additional experiments are 
required to confirm this.  
 
Previous work from our lab has shown that the induction of the Th2 response in the liver 
and spleen during S. mansoni infection is dependent on CD11c+ cells (Phythian-Adams et 
al., 2010). Similarly, MLN Th2 responses following infection with the gastrointestinal 
nematodes H. polygyrus and Nippostrongylus brasiliensis, also requires CD11c+ cells 
(Smith et al., 2012; Smith et al., 2011). 
 
In our experiments we use CD11c-DOG mice generated by Hochweller et al. (2008) rather 
than the CD11c-DTR mouse model developed by Steffen Jung (Jung et al., 2002). Both of 
these mouse models express a DTR transgene under the control of the CD11c promoter, 
however, they differ somewhat in the transgenic construct used, also, DOG mice express 
the human DTR, whilst CD11c-DTR mice express a simian receptor. The CD11c-DTR 
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mice only tolerate 1-3 administrations of DTx before they succumb to toxicity, most likely 
due to expression of the DTR on other cell populations, such as IECs (van Blijswijk et al., 
2013; Zammit et al., 2005). To avoid this BM chimeras are generated, WT irradiated 
animals reconstituted with CD11c-DTR BM can survive longer exposure to DTx (Zaft et al., 
2005; Zammit et al., 2005). The use of a BAC construct by Hochweller et al. means that 
the expression of the transgene is more restricted in CD11c-DOG animals and mice 
tolerate up to 11 days of DTx administration without ill effect. After this timepoint it is 
thought the development of DTx-specific antibodies render DTx treatment ineffectual, and 
from this time onwards levels of depletion are reduced (Hochweller et al., 2008). Both of 
these models deplete a number of other cell populations, including some monocyte and 
MΦ populations, plasmablasts, activated T cells and NK cells (van Blijswijk et al., 2013). 
This is particularly problematic in the intestine, where the CD11c-expressing LP MΦ 
population is ablated.  
 
Our results with subserosal injection of S. mansoni eggs into CD11c-DOG mice show that 
CD11c+ cells are also required for the egg-specific response in the MLN, as DTx treatment 
appeared to ablate Th2 differentiation (Fig. 6.10). Repeat experiments will confirm this 
statistically, and also reveal whether LP responses are reduced in the absence of CD11c+ 
cells. CD11c depletion in CD11c-DOG mice removed both LP DCs and MΦ, so it is 
unclear from these experiments which myeloid population is required for the induction of 
the egg-specific response in the LP and MLN. This could be addressed using a more 
specific depletion model such as zDC-DTR mice, where DTx administration selectively 
depletes populations that express the cDC-specific TF Zbtb46 (Meredith et al., 2012). 
Additionally, depletion type experiments also do not tell us whether DCs migrating from the 
LP actually prime the MLN response, or what contribution Ag draining directly to the LN, 
and MLN-resident cells, make to presentation to and polarisation of Th2 cells. This is why 
lymphatic cannulation will be such a useful tool, enabling us to identify whether egg 
deposition induces DC migration from the LP, and to characterise these cells both 
phenotypically and functionally. So far, we have found it difficult to identify whether DCs 
exposed to schistosome egg Ags migrate more readily than cells in the steady state 
(Chapter 2). Cannulation after subserosal egg injection will provide an ideal way to 
address this question, as we will be able to identify whether egg injection increases the 
number of cells migrating away from the intestine, compared to controls. 
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If infection or subserosal egg injection does stimulate increased DC migration, this will 
provide important information on the contribution of the different DC subsets in 
orchestrating the egg-specific Th response. Previous studies have identified the CD103+ 
CD11b+ DC subset as the primary migratory population that primes T cell responses in the 
MLN during the induction of Th1 and Th17 responses (Jaensson et al., 2008; Persson et 
al., 2013; Satpathy et al., 2013; Schulz et al., 2009). However, CD103+ CD11b- cells (30%) 
and CD103- CD11b+/- cells (15%) make up substantial proportions of DCs in intestinal 
lymph (Cerovic et al., 2012), thus a potential role for these subsets cannot be discounted. 
We plan to assess the importance of CD103+ CD11b- DCs using Batf3-/- mice, which are 
deficient in CD8α+ DCs (Hildner et al., 2008), and selectively lack the CD103+ CD11b- DC 
subset in the LP and other nonlymphoid tissues in the steady state (Edelson et al., 2010). 
However, compensatory mechanisms can partially rescue CD8α+ DC differentiation in the 
spleen and CD103+ CD11b- DCs in the tissues in Batf3-/- mice during inflammatory 
responses (Tussiwand et al., 2012). This response seems to be particularly driven by Th1 
cytokines, such as IL-12 (Tussiwand et al., 2012), thus it is entirely possible that there will 
be no compensation in the intestines of Batf3-/- mice during S. mansoni infection. An 
alternative approach would be the use of Irf8-/- mice, which also lack both CD103+ CD11b- 
and CD8α+ DCs (Edelson et al., 2010; Ginhoux et al., 2009; Tamura et al., 2005). IRF4 is 
required for CD11b+ DC differentiation (Suzuki et al., 2004; Tamura et al., 2005), in the 
absence of this TF in CD11c cells, the CD103+ CD11b+ DC subset are ablated in the LP 
and MLN (Persson et al., 2013). The caveat of these mice is that the CD103- CD11b+ 
population is also reduced in the steady state LP and in the MLN, however this population 
is restored under inflammatory conditions (Persson et al., 2013). Development of this 
subset is also dependent on Notch2 signalling and is completely ablated in Cd11c-
cre.Notch2fl/fl mice (Satpathy et al., 2013). These mouse models may be useful to assess 
the role of this particular DC subset in the induction of the egg-specific response following 
subserosal egg injection or during patent S. mansoni infection.  
 
The surgical egg injection model offers several advantages over natural infection. From 
our analysis of LP DCs and MΦ during S. mansoni infection (Fig.6.2- Fig.6.4), we would 
perhaps not expect to see any change in the surface phenotype of these cells following 
subserosal egg injection. However, this model provides a unique opportunity to study how 
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intestinal DCs respond to egg deposition, as it is impossible to know precisely when eggs 
have been laid during patent infection. DC activation should be assessed at early 
timepoints after injection. Our timecourse experiments using FLDCs suggest that surface 
activation in response to SEA is detectable on these cells from 6h onwards (Fig. 3.4A). We 
have also detected gene expression changes in splenic DCs within 12h after intravenous 
SEA injection (Fig. 5.1D-E). These data suggest that, if egg injection were to stimulate DC 
activation, phenotypic changes may be detectable within the first few hours.  
 
There are a huge number of exciting potential experiments that would be an extension of 
the preliminary data we have from the subserosal egg injection model. The priority is 
certainly to identify which CD11c+ cell populations are involved in the egg-specific Th2 
response in the intestine and MLN, using the depletable or knockout models discussed 
above. We also want to do these same experiments during patent infection. Prior to 
performing cannulation experiments during patent infection, it will be informative to perform 
these studies in the subserosal egg injection model to assess the DC populations 
mobilised from the intestine following injection. Prior to commencing these studies we 
need to do a similar experiment as performed in MLNX S. mansoni infected mice, in order 
to assess whether removal of the MLN impacts on the development of the egg-specific 
response in this setting. 
 
We have begun to address the cytokine production in the LP and MLN following egg 
injection, in both settings we plan to use cytokine reporter mice to fully investigate which 
cell populations are actively involved in the cytokine response. Whilst initial experiments 
have concentrated on subserosal LP egg injection, S. mansoni worms primarily lay their 
eggs in the vasculature that surround the PP (Turner et al., 2012). Thus, egg injection into 
the PP could be incorporated into this model to increase the relevance to patent infection. 
Currently, we have been using PBS as a control in the egg injection experiments, a better 
control would be latex beads, which may better mimic the presence of a solid mass 
disrupting the tissue lining of the gut.  
 
The subserosal egg injection model could also be developed further to allow controlled/ 
refined assessment of intestinal granuloma formation. Currently, the primary model of 
granuloma formation around schistosome eggs is a pulmonary model, which involves 
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intravenous injection of eggs (Edungbola and Schiller, 1979; Eltoum et al., 1995). A similar 
method modelling S. haematobium egg deposition in the bladder wall has been developed 
(Fu et al., 2012). Injecting live S. haematobium eggs into the bladder induced pathology 
and an influx of innate effector cells, such as eosinophils and neutrophils (Fu et al., 2012). 
By d28 organised granulomas were detectable in the bladder wall. Granuloma formation 
can be induced more quickly by prior sensitisation with eggs or SEA intraperitoneally, 
which is the favoured method for inducing granuloma formation in the lung in the 
pulmonary model (Joshi et al., 2008; Wynn et al., 1997). Pre-sensitisation prior to 
subserosal egg injection may actually provide a better mimic of active infection, as in this 
setting the host is exposed to systemic parasite Ag from the larval, worm and egg stages 
that will influence the response to egg deposition, due to prior APC and T cell activation by 
these schistosome Ags. Thus, pre-sensitisation followed by subserosal egg injection would 
provide a novel model with which to characterise the development of granulomas against 
S. mansoni eggs in a highly relevant tissue site. With the addition of the different DC-
depleting mouse models we will also be able to characterise the role of the DC subsets in 
the formation of granulomas in the intestine.    
 
Fu et al. (2012) used freshly isolated live eggs in their experiments, whilst we have only 
injected dead eggs up to this point. The distinct advantage of injecting live eggs is that it is 
much more analogous to patent infection, as live eggs actively secrete Ags that stimulate 
the immune response, including omega-1, the primary Th2-polarising Ag in SEA (Everts et 
al., 2009; Steinfelder et al., 2009). For this reason, live eggs are more likely to stimulate 
eosinophilia and the formation of organised granulomas. A disadvantage of injecting live 
eggs is that they must be harvested and purified from infected animals directly prior to 
injection, which must be worked in to an already complex experimental setup. Another 
possibility is harvest of freshly laid eggs from cultured perfused adult worms, this is also 
technically challenging, however, as worms do not live or continue to lay eggs very long in 
vitro (Galanti et al., 2012). However, a better understanding of the nutritional requirements 
of cultured female worms for egg laying, in particular, the importance of fatty acid 
metabolism (Huang et al., 2012), has the potential to improve fecundity of schistosome 
parasites in vitro, which could be used as a source of live eggs for injection. The benefit of 
using eggs from cultured worms is that it would require no tissue processing on the day of 
injection. A lack of any tissue processing (above and beyond worm perfusion) is also 
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beneficial, as eggs will not be negatively impacted by mechanical or enzymatic disruption, 
which is required for the purification of eggs from tissues. It has previously been shown 
that extraction methods can alter the immunogenic properties of schistosome eggs (Hirata 
et al., 1991). 
 
Overall, we have developed a model of synchronous S. mansoni egg delivery to the 
intestine that polarises an Ag-specific Th2 response in the LP and MLN. Induction of the 
Th2 response in this model depends on CD11c+ cells, thus providing an ideal system to go 
on to dissect the roles of the different myeloid cell populations in priming immune 
activation and Th2 polarisation against egg deposition. Future experiments with this model 
will inform and enhance our studies of the intestinal response to patent S. mansoni 
infection.  
 
6.3.3 S. mansoni infection and the consequent Th2 response develop normally in 
mice lacking MLN                       
Future work will include more detailed analysis of the phenotype and function of intestinal 
DCs during helminth infection; particularly, we plan to use the intestinal site to test the 
relevance of our findings with FLDCs and IFN-I. Although our egg injection models provide 
great models with which to investigate these areas, it is also necessary to examine 
whether these findings are reproducible in the more complex setting of infection. In order 
in the future to be able to develop lymphatic cannulation to study the DCs mobilised from 
the intestine during S. mansoni infection, we first had to address whether mesenteric 
lymphadenectomy would negatively impact on parasite development or the induction of the 
immune response. Thus, we infected intact or lymphadenectomised mice with S. mansoni 
cercariae 28d after surgery, and assessed parasitology and immunology in these animals 
on d56 of infection.  
 
The development of adult worms was clearly unaffected by the absence of MLN, as the 
number of worm pairs was comparable in intact and MLNX mice (Fig. 6.11C). The adult 
worms reside and deposit their eggs within the mesenteric blood vessels (Gryseels et al., 
2006), thus it was possible that surgical removal of the MLN could cause damage to the 
vasculature and negatively impact on worm fecundity or egg deposition. However, this 
proved not to be the case as egg burden (Fig. 6.11D) and egg production per worm pair 
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(Fig. 6.11E) was comparable in intact and MLNX infected mice. Similarly, there was no 
defect in the Th2 response in the liver or spleen of MLNX animals (Fig. 6.12). The only 
significant difference between the infected groups was an increase in Ag-specific IL-13 
induction in the spleen of MLNX mice (Fig. 6.12B). Following mesenteric 
lymphadenectomy, the lymphatic vessels heal, allowing intestinal lymph to flow into the 
thoracic duct (Milling et al., 2006). The thoracic duct drains into the blood system, thus any 
cells migrating from the intestine in MLNX mice will eventually reach the spleen. This may 
explain why IL-13 levels are enhanced in the spleen of infected MLNX animals, although 
there was no concurrent increase in the other Th2 cytokines in these mice (Fig. 6.12B). 
 
Given that parasite development is not affected in the absence of the MLN, it is perhaps 
unsurprising that the immune response is also intact. The immune system is clearly able to 
compensate for the absence of this secondary lymphoid organ. Studies of S. mansoni 
infection in splenectomised mice indicate that the immune response is also intact in mice 
lacking a spleen (Arruda et al., 1993; Hood and Boros, 1980; Mahmoud and Woodruff, 
1978). As outlined above, it is likely that the spleen is the primary organ to compensate for 
the lack of MLN following lymphadenectomy. We have yet to establish whether the Th2 
response or pathology is altered in the intestine itself in MLNX mice. DCs in the MLN 
uniquely prime gut-homing T cells (Johansson-Lindbom et al., 2005), so it is possible that 
there may be some defect in the generation of these cells in MLNX mice. However, it is 
likely that LP DCs which are responsible for priming gut-homing T cells migrate to the 
spleen and are able to mobilise gut-tropic CD4+ T cells from there instead. This could be 
assessed by analysing the expression of the gut-homing markers CCR9 and α4β7 on the 
T cells found in the spleen of MLNX mice during infection, particularly those that are 
producing Th2 cytokines. No weight loss was recorded for MLNX mice (Fig. 6.11B), 
indicating that the immune response was functional in both the liver (Fig. 6.12B) and the 
intestine of these mice, as cachexia is associated with severe hepatic and intestinal 
damage in S. mansoni infection (Brunet et al., 1997; Herbert et al., 2010). There was also 
no dramatic alteration in the immune cell populations in the liver or spleen during infection 
(Fig. 6.13 and Fig. 6.14), however, there was a minor increase in CD4+ T cells in the livers 
of infected mice, and in the spleen of naïve MLNX animals. There was also an increase in 
CD4+ T cells in the spleens of MLNX infected animals, although not significant, this 
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increase may account for the fact that IL-13 production was enhanced at this site (Fig. 
6.12). 
 
Having confirmed that acute S. mansoni infection develops normally, we can now go on to 
directly address whether myeloid cells are mobilised from the intestine during infection, 
and to characterise these cells. This will provide the first opportunity to elucidate the 
contribution of LP-resident DC subsets in the induction of Th2 inflammation in the 
intestine. These studies will be further enhanced by direct comparisons of the phenotype 
and function of the different DC subsets in the LP and lymph with those found in the MLN. 
Experiments in this final chapter have demonstrated that CD11c+ cells are likely to be 
essential to the induction of Th2 responses in the intestine. However, DCs and MΦs in the 
SI LP downregulate surface expression of molecules required for T cell polarisation during 
the acute stage of S. mansoni infection, suggesting that immune regulation may modulate 
the phenotype of these cells as egg burden is increased. Development of an egg 
challenge model in the intestine will allow comprehensive functional characterisation of the 
intestinal DC subsets, and enable us to study how the different subsets contribute to 
immune activation following egg deposition. 
Figure 6.1 Myeloid populations in the lamina propria of the small intestine in the steady-
state.  
Identification of F4/80+ and F4/80- MHC IIhi cell populations in the SI LP by flow cytometry, 
gating on live-singlet CD45+ cells (A). Eosinophils (Siglec-F+), inflammatory monocytes (Gr1mid) 
and neutrophils (Gr-1hi) are excluded. Within the F4/80- gate, the MHC IIhi CD11c+ LP DCs are 
further subdivided into 4 sub-populations according to their expression of CD103 and CD11b 
(A). F4/80+ MHC IIhi LP MΦ expression of CD11c, CD11b and CX3CR1 in a CX3CR1-eGFP 
mouse (B). Expression of CX3CR1 (C), CD103 (D) and the co-stimulatory molecules CD80 (E) 
and CD86 (F) on the LP DC subpopulations and on LP MΦ, gated as described. Grey-shaded 
histogram is C57BL/6 mouse (non-GFP, C) or isotype control (D-F). Fluorescence minus one 
(FMO) controls for all DC subsets are the same due to low numbers of cells collected (C-F). 












































































































































Figure 6.2 The proportions of LP MΦ and DC subsets in the small intestine are 
unaffected at d42 of S. mansoni infection.  
SI LP cells were purified from naïve or d42 S. mansoni infected mice and live-singlet 
Ly6C- cells analysed by flow cytometry for characterisation of F4/80+ MHC IIhi and 
F4/80- MHC II+ CD11c+ cell populations (B), high SSC cells were excluded from this 
analysis. CD11c+ cell populations were further characterised by their expression of 
CD103 and CD11b. The proportions of F4/80+ MHC IIhi (LP MΦ) and F4/80- MHC II+ 
CD11c+ (LP DC) were calculated as a percentage of total intact cells (C). The proportion 
of the different LP DC populations, defined by CD103 and CD11b expression, were 












































































































































































































































































































































































Figure 6.3 By d56 of infection, there is an influx of Ly6Chi cells into the SI LP and changes 
in the make up of the DC populations. 
SI LP cells were purified from naïve or d56 S. mansoni infected mice and live-singlet Ly6C- cells 
analysed by flow cytometry for characterisation of F4/80+ MHC IIhi and F4/80- MHC II+ CD11c+ 
cell populations (A), high SSC cells were excluded from this analysis. CD11c+ cell populations 
were further characterised by their expression of CD103 and CD11b. Total cell numbers from 
processed intestine samples from naïve (N) and S. mansoni infected (d56) mice (B). The 
proportions of Ly6C+CD11b+ (inflammatory monocytes), F4/80+ MHC IIhi (LP MΦ) and F4/80- 
MHC II+ CD11c+ (LP DC) were calculated as a percentage of total intact cells (C). The proportion 
of the different LP DC populations, defined by CD103 and CD11b expression, were calculated as 
a percentage of the total LP DCs in that sample (E). The number of cells from each population 
was calculated using the total cell numbers and the percentages calculated from flow analysis 
(D, F). Further characterisation of the markers expressed by the inflammatory monocyte 
population in the LP of an infected animal (G). Data representative of 2 mice (naïve) and 3 mice 













Figure 6.4 SI LP APCs downregulate their expression of co-stimulatory 
markers at later stages of S. mansoni infection.  
SI LP cells were purified from naïve, d42 (A) or d56 (B-C) S. mansoni infected mice 
and live-singlet Ly6C- LP DC and LP MΦ populations analysed by flow cytometry 
for their expression of co-stimulatory molecules, CD40 at d42 (A), CD40 and CD86 
at d56 (B-C). Values on histograms are gMFI for co-stimulatory expression (A-B). 
Grey-shaded histogram is isotype control (A-B). FMO controls for all DC subsets 
are the same due to low numbers of cells collected (A-B). GMFI was calculated for 
CD86 expression on naïve and d56 LP DCs and MΦ (C). Data representative of 2 
mice (naïve) and 3 mice (d42/56 infected). Data representative of 2 experiments 




































































































Figure 6.5 Oral administration of SEA or S. mansoni eggs has a low level effect on 
T cell cytokine responses in the MLN. 
PBS, SEA (10, 25, 50, 100µg) or S. mansoni eggs were administered by oral gavage. 7d 
later, mLN were harvested and stimulated with SEA or anti-CD3. Cell supernatants were 
harvested 72h later for analysis of cytokine production by ELISA. SEA-specific recall 
response (B) and αCD3-stimulated response (C), medium background subtracted. Data 
from 1 experiment, 3 mice per group. *P<0.05, statistical analysis is compared to PBS 


























































































































































































Figure 6.6 Subserosal egg injection into the small intestine leads to Th2 
responses in the MLN. 
Following exposure of the small intestine under anaesthetic, PBS or S. mansoni eggs 
were injected at several points along the length of the small intestine. 7d after injection, 
MLN were harvested and cells restimulated with SEA. Cell supernatants were collected 
72h later for cytokine analysis by ELISA. Data representative of 4 experiments, 3-4 
mice per group. Medium background subtracted. *P<0.05, **P<0.01, ****P<0.0001.   
A. 
1000 eggs injected into 


















































































Figure 6.7 Subserosal egg injection into the small intestine leads to Th2 
responses in the lamina propria.  
Following exposure of the small intestine, under general anaesthetic, PBS or S. 
mansoni eggs were injected at several points along the length of the small intestine. 
Small intestines were harvested 7d after injection, processed to purify PP and LP cells. 
Cells were restimulated with SEA and supernatants were collected 72h later for 
cytokine analysis by ELISA (B). Cells were stained for flow cytometry, and the presence 
of huCD2+ CD4+ T cells was analysed in the LP (C), MLN & PP (D). Gated on 
CD45+TCRβ+CD4+ live singlets (C-D). Data representative of 1 (C-D) or 2 experiments 
(B), 3-4 mice per group. Medium background subtracted (B). *P<0.05, **P<0.01, 
****P<0.0001.  
A. 
1000 eggs injected into 











































































































































Figure 6.8 Successful subserosal egg injection into the small intestine leads to 
Th2 cytokine production by CD4+ T cells in the lamina propria.  
7d after subserosal egg injection, small intestines and MLN were harvested, purified LP 
and MLN cells were stimulated with PMA/ Ionomycin plus Golgi stop. Cells were then 
stained and analysed for cytokine production by flow cytometry (B), and the percentage 
of cytokine+ CD4+ T cells calculated (C). Gated on live-singlet TCRβ+CD4+ cells (B). A 
‘successful’ injection was defined by the proportion of TCRβ+CD4+ cells expressing high 
levels of the Th2 cytokines, IL-4, IL-5 and IL-13 (B). Data from 1 experiment, 3-4 mice 
per group.  
A. 
1000 eggs injected into 












































































































































Figure 6.9 DTx treatment of CD11c-DTR mice leads to depletion of 
CD11c+ cells in the MLN and the LP of the small intestine of PBS and 
egg-injected animals.  
Mice were injected with PBS or DTx i.p. for 2d prior, and for 6d after, 
subserosal egg injection. 7d after subserosal egg injection, small intestines 
and MLN were harvested, purified LP and MLN cells were stained and 
analysed by flow cytometry. Example gating in the LP of PBS- and DTx-
treated animals (B). Gated on live-singlet CD45+ cells, eosinophils (SiglecF+), 
neutrophils (Ly6G+) and inflammatory monocytes (CD11b+Ly6Chi) are 
excluded from these plots. Percentages of macrophages (MΦ, F4/80+) in the 
LP (C), and DC (CD11c+MHC II+) percentages in the LP and MLN (D) were 
calculated. (-) represents C57 BL/6 untreated mice. Data from 1 experiment, 





































































Figure 6.10 DTx treatment of CD11c-DTR mice greatly reduces 
the Th2 response in the mLN following subserosal egg 
injection.  
Mice were injected with PBS or DTx i.p. for 2d prior, and for 6d 
after, subserosal egg injection. 7d after egg injection, mLN were 
harvested, and mLN cells were restimulatd with SEA. 72h later cell 
supernatants were collected and analysed for cytokine secretion 









































































































































Figure 6.11 S. mansoni-infected mesenteric lymphadenectomy mice show similar 
parasitology and pathology in comparison to their intact counterparts.  
MLNX mice underwent surgical removal of the mesenteric lymph nodes. 28d after surgery, a 
proportion of MLNX and intact animals were infected with 40 S. mansoni cercariae. Mouse 
weights were recorded from d35 of infection and weight change calculated over the following 
14 days (B). On d56 of infection, animals were perfused via the heart under terminal 
anaesthesia. Body and organ weights were recorded, and liver and intestine samples taken 
for overnight digestion for egg counts (D). Worm counts were performed on perfusate (C). 
Eggs per worm pair were calculated from these counts (E). Splenomegaly and hepatomegaly 
were assessed by determining spleen and liver (F) size in relation to total body weight for 
uninfected and infected intact and MLNX mice. 5 mice (naïve) or 6-7 mice (infected groups). 
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Figure 6.12 Th2 cytokine responses are unaffected in S. mansoni-
infected mice lacking MLN.  
MLNX mice underwent surgical removal of the mesenteric lymph nodes 
(MLNX). 28d after surgery, a proportion of MLNX and intact animals were 
infected with 40 S. mansoni cercariae. On d56 of infection, livers and spleens 
were harvested and cells restimulated with SEA. After 72h of culture, cell 
supernatants were harvested and analysed for cytokine secretion. 5 mice 
(naïve) or 6-7 mice (infected groups). Medium background subtracted. Data 
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Figure 6.13 MLNX has a minor impact on lymphocyte populations in the liver of S. mansoni 
infected mice. 
On d56 of infection, livers were harvested and prepared for FACS analysis. After processing, total 
cell numbers were calculated per sample (A). Cells were gated on live, intact-singlets. Proportions 
of cell populations were calculated as a percentage of intact live-singlets, using event counts for 
each population (B). Actual numbers of cell populations was calculated from cell counts using 
percentages from flow analysis (C). Livers from 5 mice pooled (naïve) or 5 individual livers 
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Figure 6.14 MLNX has a minor impact on lymphocyte populations in the spleen of S. 
mansoni infected mice. 
On d56 of infection, spleens were harvested and prepared for FACS analysis. After processing, 
total cell numbers were calculated per sample (A). Cells were gated on live, intact-singlets. 
Proportions of cell populations were calculated as a percentage of intact live-singlets, using event 
counts for each population (B). Actual numbers of cell populations was calculated from cell counts 





At the outset of the work detailed in this thesis, whilst there was some understanding of 
how DCs respond to helminth Ag, much remained unexplained about the complexity of DC 
activation and function in the context of the Th2 response. By systematically assessing the 
phenotype and function of Flt3-L-dependent DCs to S. mansoni egg Ags, with a focus on 
the role of IFN-I in this context, then beginning to link the results generated in those 
experimental systems to relevant in vivo settings, including egg or Ag injection and murine 
models of helminth infection, we have advanced our understanding of a number of key 
areas of DC orchestration of Type 2 immunity. Moreover, we have provided a platform for 
future work expanding on this, which will delineate the importance of IFN-I in Th2 settings 
and the involvement of intestinal DCs in immune activation against helminths.  
 
Different DC subsets have distinct roles in the management of immune activation, and it is 
becoming increasingly clear that this is particularly the case in the context of Th2 
responses. We have demonstrated for the first time that Flt3-L dependent DCs respond to 
S. mansoni soluble egg Ags in a subset-specific manner.  
 
7.1 Surface activation of Flt3-L dependent DCs by SEA 
Previous studies using GMDCs have demonstrated that these cells are not phenotypically 
activated by exposure to SEA (MacDonald et al., 2001; Perona-Wright et al., 2006a).  
However, we have found that Flt3-L dependent cDCs displayed a level of surface 
activation in response to SEA, upregulating expression of MHC II and co-stimulatory 
molecules (Fig. 3.2). However, SEA elicited an intermediate activation phenotype, as 
expression levels of co-stimulatory molecules were somewhat lower than those of 
classically activated DCs exposed to the bacteria St.  
 
Whilst Flt3-L generated pDCs did become activated by SEA, their level of surface 
activation was several orders of magnitude below that displayed by the Flt3-L dependent 
cDC subsets. This suggests that pDCs would not be capable of priming SEA-specific T 
cells, a hypothesis that is supported by other recent work in the lab that has shown that 
pDCs purified from the livers of S. mansoni infected mice can only initiate proliferation of 
pre-activated, or memory, T cells (Rachel Lundie et al., manuscript submitted).  
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7.2 SEA-specific cytokine production by Flt3-L-dependent DCs  
GMDCs do not produce cytokines in response to SEA (MacDonald et al., 2001; Perona-
Wright et al., 2006a), indeed, limited cytokine production is a hallmark of the response of 
DCs to helminths in general, not only S. mansoni (Balic et al., 2004; MacDonald and 
Maizels, 2008; Segura et al., 2007; Whelan et al., 2000). This is likely to be an evolved 
response that favours both the host and the parasite (Dunne and Cooke, 2005; Everts et 
al., 2010b). In natural infection, helminths may persist within the host for many years, 
meaning that the host is continuously exposed to parasite Ags for an extended period. By 
avoiding excessive and prolonged immune activation - which would be the likely outcome 
if DCs did produce large quantities of cytokines in response to helminth Ag - the host is 
protected from damaging immunopathology. A moderate response also benefits the 
parasite, as muted effector activity, alongside immune regulation, seems to favour 
helminth survival and fecundity (Dunne and Cooke, 2005; Everts et al., 2010b). 
Persistance of the parasite is dependent on host survival, thus helminths benefit from a 
muted immune response that does not cause severe morbidity or mortality. This may also 
explain why helminth Ags can act to directly inhibit classical DC activation by bacteria and 
defined TLR ligands (Carvalho et al., 2009) – dampening any resultant immune activation 
against bystander pathogens that could impact on parasite survival.  
 
We have demonstrated that FLDCs produced only very low-levels of the innate cytokines 
commonly associated with classical DC activation – for example IL-12, IL-6, TNFα – 
following exposure to SEA. Unexpectedly, however, an SEA-specific IFN-I signature was 
identified, with the CD24+ cDCs (the in vitro-generated CD8α+ cDC equivalents) alone 
secreting SEA-specific IFN-I. This surprising finding raises a number of fundamental 
questions: Why is it that CD24+ cDCs uniquely produced IFN-I following exposure to SEA? 
What are the ligands and receptors that orchestrate the IFN-I response of DCs to SEA? 
Why would DCs produce IFN-I in a Th2 setting, when this cytokine is normally more clearly 







7.2.1 Why is the SEA IFN-I response not seen in all DC subsets? SEA sensing and 
signalling pathways in the IFN-I response  
The most likely explanation for why only CD24+ cDCs produced IFN-I in response to SEA 
is that only this subset expresses the PRR(s) and/or signalling molecules necessary to 
activate this response. Thus in the process of investigating why the IFN-I response is 
unique to CD24+ cDCs, we hope to delineate the PRRs that orchestrate this response. In 
beginning to address this, we have shown that SEA-specific IFN-I production by FLDCs is 
wholly dependent on the adaptor protein TRIF, whilst optimal IFN-I induction also requires 
CD205. This CLR is selectively expressed by CD8α+ cDCs in vivo (Henri et al., 2001; 
Vremec et al., 2000), and is most likely restricted to CD24+ in vitro-generated cDCs.  
 
Given that the IFN-I response to SEA appears to be unique to CD24+ cDCs and is 
dependent on TRIF, we hypothesise that TLR3 is involved, as amongst FLDCs, this 
receptor is expressed uniquely by the CD24+ subset, and is not present at high levels in 
GMDCs (Jelinek et al., 2011; Naik et al., 2005). However, we were not able to detect any 
significant activation of a TLR3 reporter cell line by SEA (Section 3.2.8, Fig. 3.9). This 
discrepancy may be explained by the involvement of a distinct TRIF-dependent PRR, such 
as a cytosolic helicase sensor that is involved in nucleic acid sensing (Zhang et al., 
2011a). Alternatively, CD205 (and potentially other CLRs) may be essential intermediaries 
that are required for SEA-specific IFN-I induction (Fig. 7.1).  
 
CLRs, such as CD205, may enable or enhance uptake of bioactive SEA ligands that may 
be involved in the generation of further immunostimulatory Ags. It has already been shown 
that the ability of omega-1, a glycoprotein present in SEA, to activate Th2 responses is 
dependent on its RNase function (Everts et al., 2012; Steinfelder et al., 2009). MR 
mediates omega-1 uptake and in the absence of DC MR expression, omega-1 fails to elicit 
Th2 responses (Everts et al., 2012). This raises the interesting question of whether 
omega-1 – and other SEA glycoproteins – can generate nucleic acid ligands that stimulate 
the IFN-I response, following uptake by CLRs. 
 
Another CLR, Dectin-1, can initiate IFN-I production via a distinct pathway (Del Fresno et 
al., 2013), thus it should not be ruled out that CD205 ligation by SEA activates IFN-I 
production directly. It is also possible that CD205 and a TRIF-dependent receptor 
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synergise in the activation of SEA IFN-I, as has previously been shown to occur when 
Dectin-1 and MyD88-dependent TLRs are activated simultaneously (Dennehy et al., 
2008). Given that SEA is made up of a diverse and complex mixture of different Ags – 
including glyocproteins, lipids, carbohydrates and nucleic acids (Aksoy et al., 2005; Ashton 
et al., 2001; Dunne et al., 1991; Mathieson and Wilson, 2010; Meevissen et al., 2011; 
Verjovski-Almeida et al., 2003) - it is feasible that one SEA Ag activates CD205, whilst 
another stimulates TRIF-dependent receptor(s), leading to SEA-specific IFN-I production 
(Fig. 7.1).  
 
It is known that many Ags in SEA, including the most potent immune activators, are CLR 
ligands (Meevissen et al., 2011), and it had seemed that TLRs were not essential for 
recognition of SEA by DCs or for immune activation during S. mansoni infection (Jankovic 
et al., 2004; Layland et al., 2005; Vanhoutte et al., 2008). However, our findings suggest 
that there may be synergy of different PRR pathways for optimal immune activation 
against S. mansoni egg Ags. The discovery that MyD88 can negatively regulate the SEA-
specific IFN-I response is further evidence that there is a complex interplay of receptor-
signalling pathways in the recognition of these Ags.  
 
Our finding that the CLR CD205 is involved in the induction of SEA-specific IFN-I suggests 
that Ag(s) involved in this response include glycoproteins or carbohydrate ligands. This is 
in agreement with other studies that have identified a number of CLRs capable of 
recognising components of SEA (Everts et al., 2012; Meevissen et al., 2012; Meevissen et 
al., 2011; van Die et al., 2003). The involvement of TRIF suggests that nucleic acid ligands 
may also be involved in the activation of this response, as TRIF-dependent TLR3 and the 
cytosolic helicase nucleic acid sensors both recognise dsRNA (Alexopoulou et al., 2001; 
Zhang et al., 2011a). However, TRIF is also involved in mediating signals following TLR4 
activation, which recognises a range of ligands, including LPS, and the carbohydrate 
ligand LNFPIII present in SEA (Thomas et al., 2003). Thus, there are as many potential 
ligands involved in the IFN-I response as potential PRR pathways.  
 
Further work is required to identify the specific ligands and receptors that orchestrate the 
IFN-I response, and to address their importance for immune activation against S. mansoni. 
Thus far we have performed a number of studies using BMDCs deficient in specific PRRs 
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or adaptor proteins to establish their role in IFN-I induction. In the future we would like to 
assess the role of the TRIF-dependent TLRs using TLR3 and TLR4 deficient cells. 
However, with our hypothesis that a number of different receptors may be involved, 
microarray analysis of the gene expression changes of FLDC subsets following exposure 
to SEA is a key experiment. This will enable us to perform network analysis to identify the 
different signalling pathways up or downregulated in response to SEA, as well as 
potentially identifying the specific TFs involved in IFN-I activation, and other ISGs 
upregulated in response to SEA. This will give us a much greater understanding of the 
SEA-specific IFN-I signature and the potential importance of this for Th2 polarisation by 
Flt3-L dependent DCs.  
 
At the moment we have a number of different candidate pathways and TFs that may be 
involved in IFN-I induction or activated downstream of IFNAR. Whilst the transcription of 
some of these factors may be upregulated in DCs exposed to SEA, the expression of 
many will remain unchanged. Instead, they will become activated by phosphorylation. 
Phosphoproteomic analysis would identify the signalling molecules and TFs that are 
phosphorylated following exposure to SEA, providing a fuller picture of the cellular 
changes in FLDCs that may be involved in SEA sensing. This technique has already been 
used to characterise the phosphorylation events in T cells following TCR ligation (Navarro 
et al., 2011), but there have been no published studies in DCs as yet.     
 
7.2.2 The importance of SEA IFN-I for DC function in Th2 settings 
The discovery of an SEA-specific cytokine signature is a novel and exciting finding in the 
world of Th2, given that no such signal has previously been identified. However, it is 
unlikely that IFN-I is the elusive ‘signal 3’ required for Th2 induction, given that GMDCs 
readily polarise Th2 responses but fail to secrete IFN-I in response to SEA (Fig. 3.6C). In 
light of this, why do Flt3-L-dependent DCs produce IFN-I in response to SEA? Our 
hypothesis is that IFN-I acts in an autocrine manner to maximise DC functionality in 
response to helminth Ag. We have shown that optimal FLDC responses to SEA depended 
on their ability to respond to IFN-I. SEA-specific Th2 polarisation by FLDCs in vivo was 
entirely ablated in the absence of IFNAR (Fig 4.6). However, IFNAR-deficient FLDC 
function in vitro was unaffected (Fig. 4.11-Fig.4.13). This discrepancy immediately 
suggested to us that FLDC migration might be the key factor affected by IFNAR deficiency. 
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DC migration in response to helminth Ags is another major unknown in the Th2 field. 
Despite expressing relatively low-levels of CCR7 in response to SEA, FL-cDCs migrated 
effectively to the dLN. In support of our hypothesis that IFNAR is required for effective 
FLDC migration, CCR7 expression was reduced on IFNAR-deficient cDC subsets (Fig. 
4.14). However, we are yet to show definitively that IFNAR is required for FL-cDC 
migration. 
 
Intriguingly, ligation of IFNAR leads to the activation of the GTPase Rap1 (Lekmine et al., 
2002). This GTPase is able to activate a range of effector proteins involved in cellular 
processes. One such effector protein is RapL. RapL and Rap1 are crucially involved in DC 
adhesion and motility. In the absence of RapL, DC ability to adhere to the integrin ICAM-1 
via LFA-1, is severely reduced, and DC migration to and localisation within lymphoid 
organs is defective (Katagiri et al., 2004). Given that LFA-1 is also involved in the 
formation of the immunological synapse between DCs and T cells (Balkow et al., 2010; 
Brossard et al., 2005), it is likely that Rap1 effectors are also involved in this process. It is 
tempting to speculate that a deficiency in IFNAR function would impact on the activity of 
the Rap pathway, leading to defective DC migration, localisation and T cell interactions. 
Thus, we may have identified in IFN-I an important factor that facilitates the migration of 
Flt3-L dependent DCs. Further investigations of these processes will enhance our 
understanding of DC mobilisation and function in Th2 settings. The subserosal egg 
injection model, along with the development of the cannulation technique, provides an 
ideal tool to study the migration of resident DCs following exposure to helminth Ag, in a 
site that is relevant to S. mansoni infection. This model will allow us to further dissect the 
importance of IFNAR for efficient DC migration from peripheral tissues to the dLN. 
  
7.3 The role of IFN-I in helminth-induced Th2 inflammation    
We have begun to address the impact of IFN-I in vivo during patent murine helminth 
infection. Th2 cytokine levels were ablated in the MLN of S. mansoni and H. polygyrus 
infected IFNAR-deficient mice (Fig. 5.7C and 5.9D). Intriguingly, no dramatic reduction in 
the Th2 cytokine output was detected in the liver of S. mansoni infected IFNAR-deficient 
mice (Fig. 5.7B). It is not yet known whether granuloma formation or long-term host 
survival is affected in the absence of IFNAR, thus longitudinal studies are required to 
address these questions in both infection models.  
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Helminth infection is complex, with parasites - or their eggs - causing damage to tissues, 
whilst many other sites are exposed to systemic Ag. The immune response in S. mansoni 
and H. polygyrus infection is predominantly polarised towards Th2; however, there are 
also elements of Th1 and Th17 activation, as well as regulatory responses. For example, 
at the early stages of S. mansoni infection, prior to egg laying, the immune response is 
mixed Th1-Th2. Commencement of egg deposition stimulates a strongly Th2 dominated 
response, and at the chronic stages of infection, regulation comes to the fore (Pearce and 
MacDonald, 2002). Thus, various timepoints and tissue sites must be considered to 
facilitate meaningful understanding of the role of IFN-I and IFNAR during helminth 
infection. Looking at one stage of infection or at one specific tissue will not provide a 
credible or comprehensive interpretation.   
 
Given that we have identified a dichotomy between FLDCs and GMDCs in the requirement 
for IFNAR in SEA-specific Th2 induction in vivo, it was intriguing to find that Th2 responses 
in S. mansoni mice were limited in the MLN but not the liver. It could be hypothesised that 
the deficiency in Th2 induction is restricted to lymphoid organs where GM-CSF plays no 
role in DC homeostasis (Kingston et al., 2009; McKenna et al., 2000), whilst Th2 
responses remain unaffected in peripheral tissues, where GM-CSF is required for the 
maintenance of DC populations (Greter et al., 2012). Further work is needed to examine 
the Th2 response in a broader range of tissues, in both S. mansoni and H. polygyrus 
infected mice, to test this hypothesis. Analysis of the phenotype and function of DCs from 
infected IFNAR-deficient mice is also required.  
 
If IFN-I is involved in the maintenance of DCs in lymphoid organs, this may explain why 
Th2 cytokine levels were reduced in the MLN. The flaw in this hypothesis is that (GM-CSF-
dependent) DCs migrating from the tissue are almost certainly involved in Th2 polarisation, 
so would a deficiency in LN DC function impact greatly on the development of the T cell 
response? It has been shown that resident DCs within the T cell zone can take up soluble 
Ag that enters from the afferent lymphatics, and prime early T cell responses, before Ag-
loaded migrating DCs arrive in the dLN (Iezzi et al., 2006; Sixt et al., 2005). This has been 
demonstrated using fluorescently-labelled synthetic Ag (Sixt et al., 2005), but also during 
Leishmania infection (Iezzi et al., 2006). However, in both settings this phenomenon 
occurs very early, within 24h of Ag administration/ infection. One may expect by d42 of S. 
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mansoni infection that any early deficit in Th2 development would be overcome. It has 
been shown during helminth infection, that IL-4 signalling is diffuse throughout the reactive 
LN (Perona-Wright et al., 2010), which likely sustains Th2 induction. Whether DCs are 
involved in the propagation of the IL-4 signal has not been addressed. However, if LN-
resident DCs are involved, this response could be abrogated in IFNAR-deficient animals, if 
DC function in the LN is curtailed in the absence of IFN-I signalling.  
 
Studies have suggested that during helminth infection and allergic responses, a proportion 
of Th2 cytokine-producing cells in the reactive LN are Tfh cells (King and Mohrs, 2009; 
Liang et al., 2011). It has been demonstrated that during T cell priming in the MLN, Tfh 
and gut-homing T cells (expressing the gut-homing integrin α4β7) are generated as 
separate subsets (Cucak et al., 2009). The α4β7+ T cells, but not Tfh, rapidly exit the MLN 
following priming. The authors demonstrate that priming of Tfh cells is dependent on DC 
expression of IFNAR, as DCs require IFNAR expression in order to produce IL-6, which 
mediates the development of Tfh cells (Cucak et al., 2009). This would fit with our finding 
that the Th2 response in the MLN during S. mansoni and H. polygyrus infection is 
selectively affected by IFNAR-deficiency. To investigate this, future experiments should 
examine whether Tfh cells (CXCR5+ ICOS+ PD-1+ T cells) display a selective deficiency in 
Th2 cytokine production in the LNs. If Tfh responses were affected, we would also expect 
to see an impact on the development of humoral responses, which we are yet to address. 
 
We have suggested that IFNAR-deficient DCs may be unable to prime Th2 responses due 
to defective migration. As outlined above (Section 2.2.2), ligation of IFNAR leads to the 
activation of the Rap pathway, which is essential for effective DC adhesion and migration 
to the dLN (Katagiri et al., 2004). In IFNAR-deficient mice it is possible that activation of 
the Rap1 GTPase and its effector proteins would be abrogated, leading to defective DC 
mobilisation. This would certainly impact on the induction of the immune response during 
helminth infection. 
 
The drawback of investigating the role of IFN-I in complete IFNAR-deficient mice is that it 
is difficult to pinpoint which cell type(s) require IFN-I signalling for optimal Th2 induction to 
occur. Although IFN-I impacts on DC phenotype and function (Ng and Gommerman, 
2013), which influences T cell responses, it can also act directly on T cells (Tough, 2012), 
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as well as on other immune cells, including MΦs, B cells and NK cells (Cervantes-
Barragan et al., 2007; Kiefer et al., 2012; Mizutani et al., 2012). For this reason, the impact 
of IFNAR deficiency on the function of other cell types should also be considered.  
 
One aspect of immune cell function that may be altered in the absence of IFNAR is the 
controlled movement of cells in and out of lymphoid organs. IFN-I is involved in limiting 
immune cell egress from LNs - activation of IFNAR on the surface of leukocytes leads to 
the upregulation of CD69 and the consequent downregulation of S1PR1, preventing 
leukocyte exit from the LN (Cyster and Schwab, 2012; Shiow et al., 2006). In the absence 
of IFNAR, lymphocyte egress may be enhanced, resulting in a reduction in the proportion 
of Th2 cells that remain in the lymphoid organs. As well as being active in DCs, the Rap1 
pathway is also involved in the upregulation of LFA-1 following ligation of the TCR, 
allowing arrest of T cells and formation of the immunological synapse with DCs, as well as 
effective migration (Ebisuno et al., 2010; Hogg et al., 2011). If the Rap1 pathway is 
defective in the absence of IFNAR, this will likely affect the function and activation of T 
cells, as well as DCs. 
 
This does not rule out a role for DCs in this process, however, as they may act as an 
important source of IFN-I in this setting. Thus, it is necessary to further investigate the 
requirement for IFNAR on myeloid cells and T cells. This could be done by selective 
deletion of IFNAR expression on T cells or CD11c+ cells, using CD4- or CD11c-cre mice 
crossed with IFNAR-flox animals. In the absence of these models, mixed chimeras of 
CD45.1 WT: CD45.2 IFNAR-deficient BM would allow us to study IFNAR-deficient DCs or 
T cells and sort them for functional assays, whilst all radioresistant cells would be WT. This 
approach would enable assessment of the activation phenotype and priming ability of 
IFNAR-deficient DCs from S. mansoni infected mice, and the investigation of IFNAR-
deficient T cell cytokine production/ proliferation. Initially, it would be informative to 
examine the expression of CD69 and S1PR1 by different cell populations in the LN and 
peripheral tissues during helminth infection. It is also necessary to assess the proportion of 
T cells producing Th2 cytokines in the LN of IFNAR-deficient mice during infection by ICC 
or using cytokine reporter mice, such as KN2 mice, to assess IL-4 production (Mohrs et al., 
2005), and IL-4/ IL-13/ IL-10eGFP mice to measure mRNA levels of these three cytokines 
(Kamanaka et al., 2006; Mohrs et al., 2001; Neill et al., 2010).  
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If IFNAR were required to maintain T cells in the dLN, what effect would this have on the 
Th2 response in the tissues? It is possible that the Th2 response would be amplified at the 
tissue site due to an increase in the number of Th2 cells there. We do not yet know what 
impact that would have on immunopathology or the outcome of infection. Or alternatively, 
a reduction in the Th2 microenvironment in the dLN may have a negative impact on the 
longevity of the Th2 response overall. These are all interesting questions to which we do 
not yet know the answers but could be addressed experimentally by a more extensive 
characterisation of the Th2 response in the peripheral tissues and LNs, as well as 
assessment of the pathology and survival of IFNAR-deficient mice, at later timepoints of 
infection. This is also crucial to address the timing during helminth infection when IFN-I 
and IFNAR signalling impacts on the immune response. Our gene expression data from S. 
mansoni infected livers suggests that IFN-I is upregulated at the induction of the dominant 
Th2 response (d42), but also much later during infection (d105)(Fig. 5.5). Further analysis 
of systemic IFN-I at different timepoints of infection will also be informative on the timing of 
IFN-I activity. 
 
The suggestion that DCs may be an important source of IFN-I that influences T cell 
function and migration is difficult to address, as it is not yet possible to delete all IFN-I 
subtypes simultaneously. However, early induction of specific IFN-I subtypes – particularly 
IFNβ – acts in a positive feed-forward mechanism to potentiate IFN-I production via 
activation of IFNAR (Sato et al., 1998). Thus, it has been shown that deletion of the IFNβ 
gene can abolish IFNα induction (Erlandsson et al., 1998). It has also recently been shown 
that the tyrosine phosphatase PTPN22 positively regulates IFN-I production by association 
with TRAF3, and deletion of PTPN22 abrogates IFN-I production downstream of TLR 
ligation (Wang et al., 2013). Thus deletion of IFNβ or PTPN22 could provide models to 
assess the importance of IFN-I production by DCs. However, this would require DC, or at 
least CD11c, -specific deletion in order to show that DC production of IFN-I is required for 
Th2 induction.  
 
If IFN-I is required for optimal Th2 induction in vivo, this may also have therapeutic 
application, particularly for treatment of aberrant Th2 responses. Blockade of IFNAR could 
be used to limit Th2 activation in allergic individuals who suffer from asthma or food 
allergies. This would likely depend on first showing that IFN-I is important in the 
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maintenance of Th2 responses, as well as induction. However, it is likely that inhibiting 
IFNAR long-term would also have bystander effects on the development of immune 
responses against pathogens, particularly viruses. The key to this may be a very targeted 
management of the IFN-I response. If the specific IFN-I subtypes involved in the 
orchestration of the Th2 response could be identified, then it is conceivable that these IFN-
I subtypes alone could be inhibited, ideally leaving anti-viral and anti-bacterial responses 
intact. For this to be possible, we need to identify which IFN-I subtypes are activated by 
Th2 Ags. A starting point for this is to use microarray analysis of FLDC subsets to identify 
the IFN-I genes activated following exposure to SEA. Further development of this 
approach would include analysis of IFN-I gene expression changes of murine BMDCs 
stimulated by allergy-associated Th2 Ags, such as Derp1, from house dust mites, followed 
by analysis of IFN-I gene expression by human DC subsets in response to Th2 Ags.    
 
As yet we have been unable to establish whether IFN-I is active during human S. mansoni 
infection. However, given that systemic IFN-I is not easily detectable, even at the peak of 
viremia during virus infection, for example HBV and HCV (Stacey et al., 2009), it is 
perhaps unlikely that a systemic IFN-I signal will be detectable in sera during helminth 
infection. In light of this, it is perhaps also unlikely that we would be able to detect IFN-I in 
the serum of those suffering from aberrant Th2 responses, such as allergic and atopic 
individuals. In our preliminary experiments, we have so far failed to detect IFNα secretion 
by human blood DCs from Western donors following exposure to SEA. Nonetheless, we 
remain excited by the prospect that ISGs are induced in human DCs in response to SEA. If 
we were able to identify an SEA-specific ISG signature from human DCs, this would open 
up an interesting area of research for characterisation of the IFN-I response by human 
DCs exposed to Th2 Ags. It would also be interesting to investigate the IFN-I signature of 
DCs from healthy donors exposed to Th2 or TLR Ags, and compare and contrast this 
response to those of DCs from helminth infected or atopic individuals – does a pre-existing 
Th2 environment alter the IFN-I response of human DCs? 
 
Whilst work continues to establish the role of IFN-I in the development of Th2 responses, it 
is important to emphasise the value of using Flt3-L dependent BMDCs to study the 
recognition of helminth Ags. This method of DC differentiation adds a layer of complexity 
to all studies, due to the heterogeneity of the cells generated. However, this is also the 
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strength of this model, providing large numbers of cells for study that have clear in vivo 
counterparts. We have corroborated findings from GMDC studies that first highlighted the 
importance of MHC II and CD40 for the initiation of SEA-specific Th2 responses 
(MacDonald et al., 2001; MacDonald et al., 2002c)(Fig. 4.4). But we have also identified a 
potentially important role for IFN-I in Th2 induction. We are hopeful that further studies 
using FLDCs will also complement in vivo experiments investigating the contribution of the 
different DC subsets to Th2 priming in response to helminths.  
 
7.4 Tissue-resident DC subsets in the orchestration of S. mansoni-specific 
Th2 responses 
The intestines and liver are two tissues that are directly affected by egg traffic during S. 
mansoni infection, and a balanced Th2 response is essential at these sites to prevent 
severe morbidity and immunopathology (Brunet et al., 1999; Brunet et al., 1997; Fallon et 
al., 2000; Hoffmann et al., 2000). Whilst there is a growing understanding of the roles of 
intestinal DCs in maintenance of tolerance in the steady state (Coombes et al., 2007; 
Jaensson et al., 2008; Scott et al., 2011), and the development of Th17 responses during 
infection with pathogenic bacteria (Persson et al., 2013; Satpathy et al., 2013), nothing is 
yet known of the role of these cells in the induction of Th2 responses during helminth 
infection. Characterisation of the intestinal DC subsets during S. mansoni infection has 
demonstrated that increasing egg load in the tissue altered the phenotype and make-up of 
the DC compartment. This included a downregulation of activation markers and a 
reduction in the proportion of CD103+ CD11b+ DCs present in the SI LP. We have also 
shown for the first time that CD11c+ cells are required for the development of an S. 
mansoni egg-specific Th2 response in the intestine, following subserosal egg injection. 
These are exciting preliminary findings that suggest an important role for intestinal DCs in 
the development of Th2 responses against helminths.  
 
Future experiments will address the importance of DCs in the induction of the Th2 
response during patent infection, as well as extensive phenotypic and functional 
characterisation of the DC subsets found in the LP, intestinal lymph and MLN during S. 
mansoni infection and following egg injection into the intestinal tissue. There are a number 
of useful depletable mouse models that can be used in this context. Initially, we plan to 
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expand our preliminary data from subserosal egg injection in CD11c-DOG mice, 
characterising the Th2 response in the LP of these mice following egg injection, and 
investigating Th2 development in the MLN and LP during patent S. mansoni infection in 
this mouse model. Given that the LP MΦs also express CD11c (Schulz et al., 2009), a 
general CD11c-depleting model is not ideal for studying the role of intestinal DCs in the 
induction of Th2 responses. In order to more specifically address the role of cDCs we plan 
to use the zDC-DTR bone marrow chimeras to selectively deplete Zbtb46-expressing 
cDCs (Meredith et al., 2012). Use of Batf3-deficient mice will allow us to address the 
importance of the CD103+ CD11b- DC subset in the development of Th2 responses in the 
intestine, whilst the pDC-DTR model (Swiecki et al., 2010) can be used to rule out a role 
for pDCs in Th2 induction. The IRF4 (Persson et al., 2013) or Notch2 (Satpathy et al., 
2013) DC-specific knockout mice would also be useful tools to examine the role of the 
CD11b+ LP DC subsets in helminth-specific Th2 induction.    
 
In the subserosal egg injection model, we have developed an ideal model with which to 
develop our understanding of how Flt3-L-dependent tissue-resident DCs respond to 
helminth Ags, in a tissue site that is highly relevant to active infection. These studies will 
complement our ongoing work to understand the responses of splenic DCs, which are 
thought to be most comparable to FLDCs (Naik et al., 2005). Moreover, this model can be 
used to investigate the requirement for IFNAR in the optimal function of DCs and T cells in 
the development of egg-specific Th2 responses.  
 
7.5 Conclusions 
At the outset of the work detailed in this thesis we aimed to improve our understanding of 
DC subset responses to helminth Ag. In the process of pursuing this goal, we have 
identified an S. mansoni specific IFN-I signature from DCs that had been overlooked, and 
have begun to address the role of this pluripotent innate cytokine in the regulation of Th2 
inflammation. We have also developed a relevant and exciting new model with which to 
study DC responses to S. mansoni eggs in intestinal tissues. Future work will provide a 
fuller understanding of the contribution of the different cDC subsets to the development 




The characterisation of helminth-specific IFN-I has the potential to revolutionise our 
understanding of the processes involved in the development and maintenance of Th2 
immune responses, and will certainly impact on how the role of IFN-I in inflammation is 
viewed in future. Whilst a fuller understanding of the specific DC subsets involved in Th2 
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Figure 7.1 A potential positive feedback loop of SEA IFN-I in the regulation of DC function. 
The potential TRIF-dependent PRRs that might be involved in the induction of IFN-I include TLR3 
and/ or a nucleic acid sensor. The CLR, CD205, is required for optimal IFN-I production. CD205 may 
activate IFN-I directly, via Syk-dependent activation of IRFs, or facilitate the internalisation of an SEA 
ligand capable of generating nucleic acid ligands for a TRIF-dependent PRR. Potentially, omega-1 
may also generate nucleic acid ligands, or, as has been reported, inhibit protein synthesis. MyD88 
negatively regulates the induction of the IFN-I response, most likely by modulating the activity of 
TRIF, or by inhbiting the activity of kinases involved in the activation of the IFN-I response. Binding of 
IFN-I to IFNAR activates the JAK kinases, TYK2 and JAK1. There are a number of signalling 
pathways that maybe activated downstream of IFNAR, including STATs or MAPKs. Gene expression 
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